<SEC-DOCUMENT>0000275053-22-000010.txt : 20220506
<SEC-HEADER>0000275053-22-000010.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220505171226
ACCESSION NUMBER:		0000275053-22-000010
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		58
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220505
DATE AS OF CHANGE:		20220505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURES SUNSHINE PRODUCTS INC
		CENTRAL INDEX KEY:			0000275053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870327982
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34483
		FILM NUMBER:		22897645

	BUSINESS ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(801) 341-7900

	MAIL ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMTEC INDUSTRIES INC
		DATE OF NAME CHANGE:	19821108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>natr-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9,d:ad9c48b421394fa9a1823d9ecbbcf337--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:natr="http://naturessunshine.com/20220331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>natr-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xLTEtMS0xLTI2NDEy_c659d8f2-ff6c-4ff4-bba4-5bd004983f4e">0000275053</ix:nonNumeric><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M180LTEtMS0xLTI2NDEy_dc5417ef-5eb5-49a3-aac5-3933babff88b">false</ix:nonNumeric><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xMi0xLTEtMS0yNjQxMg_1e0ff08f-0475-43c0-a594-cac27c9d69fe">2022</ix:nonNumeric><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xMy0xLTEtMS0yNjQxMg_9dabb3d8-2289-4c20-bed3-cc109e7e5a25">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGV4dHJlZ2lvbjpiMWU2NTI0ZjgzMDA0OWIxYTBlMWVlMjcwZWM0ODM1Yl8xOQ_3d2940bb-b113-452b-853a-00db962e52e2">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i448f69feb8bc4e458720f20bcf268a47_D20220101-20220331" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181NS9mcmFnOmRhODc3M2U4Njg0MDQ1NDM5NGRhY2M3MTUyMGQ4MzQxL3RhYmxlOmQ4YzEwYTUyZGY2NjRhMTI5ZDU2ZmIzYzhjY2Q5OTRkL3RhYmxlcmFuZ2U6ZDhjMTBhNTJkZjY2NGExMjlkNTZmYjNjOGNjZDk5NGRfMS0xLTEtMS0yNjQxMg_9775ccef-1f10-4d37-a78d-0580e0d6208d">1</ix:nonNumeric><ix:nonNumeric contextRef="iba97bd86e7444e189f6fc7c93415f216_D20220101-20220331" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181NS9mcmFnOmRhODc3M2U4Njg0MDQ1NDM5NGRhY2M3MTUyMGQ4MzQxL3RhYmxlOmQ4YzEwYTUyZGY2NjRhMTI5ZDU2ZmIzYzhjY2Q5OTRkL3RhYmxlcmFuZ2U6ZDhjMTBhNTJkZjY2NGExMjlkNTZmYjNjOGNjZDk5NGRfMS0yLTEtMS0yNjQxMg_5921de9b-14a6-417d-9f3a-16e43ae768d2">1.25</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="natr-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ife753c21309348fa8d87e87158807672_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e35948f90de4e4bb885b253907321af_I20220422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ibd8f983b74df47e39a31782e54a1f453_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31118a41ac734f62a4a1b223c11d6388_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc00c0e066e415d97d748896c5b8293_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f80a190c774d68a92e8b1a2f88a5f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i970a18ecde554037990417bc451e2bc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f415b4db8b944d0bed042261b480afe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52ca8da5fb054fc793d0133a79547e2c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a816cff4a849aaa6899e1a2e2b5469_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia64394d8f9e149c48e32b4bf254c70b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5959344c8c8242509d2162698de11ad8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319e38ef94554c4bbee57b4e16105332_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i986b0412b49f48f7af2e01731e0207b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2815e28e436f4c61a00dc75c638b512e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i526c00954e5344319ba34979f1995514_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbf75a7daef4a46879cb80474d10c34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dda98afbcfa4f93969fa231b6d7ad7a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac093d990f747789ddc5622c8faa200_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8da7b722ce504d7796cf25d0a7d834cc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809568b0c3fe4247b38fd5463e2a656e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5065f6df791f4c01b3fd8c6ab8e971b1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib43f287504274318bf963d9a1d66f50f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcbc2254a9ff457793b34cf0b849506d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1a3638bc5e548b6aa731778d987df88_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58339cf767784484935089232da792c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-07-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3b028273b4499fa40faa68a39ebd4c_I20200611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="borrowing"><xbrli:measure>natr:borrowing</xbrli:measure></xbrli:unit><xbrli:context id="i9eebe4f1416a42e29600fbc080b00ddd_D20210308-20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-08</xbrli:startDate><xbrli:endDate>2021-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id926898d6fa64913b3ef9123f02f63cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69bfe93049647898e279137e36c29b1_D20210308-20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-08</xbrli:startDate><xbrli:endDate>2021-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32456aa4ccc64830b04647560160366a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0f1c76f2c54a56b68ab99720f974d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a5b6c9fc5c4a5c86741daebd2c055c_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia98eed0936e6455f8174af8a8890d1db_I20201119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d4e839e771459aa39d3689d857e1a9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c09354038642f186df2d18e5450419_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>natr:payment</xbrli:measure></xbrli:unit><xbrli:context id="id76496067c7b4d3f8bd85db3b5f95257_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if98b729b54f5451a829590e8adb58f29_D20210405-20210405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-05</xbrli:startDate><xbrli:endDate>2021-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id691a4ef66cf4da3b988bfbf06a2e811_I20210310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78adc08e7232473a933e1ecb19fbb047_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i555b079af2a941c182b57bfc82a439aa_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie914eddd4e9943539c51b78d2f72072b_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8f4fc34bae44f3a7053951f910b3b8_D20210505-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-05</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bf0a2bb87c04726b85a12b3aaf47333_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2766fa78dc664de49f98b43876ee0fd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402b0314d6b84b1480d0e6192c468f66_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398a4c632e9146b6a4117e9a80bd1b33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402ed898554945f59d3dcb7c9d4b63e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb365d93fed48cdb727939977fc3c22_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd7c968f4df4cc0aa01a09c2a2a9125_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if832daaf3a78404e9c159a19b9debf45_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72899eeeac6488c866c2c21e97909de_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b74d788af4647368d8064fe930b3af7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4ec581d7e641179b6e6d5671e479cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a5b39487154954983fee65eae72369_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3da7c00ee4b94166b3df419f56670028_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabbe644ac11048d2b710f145d0c3929c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87d18bc3f9040428d9eb9ea8d77994f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i348578201c544d8e9d4c3798b278b2fb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cc4557e1f545e1bc22ad3695e0973d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448f69feb8bc4e458720f20bcf268a47_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba97bd86e7444e189f6fc7c93415f216_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>natr:segment</xbrli:measure></xbrli:unit><xbrli:context id="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92527f12c51f48969241c6c015177b7e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i831c92eb3b70497eb880571439797b1d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia99ab0f2e60446ec842d8b9c7ecedda2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc50e572e4748939b523aac9f92ce3d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3833f589148a4227b4f5c984f8f200b8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aaa533e28334f489d7076c39dd1673d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d1d57f3f4a34ccdb3dbce4533de6401_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idadda0b851c948ef9359bd2d2b89e394_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b65a6d4edb47548db956eb75ac2c69_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i348e6e2f93764613b3bd554e1ef83f4b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0bf1d17dbb48cbb44d363a39cecd6c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17bade993e50434bb25d5592094f26be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8912512957214830a709fb3a0e5f6bca_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i923224bdda5a44f6b1fd81e1e95c68ad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9a2377c670243d1a78c141cc8e41170_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60c19c5ef2943ab9963e5ff0b52a2c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1318988169ff4f8fa5244b15ab3b8c19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d7e87cbccf44fda7f9f4bb20e905bb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910fb20292ee451c8d13d76fb72f1bc6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29ee274469924f98ad71b11264e3aac2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2afe0a2304a4456866df0c569f0b79b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94732c9a5ab84a539cf8295a1bee383e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e28facca7c94a3bb9ef0cbef288a9b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9d61c288624d7199064cf8381fb74c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c4bae86f8b4368a604018a81f2ec34_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70cbed7bb9954b1f8cd165f5e0ec7a32_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fe7c8a0e454ba181e8aa0117c5fe76_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902dbfce0d3d416f9e765b1c3e2da20f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a00e56648394275b3210882faf90e94_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c3f3a5a15141889d6b30d587478d20_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc88af59d684d87a1010641a53f8b29_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia25d2edee7b64a6ebb0b481f7c617554_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2358ce4157b4456ae0ba519086bc059_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40834fd02559432dae656ae4e9cde9f0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec47376a16843fe8b7959468e821063_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ea609d840d4bfcb6ac425813487379_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i767402ab744647ed99b96582c5beb3a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8732a9aa67884481b06822950adac68e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic15ce45b151e4a20adb9f451c3673c19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f5284ee739d4941a2c520f0a501c89e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c8d01d2a81452f8df2e915edc4269e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bf5d682a21749498e82089f8cad3646_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4908295d328c4841a2ee03a0b1ffd3d7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de4b6373eea45468e42ddd4316cd664_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i378b6704092a4d50ac575936de66eff3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d963c459ab44b6e925d88b0342277cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325b7a5fd36c4fe28941bfaf3f5e55f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2c0ce3a35074fb4a5417b00b210d23e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2e0b295afa4d06a33d1a682c00dbbf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2418e36a7c6d4b968097a27d457f9a08_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e927aab10b4984bee8f3006640dc63_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68972e27e09c468e998db2ff4a112ecd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ce4108dd6004d9f97aa7f7a7ed76e7d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0b0ebd208da4867a5672633b3762f8d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33417330f8f488c995347b902948643_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e313090407494ba9488fe56934f695_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23f702f0295049a28cbcdc8b4d1ef74a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f14deead68345519312a61e7ae03e71_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86021b8e2ac744dbb42d13876c378755_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ba4d14830043cfa540bfed1414f780_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004217ff71f5450a9f97499b3ad9bcf9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b1e426e6e414937a5f77169261c768c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0831f06411dc477198d772b8a9a9e543_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea186633b504a27ba220e6cfcd61edb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47363d5359bd46939ab4fc9af1589e6b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac919f4f48d240ed91a334c82ccd8334_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfaaa60da1b043588f9fae53b220069c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4376d08163e3452aa8513d7ff8613dc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i281b77f20968487b8373b3b9e315c30b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e8dbc545c204454955aab73bf9e460f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dff93085c7f44fa956bd391f58b99df_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>natr:claim</xbrli:measure></xbrli:unit><xbrli:context id="i1aa91f25a9b349ef8fdaee1bfeda71ee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4dd6c147114968863a0c8456478780_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f362c72e29e4ee8ad5ec7c2dfb61c74_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89e37a274af4cee94ebef8056298d53_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac3fd88adf7d4e73bafc50be57cbaef2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i492c57a6f9d046bda2bbdd0115e8fa08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icefc00db041a48d4a92bfbe7b4e5ad25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09a9560c1ee743039cb31edafc3294ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id57f2be0493944f4be377552827b560e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf7ca29b6fc94c6dbdc1652525619cd1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f9df89d786a41e0b3d144f941fc5d32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3d962215954cc8a9171fdd8505b3ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72fa1124277f415fb68c710bb5c87c6c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ffa4204f2244033a6387741823b1eea_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6210ad9bf96e4639909b9ee6ec5f0dee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9172a343a5724170828bcc1c87deb05b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieae5488b942241ffb6afa51639ffba10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e1cf8cd79b489185a71063b36e1414_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78f626536d54b3ca22aa7de05ba6475_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c874d0d851496d8d0b2cad723434c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0d3c071a9749e19577e2b5b5623c3f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5996eefda0d54ab59124aeaee9125db4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaaf9feba842448992af5440ff1e9ca4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60740a0aa42458e9145ad1c8f41c4a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11fc7a1040844bd1a53ed85f210878e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444dd1d44ce74fcb94a32f106266e541_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i067bf9020abe410db4a9808337bf4f61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21defeb3de3d4f229983ffbf2177bdbf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="loyaltypoint"><xbrli:measure>natr:loyaltyPoint</xbrli:measure></xbrli:unit><xbrli:unit id="productcategory"><xbrli:measure>natr:productCategory</xbrli:measure></xbrli:unit><xbrli:context id="i838fe1c774584db3baff30093827a885_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_1"></div><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNTM_7ae6eec9-a419-4bfc-97f4-2c61b7ecf9aa">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNzA_09462d8a-2f14-4bf3-84b2-6b39c1265967">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160; QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yOTc_26462779-5edf-476c-9331-03b1a26ddcdf">March&#160;31, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8zMDg_98f32ccd-815a-40a3-b9e7-3cdd34075adc">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160; TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF80OTI_667d84c3-3caa-4dbd-bbaa-83acc88c864e">001-34483</ix:nonNumeric></span></div><div style="text-align:center"><img src="natr-20220331_g1.jpg" alt="natr-20220331_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF80OTg_b43beb0b-5119-4704-9b94-143bc936deaf">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ODMzYzgzMjI1YjFjNDc1NGE1ZDAxNmYyY2YwODE2MjgvdGFibGVyYW5nZTo4MzNjODMyMjViMWM0NzU0YTVkMDE2ZjJjZjA4MTYyOF8wLTAtMS0xLTI2NDEy_ed837950-e7d7-4647-804b-3a1c8258eb74">Utah</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ODMzYzgzMjI1YjFjNDc1NGE1ZDAxNmYyY2YwODE2MjgvdGFibGVyYW5nZTo4MzNjODMyMjViMWM0NzU0YTVkMDE2ZjJjZjA4MTYyOF8wLTItMS0xLTI2NDEy_db7854ce-43de-4729-98a7-6cc3ad87249a">87-0327982</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NjA_40abeaa3-d1cd-4743-8d15-2e176499a465">2901 Bluegrass Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NjQ_d7258744-7961-4dda-96a1-3500eb487aa1">Suite&#160;100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81Njc_f9fb570f-2e2c-457b-bfa1-7f40b77dd4ef">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NzE_f3430beb-4bd8-45b4-9c3c-e55f2acfb8fd">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NzQ_d3a99486-6966-4314-bb35-734a271999a1">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF82MzQ_cd8360a7-e5b0-4587-b1a7-92e9f11cdf02">801</ix:nonNumeric>) <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF82Mzg_08588c83-132d-4e64-b3ac-38ce89d63d5a">341-7900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTAtMS0xLTI2NDEy_51384170-7017-4296-9cbb-d5c61b89fb62">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTEtMS0xLTI2NDEy_19c13c85-d11d-42d5-9c94-6552f9bfc6d7">NATR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTItMS0xLTI2NDEyL3RleHRyZWdpb246ZTc5MDYwMmM2ZWVmNGQxYzhlNDYzM2E3M2JmMjJiMjlfNA_28c3bb6f-306e-4c1a-8f62-ffdaecae4623">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant; (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xMTMy_2e5e50e9-860a-4223-84a0-d996c7e67256">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNDU4_70441151-89e7-46ec-95b4-b89af0bb13e9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and an &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml8wLTItMS0xLTI2NDEyL3RleHRyZWdpb246YzI1MWVkNWU5NGNhNDhiOTk3MDA4MjhiZmZkMDMwODBfNQ_97a3e2cf-5c4e-48f7-b50b-9d88f2ff61b6">Accelerated filer</ix:nonNumeric>&#160;&#160;&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml8yLTItMS0xLTI2NDEyL3RleHRyZWdpb246YzYwNmJjZjQ0YjU2NDI5ZmExZDQ3MGEwOTE3NWYzZDlfMzE_183ba83c-b621-4f66-b266-e6031df2d55b">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml80LTItMS0xLTI2NDEyL3RleHRyZWdpb246MTgzMThhMWYxMDA5NDhkZWI3ZDUwMTZmOTY4NDc1MDVfMzA_8c78b5cc-93a8-4ac7-a54d-36c5ec91ad99">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yMzAy_cc3ce416-f97c-4999-ad6d-1d32c163a5fc">&#253;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of Common Stock, no par value, outstanding on April 22, 2022, was <ix:nonFraction unitRef="shares" contextRef="i1e35948f90de4e4bb885b253907321af_I20220422" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yMjkx_9d941b53-97d0-42fc-aa13-bc7d86e3bf9e">19,474,806</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended March&#160;31, 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_13">Part&#160;I.&#160;Financial&#160;Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_22">Condensed Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_22">O</a>perations</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_25">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_28">Condensed Consolidated Statement</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_28">s</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_28"> of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_76">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_79">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_79">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_79">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_82">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_82">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_82">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_85">Part&#160;II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_85">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_88">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_88">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_88">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_91">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_91">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_91">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_94">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_94">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_94">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_97">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_97">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_97">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_100">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_100">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_100">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_103">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_103">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_103">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_106">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_106">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_106">32</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information included or incorporated herein by reference in this report may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. For example, information appearing under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; includes forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are more fully described in this report, including the risks set forth under &#8220;Risk Factors&#8221; in Item 1A, and in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021, but include the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">extensive government regulations to which the Company&#8217;s products, business practices and manufacturing activities are subject;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">legal challenges to the Company&#8217;s direct selling program or to the classification of its independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">liabilities and obligations arising from improper activity by the Company&#8217;s independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">product liability claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Company&#8217;s ability to attract and retain independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the loss of one or more key independent consultants who have a significant sales network;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Company&#8217;s joint venture for operations in China with Fosun Industrial Co., Ltd.;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the effect of fluctuating foreign exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">failure of the Company&#8217;s independent consultants to comply with advertising laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes to the Company&#8217;s independent consultants compensation plans;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">geopolitical issues and conflicts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">adverse effects caused by the ongoing coronavirus pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company&#8217;s customers to purchase products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks associated with the manufacturing of the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">failure to timely and effectively obtain shipments of products from our manufacturers and deliver products to our independent consultants and customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in tax laws, treaties or regulations, or their interpretation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">cybersecurity threats and exposure to data loss;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">reliance on information technology infrastructure; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the sufficiency of trademarks and other intellectual property rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this report. Except as is required by law, we expressly disclaim any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this report.&#160;Throughout this report, we refer to Nature&#8217;s Sunshine Products,&#160;Inc., together with our subsidiaries, as "we," "us," "our," "our Company" or &#8220;the Company.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMy0xLTEtMS0yNjQxMg_d67cdeb7-059e-4a76-a402-79a91d8538be">66,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMy0zLTEtMS0yNjQxMg_679ed119-5751-430c-b0fa-49e492750df4">86,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0wLTEtMS0yNjQxMi90ZXh0cmVnaW9uOjFkNGZhNjIzMjgxZTQzZDA5Y2U4OGUwMWYyY2YwOTMyXzY3_aa1a8b87-b17b-408f-a6ae-9cd5fffee7ac">148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0wLTEtMS0yNjQxMi90ZXh0cmVnaW9uOjFkNGZhNjIzMjgxZTQzZDA5Y2U4OGUwMWYyY2YwOTMyXzc0_32822031-3ed0-4983-8175-bf8c19610526">143</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0xLTEtMS0yNjQxMg_9588d517-afa4-4e48-9c88-9d4993443dce">7,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0zLTEtMS0yNjQxMg_d7e99f65-e36d-4554-ac75-9ea70e51bdbe">8,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNy0xLTEtMS0yNjQxMg_976165a8-3345-40fa-b516-0c421e7f3553">63,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNy0zLTEtMS0yNjQxMg_f7b9c587-dc5e-4761-bfc9-4d6e585b44c1">60,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOC0xLTEtMS0yNjQxMg_0c76eb80-68eb-4b57-b033-45cd033408be">10,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOC0zLTEtMS0yNjQxMg_3f4ebaa0-398f-4cb4-af11-991bcdb93263">8,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOS0xLTEtMS0yNjQxMg_1f19f7c9-249b-425b-9d54-32903467afbb">148,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOS0zLTEtMS0yNjQxMg_b9665b13-781e-4ec0-b257-995d010a0b12">164,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTEtMS0xLTEtMjY0MTI_36225e4a-b882-4bca-b418-075b1d57a58f">49,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTEtMy0xLTEtMjY0MTI_7bd173d1-c8f7-4107-b0ec-90679bcfb0c4">50,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTItMS0xLTEtMjY0MTI_d2a05a7f-029b-4c22-8801-df375f106c0e">18,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTItMy0xLTEtMjY0MTI_89f99c0d-7fdb-4b17-b625-15c5057eea3f">18,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted investment securities - trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTMtMS0xLTEtMjY0MTI_2940915b-8085-4978-98db-2aedefc65a03">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTMtMy0xLTEtMjY0MTI_af07bae2-c69f-472a-adb3-52e035b76261">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTUtMS0xLTEtMjY0MTI_8217b49f-c5bd-4168-a654-50b6c02d7640">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTUtMy0xLTEtMjY0MTI_745b2392-40dd-4bc7-b2ce-51ddcb303420">13,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTYtMS0xLTEtMjY0MTI_f6147668-d499-453f-9f54-11dafbaa694d">10,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTYtMy0xLTEtMjY0MTI_e9c02d6d-33a1-4d11-bb6b-905957364c9d">10,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTctMS0xLTEtMjY0MTI_3946c213-a275-49a0-9d2b-4840f6c57860">238,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTctMy0xLTEtMjY0MTI_a66bb994-d864-424b-af95-5bad5f341be3">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjEtMS0xLTEtMjY0MTI_effd3d13-4410-488f-b13a-5fc8f42389a3">8,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjEtMy0xLTEtMjY0MTI_309b8736-9c32-4168-9e0c-b7fce0062a92">9,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjItMS0xLTEtMjY0MTI_f1c86ac7-e6c8-4a86-b72d-187a9acfb24b">22,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjItMy0xLTEtMjY0MTI_e3958bd2-442d-4894-a7f1-1384fe95f611">23,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjMtMS0xLTEtMjY0MTI_5f7764e5-b15f-4d79-b347-237d5ae1e2b2">26,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjMtMy0xLTEtMjY0MTI_dc155d88-25fc-49e9-bdc5-03f3913ced7b">31,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjQtMS0xLTEtMjY0MTI_4bcc1c71-6a0b-4951-bbce-442bf6ccdbbd">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjQtMy0xLTEtMjY0MTI_2c72fb2f-d011-4dbc-a249-481979828bf4">3,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjYtMS0xLTEtMjY0MTI_0df78b30-78f5-410c-9fc8-f18e7672a6e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjYtMy0xLTEtMjY0MTI_223f1152-01ac-4ff7-b19d-deda46be2e62">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjctMS0xLTEtMjY0MTI_1db202d1-1939-4c4e-af86-662834b86069">2,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjctMy0xLTEtMjY0MTI_8a1062a2-cb54-4f6b-ae42-7b952620a7e3">2,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjgtMS0xLTEtMjY0MTI_2aa54291-e375-4a5a-b12d-c44de1a1b89e">4,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjgtMy0xLTEtMjY0MTI_c995590c-20a8-4c1f-bcd2-f8668ee6cfde">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt and revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjktMS0xLTEtMjY0MTI_929d3536-5702-41d1-b179-08019f488fce">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjktMy0xLTEtMjY0MTI_56e5a0ee-88e8-4aed-9aa7-c95d12bbf91f">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzAtMS0xLTEtMjY0MTI_1982da5e-5024-4fb1-b63e-90c9a3f2b270">68,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzAtMy0xLTEtMjY0MTI_76781082-9a85-4011-9caa-7443355f2b71">76,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzMtMS0xLTEtMjY0MTI_228de190-2d67-447f-a707-1471a18fff66">16,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzMtMy0xLTEtMjY0MTI_0fd8cb1f-3ff4-4b30-adc3-68875dfd0919">15,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzUtMS0xLTEtMjY0MTI_0d29d14d-5878-4726-abb7-b9b25eb79d66">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzUtMy0xLTEtMjY0MTI_a0dcc3bd-05fd-4292-90d5-480673253f5e">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzYtMS0xLTEtMjY0MTI_59553de0-860d-4bc4-98a3-9f9b947401f7">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzYtMy0xLTEtMjY0MTI_07b0078c-6df4-415a-9ac3-34ce02a78a9d">964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzctMS0xLTEtMjY0MTI_77e78ab4-f703-4a7b-b9d7-14e73c9e7666">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzctMy0xLTEtMjY0MTI_0b221b30-dadf-4243-922c-ed92703c3685">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzgtMS0xLTEtMjY0MTI_93454b47-49db-45a5-a5e2-6bc47f14704d">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzgtMy0xLTEtMjY0MTI_90a725fa-9ecd-4886-84ca-2bc04694e725">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzktMS0xLTEtMjY0MTI_3b9c8255-ad43-4c8f-978e-56d9eeafd39a">88,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzktMy0xLTEtMjY0MTI_249e76f2-20dd-4010-b7e4-cc1e50382a79">97,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="usdPerShare" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8xOA_725c982c-fd21-4d46-9d6e-c44b2d546460"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8xOA_83f5fd96-3b8e-497c-ad23-993f49dff336">no</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8zMg_944d39c0-1db8-46df-be0f-e39e59ff46ef"><ix:nonFraction unitRef="shares" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8zMg_e315809b-ecf3-4423-b5d9-529aeb02c666">50,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV81NA_1e9a5a53-6f7c-4c9f-a6b9-1159af5d8505"><ix:nonFraction unitRef="shares" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV81NA_7674fe22-6d68-43e0-a59f-44f2b3848490">19,461</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV82MQ_05b39b5f-8df8-4d48-816f-6d8ded5a8f3b"><ix:nonFraction unitRef="shares" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV82MQ_58fdcc9c-bbe7-41af-b608-32ef914b9878">19,724</ix:nonFraction></ix:nonFraction> shares issued&#160;and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMS0xLTEtMjY0MTI_a9531793-70f1-4cc6-8159-4f66b7de5190">125,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMy0xLTEtMjY0MTI_242d09d1-a54d-46dd-86af-dfc8312c379b">133,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDUtMS0xLTEtMjY0MTI_ca15f49d-f3c5-4d21-984f-7b22fc3fa5d9">32,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDUtMy0xLTEtMjY0MTI_5a235fc0-8ffd-4a07-8e0d-1d9ea3535abb">35,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDYtMS0xLTEtMjY0MTI_b43f398a-8864-4bd2-9c2c-1492ca6cfa86">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDYtMy0xLTEtMjY0MTI_8247a0a0-9628-4908-b248-20defd19db6d">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDctMS0xLTEtMjY0MTI_88ac25fd-af1a-452b-8881-e2fb4173024e">11,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDctMy0xLTEtMjY0MTI_c30f3720-951a-49df-8cf2-3d5d7e7ca1f7">10,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDgtMS0xLTEtMjY0MTI_68da4a42-e1f4-4206-9639-41c0a3fb400a">149,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDgtMy0xLTEtMjY0MTI_d30d7363-db11-430d-8da3-e6924cf21b57">161,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDktMS0xLTEtMjY0MTI_2c8f5295-4173-47f6-a599-f70a20bd67ae">238,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDktMy0xLTEtMjY0MTI_763f3fa0-e002-40c2-867e-164213fad1d5">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except per share information)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMi0xLTEtMS0yNjQxMg_cac361a9-e31a-4271-9130-d04bf4360807">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMi0zLTEtMS0yNjQxMg_c9c0ab8e-e6fc-4e54-b0ff-32e249f900d7">102,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMy0xLTEtMS0yNjQxMg_842e4e4f-2a27-4d33-8aa9-890818304058">34,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMy0zLTEtMS0yNjQxMg_e0edeac7-5b08-490f-b8fe-5ba112f4ee49">26,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNC0xLTEtMS0yNjQxMg_5a7f361f-8179-4768-820e-d4d99bb1bc83">76,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNC0zLTEtMS0yNjQxMg_25ef8312-4df6-456e-8773-bb0f7d79a9a4">75,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNy0xLTEtMS0yNjQxMg_a2eb7f26-652b-4905-b8b0-e8dabc8e61f8">34,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNy0zLTEtMS0yNjQxMg_f9c4ec16-6870-4bc0-aaf6-16c7ead359df">34,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOC0xLTEtMS0yNjQxMg_5c6995d4-a937-4ae4-b794-2444c4ffdc5c">40,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOC0zLTEtMS0yNjQxMg_850a7a0d-102e-4dcb-868c-55f4fa00ac03">33,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOS0xLTEtMS0yNjQxMg_bd587f2a-02a4-430e-acf5-625238fbe765">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOS0zLTEtMS0yNjQxMg_dc474afa-4abc-4118-af73-cd9190960c3b">7,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTAtMS0xLTEtMjY0MTI_2c9ab3b1-6c94-4ec8-9930-85bab654900d">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTAtMy0xLTEtMjY0MTI_92dd5ff2-e32b-4474-a713-baf58bf435ed">1,933</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTEtMS0xLTEtMjY0MTI_3684f313-ce1e-46b8-b713-9e6b43b9406b">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTEtMy0xLTEtMjY0MTI_67b415f3-8cb4-438e-8f9a-6d92faeb6ea3">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTItMS0xLTEtMjY0MTI_84de36bf-bcd1-40ef-90ef-633148502043">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTItMy0xLTEtMjY0MTI_520b3ee3-fcc5-45dd-8db2-b513bb7505e6">1,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTMtMS0xLTEtMjY0MTI_35484f3c-babf-4e66-8f91-5a997a009245">2,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTMtMy0xLTEtMjY0MTI_b6792b65-a69c-47b8-bf6d-99ac98adc106">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTQtMS0xLTEtMjY0MTI_e1a7c4b9-2093-455c-b1ea-ea71558e1b1b">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTQtMy0xLTEtMjY0MTI_dced22cd-570c-4cf4-a1c5-7c63463d8d09">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTUtMS0xLTEtMjY0MTI_2ffb4d3a-dd60-40a1-a830-ac048a093a2f">2,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTUtMy0xLTEtMjY0MTI_9f8756e0-87b6-414f-80ae-0ead90e2eb20">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjItMS0xLTEtMjY0MTI_a3f245d2-f30b-4983-8489-5a21e779d16f">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjItMy0xLTEtMjY0MTI_ec424b7e-e904-415d-a4d5-c704bcf03644">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjctMS0xLTEtMjY0MTI_a3221c3a-f6fe-4044-9ab1-b3d70637f2c5">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjctMy0xLTEtMjY0MTI_9a40eb95-52dc-4434-bf19-0c0dba573d3e">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjktMS0xLTEtMjY0MTI_02a2f040-dad1-430b-9276-bd25c41b7822">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjktMy0xLTEtMjY0MTI_d2b9967b-986f-4bb4-ba0d-ba7a3621b624">19,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzAtMS0xLTEtMjY0MTI_c3e3001e-cf3e-4fef-864a-70b2a3cce133">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzAtMy0xLTEtMjY0MTI_8d6c2517-8c8c-4c40-9ca9-da7b589b1e13">20,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzItMS0xLTEtMjY0MTI_bfe66a7d-468b-48a0-bb60-4f17dd96745f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzItMy0xLTEtMjY0MTI_ce1d88f9-8e67-4668-a82e-d586878a81ba">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMi0xLTEtMS0yNjQxMg_c807112d-d4af-42d9-94ff-8f9aa7a823dc">2,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMi0zLTEtMS0yNjQxMg_bb3accd5-0809-4413-a68d-04bd5a5cc68a">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation loss (net of tax)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMy0xLTEtMS0yNjQxMg_826586bf-859e-4620-b975-4cb2778fd34c">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMy0zLTEtMS0yNjQxMg_8977d63b-1144-4d52-8ce5-331032d0eee1">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfNy0xLTEtMS0yNjQxMg_2e5d1942-0762-49d4-b85d-78766902e250">3,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfNy0zLTEtMS0yNjQxMg_75a702a8-4c4a-4c7a-8da7-a3d128fd5c5c">4,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31118a41ac734f62a4a1b223c11d6388_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0xLTEtMS0yNjQxMg_d069761c-023f-4627-af04-6be404dba436">19,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31118a41ac734f62a4a1b223c11d6388_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0zLTEtMS0yNjQxMg_cbb76be4-da6d-4187-bb19-5d6f2395179a">133,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc00c0e066e415d97d748896c5b8293_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi01LTEtMS0yNjQxMg_f4503e5a-86da-4467-bbe3-4337f6bcca28">35,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f80a190c774d68a92e8b1a2f88a5f3_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi03LTEtMS0yNjQxMg_d3629eaf-b922-4042-a7fe-72b7c67cd27d">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i970a18ecde554037990417bc451e2bc6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi05LTEtMS0yNjQxMg_277ac2ba-2546-4bb3-8540-d88b4113f920">10,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0xMS0xLTEtMjY0MTI_f75db0a9-9792-4359-9a81-df35d9e8cd25">161,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMy0zLTEtMS0yNjQxMg_cc35a446-ee61-4f79-a67f-f161d01daa0f">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMy0xMS0xLTEtMjY0MTI_d406a19c-8495-4110-b105-7907d6f15bb0">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331" decimals="INF" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0xLTEtMS0yNjQxMg_7a671045-120a-4b69-9f9b-866e47f4f02b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0zLTEtMS0yNjQxMg_b29fe60e-27a5-4701-bee0-07236415e8dc">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0xMS0xLTEtMjY0MTI_f6b2039c-8861-44f0-9cc7-8eb4ba6d29aa">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331" decimals="INF" sign="-" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0xLTEtMS0yNjQxMg_b0b6f9cd-f827-4f2d-83f6-39c65f89abbb">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0zLTEtMS0yNjQxMg_8272825b-78e7-4b43-9c02-f44de56ddc32">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0xMS0xLTEtMjY0MTI_c6793705-ad29-4f9a-aed8-7f646fc2e293">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f415b4db8b944d0bed042261b480afe_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi01LTEtMS0yNjQxMg_873d6e15-cb0b-453e-b129-0a1f35016034">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ca8da5fb054fc793d0133a79547e2c_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi03LTEtMS0yNjQxMg_685c7284-4add-45a7-9998-41c9c2524f22">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi0xMS0xLTEtMjY0MTI_55a8a1b5-7580-4903-8958-54fc4983459a">2,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0a816cff4a849aaa6899e1a2e2b5469_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNy05LTEtMS0yNjQxMg_f9691d48-f2bd-43ff-a0cc-949ecf5d7ed8">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNy0xMS0xLTEtMjY0MTI_dd6c6bae-7a6c-409d-b40a-a725a5aaf604">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia64394d8f9e149c48e32b4bf254c70b1_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0xLTEtMS0yNjQxMg_30c1090f-4312-4153-91d8-f8295eca423c">19,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64394d8f9e149c48e32b4bf254c70b1_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0zLTEtMS0yNjQxMg_ed7d858f-8207-406f-b6e8-00bf0fb6e1cf">125,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5959344c8c8242509d2162698de11ad8_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC01LTEtMS0yNjQxMg_ac83cc24-ad31-494e-b952-410954da8abb">32,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319e38ef94554c4bbee57b4e16105332_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC03LTEtMS0yNjQxMg_602c08fc-1a1d-4332-ad61-1eeb935df5e3">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i986b0412b49f48f7af2e01731e0207b9_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC05LTEtMS0yNjQxMg_2a99d23f-a0dd-440c-b54b-1564ab5a5448">11,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0xMS0xLTEtMjY0MTI_d39f728b-8613-4a97-a6de-bfa35a0b3b5f">149,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0xLTEtMS0yNjQxMg_b32520f0-60bd-4761-9369-13db39bc1da7">19,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0zLTEtMS0yNjQxMg_ea7e40ed-a699-4c64-9a22-2bf19ed0e17b">139,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2815e28e436f4c61a00dc75c638b512e_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi01LTEtMS0yNjQxMg_a7dd7b40-195d-40ad-8fbe-97bd68451f02">26,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i526c00954e5344319ba34979f1995514_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi03LTEtMS0yNjQxMg_b91feab3-9438-4c24-9844-d99161006245">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbbf75a7daef4a46879cb80474d10c34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi05LTEtMS0yNjQxMg_55760c6a-2b32-4b7b-952e-3584f7dd5a69">9,955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0xMS0xLTEtMjY0MTI_a702d322-9ee4-486c-bba4-a8c82bbf60d8">157,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMy0zLTEtMS0yNjQxMg_b6468bb9-6754-4030-9cf8-acb83aac4eaa">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMy0xMS0xLTEtMjY0MTI_67bac0f4-2b1b-474c-a8f8-c23f48db7f72">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331" decimals="INF" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0xLTEtMS0yNjQxMg_51e65296-8ff9-4200-9d8a-ba0796aa5576">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0zLTEtMS0yNjQxMg_b1635ee1-7498-4b45-9a40-262be4b39171">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0xMS0xLTEtMjY0MTI_25cabd4a-ea24-4ef1-8955-659438b63beb">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0wLTEtMS0yODI1MC90ZXh0cmVnaW9uOjMxNTg4ZDU3ZjE4MDQ0YjBiMWZhNGNkMTYzNWUwZTE3XzEyNjQ0MzgzNzE5NDY1_e7b4182c-a75b-47d7-8a01-e80b06983ce4">1.00</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS01LTEtMS0yODI1MA_78d328d2-b7ba-48b2-ae1f-6f5f4ef06d6c">19,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0xMS0xLTEtMjgyNTA_f0e246b6-7e11-44f8-970d-2a9f60a00da7">19,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS01LTEtMS0yNjQxMg_5378575b-55d4-42ec-ad06-e5b706a20a8d">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dda98afbcfa4f93969fa231b6d7ad7a_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS03LTEtMS0yNjQxMg_1b6f4903-35ab-4e9f-86e3-806e3e03ac83">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0xMS0xLTEtMjY0MTI_b93b010b-f7b7-4aff-82bb-ad21a890379a">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ac093d990f747789ddc5622c8faa200_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNi05LTEtMS0yNjQxMg_0d23b9f7-448f-451f-a9bd-ecb85dbf763f">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNi0xMS0xLTEtMjY0MTI_ad074ed7-bd79-4a69-8d42-15a576b47c83">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8da7b722ce504d7796cf25d0a7d834cc_I20210331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0xLTEtMS0yNjQxMg_455cfeaa-5f78-4322-a852-07e0d12b9a1f">19,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da7b722ce504d7796cf25d0a7d834cc_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0zLTEtMS0yNjQxMg_da4950dc-b862-40ba-b260-366e4a4bb9ee">139,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809568b0c3fe4247b38fd5463e2a656e_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy01LTEtMS0yNjQxMg_f34bbd5a-f8c0-47e7-ad9f-463fdc658fa6">10,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5065f6df791f4c01b3fd8c6ab8e971b1_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy03LTEtMS0yNjQxMg_6e9313d2-da54-42cd-b5d0-59683a87a1a4">1,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib43f287504274318bf963d9a1d66f50f_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy05LTEtMS0yNjQxMg_b73a8675-8d2b-4d64-a1a3-c7cd8c8b9ce1">10,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbc2254a9ff457793b34cf0b849506d_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0xMS0xLTEtMjY0MTI_8d8cfd8b-97cc-48ad-9421-5d8010cc8176">141,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMy0xLTEtMS0yNjQxMg_6a5e0736-9b1c-4e7d-af72-92dc2a2387e9">2,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMy0zLTEtMS0yNjQxMg_c7855323-7f40-45e5-b59d-c179bd274510">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNS0xLTEtMS0yNjQxMg_991974db-7880-41c6-9ad5-b318432f4279">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNS0zLTEtMS0yNjQxMg_13b7256e-d780-4b81-bf01-33d2cb60f4c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNi0xLTEtMS0yNjQxMg_8519aed4-3ff4-4b9f-8c31-a6a812f39019">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNi0zLTEtMS0yNjQxMg_158f8f06-55db-4090-820c-ef84d21e75a3">2,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNy0xLTEtMS0yNjQxMg_440a87e9-c94b-4814-92bd-ca4d69dba6bd">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNy0zLTEtMS0yNjQxMg_c0fde6f7-cc6e-4ce7-84fd-bb93ca6ac0e6">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfOC0xLTEtMS0yNjQxMg_d7f39df8-0c68-42a4-9eab-3dd12710f7c4">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfOC0zLTEtMS0yNjQxMg_9ceeaabf-d776-48ec-9930-01fa5460500e">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTAtMS0xLTEtMjY0MTI_2022929c-3431-484d-9f4a-752384b29129">3,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTAtMy0xLTEtMjY0MTI_8dc228c7-943e-4cb6-9802-f6a75975ee40">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase of trading investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTEtMS0xLTEtMjY0MTI_6b669e22-dbd4-40ea-9a9a-931ecff66acc">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTEtMy0xLTEtMjY0MTI_91c5ecc0-0ed2-44f0-afad-1044df2b1962">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of trading investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTItMS0xLTEtMjY0MTI_b629c1f1-b8ea-4293-be84-93d0079165ac">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTItMy0xLTEtMjY0MTI_7e9c7ca8-7084-44e9-a452-1a03d7f630d3">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Realized and unrealized losses (gains) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTMtMS0xLTEtMjY0MTI_4e346005-18b1-4ccb-9fd0-b591e738e96a">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTMtMy0xLTEtMjY0MTI_bb186700-b8f2-4d58-922e-a8409bd735a0">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign exchange losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTQtMS0xLTEtMjY0MTI_d836ffec-edbd-4140-8555-71c1079ce4fd">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTQtMy0xLTEtMjY0MTI_a8083e8d-08a9-412e-a657-83a2f9781830">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTYtMS0xLTEtMjY0MTI_2a2a20ca-9286-44d7-bd94-58d2c39b68b8">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTYtMy0xLTEtMjY0MTI_455bc7b8-38bb-4dd6-9153-b557346e3878">2,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTctMS0xLTEtMjY0MTI_5b52cc60-9a30-4363-919b-1b26d502939e">3,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTctMy0xLTEtMjY0MTI_edc76e41-e748-48f1-b1f1-82455d1e4465">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTgtMS0xLTEtMjY0MTI_93d45556-d2a7-4a5c-9eb3-bd9f68face56">2,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTgtMy0xLTEtMjY0MTI_81de6494-f956-4718-ba16-d362c1e79607">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTktMS0xLTEtMjY0MTI_ff9cc4a2-b688-4e8c-9449-c6e3451fec11">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTktMy0xLTEtMjY0MTI_daf6b524-44f9-4b98-bd40-4d20c6a0239a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjAtMS0xLTEtMjY0MTI_4ebb44f5-423c-40a9-a974-45fbb43062ca">946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjAtMy0xLTEtMjY0MTI_29749c17-e525-448a-b850-7c6281c5bd19">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjEtMS0xLTEtMjY0MTI_f4115863-14fa-4b3d-9c58-21544eb1bfdb">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjEtMy0xLTEtMjY0MTI_c7be380f-2352-4a46-af80-27e1faba04c6">1,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjItMS0xLTEtMjY0MTI_ecabf0ef-c0fc-4248-b73a-75724d4153da">5,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjItMy0xLTEtMjY0MTI_beb3837c-c22e-4f7a-829b-c53f4f7e9978">6,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjMtMS0xLTEtMjY0MTI_587a033f-21cf-405c-b375-f4c1e564b2ba">1,632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjMtMy0xLTEtMjY0MTI_44320f7f-2ce4-4066-b88c-b988699f94ec">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjQtMS0xLTEtMjY0MTI_717326bd-3200-422b-88a0-8e2df1fdfd92">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjQtMy0xLTEtMjY0MTI_c825d988-a429-410b-9140-44462cab48a5">1,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjUtMS0xLTEtMjY0MTI_91d93e0d-46e3-4c64-a24e-7ef97c6de440">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjUtMy0xLTEtMjY0MTI_51f58c6e-4bbc-47c0-a69b-c63c6ecbeb8d">699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Liability related to unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjYtMS0xLTEtMjY0MTI_95f6a07d-fe1c-48e1-90b4-070e1a064551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjYtMy0xLTEtMjY0MTI_313fa516-a0cb-410b-826b-36433d467541">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjctMS0xLTEtMjY0MTI_83b7cb30-d312-4827-80cf-7aee6b4c2457">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjctMy0xLTEtMjY0MTI_53719d70-eb94-43da-86d6-9cf082e30460">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjgtMS0xLTEtMjY0MTI_6dfa124f-241e-4e09-8e15-237f5ef63b36">7,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjgtMy0xLTEtMjY0MTI_38ffe57e-bd7a-4792-a41b-6f14794f13b0">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzAtMS0xLTEtMjY0MTI_6485d124-ac97-47b1-9491-a486b4f69499">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzAtMy0xLTEtMjY0MTI_77dbcf29-5b1c-42c1-9171-586446b331f8">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzQtMS0xLTEtMjY0MTI_aabae32e-9dde-4554-9ff8-4ae782f349a1">1,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzQtMy0xLTEtMjY0MTI_a2b62ae9-4f9a-484a-87d8-3e2efb0f1daa">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzctMS0xLTEtMjY0MTI_6765f516-43ac-4dc7-a6d9-92a541e954ac">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzctMy0xLTEtMjY0MTI_489c6a21-f67b-47d2-8f85-bb1c9fd24457">397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of related party borrowing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDAtMS0xLTEtMjY0MTI_3f70bfb2-3b04-435c-b496-c03c72cb416c">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDAtMy0xLTEtMjY0MTI_dd259b29-0777-4d1f-910b-8798ffd078fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDEtMS0xLTEtMjY0MTI_d069d869-34b9-44d3-9636-d4c07107e96d">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDEtMy0xLTEtMjY0MTI_aa473446-fafb-442d-8b30-b074f454cfb9">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDQtMS0xLTEtMjY0MTI_24ee6aa2-cdd4-4811-b146-9eef0b256826">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDQtMy0xLTEtMjY0MTI_61b37bd5-89a6-4ec8-8b36-58b5cc0bcaea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDUtMS0xLTEtMjY0MTI_fb926dd3-308e-4771-a631-9c7c623109b0">9,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDUtMy0xLTEtMjY0MTI_c99d6dde-f927-4a39-9530-534c39fb1e09">1,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDYtMS0xLTEtMjY0MTI_5196bdce-6405-40da-9687-9fce7516df4e">827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDYtMy0xLTEtMjY0MTI_f468d007-e0af-4ead-87ce-442a5b9345e1">1,257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDctMS0xLTEtMjY0MTI_76b9b848-ff59-4392-b9c0-724700206e42">19,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDctMy0xLTEtMjY0MTI_b0888567-19e9-4f9c-bca2-040ddc3d9902">816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDgtMS0xLTEtMjY0MTI_332fc5ef-ebc9-4518-b045-dbd6bb2f19ff">86,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDgtMy0xLTEtMjY0MTI_462e732e-076c-460b-a706-8b6e80ede68b">92,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDktMS0xLTEtMjY0MTI_59895253-d37d-43fb-94b8-ee94e40a66a3">66,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbc2254a9ff457793b34cf0b849506d_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDktMy0xLTEtMjY0MTI_bb386d59-c451-4089-be76-fe87b078355b">91,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTEtMS0xLTEtMjY0MTI_c764f7d0-f49e-46ce-b223-0a194a0e4e7d">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTEtMy0xLTEtMjY0MTI_897675e4-5ee9-4963-94c4-b631a73ece10">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTItMS0xLTEtMjY0MTI_e5b92ea7-2a19-467d-8eaf-ed107c721678">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTItMy0xLTEtMjY0MTI_e8327cf7-2bec-49a2-a480-a404c5351e7a">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5MQ_1ef32da3-1ab4-42e6-b58f-2e1eefe77ebc" continuedAt="i19949009dbe14f86bb62fe1928bb720b" escape="true"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5Nw_6f8818d6-1c02-47bd-9c29-c9c5cc78e4c3" continuedAt="i14e3d87f2e06412fb478804f016d453f" escape="true">Basis of Presentation</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i14e3d87f2e06412fb478804f016d453f" continuedAt="i497d882a71d84a42951a86b560f4e40b"><ix:continuation id="i19949009dbe14f86bb62fe1928bb720b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM4Mw_d66d6edb-ff3d-4557-8a50-8746252b7eb8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2022, and for the three months ended March&#160;31, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5NA_5cb74e89-1086-4698-83dd-ff79a21c8ab0" continuedAt="i84d8156ec64340c5822c81db888e1cd5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates due to the uncertainty around the magnitude and duration of the COVID-19 pandemic, the current conflict between Russia and Ukraine, inflationary pressures and supply chain challenges as well as other factors and those differences could have a material effect on our financial position and results of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i84d8156ec64340c5822c81db888e1cd5">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</ix:continuation> </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzIwOA_a8fb093e-5ab2-4eb7-9a45-88e39bebcbed">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMTA5OTUxMTYzMzI5Nw_3152f0a6-eac9-42f9-a8de-9c619e6344c9">0.1</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzQzOQ_2ea37f53-a3b2-46aa-b978-d7851a52f8f0">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzQ0Ng_879fcb40-22bf-440f-9ec3-36d430f7e082">3.2</ix:nonFraction> million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Related Accruals and Expenses</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzUyMw_0cf116af-9b0c-4c6b-af64-d48283d0fbf1">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMTA5OTUxMTYzMzE4Nw_0f21ddee-6361-423e-9ff6-ed3ad192cf85">48,000</ix:nonFraction> of restructuring related expenses during the three months ended March&#160;31, 2022 and 2021, respectively. Accrued severance and restructuring related costs were $<ix:nonFraction unitRef="usd" contextRef="ia1a3638bc5e548b6aa731778d987df88_I20220331" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzc2OA_ce1af384-a60d-45a8-abea-dab5786c18fb">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i58339cf767784484935089232da792c0_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzc3NQ_a91398a2-fb1a-43cb-8032-ae7f43e4127e">0.2</ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTQwNA_768a34c3-d076-479b-9c38-332c1d061785" continuedAt="i4c74c73ff2eb47c69e6508786025a85f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria, that have contracts, hedging relationships, and other </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i497d882a71d84a42951a86b560f4e40b"><ix:continuation id="i4c74c73ff2eb47c69e6508786025a85f">transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</ix:continuation></ix:continuation></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RleHRyZWdpb246YzM1ZGY1NTBhZTQ2NDI2MGEzYzg5ZDE3ZTc3NDM5YjJfOTk_de7b0b5e-84c9-40ea-bdfd-b3688250e24d" continuedAt="i6dd9ff565c4748e799cc9cea220b3770" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i6dd9ff565c4748e799cc9cea220b3770"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RleHRyZWdpb246YzM1ZGY1NTBhZTQ2NDI2MGEzYzg5ZDE3ZTc3NDM5YjJfMTAw_aa7c3e41-5ed7-44d2-8b2e-4ac9ee24a9f1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMS0xLTEtMS0yNjQxMg_9d3dfb9e-60a2-4a37-8fb8-dccaa0d4106d">25,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMS0zLTEtMS0yNjQxMg_9249bce0-69ee-4211-acb8-4ecf382a84a6">22,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMi0xLTEtMS0yNjQxMg_bfc04e93-00fd-4f55-8b42-960264d01f42">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMi0zLTEtMS0yNjQxMg_feed5340-423d-4d27-88e1-4efb316317a5">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMy0xLTEtMS0yNjQxMg_d6d33452-6b2f-4b32-a2fd-a32a93caf975">36,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMy0zLTEtMS0yNjQxMg_0d21c239-3c6e-47f9-9322-91512a0472a6">36,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfNC0xLTEtMS0yNjQxMg_ea8492d0-f794-419b-994b-7006c3ef1de0">63,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfNC0zLTEtMS0yNjQxMg_f8b7fb32-bba2-45ea-bf75-b8fb0f3c240d">60,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMjg4_cc011d82-dcb2-4ff9-9e65-fa06ec45bc56" continuedAt="i793a0aa52b474c4c9e0630ac1a85533b" escape="true">Investment Securities - Trading</ix:nonNumeric></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i793a0aa52b474c4c9e0630ac1a85533b" continuedAt="ie02530747621436981c933b7591aa0f4">&#160;</ix:continuation></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie02530747621436981c933b7591aa0f4">Our trading securities portfolio totaled $<ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfODQ_b9c3f27d-07e2-4f75-8d83-9b90932dd635">0.9</ix:nonFraction> million at March&#160;31, 2022, and $<ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfOTg_8acea92f-1c93-4e47-ac2d-f2a25e159a06">1.0</ix:nonFraction> million at December&#160;31, 2021, and generated losses of $<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMTMy_bfdd29bb-a840-40ed-a0bc-2c6587dec415">58,000</ix:nonFraction> and gains of $<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMTQ4_c9f1544c-3638-4c72-a5a8-fc3bcde35e3b">16,000</ix:nonFraction> for the three months ended March&#160;31, 2022 and 2021, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjYyMQ_0f18aca8-1685-4d2e-adc8-e17bd4398839" continuedAt="i933357384aa04a619bb7c8d1fdf57554" escape="true">Revolving Credit Facility and Other Obligations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i933357384aa04a619bb7c8d1fdf57554"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$<ix:nonFraction unitRef="usd" contextRef="ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTc1_0686106c-ff29-4375-821d-a17ef605a0fb">25.0</ix:nonFraction> million (the &#8220;Credit Agreement&#8221;).&#160;On June 11, 2020 the credit agreement was amended to extend the term to mature on July 1, 2023. The amendment also allows for additional borrowings of $<ix:nonFraction unitRef="usd" contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMzU1_7c978e75-ad02-4342-9b34-3fde8f16eb13">15.0</ix:nonFraction>&#160;million or up to <ix:nonFraction unitRef="borrowing" contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611" decimals="INF" name="natr:LineOfCreditFacilityNumberOfSeparateIncreases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMzY3_f6b265de-be21-4657-93bb-7ca1c2d26bd6">three</ix:nonFraction> separate increases of no less than $<ix:nonFraction unitRef="usd" contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfNDA1_dc14b2fc-24d3-4cd3-a515-561c9952404e">5.0</ix:nonFraction>&#160;million each. On March 8, 2021, we signed an amendment to the credit agreement that eliminates the Index floor from the calculation of interest. Interest under the amended Credit Agreement is at the LIBOR daily floating rate, plus&#160;<ix:nonFraction unitRef="number" contextRef="i9eebe4f1416a42e29600fbc080b00ddd_D20210308-20210308" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfODYx_42b25379-7ec7-42f3-aeca-b041ad2c8e46">2.25</ix:nonFraction> percent&#160;(<ix:nonFraction unitRef="number" contextRef="id926898d6fa64913b3ef9123f02f63cf_I20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfODY1_9ed6966f-cc95-46dd-9b1e-9adf2ca47cb4">2.71</ix:nonFraction> percent as of March&#160;31, 2022), and an annual commitment fee of&#160;<ix:nonFraction unitRef="number" contextRef="id69bfe93049647898e279137e36c29b1_D20210308-20210308" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfOTEx_9a9984bd-04ec-4c1d-80b3-57c9299ca181">0.25</ix:nonFraction> percent&#160;on the unused portion of the commitment. At March&#160;31, 2022 and December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i32456aa4ccc64830b04647560160366a_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTE4Ng_61e6f0ad-6f99-4329-94bf-2bcb0d4ad6b3"><ix:nonFraction unitRef="usd" contextRef="iab0f1c76f2c54a56b68ab99720f974d0_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTE4Ng_7e388bce-e9ac-41cd-b22d-e3166935a071">no</ix:nonFraction></ix:nonFraction> outstanding balance under the Credit Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $<ix:nonFraction unitRef="usd" contextRef="ic6a5b6c9fc5c4a5c86741daebd2c055c_I20200421" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTk3Ng_104d030f-998a-4a18-a5a6-335dad082015">6.0</ix:nonFraction>&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $<ix:nonFraction unitRef="usd" contextRef="ia98eed0936e6455f8174af8a8890d1db_I20201119" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjA5Mg_0e12bfde-cff8-4cd2-b2c7-fabdee724751">3.7</ix:nonFraction>&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of <ix:nonFraction unitRef="number" contextRef="ie8d4e839e771459aa39d3689d857e1a9_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjI4MQ_673110c3-3935-417b-8c12-6f4adad4fff6">3.00</ix:nonFraction> percent and are required to settle our borrowings under the Capital Credit Agreement in <ix:nonFraction unitRef="payment" contextRef="i62c09354038642f186df2d18e5450419_D20200421-20200421" decimals="INF" name="natr:DebtInstrumentNumberOfMonthlyPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjM3Mg_e8d16c0e-1b1e-4632-a11e-fe7e632a236f">36</ix:nonFraction> monthly payments, of $<ix:nonFraction unitRef="usd" contextRef="i62c09354038642f186df2d18e5450419_D20200421-20200421" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjM5Ng_7762e3d1-97d2-4b79-a4a7-2e4033901ef9">0.1</ix:nonFraction>&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="id76496067c7b4d3f8bd85db3b5f95257_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjUxOQ_69d4fc84-80d5-4daf-8148-b62338fe4da9">2.1</ix:nonFraction>&#160;million outstanding balance under the Capital Credit Agreement, of which $<ix:nonFraction unitRef="usd" contextRef="id76496067c7b4d3f8bd85db3b5f95257_I20220331" decimals="INF" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjU4Nw_9e7869fc-68c5-4879-a9b3-58acb4a55def">1.3</ix:nonFraction>&#160;million was classified as current.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMTM5NQ_a338696f-981f-4700-9975-5e07fd456091" continuedAt="i4a46a70de6554fa68c05fbe6cd4031fb" escape="true">Net Income (Loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="i4a46a70de6554fa68c05fbe6cd4031fb" continuedAt="id00fda005bf4415994812ac5ff87dbd3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="id00fda005bf4415994812ac5ff87dbd3"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMTM5MA_dd0cf9d8-2def-46ac-a63a-5dd8b08f3118" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNS0xLTEtMS0yNjQxMg_12043be7-ec6d-4016-a65b-edc91eac6d83">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNS0zLTEtMS0yNjQxMg_e310416d-2ac1-44f5-b8d4-d2fde0337f03">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNy0xLTEtMS0yNjQxMg_785c77f9-417f-4217-87bd-be231890789a">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNy0zLTEtMS0yNjQxMg_daf45a7b-2e1e-43bc-bc85-458a57db6439">19,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTItMS0xLTEtMjY0MTI_8e017ed9-f1d7-46fd-8f2e-ab688851ece1">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTItMy0xLTEtMjY0MTI_d9c80f65-dabb-4726-b2fe-77f606b9c1fc">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTUtMS0xLTEtMjY0MTI_839a3b42-0bb5-465b-83a5-fee2df946170">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTUtMy0xLTEtMjY0MTI_0ffdeaef-126a-4adf-90e6-8977419ff009">19,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTYtMS0xLTEtMjY0MTI_2f3bde38-a252-4f5b-9543-54f0113ff634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTYtMy0xLTEtMjY0MTI_7738b3fd-eed5-4e0a-9607-3c4a80f9a6f4">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTctMS0xLTEtMjY0MTI_d7d3ffdf-9c31-41f0-a24f-143f9de86ac4">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTctMy0xLTEtMjY0MTI_bf16cea1-f8bd-47c8-917b-ba7a0cee074f">20,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjItMS0xLTEtMjY0MTI_0a6e8e01-d813-441f-b927-802171b90069">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjItMy0xLTEtMjY0MTI_fbb66f42-b59e-440c-9667-379935de46be">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjUtMS0xLTEtMjY0MTI_58e64a49-3ce0-4348-9541-3b7d7d82c66d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjUtMy0xLTEtMjY0MTI_3c7b8ae9-e7ac-4c10-bece-dd8ca7934f8b">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjgtMS0xLTEtMjY0MTI_92e86fd2-b1fd-4a46-ace5-3e0f554187ef">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjgtMy0xLTEtMjY0MTI_c1f03752-7711-4ab4-bf47-da29fd51c8b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, <ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMzg0ODI5MDY5OTM0NA_6143ccb7-3212-46b1-a606-18d1436d0642">no</ix:nonFraction> potentially dilutive securities are included in the calculation of diluted earnings (loss) per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include <ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMzg0ODI5MDY5OTM0MA_a293f7ee-521e-4e29-8171-9b3b51235617">282</ix:nonFraction> restricted stock units.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted-average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYzNA_5bce7acf-ac38-4157-9b3a-daf6e36c0865" continuedAt="id1aef11e963e45b6a3381e165e123cc4" escape="true">Capital Transactions</ix:nonNumeric></span></div><ix:continuation id="id1aef11e963e45b6a3381e165e123cc4" continuedAt="i146a6717ec5646a99bdba89d9433017a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a special non-recurring cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="if98b729b54f5451a829590e8adb58f29_D20210405-20210405" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTE2_3b69ac03-f7bd-4141-a6cb-b2e0b6b653f5">1.00</ix:nonFraction> per common share in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="if98b729b54f5451a829590e8adb58f29_D20210405-20210405" decimals="-5" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTYy_ebc218ed-7b66-444c-8734-a422940d1ab1">19.9</ix:nonFraction>&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="i146a6717ec5646a99bdba89d9433017a" continuedAt="i30f303a9606642b4a04fef7d8183b4d4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $<ix:nonFraction unitRef="usd" contextRef="id691a4ef66cf4da3b988bfbf06a2e811_I20210310" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTEzNA_9dab5a6d-09fa-4be3-ac4e-13efb55e38fd">15.0</ix:nonFraction>&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $<ix:nonFraction unitRef="usd" contextRef="i78adc08e7232473a933e1ecb19fbb047_I20220308" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQzMjg_3095441b-f07f-481d-8faf-15d8b1d289ea">30.0</ix:nonFraction>&#160;million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2022, we repurchased <ix:nonFraction unitRef="shares" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ1Mzg_53285e0b-0086-4e83-967b-3884425d8eed">451,000</ix:nonFraction> shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ1OTA_a165c3ab-0ae0-4ed0-9902-a45293a6098b">8.0</ix:nonFraction>&#160;million. <ix:nonFraction unitRef="shares" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ2ODQ_9c04b6a7-9c66-4acb-9bef-ef334a196051">No</ix:nonFraction> shares were purchased for the three months ended March 31, 2021. At March&#160;31, 2022, the remaining balance available for repurchases under the program was $<ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTA0NDUzNjA0NzM5Njg_0671f6f5-633b-4f4a-9c25-04e3dc7a856c">29.6</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of <ix:nonFraction unitRef="shares" contextRef="i555b079af2a941c182b57bfc82a439aa_I20121231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjA3Ng_5ae983ea-9873-4cb7-a315-0b13c5956715">1,500,000</ix:nonFraction> shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="ie914eddd4e9943539c51b78d2f72072b_D20150101-20151231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjM0MQ_e1fe149f-fb39-4f2c-8fb3-26bfbd083e58">1,500,000</ix:nonFraction> shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="i2c8f4fc34bae44f3a7053951f910b3b8_D20210505-20210505" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjU0OA_1f932d1f-85c6-42d6-9de7-4b8b12402491">2,000,000</ix:nonFraction> shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to <ix:nonNumeric contextRef="i7bf0a2bb87c04726b85a12b3aaf47333_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzQyMA_c0eb030a-29d2-4d33-b9f5-8bef70bed183">48</ix:nonNumeric> months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of <ix:nonFraction unitRef="number" contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU1Nw_c41ef245-dfc1-48b5-82c6-8c463858075e">six</ix:nonFraction>, <ix:nonFraction unitRef="number" contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU2MQ_3148f7a4-3649-4647-b120-176b1277a068">eight</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU2OA_7df44196-3663-49a7-8449-f93c96537472">ten</ix:nonFraction> percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYyMg_1acbf1e5-e896-4949-9dca-be3082dc6132" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS0xLTEtMS0yNjQxMg_f45caef1-cc44-4486-a01a-4e1243338220">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS0zLTEtMS0yNjQxMg_c2dd3ffc-64c8-4ea0-99cc-df431b79a260">12.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS01LTEtMS0yNjQxMg_69019931-543b-4449-89c0-e43eb17b0555">5.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi0xLTEtMS0yNjQxMg_abdf9f1a-a94d-49d1-96d7-7c52047e8179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi0zLTEtMS0yNjQxMg_2ea8cef5-8326-4fb1-8817-32adcb67d4a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi01LTEtMS0yNjQxMg_336f9a2c-2290-4183-9b92-3119c89ef942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy0xLTEtMS0yNjQxMg_94acd22b-4cc4-454e-9631-1fa1fe27c2cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy0zLTEtMS0yNjQxMg_229f6304-734d-4cde-94ba-a82fe8b77a4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy01LTEtMS0yNjQxMg_9ce6d456-a59a-44c9-9120-72150a836374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC0xLTEtMS0yNjQxMg_7ac2cb58-6520-4e08-9b6d-f944687ebe00">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC0zLTEtMS0yNjQxMg_8f6203d7-38fa-4207-8270-251277ff348c">9.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC01LTEtMS0yNjQxMg_ace0938c-af8d-4005-856a-fd227cacedfe">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS0xLTEtMS0yNjQxMg_17ab3d66-861a-44bc-9979-5d87e111dfec">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS0zLTEtMS0yNjQxMg_1f200c04-b4a7-448f-ad76-aa6e527c2e24">12.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS01LTEtMS0yNjQxMg_0b602caa-a5e3-4bf1-893e-fd97ea9a7eae">5.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzc5Ng_7cca0651-9cc6-4a4b-964d-f3c77b6b3ce0"><ix:nonFraction unitRef="usd" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzc5Ng_a27dbc5f-b281-4a5b-8f31-4a4644c4e740">no</ix:nonFraction></ix:nonFraction> share-based compensation expense for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 and December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzkxMg_5166c266-e6c7-4bbb-b069-b52fae1c64a3"><ix:nonFraction unitRef="usd" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzkxMg_6bc66fb7-114b-4e87-8559-3136ea1e2283">no</ix:nonFraction></ix:nonFraction> unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase <ix:nonFraction unitRef="shares" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDQxNg_ae49936a-e17c-4a01-9e3c-71d61f67b8ff">143,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDQ0Ng_8d6aff05-b856-4e62-b432-44f242f47989">0.6</ix:nonFraction> million. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase <ix:nonFraction unitRef="shares" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDUzOA_d4529102-9870-4888-b76c-ae3d63ba96ae">172,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDU2OA_c2604f94-5c33-47cb-a2e4-815dc2eb383c">1.1</ix:nonFraction> million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022 and 2021, we issued <ix:nonFraction unitRef="shares" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDYyNQ_3c790816-8cd8-4c6e-b03d-ba3ce7af2db5">29,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDYzMg_67863da4-a173-4940-9310-6e7d4a6d3255">2,500</ix:nonFraction> shares of common stock upon the exercise of stock options at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDcyNQ_2400334c-8513-4110-8620-9150be1a98fa">9.17</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDczMg_70631688-be50-4e2c-bbbb-d56554a89b40">11.98</ix:nonFraction> per share, respectively. The aggregate intrinsic value of options exercised during the three months ended March&#160;31, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDg2MA_59c9ec8f-4752-4707-bb87-fa63ec716929">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDg2Nw_427ff19c-77ab-43f9-9b36-7a94cc93ae19">19,000</ix:nonFraction>, respectively. For the three months ended March&#160;31, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDk1MA_0a2edca9-e405-4591-9132-b7019df9ce1e">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDk1Nw_875803d7-f731-4033-b1e3-6c0b42d7ff2e">9,000</ix:nonFraction> of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, we did <ix:nonFraction unitRef="shares" contextRef="i398a4c632e9146b6a4117e9a80bd1b33_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTA1MQ_5ee9ad4c-b698-4167-ae47-39f50a0eedae"><ix:nonFraction unitRef="shares" contextRef="i402ed898554945f59d3dcb7c9d4b63e1_I20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTA1MQ_fee9bd14-4cb3-40c5-8a63-3f26b4184106">no</ix:nonFraction></ix:nonFraction>t have any unvested options outstanding.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="i30f303a9606642b4a04fef7d8183b4d4" continuedAt="i2553fd219f3e401999279a04b0d40558"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from <ix:nonNumeric contextRef="i3fb365d93fed48cdb727939977fc3c22_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTI3NA_e4438171-c77e-44da-9f85-f38e20a38ef4">12</ix:nonNumeric> months to up to <ix:nonNumeric contextRef="iccd7c968f4df4cc0aa01a09c2a2a9125_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTI4Ng_4ecb2931-7d93-4159-9160-c437a7d5b853">36</ix:nonNumeric> months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to revenue and earnings growth, earnings-per-share, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until <ix:nonNumeric contextRef="if832daaf3a78404e9c159a19b9debf45_D20220101-20220331" name="natr:RestrictionPeriodForIssuanceOfShares" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTU5MQ_f8143c57-8d4b-448d-929f-4515bcb2dd55">two years</ix:nonNumeric> after vesting. At March&#160;31, 2022 and December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="ia72899eeeac6488c866c2c21e97909de_I20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTYzNA_4ebb7167-eff2-4bca-a0ac-b7edcf84caa3">95,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i8b74d788af4647368d8064fe930b3af7_I20211231" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTY0MQ_f95b5973-6e3e-48a5-a6cf-cc1e3c38bb34">88,000</ix:nonFraction> vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYxNg_0694e3ec-cd84-4203-b9e4-a0165af8746d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMS0xLTEtMS0yNjQxMg_568dc22e-28a3-410d-aab4-ac94b9bee831">830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMS0zLTEtMS0yNjQxMg_b82a6328-8d2f-473d-9684-0faf3965c820">9.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMi0xLTEtMS0yNjQxMg_71879726-a593-4fa4-ab45-fb2df04c0fed">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMi0zLTEtMS0yNjQxMg_efcf0eca-2c8f-448e-92aa-75d2f59476c9">16.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMy0xLTEtMS0yNjQxMg_7801b331-e247-42ee-b3b9-ed89e9e962d7">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMy0zLTEtMS0yNjQxMg_1fcd4226-0cf7-4a5e-80f7-5d94568879f3">3.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNC0xLTEtMS0yNjQxMg_56f07474-2fc3-476b-8483-da9aafaf4cdf">220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNC0zLTEtMS0yNjQxMg_485b527d-7615-4af8-b16d-5c2e15997842">8.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f4ec581d7e641179b6e6d5671e479cc_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNS0xLTEtMS0yNjQxMg_f436158a-5bee-44c0-a89f-95d575dd7a6b">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f4ec581d7e641179b6e6d5671e479cc_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNS0zLTEtMS0yNjQxMg_e1c19a18-5096-443f-8a96-82c8d02c541f">10.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we granted <ix:nonFraction unitRef="shares" contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTkzMQ_9c57d53b-9666-445f-b537-0367707c6f2e">2,000</ix:nonFraction> time-based RSUs under the 2012 Incentive Plan to new members of the Board of Directors. The RSUs were issued with a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i84a5b39487154954983fee65eae72369_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNjIwMw_2a6b3ac0-7ec4-4d97-9ef8-d9a1d0d9771e">16.35</ix:nonFraction> per share and vest in monthly installments over a period less than one year from the grant date. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately <ix:nonFraction unitRef="number" contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331" decimals="3" name="natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzE0NQ_7d199c2b-b3b8-4af0-8d8d-44859f620be5">12.9</ix:nonFraction> percent for a common share.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzg0ODI5MDcxMjYwOA_b1742702-9296-4807-a674-b8287cbb1d13">no</ix:nonFraction> share-price performance-based RSUs were issued. Historically, share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three months ended March&#160;31, 2022 and 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzY0NQ_f18ff9e0-6868-46a6-82c0-f521af9232fd">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzY1Mg_2fb164bc-b5d7-4a0d-af07-a97dec54972b">0.4</ix:nonFraction> million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $<ix:nonFraction unitRef="usd" contextRef="i3da7c00ee4b94166b3df419f56670028_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzk1Mg_3ffb0f71-986b-4d23-9b8d-a97a1bb6730b">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabbe644ac11048d2b710f145d0c3929c_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzk1OQ_2e13d73b-5ec2-472c-9482-1ce12741d20a">1.6</ix:nonFraction> million, respectively. As of March&#160;31, 2022, the remaining compensation expense is expected to be recognized over the weighted average period of approximately <ix:nonNumeric contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODA5MQ_b778c15d-51e7-49d2-a4db-a5a610daa3ab">0.5</ix:nonNumeric> years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three months ended March&#160;31, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="ib87d18bc3f9040428d9eb9ea8d77994f_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODIxMw_88eb2e52-c809-419d-a5f6-5ac455a9ff20">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i348578201c544d8e9d4c3798b278b2fb_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODIyMA_9d0ab07b-5ba8-421b-b2dd-53117597c3c5">0.4</ix:nonFraction> million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would, and expect to, recognize up to $<ix:nonFraction unitRef="usd" contextRef="i22cc4557e1f545e1bc22ad3695e0973d_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODQ5NA_33612f62-53fa-41f0-872e-938d975ccd08">2.0</ix:nonFraction> million of potential share-based compensation expense. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2553fd219f3e401999279a04b0d40558">The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was <ix:nonFraction unitRef="shares" contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTI1MA_1449962b-3dad-4d2c-9356-3519fe19f021">60,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTI1Nw_bea54a97-b63d-4c08-baf5-c061360be1d6">75,000</ix:nonFraction> shares for the three months ended March&#160;31, 2022 and 2021, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</ix:continuation>&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk2Mw_71a48531-c356-471c-9120-98f78906defc" continuedAt="ibf44f7c3f83942c6af9e0efcd0611a40" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="ibf44f7c3f83942c6af9e0efcd0611a40" continuedAt="i092d1bde75e747d98ed03e203474b483"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMzk_c8013bd2-1182-4ebe-8c81-f9399a6b433a">four</ix:nonFraction> business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy&#174; WorldWide brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk2MQ_3bb45829-2a59-4903-8d53-990b00c28a3a" continuedAt="ie68ec16a0f39489abcb23cf9553c135e" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMy0xLTEtMS0yNjQxMg_45769c76-8459-4f07-bb14-769bc916a5d0">46,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMy0zLTEtMS0yNjQxMg_a1bef39f-d23e-4fbe-95bf-a968c22b43a6">35,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNC0xLTEtMS0yNjQxMg_72fff09d-6077-4995-ae1c-fa7243721fd9">21,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNC0zLTEtMS0yNjQxMg_3dac81a9-371f-4a74-84d4-30f703deaa2d">22,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNS0xLTEtMS0yNjQxMg_80d2bb7e-c8c0-4f3f-af39-b98fd678ccc4">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNS0zLTEtMS0yNjQxMg_e9d7430f-b24a-4017-9f51-7e56007df55e">37,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNi0xLTEtMS0yNjQxMg_0e87b6b7-40a0-49cd-9586-bfaa11535cd4">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNi0zLTEtMS0yNjQxMg_6f81a7e2-fb32-4586-8bc2-1bdf763fd716">6,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNy0xLTEtMS0yNjQxMg_20181deb-8270-4879-844c-f3dacac4f6ab">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNy0zLTEtMS0yNjQxMg_ebf76803-1231-46af-b956-1bc73cae7c2d">102,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTAtMS0xLTEtMjY0MTI_84ac82b4-04ea-4b87-b35f-290915dee14d">21,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTAtMy0xLTEtMjY0MTI_563cb17f-ffb3-4da2-8718-8683812c2674">15,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTEtMS0xLTEtMjY0MTI_faaf27cd-825d-412f-b66c-2f1a4c427e10">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTEtMy0xLTEtMjY0MTI_537677e7-1cb4-4a28-a708-d860fc9fec01">6,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTItMS0xLTEtMjY0MTI_6ad67ba5-50a6-4f63-a0da-f9d19efcc3bf">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTItMy0xLTEtMjY0MTI_fe7aebd4-8f94-49a5-9f9c-6c8488f310de">15,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTMtMS0xLTEtMjY0MTI_a790ce10-dce7-41aa-ac33-d7155f87c1ed">2,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTMtMy0xLTEtMjY0MTI_b83ae878-aef4-4de3-b748-cee009f378c7">3,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTQtMS0xLTEtMjY0MTI_fe5a337b-3e15-4e7d-9405-8bbb84da2cf7">41,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTQtMy0xLTEtMjY0MTI_ff5dba52-a07a-4a76-acc1-f30c8bfe06b0">41,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTYtMS0xLTEtMjY0MTI_76c5be05-1b10-4245-ad94-4ef268b6aa04">40,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTYtMy0xLTEtMjY0MTI_34be9952-6e46-4e0e-91bd-931144a99e9b">33,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTctMS0xLTEtMjY0MTI_bac5d7b2-73ec-42de-b825-2901129575c5">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTctMy0xLTEtMjY0MTI_8166c15f-d16e-4973-8727-2dba9dd904aa">7,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTktMS0xLTEtMjY0MTI_60319e70-e070-4a98-b79a-0c5ee2839fad">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTktMy0xLTEtMjY0MTI_9b887d3e-0e10-484d-9164-534706570c10">1,933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMjAtMS0xLTEtMjY0MTI_49558254-0287-4a76-bf16-5f2f5d8dab90">995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMjAtMy0xLTEtMjY0MTI_abe7cccd-1376-42c5-90ab-2dde9a320312">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div></ix:nonNumeric><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="ie68ec16a0f39489abcb23cf9553c135e">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $<ix:nonFraction unitRef="usd" contextRef="ia99ab0f2e60446ec842d8b9c7ecedda2_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTE3NQ_fe519836-424c-46b2-9b08-79c133495dbc">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3dc50e572e4748939b523aac9f92ce3d_D20210101-20210331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTA0NDUzNjA0NjU4NzQ_cad0f75b-0a9a-4b2e-811a-4dc109b8ea8f">2.8</ix:nonFraction> million for the three months ended March&#160;31, 2022, and March&#160;31, 2021, respectively. These service fees are included in selling, general and administrative expenses.</ix:continuation> </span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="i092d1bde75e747d98ed03e203474b483" continuedAt="id3ddb271c67d456b9f71d6fd27b5a58d"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk1Ng_7f32157d-a3ce-478c-ab49-428f99de6f4e" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March&#160;31, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3833f589148a4227b4f5c984f8f200b8_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfMy0xLTEtMS0yNjQxMg_368b1b21-3cbf-46a1-bf35-5395c028a99d">33,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aaa533e28334f489d7076c39dd1673d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfMy0zLTEtMS0yNjQxMg_de3981e2-9066-4dc6-a0fb-63859a473ee2">34,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1d57f3f4a34ccdb3dbce4533de6401_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNC0xLTEtMS0yNjQxMg_33a48256-68f6-4777-8a27-2a9fe6484631">13,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadda0b851c948ef9359bd2d2b89e394_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNC0zLTEtMS0yNjQxMg_5d7e509e-be15-4dd2-a019-ecd2bc9ba5a5">14,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b65a6d4edb47548db956eb75ac2c69_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNS0xLTEtMS0yNjQxMg_b1a7cae5-c979-467e-9911-f793cdb01030">63,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i348e6e2f93764613b3bd554e1ef83f4b_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNS0zLTEtMS0yNjQxMg_5e8a2940-bf85-47f1-b526-ec6ad997f846">52,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNi0xLTEtMS0yNjQxMg_581c5678-9103-4473-bee9-c4e8633eeef5">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNi0zLTEtMS0yNjQxMg_1439803b-7059-4608-9aab-fc16d9ccf386">102,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk3MQ_667c71ac-0ff0-48dc-9f42-50d0e3c86542" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0bf1d17dbb48cbb44d363a39cecd6c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMy0xLTEtMS0yNjQxMg_16009aa0-c2ca-4e6f-9687-460987cb905e">12,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17bade993e50434bb25d5592094f26be_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMy0zLTEtMS0yNjQxMg_3635a77a-0d4e-4f58-8c80-bdbd1e9cae89">11,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8912512957214830a709fb3a0e5f6bca_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNC0xLTEtMS0yNjQxMg_42833ecd-c89b-49de-8a1f-2cd0c95ce388">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i923224bdda5a44f6b1fd81e1e95c68ad_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNC0zLTEtMS0yNjQxMg_e7234975-07ef-4573-8821-ec517cfbba9d">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9a2377c670243d1a78c141cc8e41170_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNS0xLTEtMS0yNjQxMg_f2a83684-ca9b-4c61-8b21-8151dbb63745">13,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60c19c5ef2943ab9963e5ff0b52a2c0_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNS0zLTEtMS0yNjQxMg_7bfbfb17-818a-4bbd-96f9-b5a99af4684b">9,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1318988169ff4f8fa5244b15ab3b8c19_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNi0xLTEtMS0yNjQxMg_1ebb8d79-aea3-44fe-99d7-55a244e47535">9,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d7e87cbccf44fda7f9f4bb20e905bb_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNi0zLTEtMS0yNjQxMg_dfe1aa20-927f-4dc9-a882-1bfe0eee30d4">6,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910fb20292ee451c8d13d76fb72f1bc6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNy0xLTEtMS0yNjQxMg_8bd120f4-a4db-4c5a-b021-cf370efc481a">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ee274469924f98ad71b11264e3aac2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNy0zLTEtMS0yNjQxMg_350eba26-4a3b-44fa-bacc-799e0b56623b">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2afe0a2304a4456866df0c569f0b79b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOC0xLTEtMS0yNjQxMg_05888027-df4b-49b4-9059-2212344a7f9d">6,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94732c9a5ab84a539cf8295a1bee383e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOC0zLTEtMS0yNjQxMg_6dd35fc7-9bf9-4d3f-86d3-24e44256bc92">4,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOS0xLTEtMS0yNjQxMg_778c9f2c-c30b-4605-9557-e89bf01432c5">46,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOS0zLTEtMS0yNjQxMg_7e93e657-0dbd-4c7c-ac28-c24877fd856c">35,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e28facca7c94a3bb9ef0cbef288a9b3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTEtMS0xLTEtMjY0MTI_7a39909f-11c8-4256-af87-49b9912b3a74">9,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9d61c288624d7199064cf8381fb74c_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTEtMy0xLTEtMjY0MTI_0ed6b857-7062-45bc-aa68-b0ee9f9ef23d">9,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c4bae86f8b4368a604018a81f2ec34_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTItMS0xLTEtMjY0MTI_897dee2b-e749-4f60-8a01-52d06983470a">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cbed7bb9954b1f8cd165f5e0ec7a32_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTItMy0xLTEtMjY0MTI_e37694e6-f1ad-4a00-a727-ec63b0c7a9c3">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fe7c8a0e454ba181e8aa0117c5fe76_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTMtMS0xLTEtMjY0MTI_698b536f-8fca-415c-bbf7-6988e91c6c34">2,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902dbfce0d3d416f9e765b1c3e2da20f_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTMtMy0xLTEtMjY0MTI_7832dde0-e8ca-4d59-8e4c-7cca0f3a71fc">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a00e56648394275b3210882faf90e94_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTQtMS0xLTEtMjY0MTI_45ae3a6e-2940-49eb-8fa1-79f486e83029">5,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3f3a5a15141889d6b30d587478d20_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTQtMy0xLTEtMjY0MTI_c82e0e0b-b0c5-4f88-808a-4d10b111d677">5,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc88af59d684d87a1010641a53f8b29_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTUtMS0xLTEtMjY0MTI_66001779-b7b1-4fb0-aab6-0ee8b27e2868">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25d2edee7b64a6ebb0b481f7c617554_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTUtMy0xLTEtMjY0MTI_ae073959-394e-465d-887c-ef9d10c148b0">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2358ce4157b4456ae0ba519086bc059_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTYtMS0xLTEtMjY0MTI_5385bb3b-1a8f-4375-927c-a88b8316fa28">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40834fd02559432dae656ae4e9cde9f0_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTYtMy0xLTEtMjY0MTI_9ecb384c-b295-4642-8bfa-a5eb4ecd5fc7">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTctMS0xLTEtMjY0MTI_7f0930a3-3a67-46e1-8870-85f5cd1a0000">21,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTctMy0xLTEtMjY0MTI_092a2099-4181-4401-bbf8-f8d09b86271f">22,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec47376a16843fe8b7959468e821063_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTktMS0xLTEtMjY0MTI_1f1076b1-7958-48a5-8397-b667d4261cb7">15,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ea609d840d4bfcb6ac425813487379_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTktMy0xLTEtMjY0MTI_6ba2fe1f-a405-4023-8c8d-ddd505f1b834">16,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767402ab744647ed99b96582c5beb3a2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjAtMS0xLTEtMjY0MTI_a43d181d-f7cc-4c72-86e6-0c6057d44ab7">4,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8732a9aa67884481b06822950adac68e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjAtMy0xLTEtMjY0MTI_270d990e-7a02-40ab-a776-21778dd5dbe2">4,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic15ce45b151e4a20adb9f451c3673c19_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjEtMS0xLTEtMjY0MTI_006addd8-6c4d-4772-b039-d6f91754c7da">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5284ee739d4941a2c520f0a501c89e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjEtMy0xLTEtMjY0MTI_1aab3d52-62e1-43bd-b5c6-5dde7275139b">4,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c8d01d2a81452f8df2e915edc4269e_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjItMS0xLTEtMjY0MTI_c39d61b3-1fb1-48b1-9f95-3f488dbe4469">8,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf5d682a21749498e82089f8cad3646_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjItMy0xLTEtMjY0MTI_d4e9aeb2-71a7-4f81-a904-3e41c05d2a97">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4908295d328c4841a2ee03a0b1ffd3d7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjMtMS0xLTEtMjY0MTI_579669d4-e87a-427e-8bf8-69d6425442af">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de4b6373eea45468e42ddd4316cd664_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjMtMy0xLTEtMjY0MTI_47dfbddc-4c2e-467f-abee-a539e450828f">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378b6704092a4d50ac575936de66eff3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjQtMS0xLTEtMjY0MTI_e145f9b7-c5ef-4db3-8ae5-3a0d52e4f87e">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d963c459ab44b6e925d88b0342277cf_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjQtMy0xLTEtMjY0MTI_6a7306f4-7c4b-404f-9979-2621dd079396">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjUtMS0xLTEtMjY0MTI_01cce19c-b5cb-4ed8-b880-7b7ae2160694">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjUtMy0xLTEtMjY0MTI_3209ed6b-004c-4d95-9aee-cdbd7c876315">37,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325b7a5fd36c4fe28941bfaf3f5e55f7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjctMS0xLTEtMjY0MTI_951caa25-43c1-447b-8954-1abc6bde4343">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2c0ce3a35074fb4a5417b00b210d23e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjctMy0xLTEtMjY0MTI_1ac919a4-285d-49b0-9a4a-23050e820419">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2e0b295afa4d06a33d1a682c00dbbf_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjgtMS0xLTEtMjY0MTI_71611633-9ba8-4be9-9ebf-1b6c6f7a615d">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2418e36a7c6d4b968097a27d457f9a08_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjgtMy0xLTEtMjY0MTI_803c3cee-c069-4127-8f1d-392a363a7b1a">811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e927aab10b4984bee8f3006640dc63_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjktMS0xLTEtMjY0MTI_17565d03-0f49-4af5-b867-0a0a2fa1cae4">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68972e27e09c468e998db2ff4a112ecd_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjktMy0xLTEtMjY0MTI_d698946b-b738-4354-aec5-3a0e26950e2c">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce4108dd6004d9f97aa7f7a7ed76e7d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzAtMS0xLTEtMjY0MTI_3d0b2c92-b557-4962-8334-884e8ecb3632">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0b0ebd208da4867a5672633b3762f8d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzAtMy0xLTEtMjY0MTI_6d408fca-62d9-497c-95a8-7223515cef5e">2,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33417330f8f488c995347b902948643_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzEtMS0xLTEtMjY0MTI_bf128203-44a0-485c-87ad-9c1f2097115b">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e313090407494ba9488fe56934f695_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzEtMy0xLTEtMjY0MTI_1c1486e3-8a12-44b8-8b68-35f4ade8683f">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23f702f0295049a28cbcdc8b4d1ef74a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzItMS0xLTEtMjY0MTI_f006fac3-cc3a-400a-8792-c86350a0bb19">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f14deead68345519312a61e7ae03e71_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzItMy0xLTEtMjY0MTI_2efeb951-3502-4757-8cd6-dbf9eaca0738">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzMtMS0xLTEtMjY0MTI_27e50ec4-ebdb-4e89-859d-b165f48b560a">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzMtMy0xLTEtMjY0MTI_0218e3c6-16aa-49df-904c-766df8bdf83d">6,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzQtMS0xLTEtMjY0MTI_1ee27e1c-a7c5-4ca9-96b6-8a19002db5e7">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzQtMy0xLTEtMjY0MTI_227c6989-735d-4025-8e29-9205ee19b7e0">102,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="id3ddb271c67d456b9f71d6fd27b5a58d"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk1Mg_fc9cee3d-35c4-4650-82a8-570a303d4037" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86021b8e2ac744dbb42d13876c378755_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMi0xLTEtMS0yNjQxMg_9accddcd-ef2e-4ee3-a91a-2dc2aae83b12">45,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ba4d14830043cfa540bfed1414f780_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMi0zLTEtMS0yNjQxMg_52bb2a4b-f4cf-4591-ae35-65a9436539e6">46,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004217ff71f5450a9f97499b3ad9bcf9_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMy0xLTEtMS0yNjQxMg_55ac564b-2b45-45f7-90ee-840b0470b2e3">3,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1e426e6e414937a5f77169261c768c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMy0zLTEtMS0yNjQxMg_7a71591d-6484-41a2-8cab-fa6310e29ba5">4,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfNC0xLTEtMS0yNjQxMg_e9734360-8876-4871-9efe-971b111ec444">49,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfNC0zLTEtMS0yNjQxMg_0c3f0ffc-18b4-4b77-ad08-7affe42961ff">50,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:29.25pt"><span><br/></span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk3Mg_7bc0913c-7d2f-4da5-bcbf-bd20962b7ed4" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0831f06411dc477198d772b8a9a9e543_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMi0xLTEtMS0yNjQxMg_35168607-61c6-44b2-8b6c-9e8e949f806b">93,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea186633b504a27ba220e6cfcd61edb_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMi0zLTEtMS0yNjQxMg_6e20b50a-6a52-49cb-ac39-cbfae02da25f">104,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47363d5359bd46939ab4fc9af1589e6b_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMy0xLTEtMS0yNjQxMg_89f67d69-7b82-4cbb-8f83-4cc0c91b076d">14,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac919f4f48d240ed91a334c82ccd8334_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMy0zLTEtMS0yNjQxMg_8a38c1b3-461f-4382-9013-bf252ee609fc">15,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfaaa60da1b043588f9fae53b220069c_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNC0xLTEtMS0yNjQxMg_f2fcb269-0458-4d50-9016-e232dddaf354">122,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4376d08163e3452aa8513d7ff8613dc3_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNC0zLTEtMS0yNjQxMg_aab82536-0325-4270-83dd-fc255b4593fa">131,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281b77f20968487b8373b3b9e315c30b_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNS0xLTEtMS0yNjQxMg_7a917e7d-4692-4181-a4c9-eb81d67bbaa7">7,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8dbc545c204454955aab73bf9e460f_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNS0zLTEtMS0yNjQxMg_1d78ddba-7d13-4f10-bfe1-407139c74bc4">7,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNi0xLTEtMS0yNjQxMg_ba877516-70f0-4bbc-a2b0-426070aeabb4">238,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNi0zLTEtMS0yNjQxMg_3e3cef3b-4408-4b7a-9347-39c4073e4f3c">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMzM4NQ_ed30dc75-e07d-4736-ad2d-789cf02cc361" continuedAt="id811d32d6f01484d8d9b9bbe5599f8cc" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="id811d32d6f01484d8d9b9bbe5599f8cc"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was <ix:nonFraction unitRef="number" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMTU0_4c63731f-1d1a-4410-b77e-7d307adf64dc">369.9</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMTYx_6b9746f0-d22a-41d8-ab11-c0e05db88c88">27.2</ix:nonFraction> percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets which are expected to expire before utilization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2021, was primarily attributed to transfer pricing adjustments and non-deductible executive compensation, partially offset by favorable deductions for stock compensation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three months ended March&#160;31, 2022 compared to March&#160;31, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets which are expected to expire before utilization. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2018 through 2020 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, we do <ix:nonFraction unitRef="usd" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMjE5OTAyMzI2MTQzNw_654ad8fd-e8c3-49a1-ab58-7af0875415ad"><ix:nonFraction unitRef="usd" contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231" decimals="INF" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMjE5OTAyMzI2MTQzNw_ed0904ee-5746-4a01-ba45-f90502366e54">no</ix:nonFraction></ix:nonFraction>t have any amounts accrued for unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div></ix:continuation><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY4Nw_3c3c4601-a98f-4fbb-bb57-553a3c253f37" continuedAt="ie5fd105becf9441995f74b2834e1ed94" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ie5fd105becf9441995f74b2834e1ed94" continuedAt="i42d115c6747441b585a13a7b7342d983"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;<ix:nonFraction unitRef="claim" contextRef="i2dff93085c7f44fa956bd391f58b99df_I20220331" decimals="INF" name="natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfODc2_5869fdff-aca2-4a08-bc98-19b2fa4d1084">one</ix:nonFraction> or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="i1aa91f25a9b349ef8fdaee1bfeda71ee_I20220331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMTcyMw_7fc805bb-17c2-4e63-b7b2-bfd2d4c98ffe">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e4dd6c147114968863a0c8456478780_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMTczMA_d2907687-aac1-498d-a048-ac25154d51e7">0.2</ix:nonFraction> million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i1f362c72e29e4ee8ad5ec7c2dfb61c74_I20220331" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjAzNw_5158315d-d611-4adf-b920-b384b3241501">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="ib89e37a274af4cee94ebef8056298d53_I20220331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjA1Nw_19e4b81c-cddf-4e66-8396-aba8dd43c709">3.1</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42d115c6747441b585a13a7b7342d983">We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="iac3fd88adf7d4e73bafc50be57cbaef2_I20220331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjIzNQ_9b7ea729-85a3-415d-8a46-e678de27af0b"><ix:nonFraction unitRef="usd" contextRef="i492c57a6f9d046bda2bbdd0115e8fa08_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjIzNQ_e979a653-2e59-44de-a444-7fec4eb67df0">0.5</ix:nonFraction></ix:nonFraction> million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, <ix:nonFraction unitRef="usd" contextRef="icefc00db041a48d4a92bfbe7b4e5ad25_D20220101-20220331" decimals="INF" name="us-gaap:LossContingencyLossInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjU0NQ_ba0047ae-c776-4b2b-bbe2-50d4c383da58">no</ix:nonFraction> provision for losses has been provided.&#160;We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i09a9560c1ee743039cb31edafc3294ab_I20220331" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY1Nw_844e4c92-eda8-4b55-b2a2-7f9208d1488b">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="id57f2be0493944f4be377552827b560e_I20220331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY3Nw_400bbcbd-7b38-420e-a7a1-e6bc550722dd">0.5</ix:nonFraction> million.</ix:continuation> </span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNjEz_36c79b02-8614-4cac-9c09-84863da5c105" continuedAt="icbe483c4a20646ad8c271464bc0eaa46" escape="true">Related Party Transactions</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icbe483c4a20646ad8c271464bc0eaa46">During the three months ended March&#160;31, 2022 and 2021, our joint venture in China, owned <ix:nonFraction unitRef="number" contextRef="idf7ca29b6fc94c6dbdc1652525619cd1_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTIx_6015c34d-6b0d-4284-8378-2a695be87eb6"><ix:nonFraction unitRef="number" contextRef="i3f9df89d786a41e0b3d144f941fc5d32_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTIx_eedbb422-668d-4fb1-8654-3b60ee0a4223">80</ix:nonFraction></ix:nonFraction> percent by us and <ix:nonFraction unitRef="number" contextRef="i8d3d962215954cc8a9171fdd8505b3ba_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTM0_b9cc73d5-7116-4f22-bb95-fff2932bdfd5"><ix:nonFraction unitRef="number" contextRef="i72fa1124277f415fb68c710bb5c87c6c_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTM0_be63222b-4b93-4535-8682-08ae7e3209f4">20</ix:nonFraction></ix:nonFraction> percent by a wholly owned subsidiary of Fosun Pharma, did <ix:nonFraction unitRef="usd" contextRef="i3ffa4204f2244033a6387741823b1eea_D20210101-20210331" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTg3_ae6a17fb-9829-40d9-9e49-c5833ee30b89"><ix:nonFraction unitRef="usd" contextRef="i6210ad9bf96e4639909b9ee6ec5f0dee_D20220101-20220331" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTg3_b1148e56-70c5-4517-ba23-548f0e7379c1">no</ix:nonFraction></ix:nonFraction>t borrow any amounts from the Company or our joint venture partner. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $<ix:nonFraction unitRef="usd" contextRef="i9172a343a5724170828bcc1c87deb05b_I20220331" decimals="INF" name="us-gaap:NotesReceivableRelatedPartiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMzMx_a88604db-6bc8-4a9a-8e81-09cd90d91f09">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ieae5488b942241ffb6afa51639ffba10_I20211231" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMzM4_4bd33d23-f6c2-4313-a5c7-7a8c84396a1e">1.2</ix:nonFraction> million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $<ix:nonFraction unitRef="usd" contextRef="if4e1cf8cd79b489185a71063b36e1414_I20220331" decimals="INF" name="us-gaap:NotesReceivableRelatedPartiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNDQ0_c3d27fbf-0834-4c9d-9c5f-ba64c50c8f7b">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie78f626536d54b3ca22aa7de05ba6475_I20211231" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNDUx_d4cdebc4-8f9a-48b6-aba0-fd38b2ed5dd7">0.3</ix:nonFraction> million, respectively. These notes were payable in less than one year and bore interest of <ix:nonFraction unitRef="number" contextRef="id5c874d0d851496d8d0b2cad723434c2_D20220101-20220331" decimals="INF" name="us-gaap:RelatedPartyTransactionRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNTM2_7e126d81-e536-4790-a6d3-a08b61dfae32">3.0</ix:nonFraction> percent. The notes between NSP China and the Company eliminated in consolidation. In March 2022 the outstanding principal and interest amounts were repaid.</ix:continuation></span></div><div><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RleHRyZWdpb246ODIzOTVkN2U3OTQzNDc5YWJlM2YxOTVhYTgxZmZlMjJfMjE2NQ_3cd5a404-2415-47e1-963c-450fb7459545" continuedAt="ib21a3f1d7a404d8d907343abadc6ea32" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ib21a3f1d7a404d8d907343abadc6ea32" continuedAt="ic759b060f9fa48758ce6922ce6c1e006"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><ix:continuation id="ic759b060f9fa48758ce6922ce6c1e006"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RleHRyZWdpb246ODIzOTVkN2U3OTQzNDc5YWJlM2YxOTVhYTgxZmZlMjJfMjE2Mg_3fb127de-61c3-4522-be47-26ad71f24e94" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0d3c071a9749e19577e2b5b5623c3f_I20220331" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi0xLTEtMS0yNjQxMg_06ab6e1e-1587-4863-8e01-74c93e0c98e2">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5996eefda0d54ab59124aeaee9125db4_I20220331" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi0zLTEtMS0yNjQxMg_de517eb3-696c-4d57-9d38-e57b0868c625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaf9feba842448992af5440ff1e9ca4_I20220331" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi01LTEtMS0yNjQxMg_b18696a0-7e79-4878-a607-138d02c179c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60740a0aa42458e9145ad1c8f41c4a2_I20220331" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi03LTEtMS0yNjQxMg_3acfc5cf-4a03-4ef7-88be-dd6e9ccec16e">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0d3c071a9749e19577e2b5b5623c3f_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy0xLTEtMS0yNjQxMg_e8b965f1-182a-490b-972c-8db153210644">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5996eefda0d54ab59124aeaee9125db4_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy0zLTEtMS0yNjQxMg_c4adc597-b795-465e-a36b-160c0f3ef197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaf9feba842448992af5440ff1e9ca4_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy01LTEtMS0yNjQxMg_86fcd6f5-9d47-46bf-9295-c96bf7d8b732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60740a0aa42458e9145ad1c8f41c4a2_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy03LTEtMS0yNjQxMg_809c2640-7f91-42c3-925a-ac5fef9639b5">888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11fc7a1040844bd1a53ed85f210878e8_I20211231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC0xLTEtMS0yNjQxMg_2f506aca-fa90-4bdb-9753-4a9ae4dba3ff">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444dd1d44ce74fcb94a32f106266e541_I20211231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC0zLTEtMS0yNjQxMg_3d844df9-6b0d-4d08-928f-c3ce29d85868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067bf9020abe410db4a9808337bf4f61_I20211231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC01LTEtMS0yNjQxMg_7649fa8a-ec07-48e2-ad7f-443327e6c285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21defeb3de3d4f229983ffbf2177bdbf_I20211231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC03LTEtMS0yNjQxMg_b62fa650-02e3-474b-8b3f-b21d321226e4">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11fc7a1040844bd1a53ed85f210878e8_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS0xLTEtMS0yNjQxMg_7ca9cc6a-03a6-4e33-a249-ef50bed32d25">964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444dd1d44ce74fcb94a32f106266e541_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS0zLTEtMS0yNjQxMg_36ca2a65-fa57-448a-957f-972f3e916d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067bf9020abe410db4a9808337bf4f61_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS01LTEtMS0yNjQxMg_b7957540-1f8b-4254-8943-e92052bd7de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21defeb3de3d4f229983ffbf2177bdbf_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS03LTEtMS0yNjQxMg_14729de8-a388-4c60-a463-3404d621926a">964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfNDA1NA_df83aef7-88a0-494d-8bb7-95740f0a26ff" continuedAt="i4f19205f698044cf9b67a6a2ec7b5ce4" escape="true">Revenue Recognition</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i4f19205f698044cf9b67a6a2ec7b5ce4" continuedAt="i0c50578cccc8431ca3432e23c30bea42"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at the point in time in which the customer obtains control of the products, per the agreed shipping terms in the respective market. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Amounts received for unshipped merchandise are recorded as deferred revenue. Membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within <ix:nonNumeric contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" name="natr:RevenuefromContractwithCustomerRefundPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMTQxNA_e7edbe3b-8807-4dad-bdf6-2e4242dd53c8">ninety days</ix:nonNumeric> of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="i0c50578cccc8431ca3432e23c30bea42"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Liabilities - Customer Loyalty Programs</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have offered loyalty point programs which allowed customers to earn loyalty points on personal orders. Loyalty points were recorded as contract liabilities in deferred revenue. These programs were accounted for as a reduction in the transaction price and generally recognized as points that were redeemed for additional products. During the year ended December 31, 2020 these programs were discontinued. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="loyaltypoint" contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331" decimals="INF" name="natr:CustomerLoyaltyProgramLoyaltyPoints" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzAxNg_129ce1f1-8fbe-416d-968b-0c683c3196f2">no</ix:nonFraction> outstanding loyalty points.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into <ix:nonFraction unitRef="productcategory" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="INF" name="natr:NumberofPrincipalCategoriesofProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzEwNQ_bd48a613-3a4a-4233-a568-2b0b0c942e49">six</ix:nonFraction> principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have <ix:nonFraction unitRef="segment" contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzIyNg_9e1ccab8-be2e-4379-9727-5451f2efabf4">four</ix:nonFraction> business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy&#174; WorldWide brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense volume incentives when incurred because the amortization period would have been one year or less.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our contracts with customers have a duration of less than <ix:nonNumeric contextRef="i838fe1c774584db3baff30093827a885_D20220101-20220331" name="natr:ContractWithCustomerContractTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzk3OQ_4fa27199-4e93-484c-96c0-4e3828e58b8f">one year</ix:nonNumeric>. The value of any unsatisfied performance obligations is insignificant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in this report, as well as the consolidated financial statements, the notes thereto, and management&#8217;s discussion and analysis included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, and our other reports filed since the date of such Form&#160;10-K.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent consultants market and sell our products to customers and sponsor other independent consultants who also market our products to customers. Our sales are highly dependent upon the number and productivity of our independent consultants. Growth in sales volume generally requires an increase in the productivity of our independent consultants and/or growth in the total number of independent consultants. We seek to motivate and provide incentives to our independent consultants by offering high quality products and providing independent consultants with product support, training seminars, sales conventions, travel programs and financial incentives.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In or about December 2019, a novel strain of coronavirus, SARS-CoV-2 &#8220;COVID-19&#8221;, began aggressively spreading throughout the world, including all the primary markets where we conduct business. As COVID-19 has spread throughout the world, it has impacted our markets differently. At various times during the course of the pandemic and throughout our markets, governments have issued orders and restrictions that have limited the ability of our consultants to meet with consumers, put downward pressure on our sales in many of our markets and added substantial uncertainties to our global supply chain. We continue to take actions to mitigate the effects COVID-19 may have on our business, such actions may ultimately be insufficient to avoid substantial impact on the consolidated financial statement or material health of the Company. At this time, the duration of any business disruption and related financial impact cannot be reasonably estimated.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is likely. In response to the ongoing conflict in Ukraine, we have currently suspended the shipment of products to Russia. However, our consultants in our Russia and Other market, a market within our Europe business segment that includes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Russia, Ukraine, Belarus and other Common Independent States in the region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, continue to operate their independent businesses, albeit at a reduced level than prior to the start of the conflict. We have recorded a pretax charge of $3.1&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the first quarter of 2022, primarily related to the impairment of inventory, as well as accruals for contractual obligations related to Russian operations. We expect that this will continue to impact our business for the foreseeable future. We will continue monitoring the social, political, regulatory and economic environment in Ukraine and Russia, and will consider further actions as appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, Russia and Other had net sales and operating income of $61.4 million and $5.8 million, respectively. For the three months ended March 31, 2022, net sales were $14.5 million and operating income was $1.2 million, prior to the charges noted above. As of March 31, 2022, Russia and Other had assets of $4.2 million which primarily consisted of inventories. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More broadly, there could be additional negative impacts to our net sales, earnings and cash flows should the situation escalate beyond its current scope, including, among other potential impacts, economic recessions in certain neighboring countries or globally due to inflationary pressures and supply chain cost increases or the geographic proximity of the war relative to the rest of Europe. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the inflation rate in the U.S. began to increase significantly. In 2022, the inflation rate increase accelerated and during the three months ended March 31, 2022, was the highest in 40 years. Our operations can be adversely impacted by inflation, primarily from higher costs of raw materials, labor, production and transportation costs.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we experienced an increase in our consolidated net sales of 7.9 percent (or 10.3 percent in local currencies) compared to the same period in 2021. Asia net sales increased approximately 29.0 percent (or 34.1 percent in local currencies) compared to the same period in 2021. Europe net sales decreased approximately 1.9 percent (or increased 0.6 percent in local currencies) compared to the same period in 2021. North America net sales decreased approximately 4.7 percent </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(or 4.7 percent in local currencies) compared to the same period in 2021. Latin America and Other net sales decreased approximately 1.2 percent (or 0.2 percent in local currencies) compared to the same period in 2021. The strengthening of the U.S. dollar versus the local currencies, primarily in our Asian and European markets, resulted in an approximate 2.4 percent, or $2.5 million, decrease of our net sales during the quarter.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $7.5 million during the three months ended March&#160;31, 2022, compared to the same period in 2021, and as a percentage of net sales were 31.2 and 26.3 percent for the three months ended March&#160;31, 2022 and 2021, respectively. The increase in cost of sales percentage is primarily due to changes in inventory valuation reserves as a result of the conflict between Russia and Ukraine, as well as reserves for other markets, changes in market mix, persistent inflation, and increases in raw materials, production and transportation costs. For the three months ended March&#160;31, 2022, we had incremental valuation charges of $4.2&#160;million related to inventory. Of that amount $3.1&#160;million related to the conflict between Russia and Ukraine, and $1.1&#160;million related to changes in forecast demand and production issues, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In absolute terms, selling, general and administrative expenses increased $7.1 million during the three months ended March&#160;31, 2022, compared to the same period in 2021, and as a percentage of net sales were 36.8 percent and 32.8 percent for the three months ended March 31, 2022 and 2021, respectively. The dollar increase in selling, general and administrative expenses was primarily related to higher service fees that resulted from growth in China's net sales, increased selling costs and direct marketing spend intended to drive growth, increase in expected level of convention and distributor events, as well as growth in markets with higher variable costs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an international business, we have significant sales and costs denominated in currencies other than the U.S. Dollar. Sales in international markets denominated in foreign currencies are expected to continue to represent a substantial portion of our sales. Likewise, we expect foreign markets with functional currencies other than the U.S. Dollar will continue to represent a substantial portion of our overall sales and related operating expenses. Accordingly, changes in foreign currency exchange rates could materially affect sales and costs or the comparability of sales and costs from period to period as a result of translating foreign markets financial statements into our reporting currency.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our unaudited consolidated operating results from continuing operations in U.S. dollars and as a percentage of net sales for the three months ended March&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,326)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income&#160;taxes</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,702&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,707)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,686)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,838)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International operations have provided, and are expected to continue to provide, a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the U.S. dollar against foreign currencies. In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, in addition to comparing the percent change in net sales from one period to another in U.S. dollars, we present net sales excluding the impact of foreign exchange fluctuations. We compare the percentage change in net sales from one period to another period by excluding the effects of foreign currency exchange as shown below. Net sales excluding the impact of foreign exchange fluctuations is not a U.S. GAAP financial measure and removes from net sales in U.S. dollars the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries, by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. However, net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP. Throughout the last five years, foreign currency exchange rates have fluctuated significantly. See Item 3.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in net sales by operating segment with a reconciliation to net sales excluding the impact of currency fluctuations for the three months ended March&#160;31, 2022 and 2021 (dollar amounts in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Sales&#160;by&#160;Operating&#160;Segment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact&#160;of<br/>Currency<br/>Exchange</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change<br/>Excluding<br/>Impact&#160;of<br/>Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,467)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales for the three months ended March&#160;31, 2022 and 2021, were $110.5 million and $102.4 million, respectively, which represents an increase of 7.9 percent. The increase for the three months ended March&#160;31, 2022, was primarily related to notable product sales growth in our Asia operating segment. Excluding the impact of foreign currency exchange rate fluctuations, consolidated net sales for the three months ended March&#160;31, 2022, increased 10.3 percent from the same period in 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Asia for the three months ended March&#160;31, 2022 and 2021, were $46.1 million and $35.8 million, respectively, or an increase of 29.0 percent. In local currency, net sales for the three months ended March&#160;31, 2022, increased 34.1 percent compared to the same period in 2021. Fluctuations in foreign exchange rates had an unfavorable impact on net sales of $1.9 million for the three months ended March&#160;31, 2022.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notable activity in the following markets contributed to the results of Asia:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our South Korea market, net sales decreased $1.2 million, or 7.8 percent, for the three months ended March&#160;31, 2022, compared to the same period in 2021. In local currency, net sales for the three months ended March&#160;31, 2022, decreased 0.3 percent, compared to the same period in 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Japan market, net sales increased $1.6 million, or 20.9 percent, for the three months ended March&#160;31, 2022, compared to the same period in 2021. In local currencies, net sales for the three months ended March&#160;31, 2022, increased 32.6 percent, compared to the same period in 2021. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our China market, net sales increased $4.0 million, or 48.2 percent, for the three months ended March&#160;31, 2022, compared to the same period in 2021. In local currencies, net sales for the three months ended March&#160;31, 2022, increased 45.8 percent, compared to the same period in 2021. We attribute the growth in net sales primarily to initiatives designed to increase independent service providers&#8217; engagement levels and gain market share. During March 2022, the government has instituted additional restrictions in the market intended to slow the spread of COVID-19, that may impact our sales activities during the rest of 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Taiwan market, net sales increased $7.0 million, or 252.2 percent, for the three months ended March&#160;31, 2022, compared to the same period in 2021. In local currencies, net sales for the three months ended March&#160;31, 2022, increased 251.0 percent, compared to the same period in 2021. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Europe</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Europe for the three months ended March&#160;31, 2022, were $21.8 million, compared to $22.2 million for the same period in 2021, or a decrease of 1.9 percent. In local currency, net sales for the three months ended March&#160;31, 2022, increased 0.6 percent, compared to the same period in 2021. The functional currency for many of these markets is the U.S. Dollar which reduces the effect from foreign currency fluctuations. Fluctuations in foreign exchange rates had an unfavorable impact on net sales of $0.6 million for the three months ended March&#160;31, 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">North America</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to North America for the three months ended March&#160;31, 2022, were $36.0 million, compared to $37.8 million for the same period in 2021, or a decrease of 4.7 percent. In local currency, net sales for the three months ended March&#160;31, 2022, decreased 4.7 percent, compared to the same period in 2021. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, net sales decreased $1.7 million, or 4.8 percent, for the three months ended March&#160;31, 2022, respectively, compared to the same period in 2021. The decrease in sales is due primarily to stock outs of certain products as a result of supply chain challenges, and a reduction in the average order size attributed to customer sensitivity due to inflationary pressures, among other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Latin America and Other</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Latin America and Other markets for the three months ended March&#160;31, 2022, were $6.6 million, compared to $6.7 million for the same period in 2021, or a decrease of 1.2 percent, respectively. In local currency, net sales for the three months ended March&#160;31, 2022, decreased 0.2 percent, compared to the same period in 2021. Fluctuations in foreign currency had unfavorable impacts on net sales of $0.1 million for the three months ended March&#160;31, 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information related to our Asia, Europe, North America, and Latin America and Other business segments is set forth in Note 7 to the Unaudited Condensed Consolidated Financial Statements in Part&#160;1,&#160;Item 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales as a percent of net sales was 31.2 percent for the three months ended March&#160;31, 2022, compared to 26.3 percent for the same period in 2021. The increase in cost of sales percentage is primarily due to changes in inventory valuation reserves as a result of the conflict between Russia and Ukraine, as well as reserves for other markets, changes in market mix, persistent inflation, and increases in raw materials, production and transportation costs. For the three months ended March&#160;31, 2022, we had incremental valuation charges of $4.2&#160;million related to inventory. Of that amount $3.1&#160;million related to the conflict between Russia and Ukraine, and $1.1&#160;million related to changes in forecast demand and production issues, among other factors.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volume Incentives</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives expense as a percent of net sales was 30.9 percent for the three months ended March&#160;31, 2022, respectively, compared to 33.4 percent for the same period in 2021. These payments are designed to provide incentives for reaching certain sales levels. Volume incentives vary slightly, on a percentage basis, by product due to pricing policies and commission plans in place in our various operations. We do not pay volume incentives in China, instead we pay independent service fees which are included in selling, general and administrative expenses. Volume incentives as a percentage of net sales can fluctuate based on promotional activity and mix of sales by market. The decrease in volume incentives as a percent of net sales is primarily due to change in market mix, reflecting growth in markets where volume incentives as a percentage of net sales are lower than the consolidated average, and the growth in NSP China. The decrease also reflects cost savings from the September 2020 launch of our new consultant sales and compensation plan in North America and LATAM.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses represent operating expenses, components of which include labor and benefits, sales events, professional fees, travel and entertainment, marketing, occupancy costs, communications costs, bank fees, depreciation and amortization, independent services fees paid in China, and other miscellaneous operating expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by $7.1 million, to $40.6 million for the three months ended March&#160;31, 2022, compared to the same period in 2021. Selling, general and administrative expenses were 36.8 percent of net sales for the three months ended March&#160;31, 2022, compared to 32.8 percent for the same period in 2021. The dollar increase in selling, general and administrative expenses was primarily related to higher service fees that resulted from growth in China's net sales, increased selling costs and direct marketing spend intended to drive growth, increase in expected level of convention and distributor events, as well as growth in markets with higher variable costs.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Loss, Net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other loss, net, for the three months ended March&#160;31, 2022, was $0.3 million, compared to $1.9 million during the same period in 2021. Other loss, for the three months ended March&#160;31, 2022 and 2021 primarily consisted of foreign exchange gains and losses as a result of overall unfavorable net changes in foreign currencies primarily in Asia, Europe and Latin America.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 369.9 percent and 27.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The large increase in the rate for the current period is primarily attributed to recording a valuation allowance against deferred tax assets which are expected to expire before utilization. The current conflict between Russia and Ukraine has created significant uncertainty in our ability to utilize existing foreign tax credits. The carryforward period for many of these existing credits expires in 2024. This is a matter which requires significant accounting estimates and actual results could differ from these estimates.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Categories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our line of over 700 products includes several product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. We purchase herbs and other raw materials in bulk, and after rigorous quality control testing, we formulate, encapsulate, tablet or concentrate them, label and package them for shipment. Most of our products are manufactured at our facility in Spanish Fork, Utah. Contract manufacturers produce some of our products in accordance with our specifications and standards. We have implemented stringent quality control procedures to verify that our contract manufacturers have complied with our specifications and standards.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 7, Segment Information, for a summary of the U.S. dollar amounts from the sale of general health, immune, cardiovascular, digestive, personal care and weight management products for the three months ended March&#160;31, 2022 and 2021, by business segment.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution and Marketing</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products primarily through our network of independent consultants, who market our products to customers through direct selling techniques and sponsor other independent consultants who also market our products to customers. We seek to motivate and provide incentives to our independent consultants by offering high quality products and providing independent consultants with product support, training seminars, sales conventions, travel programs and financial incentives.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products sold in the United States are shipped directly from our manufacturing and warehouse facilities located in Spanish Fork, Utah, as well as from our regional warehouses located in Georgia, Ohio and Texas. Many of our international operations maintain warehouse facilities and inventory to supply their independent consultants. However, in foreign markets where we do not maintain warehouse facilities, we have contracted with third-parties to distribute our products and provide support services to our force of independent consultants.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, we generally sell our products on a cash or credit card basis. From time to time, our U.S. operations extend short-term credit associated with product promotions. For certain of our international operations, we use independent distribution centers and offer credit terms that are generally consistent with industry standards within each respective country.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay sales commissions, or &#8220;volume incentives&#8221; to our independent consultants based upon their own product sales and the product sales of their sales organization. As an exception, in NSP China, we do not pay volume incentives; rather, we pay independent service fees, which are included in selling, general and administrative expenses. These volume incentives are recorded as an expense in the year earned. The amounts of volume incentives that we expensed during the quarters ended March&#160;31, 2022 and 2021, are set forth in the Condensed Consolidated Financial Statements in Item 1 of this report. In addition to the opportunity to receive volume incentives, independent consultants who attain certain levels of monthly product sales are eligible for additional incentive programs including automobile allowances, sales convention privileges and travel awards.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal use of cash is to pay for operating expenses, including volume incentives, inventory and raw material purchases, capital assets and funding of international expansion. As of March&#160;31, 2022, working capital was $80.3 million, compared to $88.0 million as of December&#160;31, 2021. At March&#160;31, 2022, we had $66.5 million in cash, of which $8.5 million was held in the U.S. and $58.0 million was held in foreign markets and may be subject to various withholding taxes and other restrictions related to repatriation before becoming available to be used along with the normal cash flows from operations to fund any unanticipated shortfalls in future cash flows.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net consolidated cash inflows (outflows) are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, operating activities used cash of $7.9 million, compared to providing cash of $2.7 million in the same period in 2021. Operating cash flows decreased primarily due to increased inventory purchases before any changes in reserves and timing of payments on accounts payable and accrued liabilities partially offset by the timing of receivable payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, investing activities used $1.5 million, compared to $1.0 million for the same period in 2021. Capital expenditures related to the purchase of equipment, computer systems and software for the three months ended March&#160;31, 2022 and 2021, were $1.5 million and $1.0 million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, financing activities used $9.4 million, compared to providing $1.3 million in cash for the same period in 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we used cash to repurchase 451,000 shares of our common stock under the share repurchase program for $8.0 million. At March&#160;31, 2022, the remaining balance available for repurchases under the program was $29.6 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a revolving credit agreement with Bank of America, N.A (the &#8220;Credit Agreement&#8221;), as well as a credit agreement with Banc of America Leasing and Capital, LLC (the "Capital Credit Agreement"). During the three months ended March&#160;31, 2022, we made no additional borrowings from either agreement. At March&#160;31, 2022, there was no outstanding balance under the Credit Agreement. During the three months ended March&#160;31, 2022 we made monthly payments of $0.1&#160;million pursuant to the Capital Credit Agreement. As of March&#160;31, 2022, there was $2.1&#160;million outstanding balance under the Capital Credit Agreement, $1.3&#160;million of which was classified as current. Our debt obligations are discussed in greater detail in Note 4, &#8220;Revolving Credit Facility and Other Obligations,&#8221; to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash generated from operations, along with available cash and cash equivalents, will be sufficient to fund our normal operating needs, including capital expenditures, on both a short- and long-term basis.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Events, such as a prolonged economic downturn, an increase in geopolitical issues, a decrease in demand for our products, an unfavorable settlement of our unrecognized tax positions or non-income tax contingencies could adversely affect our long-term liquidity.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and form the basis for the following discussion and analysis on critical accounting policies and estimates. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On a regular basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations. We have discussed the development, selection and disclosure of these estimates with the Board of Directors and our Audit Committee.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in Item 8 of the Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. We believe the critical accounting policies and estimates described below reflect our more significant estimates and assumptions used in the preparation of the consolidated financial statements. The impact and any associated risks on our business that are related to these policies are also discussed throughout this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; where such policies affect reported and expected financial results.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue recognition practices are discussed in Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue Recognition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are adjusted to lower of cost and net realizable value, using the first-in, first-out method. The components of inventory cost include raw materials, labor and overhead. To estimate any necessary adjustments, various assumptions are made in regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning and market conditions. If future demand and market conditions are less favorable than our assumptions, additional inventory adjustments could be required.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Trip Accrual</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for expenses associated with our direct sales program, which rewards independent consultants with paid attendance for incentive trips, including our conventions and meetings. Expenses associated with incentive trips are accrued over qualification periods as they are earned. We specifically analyze incentive trip accruals based on historical and current sales trends as well as contractual obligations when evaluating the adequacy of the incentive trip accrual. Actual results could generate liabilities more or less than the amounts recorded.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in certain legal proceedings and disputes. When a loss is considered probable in connection with litigation or non-income tax contingencies and when such loss can be reasonably estimated with a range, we record our best estimate within the range related to the contingency. If there is no best estimate, we record the minimum of the range. As additional information becomes available, we assess the potential liability related to the contingency and revise the estimates. Revision in estimates of the potential liabilities could materially affect our results of operations in the period of adjustment. Our contingencies are discussed in further detail in Note 10, &#8220;Commitments and Contingencies&#8221;, to the Notes of our Condensed Consolidated Financial Statements, of Item 1, Part&#160;1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes, deferred tax assets and liabilities and contingent reserves reflect management&#8217;s best assessment of estimated future taxes to be paid. We are subject to income taxes in both the United States and numerous foreign jurisdictions. Significant judgments and estimates are required in determining our consolidated provision for income taxes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, management considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, we develop assumptions including the amount of future state, federal and foreign pretax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income, and are consistent with the plans and estimates that we are using to manage the underlying businesses. Valuation allowances are recorded as reserves against net deferred tax assets by us when it is determined that net deferred tax assets are not likely to be realized in the foreseeable future.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes that would have a material effect on our results of operations, cash flows or financial position.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized.</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several countries and intend to grow our international operations. Net sales, operating income and net income are affected by fluctuations in currency exchange rates, interest rates and other uncertainties inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks associated with changes in social, political and economic conditions inherent in international operations, including changes in the laws and policies that govern international investment in countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment. For further information, see Part II, Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;under the Exchange Act) are designed to provide reasonable assurance that the information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules&#160;and forms adopted by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Officer, to allow timely decisions regarding required disclosures. Our management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March&#160;31, 2022. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March&#160;31, 2022, at the reasonable assurance level.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting (as defined in Rule&#160;13a-15(f)&#160;under the Exchange Act) during the quarter ended March&#160;31, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II OTHER INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the information set forth in this report, you should carefully consider the risks discussed under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, which could have a material adverse effect on our business or consolidated financial statements, results of operations, and cash flows. Additional risks not currently known, or risks that are currently believed to be not material, may also impair business operations.&#160;There have been no material changes to our risk factors since the filing of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, except as set forth below.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geopolitical issues, conflicts and other global events could adversely affect our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because a substantial portion of our business is conducted outside of the United States, our business is subject to global political issues and conflicts. Such political issues and conflicts could have a material adverse effect on our results of operations and financial condition if they escalate in areas in which we do business. In addition, changes in and adverse actions by governments in foreign markets in which we do business could have a material adverse effect on our results of operations and financial condition. Russia&#8217;s invasion of Ukraine and the continuing war between Russia and Ukraine has negatively impacted our operations in both countries and the region. In fiscal 2021, operations in our Russia and Other market, a market within our Europe business segment that includes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Russia, Ukraine, Belarus and other Common Independent States in the region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, accounted for 13.8% of net sales. As of March 31, 2022, Russia and Other had assets of $4.2 million which primarily consisted of inventories and accounts receivable. We are unable to estimate future impacts to our business due to the high level of uncertainty as to how the war will evolve, its duration, and its ultimate resolution. Within Ukraine, there is a possibility of loss of life, physical damage and destruction of property, and loss of earning opportunities for many of our independent distributors and dealers. We may not be able to operate in many areas due to damage and safety concerns. Within Russia, we may need to further reduce our operations due to sanctions and counter sanctions, currency or payment controls, and supply chain challenges. Certain suppliers, vendors, independent distributors and customers are all impacted by the war and their ability to successfully maintain their operations could also impact our results of operations or product sales throughout the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing coronavirus pandemic and the responses thereto around the world could adversely impact our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, governments around the world have issued orders restricting travel, the number of people who may gather, or for their citizens to shelter-in-place to slow the spread of COVID-19. Such orders, restrictions and recommendations have resulted in widespread closures of businesses not deemed &#8220;essential,&#8221; work stoppages, limitations on the number of people allowed to gather in one location, slowdowns and delays in world-wide supply chains, work-from-home policies, travel restrictions and cancellation of events, among other effects. In particular, travel and logistics restrictions, shelter-in-place orders and other measures, including working remotely, social distancing and other policies implemented in foreign and domestic sites to protect the health and safety of employees, have resulted in, and are expected to continue to result in, transportation disruptions (such as reduced availability of air transport, port closures, and increased border controls or closures), production delays and capacity limitations at our facilities and some of our customers and suppliers, as well as reduced workforce availability or productivity. These and other adverse impacts on our supply chain could limit our ability to obtain required materials in a timely manner, maintain adequate inventory levels, and respond to changes in customer demand, which could adversely affect our business and result of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duration and extent of COVID-19&#8217;s impact on our business are difficult to assess or predict. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While conditions related to the pandemic generally have improved in 2022 compared to 2021, conditions vary significantly by geography. For example, late in the first quarter of 2022, an increase of COVID-19 related cases in certain parts of China resulted in the re-imposition of widespread lock-downs and restrictions. Stay-at-home and quarantine mandates have disrupted or halted our operations in certain parts of China and may continue to impact our business in the near-term. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further quarantines, government reactions or shutdowns could disrupt or halt our operations and materially harm our business, financial condition and results of operations. Our manufacturing personnel and other employees could also be affected by COVID-19, potentially reducing their availability, and a widespread outbreak of COVID-19 among our manufacturing or supply-chain employees could disrupt or halt our operations. Further, restrictions on gatherings of individuals may limit the ability of our independent consultants to sell our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products. Additionally, the procedures we take to mitigate the effect of COVID-19 on our workforce, including but not limited to, social distancing and additional sanitizing measures, could reduce the efficiency of our operations, increase our operating costs or prove insufficient to protect our employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High inflation and other difficult economic conditions could adversely affect our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer spending, including spending for our products, is affected by, among other things, prevailing economic conditions, including, among others, unemployment rates, inflation, fuel prices, salaries and wages, the availability of consumer credit, consumer confidence and consumer perception of economic conditions. According to the U.S. Bureau of Labor Statistics, during the twelve-month period ending March 31, 2022, the consumer price index, a measure of the average change over time in the prices paid by consumers, increased by 8.5 percent, which is the highest level of inflation in the U.S. in over forty years. Europe and other areas in which we do business are also experiencing higher than desired inflation. Inflation may require consumers to reconsider purchases of items they consider nonessential and, as a result, consumers may purchase fewer of our products if they consider our products nonessential. We believe high levels of inflation in the U.S. and other regions in which we do business have resulted, and will continue to result, in lower net sales of our products. A prolonged period of high inflation and other unfavorable economic conditions that adversely affect the ability of consumers to pay for our products could have a material adverse effect on our business, financial condition, cash flows, and results of operations.</span></div><div><span><br/></span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchases of our common stock during the fiscal quarter ended March&#160;31, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Periods</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs<br/>&#160;(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 to January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2022 to February 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022 to March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. We purchased 451,000 shares of our common stock during the quarter ended March&#160;31, 2022 under the terms of this Board approved plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual timing, number, and value of common shares repurchased under our board-approved plan will be determined at our discretion and will depend on a number of factors, including, among others, general market and business conditions, the trading price of common shares, and applicable legal requirements. We have no obligation to repurchase any common shares under the authorization, and the repurchase plan may be suspended, discontinued, or modified at any time for any reason.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Index to Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022331-ex311.htm">Certification of Chief Executive Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022331-ex312.htm">Certification of Chief Financial Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022331-ex321.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350 Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022331-ex322.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350 Financial Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page Interactive Data File (the cover page XBRL tags are embedded within iXBRL (Inline Extensible Business Reporting Language) document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)&#160;&#160;&#160;&#160;Filed currently herewith.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="iad9c48b421394fa9a1823d9ecbbcf337_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iad9c48b421394fa9a1823d9ecbbcf337_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">s Sunshine Products, Inc.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Terrence O. Moorehead</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joseph W. Baty</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph W. Baty, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>natr2022331-ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id5f3c2c6cc234edcaa9b4df1b7d14cbc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Terrence O. Moorehead, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (&#8220;the registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>natr2022331-ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i59a94be1fc674f9d826bd7beea30ee8b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joseph W. Baty, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph W. Baty</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph W. Baty</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>natr2022331-ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6d8cd1137032421d873e75f558dfab57_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Terrence O. Moorehead, President and Chief Executive Officer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>natr2022331-ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i733120b395ea49338540dcf55191f9d2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Joseph W. Baty, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph W. Baty</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph W. Baty</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>natr-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:natr="http://naturessunshine.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://naturessunshine.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://naturessunshine.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL">
        <link:definition>1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://naturessunshine.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://naturessunshine.com/role/BasisofPresentationDetails">
        <link:definition>2403402 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://naturessunshine.com/role/Inventories">
        <link:definition>2104102 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://naturessunshine.com/role/InventoriesTables">
        <link:definition>2305301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://naturessunshine.com/role/InventoriesDetails">
        <link:definition>2406403 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTrading" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading">
        <link:definition>2107103 - Disclosure - Investment Securities - Trading</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTradingDetails" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails">
        <link:definition>2408404 - Disclosure - Investment Securities - Trading (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligations" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations">
        <link:definition>2109104 - Disclosure - Revolving Credit Facility and Other Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligationsDetails" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails">
        <link:definition>2410405 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://naturessunshine.com/role/NetIncomeLossPerShare">
        <link:definition>2111105 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://naturessunshine.com/role/NetIncomeLossPerShareTables">
        <link:definition>2312302 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareDetails" roleURI="http://naturessunshine.com/role/NetIncomeLossPerShareDetails">
        <link:definition>2413406 - Disclosure - Net Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactions" roleURI="http://naturessunshine.com/role/CapitalTransactions">
        <link:definition>2114106 - Disclosure - Capital Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsTables" roleURI="http://naturessunshine.com/role/CapitalTransactionsTables">
        <link:definition>2315303 - Disclosure - Capital Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsNarrativeDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails">
        <link:definition>2416407 - Disclosure - Capital Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsStockOptionActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails">
        <link:definition>2417408 - Disclosure - Capital Transactions - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsRSUActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails">
        <link:definition>2418409 - Disclosure - Capital Transactions - RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://naturessunshine.com/role/SegmentInformation">
        <link:definition>2119107 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://naturessunshine.com/role/SegmentInformationTables">
        <link:definition>2320304 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://naturessunshine.com/role/SegmentInformationDetails">
        <link:definition>2421410 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://naturessunshine.com/role/IncomeTaxes">
        <link:definition>2122108 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://naturessunshine.com/role/IncomeTaxesDetails">
        <link:definition>2423411 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://naturessunshine.com/role/CommitmentsandContingencies">
        <link:definition>2124109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2425412 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://naturessunshine.com/role/RelatedPartyTransactions">
        <link:definition>2126110 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2427413 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://naturessunshine.com/role/FairValueMeasurements">
        <link:definition>2128111 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables">
        <link:definition>2329305 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails">
        <link:definition>2430414 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://naturessunshine.com/role/RevenueRecognition">
        <link:definition>2131112 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>2432415 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="natr_DigestiveProductsMember" abstract="true" name="DigestiveProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_FosunPharmaMember" abstract="true" name="FosunPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ChinaJointVentureMember" abstract="true" name="ChinaJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_A2012IncentivePlanMember" abstract="true" name="A2012IncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ImmunityProductsMember" abstract="true" name="ImmunityProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_CardiovascularProductsMember" abstract="true" name="CardiovascularProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" abstract="true" name="BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ContributionMarginAbstract" abstract="true" name="ContributionMarginAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" abstract="false" name="MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" abstract="true" name="PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" abstract="true" name="DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_TimeBasedStockOptionsMember" abstract="true" name="TimeBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_PerformanceBasedRestrictedStockUnitsRSUsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ContractWithCustomerContractTerm" abstract="false" name="ContractWithCustomerContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedfromComputationofEarnings" abstract="false" name="DilutiveSecuritiesExcludedfromComputationofEarnings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_LatinAmericaAndOtherSegmentMember" abstract="true" name="LatinAmericaAndOtherSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NumberofPrincipalCategoriesofProducts" abstract="false" name="NumberofPrincipalCategoriesofProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_CompanysJointVenturePartnerMember" abstract="true" name="CompanysJointVenturePartnerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_RevenuefromContractwithCustomerRefundPeriod" abstract="false" name="RevenuefromContractwithCustomerRefundPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_OperatingLeaseNonCashLeaseExpense" abstract="false" name="OperatingLeaseNonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_LineOfCreditFacilityNumberOfSeparateIncreases" abstract="false" name="LineOfCreditFacilityNumberOfSeparateIncreases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" abstract="false" name="ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" abstract="true" name="AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_PersonalCareProductsMember" abstract="true" name="PersonalCareProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_CustomerLoyaltyProgramLoyaltyPoints" abstract="false" name="CustomerLoyaltyProgramLoyaltyPoints" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_BankofAmericaCreditAgreementMember" abstract="true" name="BankofAmericaCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_GeneralHealthProductsMember" abstract="true" name="GeneralHealthProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_AccruedSeveranceandRentCostsMember" abstract="true" name="AccruedSeveranceandRentCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" abstract="false" name="IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_VolumeIncentives" abstract="false" name="VolumeIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_WeightManagementProductsMember" abstract="true" name="WeightManagementProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_RestrictionPeriodForIssuanceOfShares" abstract="false" name="RestrictionPeriodForIssuanceOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NaturesSunshineProductsChinaMember" abstract="true" name="NaturesSunshineProductsChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NonIncomeTaxMember" abstract="true" name="NonIncomeTaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_DebtInstrumentNumberOfMonthlyPayments" abstract="false" name="DebtInstrumentNumberOfMonthlyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_NorthAmericaSegmentMember" abstract="true" name="NorthAmericaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_AccruedVolumeIncentiveandServiceFees" abstract="false" name="AccruedVolumeIncentiveandServiceFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_IndicativeIndexMember" abstract="true" name="IndicativeIndexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_TimeBasedRestrictedStockUnitsRSUsMember" abstract="true" name="TimeBasedRestrictedStockUnitsRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" abstract="true" name="ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" abstract="false" name="IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_AsiaSegmentMember" abstract="true" name="AsiaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>natr-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b4425258-8538-4ff1-90d9-564953af1d79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_AccountsPayableCurrent_b4425258-8538-4ff1-90d9-564953af1d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_fa7f10ba-9a6d-40f6-bc44-04b225e7e40c" xlink:href="natr-20220331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_fa7f10ba-9a6d-40f6-bc44-04b225e7e40c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_79ee3e52-9d13-4797-8f50-1a375465241d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_79ee3e52-9d13-4797-8f50-1a375465241d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f6a9247d-4c9a-4595-b027-857dc1bc0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f6a9247d-4c9a-4595-b027-857dc1bc0f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_a861680a-674a-4b50-a709-7aed9165a474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_a861680a-674a-4b50-a709-7aed9165a474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_41054316-2208-44ec-a7a0-3a6afbefb2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_41054316-2208-44ec-a7a0-3a6afbefb2ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_51a16b88-f94c-4c24-9a2d-d3c202b93452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_51a16b88-f94c-4c24-9a2d-d3c202b93452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2aa7aed6-7a8c-4d35-a5b9-0ec6d63d9157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6106625e-5c4e-4b27-9133-2608b3a94be7" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2aa7aed6-7a8c-4d35-a5b9-0ec6d63d9157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f7a3a7b-5578-4f54-bd8a-eee6472d1b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fc4264da-8917-4520-aa50-96bc2aafec59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f7a3a7b-5578-4f54-bd8a-eee6472d1b9a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fc4264da-8917-4520-aa50-96bc2aafec59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_80599287-f995-4930-8525-3171d2402f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f7a3a7b-5578-4f54-bd8a-eee6472d1b9a" xlink:to="loc_us-gaap_MinorityInterest_80599287-f995-4930-8525-3171d2402f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_89b3f192-ace4-4b88-bbad-f13e6debe4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f7a3a7b-5578-4f54-bd8a-eee6472d1b9a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_89b3f192-ace4-4b88-bbad-f13e6debe4ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42d33b4a-deda-4e8a-ac84-42762d22247a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f7a3a7b-5578-4f54-bd8a-eee6472d1b9a" xlink:to="loc_us-gaap_CommonStockValue_42d33b4a-deda-4e8a-ac84-42762d22247a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a4d7595e-e467-425c-9b7e-2bd3a0e5a61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_LiabilitiesCurrent_a4d7595e-e467-425c-9b7e-2bd3a0e5a61c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc015693-4308-441f-9056-0ad7f3fd22c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc015693-4308-441f-9056-0ad7f3fd22c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_8fd381a2-2fee-47f8-b134-2b13dcf79e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_LongTermNotesPayable_8fd381a2-2fee-47f8-b134-2b13dcf79e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_05022b6e-4cac-4279-9d87-905037d47ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_05022b6e-4cac-4279-9d87-905037d47ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_202b8079-1fbc-4f39-9def-c3b9a739fa1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_202b8079-1fbc-4f39-9def-c3b9a739fa1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_78fa36a8-5517-446d-8bc6-e695c77868ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_988d6cd4-fba1-458e-9dd4-85207f523d52" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_78fa36a8-5517-446d-8bc6-e695c77868ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_23cc62a9-0bef-4ee3-a05f-ac88a94bdb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_24ca9e8b-1bbf-47d2-b2c5-b0efafbe2203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_23cc62a9-0bef-4ee3-a05f-ac88a94bdb55" xlink:to="loc_us-gaap_Liabilities_24ca9e8b-1bbf-47d2-b2c5-b0efafbe2203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42cc89c0-e781-4d59-b85f-51aee948e7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_23cc62a9-0bef-4ee3-a05f-ac88a94bdb55" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42cc89c0-e781-4d59-b85f-51aee948e7c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0f606029-c41a-4b17-bb51-6e6fdec21e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2264e8a1-47b1-41f6-b002-6a04e8ee24fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f606029-c41a-4b17-bb51-6e6fdec21e3d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2264e8a1-47b1-41f6-b002-6a04e8ee24fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_63458ad9-fabc-42ef-a771-64ef67ea7d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f606029-c41a-4b17-bb51-6e6fdec21e3d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_63458ad9-fabc-42ef-a771-64ef67ea7d7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_170e5581-398b-48a0-8a79-f9144a1d4a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f606029-c41a-4b17-bb51-6e6fdec21e3d" xlink:to="loc_us-gaap_InventoryNet_170e5581-398b-48a0-8a79-f9144a1d4a5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f0d36c97-25d9-4336-8d6b-757328588d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f606029-c41a-4b17-bb51-6e6fdec21e3d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f0d36c97-25d9-4336-8d6b-757328588d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_18d75e1e-a649-43b2-9f3d-ff63bc00dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_AssetsCurrent_18d75e1e-a649-43b2-9f3d-ff63bc00dad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b4be9b6-1b52-4f41-84d5-5a2ea82ecc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b4be9b6-1b52-4f41-84d5-5a2ea82ecc49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bad12126-3509-4afa-aa65-f84c57da0cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bad12126-3509-4afa-aa65-f84c57da0cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_0c430cb4-5f2c-4a48-a345-1f4b3de08618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_0c430cb4-5f2c-4a48-a345-1f4b3de08618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9fbaa83a-d387-4846-890e-6c72255b0054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9fbaa83a-d387-4846-890e-6c72255b0054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8095d903-43d8-4738-9fcc-4d40c88e69f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6cec0673-99d1-4962-a8f7-2588ab6f70aa" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8095d903-43d8-4738-9fcc-4d40c88e69f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bbea0fe4-4f4f-4aff-85a5-0b65e83c8f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83419b51-9411-40e8-9532-076e90e55a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bbea0fe4-4f4f-4aff-85a5-0b65e83c8f73" xlink:to="loc_us-gaap_OperatingIncomeLoss_83419b51-9411-40e8-9532-076e90e55a71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4bfa0ba7-743a-468a-921b-24597d41b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bbea0fe4-4f4f-4aff-85a5-0b65e83c8f73" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4bfa0ba7-743a-468a-921b-24597d41b5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d9c094ac-912a-4343-b878-cc465ee7e027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f7c3f4d3-0f0e-4db5-99ff-e67a5a1bbd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d9c094ac-912a-4343-b878-cc465ee7e027" xlink:to="loc_us-gaap_ProfitLoss_f7c3f4d3-0f0e-4db5-99ff-e67a5a1bbd5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6ea3a748-f245-4769-b4c1-556094bbbeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d9c094ac-912a-4343-b878-cc465ee7e027" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6ea3a748-f245-4769-b4c1-556094bbbeaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0705ab36-3319-4265-8ec3-be2e242df344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e8e85de5-6fdc-4c66-82cd-b24c15085225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0705ab36-3319-4265-8ec3-be2e242df344" xlink:to="loc_us-gaap_GrossProfit_e8e85de5-6fdc-4c66-82cd-b24c15085225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_98363351-a2b2-41c9-ae24-ea2e2cbb07fa" xlink:href="natr-20220331.xsd#natr_VolumeIncentives"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0705ab36-3319-4265-8ec3-be2e242df344" xlink:to="loc_natr_VolumeIncentives_98363351-a2b2-41c9-ae24-ea2e2cbb07fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eca08486-2449-4c60-8a45-2a493e2b88b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0705ab36-3319-4265-8ec3-be2e242df344" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eca08486-2449-4c60-8a45-2a493e2b88b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_770b55cf-6c2a-49d5-95c1-07e6d8ceb2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f45748d0-2533-4ca7-af8d-392f0f4e41a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_770b55cf-6c2a-49d5-95c1-07e6d8ceb2cf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f45748d0-2533-4ca7-af8d-392f0f4e41a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b1c60d1b-8b74-4791-aa78-a852663276b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_770b55cf-6c2a-49d5-95c1-07e6d8ceb2cf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b1c60d1b-8b74-4791-aa78-a852663276b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e03a14d4-74ef-4f7d-9897-cd8b3840be36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_368e36dd-4bf2-4e63-8c6a-36d321993f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_e03a14d4-74ef-4f7d-9897-cd8b3840be36" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_368e36dd-4bf2-4e63-8c6a-36d321993f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4feb386c-c7fd-4984-88b7-f64a0d3a72d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_e03a14d4-74ef-4f7d-9897-cd8b3840be36" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4feb386c-c7fd-4984-88b7-f64a0d3a72d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3c556b8d-7b8d-4ec5-bb1e-34f9b5673454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_47fb578a-3871-49a6-a129-571b82155a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3c556b8d-7b8d-4ec5-bb1e-34f9b5673454" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_47fb578a-3871-49a6-a129-571b82155a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_35efc826-1e82-444d-b167-4506b0aaca92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3c556b8d-7b8d-4ec5-bb1e-34f9b5673454" xlink:to="loc_us-gaap_ProfitLoss_35efc826-1e82-444d-b167-4506b0aaca92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99596d3d-bda5-40a0-bea3-59535f1822d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1f92e54-2aec-4212-87aa-24d9723c4354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99596d3d-bda5-40a0-bea3-59535f1822d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1f92e54-2aec-4212-87aa-24d9723c4354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e82c00e-0da6-4432-83cb-97487b75643d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99596d3d-bda5-40a0-bea3-59535f1822d9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e82c00e-0da6-4432-83cb-97487b75643d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25fa38df-3f20-46c2-9dc5-f0e2826473aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99596d3d-bda5-40a0-bea3-59535f1822d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25fa38df-3f20-46c2-9dc5-f0e2826473aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d124922-63fb-45a7-bc86-af56f96d0ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99596d3d-bda5-40a0-bea3-59535f1822d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d124922-63fb-45a7-bc86-af56f96d0ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9ab01f69-4d8b-4042-8f28-88024d982e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_ProfitLoss_9ab01f69-4d8b-4042-8f28-88024d982e97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0c124ef3-26f2-486e-a9ac-f287973280cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0c124ef3-26f2-486e-a9ac-f287973280cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1a067519-dd30-48b0-aa6b-069030ea4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1a067519-dd30-48b0-aa6b-069030ea4f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_f8355bd6-940c-452c-9065-6afb62d7c3df" xlink:href="natr-20220331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_f8355bd6-940c-452c-9065-6afb62d7c3df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f3e1abce-54d3-4a67-984a-441b57fd7c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_ShareBasedCompensation_f3e1abce-54d3-4a67-984a-441b57fd7c2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_04a2e3aa-fe83-4a2c-b0c2-d48cb26c0521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_04a2e3aa-fe83-4a2c-b0c2-d48cb26c0521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_20044b49-2ee6-4034-b8bb-14801c877ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_20044b49-2ee6-4034-b8bb-14801c877ede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_1b12ca5b-cb01-4df6-8b9d-cb1338fa7b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_1b12ca5b-cb01-4df6-8b9d-cb1338fa7b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_8ffdbeef-aad1-491e-85a4-ac98d69d284d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_GainLossOnInvestments_8ffdbeef-aad1-491e-85a4-ac98d69d284d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84a7827e-40a6-4538-adc7-2db03129b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84a7827e-40a6-4538-adc7-2db03129b0eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e513d680-9a6a-45ad-b1b9-439a6f11b43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e513d680-9a6a-45ad-b1b9-439a6f11b43e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a2c7d741-ab28-44c2-b594-528e7ad3b530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a2c7d741-ab28-44c2-b594-528e7ad3b530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6270824-1cdb-4104-865f-0d145197d771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6270824-1cdb-4104-865f-0d145197d771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6c797023-6325-400d-bdd0-b1ae18face51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6c797023-6325-400d-bdd0-b1ae18face51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f5494eb2-ff3c-4011-a5a6-47f39cdda367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f5494eb2-ff3c-4011-a5a6-47f39cdda367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_17f372a8-e0c7-47fb-ab78-f4c28a42bb3b" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_17f372a8-e0c7-47fb-ab78-f4c28a42bb3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7137d33f-927a-49c2-87bc-bd5fec06a878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7137d33f-927a-49c2-87bc-bd5fec06a878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9a607834-759e-4af6-a72c-f14e01f0c21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9a607834-759e-4af6-a72c-f14e01f0c21b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a155656c-182b-4f22-87bc-973b5e7318e3" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a155656c-182b-4f22-87bc-973b5e7318e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3eee47e6-a0f3-479e-bb56-fa624baf505f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3eee47e6-a0f3-479e-bb56-fa624baf505f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_f57ba322-a93a-481c-9eb9-38dd4331382c" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_f57ba322-a93a-481c-9eb9-38dd4331382c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_7b59f8e5-0a19-4ef9-9222-122d75b9982c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f8c03bc-816a-49f5-afac-9b8b445bce3c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_7b59f8e5-0a19-4ef9-9222-122d75b9982c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_369c4723-523a-4400-84c7-f008c1926c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_046b7b04-deb3-40a9-83aa-0da981667337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_369c4723-523a-4400-84c7-f008c1926c74" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_046b7b04-deb3-40a9-83aa-0da981667337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_5154d7f0-34ba-4efb-aaac-b95e59b8e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_369c4723-523a-4400-84c7-f008c1926c74" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_5154d7f0-34ba-4efb-aaac-b95e59b8e47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_49e57c91-476f-4e8f-840b-b0ce318085ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_369c4723-523a-4400-84c7-f008c1926c74" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_49e57c91-476f-4e8f-840b-b0ce318085ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20c9aac9-1f64-4d85-8dd1-872196b81d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_369c4723-523a-4400-84c7-f008c1926c74" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_20c9aac9-1f64-4d85-8dd1-872196b81d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9795450f-9cfb-422a-abd5-47e21c08ff93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dbf6f208-d5a2-4b2a-97ae-b1ba6f7e281f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9795450f-9cfb-422a-abd5-47e21c08ff93" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dbf6f208-d5a2-4b2a-97ae-b1ba6f7e281f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e9400df6-d321-4f99-9e9f-9b2a6ae2a298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_85076afa-55dc-439e-a208-63e4e0a7de0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9400df6-d321-4f99-9e9f-9b2a6ae2a298" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_85076afa-55dc-439e-a208-63e4e0a7de0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b3619f36-ef6f-4f26-a56b-33e8055b58ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9400df6-d321-4f99-9e9f-9b2a6ae2a298" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b3619f36-ef6f-4f26-a56b-33e8055b58ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_aa868f45-893f-4681-bf27-8b069e415a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9400df6-d321-4f99-9e9f-9b2a6ae2a298" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_aa868f45-893f-4681-bf27-8b069e415a8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#NetIncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/NetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d9abc071-07b9-422d-9a74-2aee6589e39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e36d2a03-feb0-4a80-85be-375b7dab2aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d9abc071-07b9-422d-9a74-2aee6589e39c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e36d2a03-feb0-4a80-85be-375b7dab2aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f14fefb-4f7e-4035-b42d-8081f56dca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d9abc071-07b9-422d-9a74-2aee6589e39c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f14fefb-4f7e-4035-b42d-8081f56dca3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_119e6366-e102-437d-9605-8ac5426bfea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_8e0f94c0-6853-4165-808f-cb72e3206c75" xlink:href="natr-20220331.xsd#natr_ContributionMargin"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_119e6366-e102-437d-9605-8ac5426bfea5" xlink:to="loc_natr_ContributionMargin_8e0f94c0-6853-4165-808f-cb72e3206c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6d6c034-5875-4956-a92e-4bf1ac3a04de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_119e6366-e102-437d-9605-8ac5426bfea5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c6d6c034-5875-4956-a92e-4bf1ac3a04de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5dac11ee-44c4-4502-947d-5b3a99c69f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_d2879e4c-8309-4678-aedc-fb69b3574bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5dac11ee-44c4-4502-947d-5b3a99c69f3c" xlink:to="loc_us-gaap_TradingSecurities_d2879e4c-8309-4678-aedc-fb69b3574bb4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>natr-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended" id="ia77bba1f12c04280a282c7fab7c09235_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_aa16d437-05ab-440c-934a-605e077fb7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_CommonStockSharesIssued_aa16d437-05ab-440c-934a-605e077fb7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e3087c9-f8c4-41e4-a3da-7d0689a889bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e3087c9-f8c4-41e4-a3da-7d0689a889bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_71f9194c-03ea-4946-a2ae-d70f1ac49469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_71f9194c-03ea-4946-a2ae-d70f1ac49469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_0af5cf5d-c36b-4998-b40e-b95f4fa05fc4" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_0af5cf5d-c36b-4998-b40e-b95f4fa05fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_bdc5c4b3-d775-4f8c-8ec0-7eb9cfabcfe3" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_bdc5c4b3-d775-4f8c-8ec0-7eb9cfabcfe3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6b29e038-bc4d-4d05-be2a-341cf9d5fac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6b29e038-bc4d-4d05-be2a-341cf9d5fac1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f1cc85fa-afbb-4f14-9f57-5cba5bdc6dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f1cc85fa-afbb-4f14-9f57-5cba5bdc6dea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9cc82469-4c53-498d-9003-e64b06cd8e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_DividendsCommonStockCash_9cc82469-4c53-498d-9003-e64b06cd8e01" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_692715c8-1ddc-4720-aa04-e4356ed23309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_ProfitLoss_692715c8-1ddc-4720-aa04-e4356ed23309" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d43dc42d-a031-4345-ae8a-fd55ea4d6b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d43dc42d-a031-4345-ae8a-fd55ea4d6b77" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_86674eab-5ce8-44ea-a17d-e17074505fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942fa2f0-052a-4061-b25d-c2bed7069477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:to="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:to="loc_us-gaap_EquityComponentDomain_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:to="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_10176005-6a95-4f08-9517-fd10863e0b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_CommonStockMember_10176005-6a95-4f08-9517-fd10863e0b89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a3902af-8507-4767-8f14-7e14f0a16f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_RetainedEarningsMember_0a3902af-8507-4767-8f14-7e14f0a16f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_68e3c82b-ba9e-42f9-be32-4bb0e79409e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_NoncontrollingInterestMember_68e3c82b-ba9e-42f9-be32-4bb0e79409e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_80612c6b-23f9-4653-bb79-4e2ad992c121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_80612c6b-23f9-4653-bb79-4e2ad992c121" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#BasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="extended" id="i6cb93c118cc64d74aa076844889bbaf6_BasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_e1c53ab7-23e2-4330-9c0e-c07e1057cb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_e1c53ab7-23e2-4330-9c0e-c07e1057cb12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ae4b88bb-eb7e-4a35-808a-db71828a97ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_MinorityInterest_ae4b88bb-eb7e-4a35-808a-db71828a97ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_abd8eea4-8ed2-45a9-ad67-83b5427dad11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_RestructuringCharges_abd8eea4-8ed2-45a9-ad67-83b5427dad11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c47d12fb-6ca2-4ee7-96e1-9128586d786d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_RestructuringReserve_c47d12fb-6ca2-4ee7-96e1-9128586d786d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_847fb543-ee7c-471b-b021-a7e624ad92a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_847fb543-ee7c-471b-b021-a7e624ad92a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember_0b38bb41-ba0e-415b-9f47-53c8350975f4" xlink:href="natr-20220331.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:to="loc_natr_AccruedSeveranceandRentCostsMember_0b38bb41-ba0e-415b-9f47-53c8350975f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended" id="i2dbcfbef47ae4548a0ac9c490b917897_RevolvingCreditFacilityandOtherObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4af0667e-76b8-4151-a885-c233f119be2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4af0667e-76b8-4151-a885-c233f119be2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_a1f5de46-043e-4d79-b1ec-f1cbf0888b5f" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_a1f5de46-043e-4d79-b1ec-f1cbf0888b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_ba0ae5dd-d94e-4553-852d-f895e86e032b" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_ba0ae5dd-d94e-4553-852d-f895e86e032b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_0f9208d0-ebae-48ed-88d7-6f06bf3479fb" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_0f9208d0-ebae-48ed-88d7-6f06bf3479fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1d49a92f-d363-410c-b89c-c0a826317069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1d49a92f-d363-410c-b89c-c0a826317069" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8190669-79e9-47fc-a468-b0f51a10e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8190669-79e9-47fc-a468-b0f51a10e24a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_270326cc-4205-44b1-84d1-716c9e021b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_270326cc-4205-44b1-84d1-716c9e021b2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b0188949-ce21-48b5-802e-da7ce1da406d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCredit_b0188949-ce21-48b5-802e-da7ce1da406d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_77c72d60-dffa-41b2-9e62-4ca40ad05e2a" xlink:href="natr-20220331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_77c72d60-dffa-41b2-9e62-4ca40ad05e2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1549b205-6e42-4228-ab31-d6aaccec882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1549b205-6e42-4228-ab31-d6aaccec882b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_fa1b9694-e7d1-446b-85ce-b104d0d6d791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LinesOfCreditCurrent_fa1b9694-e7d1-446b-85ce-b104d0d6d791" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_41c65941-ccfc-4a2d-8361-7d6819205515_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:to="loc_us-gaap_CreditFacilityDomain_41c65941-ccfc-4a2d-8361-7d6819205515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:to="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3381f5bd-b4af-4920-a1b0-8b0fefcb76eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3381f5bd-b4af-4920-a1b0-8b0fefcb76eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_660d1cae-092c-4a1a-abf9-f01feb8caca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:to="loc_us-gaap_LineOfCreditMember_660d1cae-092c-4a1a-abf9-f01feb8caca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ccc9a03e-64bc-49c7-93f7-2475d5037c19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:to="loc_us-gaap_VariableRateDomain_ccc9a03e-64bc-49c7-93f7-2475d5037c19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:to="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f7e9daad-50a2-4678-a35d-b06105ad8bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f7e9daad-50a2-4678-a35d-b06105ad8bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_ccdb2af5-403a-4d9e-b642-5078a1359455" xlink:href="natr-20220331.xsd#natr_IndicativeIndexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:to="loc_natr_IndicativeIndexMember_ccdb2af5-403a-4d9e-b642-5078a1359455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ffc5c410-02ba-4834-af4b-20f5d4e8af1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ffc5c410-02ba-4834-af4b-20f5d4e8af1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_94b733c8-def8-485f-a01b-80589b86b21a" xlink:href="natr-20220331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_94b733c8-def8-485f-a01b-80589b86b21a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e305166d-24bd-4e63-8fa1-cac8e3192b16" xlink:href="natr-20220331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e305166d-24bd-4e63-8fa1-cac8e3192b16" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended" id="ib57fbdb7447c4b948345b5711eaeca59_CapitalTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8b8a4c2d-bf1a-4f5a-9b86-be636ea6b4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8b8a4c2d-bf1a-4f5a-9b86-be636ea6b4bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_a96e9a3a-64f3-4980-bdbc-a6f17d3daa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_DividendsCommonStockCash_a96e9a3a-64f3-4980-bdbc-a6f17d3daa75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d469731-a5ea-4824-a05a-7bf375213f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d469731-a5ea-4824-a05a-7bf375213f51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c4d4d145-c000-474e-8177-46d886f6fbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c4d4d145-c000-474e-8177-46d886f6fbef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3826aace-caf0-4c2d-9e60-5a0707571c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3826aace-caf0-4c2d-9e60-5a0707571c79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_95038e99-282d-4253-b905-9d1fee880f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_95038e99-282d-4253-b905-9d1fee880f5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_881b262d-9711-4fe8-b98e-392706c71446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_881b262d-9711-4fe8-b98e-392706c71446" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b986aa7-685c-4757-a467-6df0cbf519c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b986aa7-685c-4757-a467-6df0cbf519c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_289391f2-7d82-41a2-ab90-b1dd44093f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_289391f2-7d82-41a2-ab90-b1dd44093f64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_d6f98c66-a988-43c5-8557-4f5210de5926" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_d6f98c66-a988-43c5-8557-4f5210de5926" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_998e46ac-94f0-4d47-be46-32d31e71cdd0" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_998e46ac-94f0-4d47-be46-32d31e71cdd0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_cfe30b0c-2e33-4e87-ae52-6888bb94e1bf" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_cfe30b0c-2e33-4e87-ae52-6888bb94e1bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_32be4d99-b5b5-40b5-b4f8-d6e8ea154966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_32be4d99-b5b5-40b5-b4f8-d6e8ea154966" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8de02fba-c5d5-4a45-8005-128e58255653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8de02fba-c5d5-4a45-8005-128e58255653" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba398d71-0686-45f8-a86f-0a5769595337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba398d71-0686-45f8-a86f-0a5769595337" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_93a96cb2-9d54-4d3f-9687-245d9dd41a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_93a96cb2-9d54-4d3f-9687-245d9dd41a5d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97f03565-9f29-47bb-a025-e4c97722e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97f03565-9f29-47bb-a025-e4c97722e8c7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_09572cf5-149e-4888-b9cf-3ea82f40d3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_09572cf5-149e-4888-b9cf-3ea82f40d3df" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92b0e9d2-e861-4d9e-b99a-347c4d4fe58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92b0e9d2-e861-4d9e-b99a-347c4d4fe58f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_41e05d0a-c219-44e5-85b2-8feb404290fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_41e05d0a-c219-44e5-85b2-8feb404290fc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3c274e47-12df-44fd-8db9-8921e5d0219c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3c274e47-12df-44fd-8db9-8921e5d0219c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_8b14c3bb-14e5-4182-bd99-728c0208e6bd" xlink:href="natr-20220331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_8b14c3bb-14e5-4182-bd99-728c0208e6bd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_0d8291a5-be34-4f8a-b2f8-8180b1eaf14b" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_0d8291a5-be34-4f8a-b2f8-8180b1eaf14b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3d9815fe-87c5-4c35-a66d-7fc69bf5bf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3d9815fe-87c5-4c35-a66d-7fc69bf5bf7d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7a2252c5-f7af-4d6c-9196-41d5eee55144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7a2252c5-f7af-4d6c-9196-41d5eee55144" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_80a28c77-c3d4-40c8-b28f-8b3082bfd78b" xlink:href="natr-20220331.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_80a28c77-c3d4-40c8-b28f-8b3082bfd78b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8fcf42bd-7c48-4d89-8aad-b0bfe6b0d08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8fcf42bd-7c48-4d89-8aad-b0bfe6b0d08b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5c2a9c16-e252-47bb-bb72-c9e01eb7671d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5c2a9c16-e252-47bb-bb72-c9e01eb7671d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_c3ad336c-8cd2-42b8-a03c-7d5a35d9e312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_c3ad336c-8cd2-42b8-a03c-7d5a35d9e312" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_e8dd00db-d7fe-4330-b68e-e3ffe42b4dbb" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_e8dd00db-d7fe-4330-b68e-e3ffe42b4dbb" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_9909b4b3-620d-4b50-970a-94d920ef6064" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_9909b4b3-620d-4b50-970a-94d920ef6064" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_295703a3-ade7-48d5-b323-8b2f47297699_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_295703a3-ade7-48d5-b323-8b2f47297699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_56ec8bc5-c543-4f4f-8e82-02e869acb0f9" xlink:href="natr-20220331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:to="loc_natr_TimeBasedStockOptionsMember_56ec8bc5-c543-4f4f-8e82-02e869acb0f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_395c653d-4a12-4f31-bb8f-0f8bdd3ef1dd" xlink:href="natr-20220331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_395c653d-4a12-4f31-bb8f-0f8bdd3ef1dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember_483502db-1b9f-451c-8a31-0b1ddf5b8f55" xlink:href="natr-20220331.xsd#natr_TimeBasedRestrictedStockUnitsRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember_483502db-1b9f-451c-8a31-0b1ddf5b8f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_2d42ccaa-9193-4d62-9e70-953bfb6e3a7d" xlink:href="natr-20220331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_2d42ccaa-9193-4d62-9e70-953bfb6e3a7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f460c812-56d1-4c4b-83f2-12e5a29b6fe5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:to="loc_srt_DirectorMember_f460c812-56d1-4c4b-83f2-12e5a29b6fe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:to="loc_srt_RangeMember_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:to="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_110206bc-85ff-4ab7-b843-421493b53a69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:to="loc_srt_MinimumMember_110206bc-85ff-4ab7-b843-421493b53a69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_94d62245-e370-4374-94e2-1b725f160df0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:to="loc_srt_MaximumMember_94d62245-e370-4374-94e2-1b725f160df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5b514922-82f9-4309-a66a-d63410ca4d02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:to="loc_us-gaap_PlanNameDomain_5b514922-82f9-4309-a66a-d63410ca4d02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:to="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_1c4da071-327b-488d-90f9-1b226073544b" xlink:href="natr-20220331.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:to="loc_natr_A2012IncentivePlanMember_1c4da071-327b-488d-90f9-1b226073544b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended" id="ifa7a7cebb91841b9a10a81baae10411f_CapitalTransactionsStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8a9422f7-8bd3-41e2-b67f-69ee48218260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8a9422f7-8bd3-41e2-b67f-69ee48218260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3120ee2c-e2ee-4d31-a3f4-ae98890592d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3120ee2c-e2ee-4d31-a3f4-ae98890592d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ecbf48cd-3f62-4f05-b6d8-dae47733207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ecbf48cd-3f62-4f05-b6d8-dae47733207f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a88a3a24-423e-450c-b1de-2ebb2e2e7183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a88a3a24-423e-450c-b1de-2ebb2e2e7183" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fb24f8a2-a156-44ca-91ab-920914f3be06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f9c3957f-e8ed-4622-937a-95c31455c981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f9c3957f-e8ed-4622-937a-95c31455c981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fb5aac4f-6c9a-4f73-b956-d8f4f1b1d3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fb5aac4f-6c9a-4f73-b956-d8f4f1b1d3a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_49b1b157-e779-4de5-995f-2184329955ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_49b1b157-e779-4de5-995f-2184329955ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41d7f54e-be04-4194-9c19-a8b2563072c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41d7f54e-be04-4194-9c19-a8b2563072c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d289577a-fd0f-48e2-b322-423cea5cc90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3c87246a-f705-47fb-9d86-05e250577bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3c87246a-f705-47fb-9d86-05e250577bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f52f645a-4ee5-4211-837c-ca2b2c681553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f52f645a-4ee5-4211-837c-ca2b2c681553" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_1bc3c8ea-4aa3-448f-a717-be71346d94e5" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_1bc3c8ea-4aa3-448f-a717-be71346d94e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_886b9292-d3aa-4d41-ab28-144d8b362748" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_886b9292-d3aa-4d41-ab28-144d8b362748" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6d1f8400-da57-4464-975e-0f5d8e5b1d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:to="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de205ef-b8f5-4e07-93a0-c96a09496ab1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de205ef-b8f5-4e07-93a0-c96a09496ab1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_92af6dbb-2b34-4a14-9925-52217978e506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_92af6dbb-2b34-4a14-9925-52217978e506" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended" id="i7d6b7a371f35421396e9c2bc24f03dbd_CapitalTransactionsRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77fb66d3-eba3-488a-bc7f-7f1edbe261c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77fb66d3-eba3-488a-bc7f-7f1edbe261c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6743fbd-3892-42a7-88c5-767f95c78423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6743fbd-3892-42a7-88c5-767f95c78423" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e841fa8a-e302-4411-965c-eb0779d5782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e841fa8a-e302-4411-965c-eb0779d5782b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_38b80f70-9b79-4002-8822-5c972a31af98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_38b80f70-9b79-4002-8822-5c972a31af98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1369d8f6-1669-4d82-86c2-a55c23d564bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4cd3f76-e9f8-496e-86ae-64f0d9600c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4cd3f76-e9f8-496e-86ae-64f0d9600c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aac38b12-0b2e-48bd-9f54-7392f0e72de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aac38b12-0b2e-48bd-9f54-7392f0e72de3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_70e4e29a-2c79-4f6c-931c-4abec2011247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_70e4e29a-2c79-4f6c-931c-4abec2011247" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_049d019a-d3f8-497f-bfa3-e1b8e314bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_049d019a-d3f8-497f-bfa3-e1b8e314bdae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4bbb49b7-faf4-4e70-be97-a2f05dadf4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:to="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0d70ede4-5648-4739-ba75-e5d148e08e47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:to="loc_us-gaap_PlanNameDomain_0d70ede4-5648-4739-ba75-e5d148e08e47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:to="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_0ebf035f-7c97-48bc-8e6c-1a384befdaa4" xlink:href="natr-20220331.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:to="loc_natr_A2012IncentivePlanMember_0ebf035f-7c97-48bc-8e6c-1a384befdaa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:to="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_608e75b4-38ab-4932-9ccb-799047043906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_608e75b4-38ab-4932-9ccb-799047043906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0a1f0340-2bd8-464c-aa74-d93bcd7f57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0a1f0340-2bd8-464c-aa74-d93bcd7f57c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended" id="i1764c1437b7c4992b25cabcb65c56a0c_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_dfc3ce77-911a-4a5e-b160-36d78c88203a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_NumberOfReportableSegments_dfc3ce77-911a-4a5e-b160-36d78c88203a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f9890f-11cb-4859-9634-8bd1cee4413b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f9890f-11cb-4859-9634-8bd1cee4413b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:href="natr-20220331.xsd#natr_ContributionMarginAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_4661108a-e2f8-4d4c-9333-813222251ea1" xlink:href="natr-20220331.xsd#natr_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:to="loc_natr_ContributionMargin_4661108a-e2f8-4d4c-9333-813222251ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_92299644-2819-48ae-926b-fad1bde62eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_92299644-2819-48ae-926b-fad1bde62eb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_74a0a6e7-a0ef-44cf-8edb-9b36ab413f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_OperatingIncomeLoss_74a0a6e7-a0ef-44cf-8edb-9b36ab413f0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7deed6ca-dc07-4b2b-823d-04fde7c16774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7deed6ca-dc07-4b2b-823d-04fde7c16774" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21958505-2f5a-470b-b5a5-11470e461fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21958505-2f5a-470b-b5a5-11470e461fd5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_854feb2d-2b43-4a73-b64c-d9b4308696bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_854feb2d-2b43-4a73-b64c-d9b4308696bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6ae4d0e4-09d7-4b29-bf7f-fa24f69f3944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_Assets_6ae4d0e4-09d7-4b29-bf7f-fa24f69f3944" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:to="loc_srt_SegmentGeographicalDomain_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:to="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_da2d9faa-2559-4934-b510-67bf4c6d716e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_CN_da2d9faa-2559-4934-b510-67bf4c6d716e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_863f116a-05d2-46d6-b646-f9cdfc060b6b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_US_863f116a-05d2-46d6-b646-f9cdfc060b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_3c9419be-198a-47cb-b29d-242ef3484c95" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_KR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_KR_3c9419be-198a-47cb-b29d-242ef3484c95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_5b1401f3-afa1-4fe5-9491-09b39fec4f6e" xlink:href="natr-20220331.xsd#natr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_natr_OtherCountriesMember_5b1401f3-afa1-4fe5-9491-09b39fec4f6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:to="loc_us-gaap_SegmentDomain_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:to="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_ea403b6a-3ce4-4313-9a61-8d34559f6ad4" xlink:href="natr-20220331.xsd#natr_AsiaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_AsiaSegmentMember_ea403b6a-3ce4-4313-9a61-8d34559f6ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_27b7f0a4-3783-4521-a731-2a85ced85c1c" xlink:href="natr-20220331.xsd#natr_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_EuropeSegmentMember_27b7f0a4-3783-4521-a731-2a85ced85c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_26a2f62f-3092-46ad-91c1-8494aa25933d" xlink:href="natr-20220331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_NorthAmericaSegmentMember_26a2f62f-3092-46ad-91c1-8494aa25933d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_e284edb7-194a-4938-9654-7722694dadaf" xlink:href="natr-20220331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_e284edb7-194a-4938-9654-7722694dadaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3bbad7db-c7a9-4d17-8e2f-21663614d1e5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:to="loc_srt_ProductsAndServicesDomain_3bbad7db-c7a9-4d17-8e2f-21663614d1e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:to="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_df3e0a94-c269-4ed6-a9f8-de1706ea09af" xlink:href="natr-20220331.xsd#natr_GeneralHealthProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_GeneralHealthProductsMember_df3e0a94-c269-4ed6-a9f8-de1706ea09af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_17284364-e9ea-4f6a-908f-0cd1b2cd206f" xlink:href="natr-20220331.xsd#natr_ImmunityProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_ImmunityProductsMember_17284364-e9ea-4f6a-908f-0cd1b2cd206f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_511320ab-cfd7-426b-981d-2fad4e5f7ec5" xlink:href="natr-20220331.xsd#natr_CardiovascularProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_CardiovascularProductsMember_511320ab-cfd7-426b-981d-2fad4e5f7ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_2c4deafe-9676-4d67-bd92-4cc080968bd5" xlink:href="natr-20220331.xsd#natr_DigestiveProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_DigestiveProductsMember_2c4deafe-9676-4d67-bd92-4cc080968bd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_330c5398-6d8f-4910-8e0b-1cf7092d97a6" xlink:href="natr-20220331.xsd#natr_PersonalCareProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_PersonalCareProductsMember_330c5398-6d8f-4910-8e0b-1cf7092d97a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_e812b8c6-942f-4532-9970-315325c1449a" xlink:href="natr-20220331.xsd#natr_WeightManagementProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_WeightManagementProductsMember_e812b8c6-942f-4532-9970-315325c1449a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ic1f32167c0164d1a8b7791882866da52_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_1a747fb0-e5dd-4a36-b9a4-4248b48fb2e7" xlink:href="natr-20220331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_1a747fb0-e5dd-4a36-b9a4-4248b48fb2e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_edea6e1f-a73f-4ce9-a872-7c82e9e02ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_edea6e1f-a73f-4ce9-a872-7c82e9e02ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_fd98c199-ed9b-4f0d-8a65-f0a4ca98bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_fd98c199-ed9b-4f0d-8a65-f0a4ca98bbf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_dbc70e51-d016-4c4a-975d-ae7694fff9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_dbc70e51-d016-4c4a-975d-ae7694fff9a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:to="loc_us-gaap_LitigationStatusDomain_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:to="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c14e8b33-27f0-472a-93c9-580e640b01cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:to="loc_us-gaap_PendingLitigationMember_c14e8b33-27f0-472a-93c9-580e640b01cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:to="loc_srt_RangeMember_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:to="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc271060-46b6-4821-aeaa-5e16d6d604d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:to="loc_srt_MinimumMember_bc271060-46b6-4821-aeaa-5e16d6d604d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dc32dfbc-8213-40db-84bd-a530a3d99466" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:to="loc_srt_MaximumMember_dc32dfbc-8213-40db-84bd-a530a3d99466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a85c9556-2c9a-4899-aa55-7d8a78997a64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a85c9556-2c9a-4899-aa55-7d8a78997a64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_8579f8ab-aa4c-42ba-bbfb-cec0743c43be" xlink:href="natr-20220331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_8579f8ab-aa4c-42ba-bbfb-cec0743c43be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_eef314ce-5214-4789-a01b-3620e10f53b3" xlink:href="natr-20220331.xsd#natr_NonIncomeTaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:to="loc_natr_NonIncomeTaxMember_eef314ce-5214-4789-a01b-3620e10f53b3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="id1d0c1c5a4014acc855d95f73de2a5ff_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a229e8d4-887e-409f-a9cb-a0ef8ed71a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a229e8d4-887e-409f-a9cb-a0ef8ed71a2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ae1210f5-3ad4-464b-9487-c06cd8452dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ae1210f5-3ad4-464b-9487-c06cd8452dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ff619d28-56cd-4863-a140-64e0f8f5f818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ff619d28-56cd-4863-a140-64e0f8f5f818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_e50c8278-19dc-4ccf-87fc-8f8829fca868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_e50c8278-19dc-4ccf-87fc-8f8829fca868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_947d55df-2600-4ee0-83bf-c667a7ca9989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_947d55df-2600-4ee0-83bf-c667a7ca9989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7fd73faa-a7c3-487d-8da6-10f560f69f15_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7fd73faa-a7c3-487d-8da6-10f560f69f15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_9fb40857-b5b5-4d8d-9061-7af518c94711" xlink:href="natr-20220331.xsd#natr_ChinaJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:to="loc_natr_ChinaJointVentureMember_9fb40857-b5b5-4d8d-9061-7af518c94711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember_6f0b97be-5a23-4f45-a435-b083481889f0" xlink:href="natr-20220331.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:to="loc_natr_NaturesSunshineProductsChinaMember_6f0b97be-5a23-4f45-a435-b083481889f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8deb741a-2bd5-4187-814b-8036162746b9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:to="loc_srt_OwnershipDomain_8deb741a-2bd5-4187-814b-8036162746b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:to="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_52f756cd-ee7f-40f6-9c4a-2a5463948578" xlink:href="natr-20220331.xsd#natr_ChinaJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:to="loc_natr_ChinaJointVentureMember_52f756cd-ee7f-40f6-9c4a-2a5463948578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_edc9f34d-fd74-48d2-8df3-28fe0a996a86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:to="loc_us-gaap_RelatedPartyDomain_edc9f34d-fd74-48d2-8df3-28fe0a996a86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:to="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_3cef1d25-948b-4cb2-8e50-8d4cc0935f0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:to="loc_srt_SubsidiariesMember_3cef1d25-948b-4cb2-8e50-8d4cc0935f0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_f73544f6-6cdb-48ae-bec0-9fcb2a3d863d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:to="loc_us-gaap_NotesReceivableMember_f73544f6-6cdb-48ae-bec0-9fcb2a3d863d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_09576a11-ed32-4900-9c49-49ac06facd71_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:to="loc_dei_EntityDomain_09576a11-ed32-4900-9c49-49ac06facd71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:to="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember_37509442-b7be-42dd-86f8-c9f26a7543d6" xlink:href="natr-20220331.xsd#natr_FosunPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:to="loc_natr_FosunPharmaMember_37509442-b7be-42dd-86f8-c9f26a7543d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember_fd53494b-e305-43dc-8c53-a5318cb83d85" xlink:href="natr-20220331.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:to="loc_natr_CompanysJointVenturePartnerMember_fd53494b-e305-43dc-8c53-a5318cb83d85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ic769250cb5c54697a80727995b5f68df_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f8393337-3496-4952-88e1-6b7454c1cee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:to="loc_us-gaap_TradingSecurities_f8393337-3496-4952-88e1-6b7454c1cee5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ff799b42-e6f9-471b-addf-d7f2189b78d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ff799b42-e6f9-471b-addf-d7f2189b78d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_36a4b7a3-e859-4923-936f-05ee81867861_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_36a4b7a3-e859-4923-936f-05ee81867861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1eea58dc-ac3b-48ec-8374-7211feb01971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1eea58dc-ac3b-48ec-8374-7211feb01971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_807b073a-35c1-4a1e-8629-537cc23f9b50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_807b073a-35c1-4a1e-8629-537cc23f9b50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f5a6335a-f556-4b9c-a879-65b3fd7f5938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f5a6335a-f556-4b9c-a879-65b3fd7f5938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a75ee01f-d139-4abd-bc6e-a9e5e6fdcef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a75ee01f-d139-4abd-bc6e-a9e5e6fdcef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_52d20e8d-d233-4149-b286-8f82fdde6f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_52d20e8d-d233-4149-b286-8f82fdde6f7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8743767e-aec7-4d2b-8f51-31d75199bbe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8743767e-aec7-4d2b-8f51-31d75199bbe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a8324d8-cd56-41c3-8377-2e0caa139746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a8324d8-cd56-41c3-8377-2e0caa139746" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended" id="id75c8ba3e65549339cb461c81de55e3e_RevenueRecognitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod_7933d6cc-24d6-42e8-a281-e6a08c445ead" xlink:href="natr-20220331.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_RevenuefromContractwithCustomerRefundPeriod_7933d6cc-24d6-42e8-a281-e6a08c445ead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CustomerLoyaltyProgramLoyaltyPoints_71b74a78-c459-417e-820a-322f6ebaea7b" xlink:href="natr-20220331.xsd#natr_CustomerLoyaltyProgramLoyaltyPoints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_CustomerLoyaltyProgramLoyaltyPoints_71b74a78-c459-417e-820a-322f6ebaea7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts_87efe5f0-f818-4c32-b9ee-926768e7721b" xlink:href="natr-20220331.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_NumberofPrincipalCategoriesofProducts_87efe5f0-f818-4c32-b9ee-926768e7721b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_17fbebdf-7b0b-4973-b4eb-7e8c97d24328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_us-gaap_NumberOfReportableSegments_17fbebdf-7b0b-4973-b4eb-7e8c97d24328" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm_837c5daa-fec1-4e95-a951-f43a86a8d2a0" xlink:href="natr-20220331.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_ContractWithCustomerContractTerm_837c5daa-fec1-4e95-a951-f43a86a8d2a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:to="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a97df81-2f26-4887-bc11-1f4c51890bf1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:to="loc_srt_RangeMember_5a97df81-2f26-4887-bc11-1f4c51890bf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:to="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8002de99-8671-49d0-a893-51e7e172609b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:to="loc_srt_MaximumMember_8002de99-8671-49d0-a893-51e7e172609b" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>natr-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_cac37df3-a43c-4df9-8340-147ad5092815_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_d99b0fac-8cce-43cd-9575-2f2584c8e523_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards (in shares)</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_documentation_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:href="natr-20220331.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:to="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_97729f31-8946-4f35-8b93-cba571cfdb94_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_b8eceef7-fdd3-41c9-8611-d1a5cc776fcd_terseLabel_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax assessments and other civil litigation</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_label_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Assessments And Other Civil Litigation [Member]</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_documentation_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:href="natr-20220331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:to="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AsiaSegmentMember_61512106-45f4-4815-a1c6-d00e1083741d_terseLabel_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_label_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_documentation_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember" xlink:href="natr-20220331.xsd#natr_AsiaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AsiaSegmentMember" xlink:to="lab_natr_AsiaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c75ab9b5-4b86-4c06-9244-78aae5e9ca0b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_de20e60c-bfb7-4b7f-9e0b-2b034bd1c4ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7b3e23f1-316e-4b9d-ad74-bf4c7bcf190f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_131ef2bd-1c84-4251-b72c-c56f0ab76384_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_bd37a5cd-d703-4895-a109-11af978f2808_terseLabel_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Other</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_label_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_documentation_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:href="natr-20220331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:to="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember_052ed4e8-4860-47fd-8f11-88093afb4317_terseLabel_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember_label_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember_documentation_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:href="natr-20220331.xsd#natr_TimeBasedRestrictedStockUnitsRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:to="lab_natr_TimeBasedRestrictedStockUnitsRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PersonalCareProductsMember_3a44a2f0-a244-4ac0-95a7-ffc79ab2b916_terseLabel_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal care</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_label_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Care Products [Member]</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_documentation_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to personal care products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember" xlink:href="natr-20220331.xsd#natr_PersonalCareProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PersonalCareProductsMember" xlink:to="lab_natr_PersonalCareProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d4116b25-87ec-427f-8d94-0f55c07f2736_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NonIncomeTaxMember_320725b5-e4fe-4bf2-b6f6-0dc5c134e2c7_terseLabel_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Contingencies</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_label_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Income Tax [Member]</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_documentation_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to non-income tax matters, including value-added taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember" xlink:href="natr-20220331.xsd#natr_NonIncomeTaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NonIncomeTaxMember" xlink:to="lab_natr_NonIncomeTaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_0a97c683-ab81-4497-8d32-22b25892aac5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated net sales revenue by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_fbcf0c23-ecf2-4824-b715-73626497af4b_terseLabel_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of monthly payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_label_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_documentation_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:href="natr-20220331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:to="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_e708335f-0dcf-4ee2-a745-391d80e202e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_0d6b3015-1c88-403d-8481-32909759430a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, common stock, cash</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_864fe3ec-ef50-4270-8187-3398deac8fef_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_759854d5-ea85-45f1-8028-65747b63c85e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3fe8e28b-39df-4d9f-9f92-10027d0e9ebb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_812bc51c-1797-451e-94db-db8a33f84154_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_83545898-4efd-4bc0-856f-80606cb90bed_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e8f98c2c-c8a8-45f1-9070-59d73adf0a86_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e53ce417-5f1e-4f89-bce4-4a1c59929d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5788023f-1979-4ae8-931d-635316903e39_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5442e41f-24e3-4dcf-90aa-b698b4bc0588_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f3be7e97-50c2-4005-ae50-32c8520573fa_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_GeneralHealthProductsMember_80bf9f52-5e61-4b8c-bf7a-1700be85f1d4_terseLabel_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General health</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_label_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Health Products [Member]</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_documentation_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to general health products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember" xlink:href="natr-20220331.xsd#natr_GeneralHealthProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_GeneralHealthProductsMember" xlink:to="lab_natr_GeneralHealthProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_160cf9fb-1df0-474c-aff7-e48d26452f29_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a14ca534-f91a-42f3-b812-ad6cf581f787_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic values of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_a5fa975c-8c54-40b4-a83a-926d45bc6142_terseLabel_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_label_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_documentation_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:href="natr-20220331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:to="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_eaa50b6a-a531-4b11-9ce2-aa0c64934e10_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6fee0e59-7f66-4236-93f4-e8c3def570a3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ad6b0849-e5ac-46f8-97e9-e66f7de59e88_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a102c96e-e14c-4066-b184-aab571690dae_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_8a3ac914-8c32-441e-8c50-9ad4697d13cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_6788d4bb-5a0d-42bc-ad9e-35e2f5d71f29_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_b7eafb12-24d9-4eb0-b70f-27584636cc7b_terseLabel_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount for lack of marketability</link:label>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_label_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</link:label>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_documentation_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:href="natr-20220331.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:to="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21069bbe-2980-4c69-bd13-8a6d8b33ba57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_0376a1aa-53e5-4671-99ae-4905e2afd5e4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_f34c1172-f2f7-4904-8376-1aef7836eb6a_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a8fdf08-84cb-43d1-8c67-cc0923d3fec8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_6aab1452-98c6-4903-87ab-3332a82a36e1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_488d7986-7e81-49b9-82fb-9c2a81975dda_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_8a6c8deb-0727-4f45-a72c-56dc1e7db1cd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_20d07d44-dd59-4ccf-a785-12ede7714b22_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_8ee98aa9-0a8f-47ff-a052-d4987bfe2180_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ChinaJointVentureMember_e49cd89e-6713-48f8-8c5d-20117687af62_terseLabel_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture</link:label>
    <link:label id="lab_natr_ChinaJointVentureMember_label_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture [Member]</link:label>
    <link:label id="lab_natr_ChinaJointVentureMember_documentation_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember" xlink:href="natr-20220331.xsd#natr_ChinaJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ChinaJointVentureMember" xlink:to="lab_natr_ChinaJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_19f74840-058d-420b-8818-0b803170d1ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_09c234ea-cf27-4a33-bb3a-17a9601f48a2_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of separate increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:to="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_55781cb2-5ad6-424d-8578-a77d4034582b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8cd215b0-cd15-4ad5-8d3f-637517966a59_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85885347-0d39-40cd-a204-c7afd2f9aed0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_95614da6-0c89-4723-ad85-d41be54c3a42_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d006c868-528f-4814-b697-142ffb3d8983_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bd47c02e-b962-4567-84e3-f69b5714a323_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_59002a74-d5f3-439a-bada-01ae2061a793_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_5f03a136-f849-42a0-94b9-84c7a3c87d31_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_62fe6986-7e88-4a83-9910-2808aef7b70a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_50c3a1c2-d35a-4c0e-8173-5d797599c750_terseLabel_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets per segment</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_label_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1 [Table Text Block]</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_documentation_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:href="natr-20220331.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:to="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_737c9301-7449-4421-a413-084276e622c8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMargin_f1dfa514-c43b-42ee-89e2-4eeed5b77543_terseLabel_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contribution margin</link:label>
    <link:label id="lab_natr_ContributionMargin_label_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_natr_ContributionMargin_documentation_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin" xlink:href="natr-20220331.xsd#natr_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMargin" xlink:to="lab_natr_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_36fd286a-4f2c-4b28-be42-54fc0b6b711d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dca1e27e-9ccb-4bc6-be8b-718e1629e640_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_736743a1-c053-4bd2-bd99-d2059662dfac_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2765e29b-c541-4dd8-879b-f14d8942ee11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_28929c7b-ff4e-47d9-a9c6-32f539cb6db3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_256f0f68-87d7-44d0-9abf-5023bcc182a5_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a4ac599d-1da1-4b0a-90ae-726801682f58_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_653f5119-0731-424c-b6f3-e0837c87b510_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_08f9673e-7748-4ba4-9246-cad07a60e696_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_b67065bc-9de4-424d-8cde-6d70b8803fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated property, plant and equipment by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f34c25e-bcb2-4326-a107-b276598140ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_00b4a8f9-ab12-485f-b230-dd910416c328_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_da3b6c6c-1edd-4f31-a8af-722319bf9962_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_12213881-2b8b-4d06-b42d-8bb02a4d5910_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_fa55ab67-dd9e-4b92-91a8-d5feffa1da1d_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_816228d3-7f2e-415d-b7e0-7e2b5b83988b_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_5cbcfafd-b3b3-481c-9d27-f592532e3475_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities - trading</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_59f65c47-53b7-4e8b-bcd6-5c13d7d2f189_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current installments of long-term debt and revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_19192ef5-e94c-4e61-bc2d-2280e6112455_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_bf5694d5-d640-4ebc-b2cb-3c74a472a7db_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party note</link:label>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_56601937-1642-45be-9f69-4e625724bf06_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1bcde0ba-063a-433d-9c1e-248c205aca89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 - Quoted Prices in Active Markets for Identical Assets</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f21adcc-f48b-4988-b74f-d80102123b3b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_302fcf6e-4e6a-4c3e-8ef3-64d23f2e1863_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_d419fed0-8a03-43dd-8ed3-7b1060e7a7b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_d73cddb7-1ed5-4aee-89a8-023f2db94606_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, three (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the three operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_23e20b96-6bbd-4843-8187-ae1f6fdcbc80_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_5d66f126-e73f-4d5d-806a-b61b3d2781ea_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8bd6eba4-3100-460a-abfd-3d7df7af0b39_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_208b3998-0b59-4a58-80df-a5b17b95ca04_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_66a01b72-8f19-42f7-a172-84e1bb8203b0_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, one (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the first operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1a3a9201-9342-45a2-9167-ae0e5ec6e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_093895bb-c510-486d-98c6-6fd2a3e3b972_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_dbfe41ff-a13a-4296-b13d-206d602a4567_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, two (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7d61f032-b52e-4a34-9833-68384646966e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_92799c25-85cb-47db-8630-62d10276b2c9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_80195fbf-c0ac-4930-85cb-17a413f346b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e6b24dad-48b0-4661-ad9e-f234a099c267_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_db1cd2bb-ab9b-41e1-86c9-66a4740b336b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_08b39dac-4bb3-421c-a204-e681096378bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_36de4ce1-c6e8-4f0c-acdc-dae015a18d49_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_EuropeSegmentMember_4c679579-5d97-4f2e-a6bb-fb402def2d41_terseLabel_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_label_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_documentation_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember" xlink:href="natr-20220331.xsd#natr_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_EuropeSegmentMember" xlink:to="lab_natr_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1a404472-c3b1-4ea7-8d14-7c8a91f7c335_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_5af1bddf-f38e-4e1f-8830-f680d930a5a6_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_8efb8635-5e77-42e9-8427-8b38c836ced1_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f193c7d-4c29-4bd3-9061-7ff94ffb9e74_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_8a5b8a0a-4b3a-4181-bcf1-45870ac5b2b6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1868415e-8fed-41f6-8716-e526e241e936_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_55894f04-88f0-43f9-a396-47138b2ce848_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_3e4e4529-ee2d-45ed-b1d8-35022700549f_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_5951645f-e890-4616-add2-c22cc04b5734_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a6587895-0312-4e64-8ef1-6eceed0944f0_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_45f47ce6-c19c-47b1-9409-532ed45bc77a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_48b5fe4c-333a-48e6-ac66-128ee19dddaa_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_FosunPharmaMember_019ec4a4-dea1-4d55-8308-b739e7f1ebb3_terseLabel_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma Member</link:label>
    <link:label id="lab_natr_FosunPharmaMember_label_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma [Member]</link:label>
    <link:label id="lab_natr_FosunPharmaMember_documentation_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember" xlink:href="natr-20220331.xsd#natr_FosunPharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_FosunPharmaMember" xlink:to="lab_natr_FosunPharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_fdfdfe45-678c-4d78-9d6d-479457ecb1d0_terseLabel_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_label_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Number of Claims Companies Insurance Coverage May Not Cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_documentation_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:href="natr-20220331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:to="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_e7561178-78d1-4691-a79f-c30a13387fe9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_be46991f-0f19-4ad6-ac3d-a322ea4dd21b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_3646d3c3-ac8c-4809-830a-459c88becd13_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_8bdf997d-004a-485a-ba21-77a3ee79e90b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 - Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_1f99da4f-65b1-4212-a65e-0d756d652dd8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4e8b31ee-11ee-49c4-b021-ba4a9ac106ed_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_dd630276-0cf3-46e2-9e38-0cd66b517bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of revenue generated by each of the Company's product lines</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_35c21a62-078c-44e0-8751-b0752c032c18_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2ac1372d-fac9-461c-84b0-f23b70034b42_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value, 50,000 shares authorized, 19,461 and 19,724 shares issued&#160;and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_c90e809a-8542-4ea6-bb1b-a3e3dd85ef41_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a6299dfa-5c99-4a11-8015-904e0bdb7039_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which the remaining compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_802e0a26-2a0c-4725-a4b3-5f6eafedaebb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3bd289df-2364-414d-886b-9e4203cb1e4b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d89e69d7-6667-4db1-ae0b-61a0446613ff_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e46cdc4-b5c3-4026-9153-1b4b0e80eba0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_35916c8d-0d4b-4c99-828f-91bd96c5e52a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_50faca17-4b26-4f75-81f2-4d3c9666a562_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_69bf7a21-e9fc-4988-a5b7-5dde450c5110_verboseLabel_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NSP China</link:label>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_label_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natures Sunshine Products, China [Member]</link:label>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_documentation_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natures Sunshine Products, China [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember" xlink:href="natr-20220331.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NaturesSunshineProductsChinaMember" xlink:to="lab_natr_NaturesSunshineProductsChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_e2070a29-9e6f-4144-8315-51273062ca2a_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:href="natr-20220331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:to="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_d50d941d-682b-4cfd-b7a0-1fc96bf095a9_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ed9d66c4-e67c-4175-a379-9a34fa723968_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities - Trading</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_88c1e112-e7c9-4f5a-a93c-992588959713_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f08b9655-3b8e-4c7b-b57f-35ee924db7cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_833b5f81-b16d-476e-879a-4268e540eaf8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_8ee486a0-0d02-4a43-8fe5-fa67789e4f85_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_40628efe-a3f3-4959-9a58-6f3ac1a7dd1c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bebaf4c9-006f-450c-b726-8650c777d459_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_3136e9d9-f960-4ff6-ac3f-f59c2d1f0e54_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_730c4a3b-0837-4d87-ac41-f9cfb85c82e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_76815972-eea7-4fe2-97c8-15717bd508b7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ffdf9542-428a-44b6-ba1e-f204ae9528e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_246523d4-1e4a-4b6b-86d0-b293cf7146e4_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0b304cb9-1e5b-4a22-b045-98fff7cd8989_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c93c2466-6774-4d79-a27a-6b8200f953c5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_24131b75-bc48-4689-813b-60202e140937_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_698a4a8d-fffe-4b57-a350-4a82e85d2b5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_5241efb9-1fe0-4bf1-a3c5-e20352be16b8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9454acc6-4cb4-49cb-adfd-5a9fc2a46617_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_84659ebd-166a-445a-870b-928d34f12747_terseLabel_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, contract term</link:label>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_label_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Contract Term</link:label>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_documentation_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm" xlink:href="natr-20220331.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContractWithCustomerContractTerm" xlink:to="lab_natr_ContractWithCustomerContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9c6d304b-2f05-4bbf-9542-e690e0d5f5a1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_89471c5f-6e5f-4ba1-a0eb-505f1b761576_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_599c20db-68e8-4e3c-a045-4a3c48ab5efd_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8bc31545-7681-4de1-a3a4-74eef16ece77_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesCurrent_1e5842bc-54de-40a5-a8d2-472b0da68947_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, related parties, current</link:label>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:to="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bb1a28b2-62ea-4b3d-9f8a-90d4a09c8cc6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_165b870b-85cc-4670-9169-eaddc9b4a5df_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28b3c0ad-796b-4d45-a7df-a0e8e4c25433_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b0d13676-357d-484c-954d-c04ca0c9b2a6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_08bba179-9e10-4fdd-a1bc-94e0d2c449aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b121430f-9e97-4879-a044-a7681d871d14_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a507818d-be92-433a-8214-d37ebd690a6c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_bfdd79dd-4053-469f-80e5-b4a9c8528897_terseLabel_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_label_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_documentation_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:href="natr-20220331.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:to="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c646737b-6234-4bd1-96fa-7f837b062794_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, amount</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_fabc0746-e13e-4ea2-8f80-b759d78807df_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividends (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_country_KR_e0e13684-d72a-4445-9d10-fed4c399c9ad_terseLabel_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea</link:label>
    <link:label id="lab_country_KR_label_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KOREA, REPUBLIC OF</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_KR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_KR" xlink:to="lab_country_KR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_f26563a7-6ba0-42b8-851f-d0f87b025d35_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_36b7beea-cab8-47b5-bd00-ced9342f9d6c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_9da55981-976a-490e-abb4-184a5dee22e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_07ff3d23-c818-45f2-8e9d-d73fceee63a1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other loss, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9da3d754-40e5-45f5-aa6a-8519a1ea2193_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other loss, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_836dcd58-dd77-4441-93a9-6e77f3cd476f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_606e9ab1-6fc6-419b-9ebe-dd7e7c87c2ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, trading, realized gains (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d0587b0b-6f60-4d05-a277-fac7da4c58ae_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_86e39d4e-2e49-453d-9cd9-1bcfba8cfe80_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9b7ca2eb-3ee0-4308-905c-4b6b240a7fb3_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_31d6f0aa-4adc-4bd1-8ed8-e512756d7302_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_af48566b-9c47-42da-afc4-644090353d2e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1a12aaa2-e5b9-48ad-9836-66c88e3e7135_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fccccbd-a8b7-4e2a-9bd8-c2a7089016a2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_02c021bd-af28-41d6-885e-1efe35e7166f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_WeightManagementProductsMember_0e0b7f98-6c1d-4aa7-a2da-dac91fe0ab0e_terseLabel_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight management</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_label_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight Management Products [Member]</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_documentation_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to weight management products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember" xlink:href="natr-20220331.xsd#natr_WeightManagementProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_WeightManagementProductsMember" xlink:to="lab_natr_WeightManagementProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_383abb62-778c-4546-8181-e4b24ace0568_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fd2707ba-7d8c-4b61-9ea0-7a5cf5a0c7b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b990515d-6516-4332-971c-f62d11bb20aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1b332461-af89-4ec2-8455-d5ec2ea4b43f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_726708d8-c02f-4118-a076-2661389a5f57_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_17da3944-5d00-452d-bb7c-1988a525b505_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1dc04180-5fd4-4a85-954b-0eb09da6b13b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_adc6584f-1dfd-44d1-984a-33307c39dbfc_terseLabel_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs</link:label>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_label_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs [Member]</link:label>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_documentation_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember" xlink:href="natr-20220331.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AccruedSeveranceandRentCostsMember" xlink:to="lab_natr_AccruedSeveranceandRentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f377560f-a5ea-4bbf-834e-c8c32bc84cb7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_0e0f67b3-3b53-423b-9b75-3cbb302d6008_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c64727f1-0753-4423-8a4e-f94c2e759d70_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_a3ca0c85-25bb-45d6-9586-6d768e41376c_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_033538da-9a6d-43d2-83a2-48266a673103_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_588abde6-b552-4682-84b4-3de622713811_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_6fc55b02-fdf7-46a2-8ab0-9cb403fa4e5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted investment securities - trading</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_21565aec-60ef-47e0-8f8e-9338c9ce337e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities portfolio</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:to="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_31ca0957-0407-4f7f-8b99-4b5a77dbf5a9_terseLabel_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal categories of products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_label_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_documentation_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:href="natr-20220331.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:to="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f104aeee-7324-4124-932a-50d4e1671d1b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bcc3e13a-7485-4cdc-a9cf-296a6566f40c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_22b65172-12af-42cb-afe1-4f3b7d95cd47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_217844c1-9a6e-4f53-b15d-d2edfaa41d52_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_99cedfbe-fd65-4346-ad35-849cc4c49f08_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized losses (gains) on investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_483e6f67-337c-4435-9533-f83e9adce585_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4bc10437-3e8b-4325-8dc5-1d9e82deb303_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4f2bd31f-2e37-422d-b1d6-bc79e1d373b4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_e0aff177-bb19-40ea-89bc-7735989205b1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_9d4a14bb-b78c-41d6-b91d-93b9736c4097_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_a2d91b8e-b292-4f46-ab6e-80de5b42a11d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_78482fb0-8642-484f-8022-cc8ec1ecb83e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e805490d-4a2a-43b1-a756-ab5538765750_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a0bf7e8-3f18-42f5-83bf-127695b02bd1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d89ec81e-66ea-41bd-b0b0-8eaa3ca344ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_991540ac-fd03-4994-84da-ca4e32aa9516_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_09dbe7f6-f4e9-4978-ac05-7c9f5b196dc2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $148 and $143, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9288fa34-ee6e-430f-a096-0fee3e6cdb45_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5a87f2d0-80de-4424-a806-fe8a382b4c22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_a06a261d-332f-4450-a21a-3e16e6d6dbd8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_A2012IncentivePlanMember_a98a1414-c261-42e5-883f-2868e8ed9630_terseLabel_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Stock Incentive Plan</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_label_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Incentive Plan [Member]</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_documentation_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to 2012 incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember" xlink:href="natr-20220331.xsd#natr_A2012IncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_A2012IncentivePlanMember" xlink:to="lab_natr_A2012IncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_71edae9c-0fea-4800-ba19-b887228a2954_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_56f3c75b-c2c7-4afd-a636-86b69622dbf5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5d20ace2-fdfb-44af-8687-5ffad95a64b3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_40dd503b-6fc0-434a-a522-44ea3abffdda_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_945b48e2-0f99-4601-b8fc-61a0dbc8d83a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b38058d6-42fd-44f5-8a50-40ffef8ee533_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_77b6fb43-bd0a-44d1-b8d9-b1cd1bc83ba0_terseLabel_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period for issuance of shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_label_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction Period for Issuance of Shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_documentation_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the restriction period before shares will be issued related to a share-based compensation plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:href="natr-20220331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:to="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a6212f6a-c72f-40a0-a2d4-1a989873f873_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_7c13a6d5-14d7-40e8-a608-199af863f561_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bef41c07-1819-45e4-8fee-ebec26c3ccc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reportable business segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1453dbf1-0072-4b47-a5da-5fa4847296c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_593d96f2-f138-499e-bcbf-f1a3f05cddc9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_4a5d625a-a2d5-4de2-8d70-cb54809db7d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_d6c224e4-e1a2-4ea2-b0a2-f8115ffdd7df_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34feb4a9-eefd-4d58-a125-57914a4a5105_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_354bef60-469a-4bb3-b4b9-a663faea4bba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_feab2632-9201-46a9-9021-a04afbe0e6e4_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_d28cb7f5-3828-4537-9f94-5edb181e5595_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation loss (net of tax)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_01447ab1-c161-4b76-83d0-1fb0b20f4e59_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_label_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Volume Incentives and Service Fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:to="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_894416fc-3279-45e4-8fb3-f007119efb05_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum withholding requirements (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_adc135ce-1319-41b9-b483-075a8d03752f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_1d390c91-d09d-4126-97da-4b08e55688e3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_920aacf7-dc07-45d4-9d61-b4f12e21c2d9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of trading investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Purchase of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_fe662024-669c-43c1-9ceb-7ca2d3964ba4_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_76215fca-ffe1-4ae9-8135-f7797afc798a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation potential compensation expense to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84f2040f-0f89-4316-bf96-81424fc8d0e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f584d774-2b59-4e0e-bff4-bbe12882c14e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_96dfac72-efdf-4b46-a8a4-f4773df0164a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_08765723-14de-4f6c-a193-6ab94f2998df_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested subject to restriction period (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_fae9112b-7995-4062-840b-f6c8226bca59_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_225b7518-755e-4427-999e-56871a3410c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_6ec2a06d-2ee4-4d89-8243-3f6dad38f3c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_7daa5199-f5cc-40de-9419-dff48c7fc3c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_43cc1f68-375c-4b42-87ee-ac2f40b26df9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ddb5c6b2-6829-4339-b23c-b0027bbc0f4b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b74ba14b-f1f4-4138-b25d-e90eb53441ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_204bfefe-7e01-4175-a070-c43d57be9786_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Exercise Price&#160;Per&#160;Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b17b75e4-8fba-481b-9468-0d95b2f56a58_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_70fa9590-8fdf-4cb8-b74d-4f0a64b440a1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_60357723-5207-41b1-8cd7-6d25b11dbccb_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:href="natr-20220331.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:to="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_af40478e-cf68-40d0-a3e2-c094051fd834_terseLabel_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:href="natr-20220331.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:to="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4577f666-fb96-40b9-a186-3460ced0312c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af357317-1e3a-4228-8b97-f43ff4c4daf6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9f4a3978-07ed-454d-a13b-6c3dea14e203_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 - Significant Other Observable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_235e546d-fa09-40fd-97f6-d218b7cbf8be_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6da483bd-d250-489e-b01c-6f5624af8934_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_8b292a5f-8c25-4a58-b6af-329896275650_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_efbf3f57-ee96-4b52-8000-7984cd03db3e_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, outstanding, current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_VolumeIncentives_5d323de2-e6b7-470d-98f3-9e7aac9285c7_terseLabel_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_label_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume Incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_documentation_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives" xlink:href="natr-20220331.xsd#natr_VolumeIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_VolumeIncentives" xlink:to="lab_natr_VolumeIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a510ff75-aebd-4f38-9ed9-c6fc7e66e323_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5b0ce75e-fb2b-471b-b401-3146c3a3cfc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_954d53b2-7f40-4d5f-962f-dd537ca7bbce_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c93f7123-0170-46e8-852a-e1e0a3d0b214_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_c29598bc-391c-4549-9a6e-d6ea2d9f3057_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_8fb1b285-72ea-4f0b-acb3-fad4d455d2a2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_e3a568f0-ea62-4492-ab79-dab9c25a6708_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_97be189e-bc6e-4664-b016-d3a93375087f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DigestiveProductsMember_690691a1-c077-4469-a081-76869b00a942_terseLabel_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_label_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Products [Member]</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_documentation_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to digestive products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember" xlink:href="natr-20220331.xsd#natr_DigestiveProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DigestiveProductsMember" xlink:to="lab_natr_DigestiveProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0819370d-e336-4709-b7ce-b7c2e326800b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0ae575d6-09a9-4f3b-abd4-aea271e48b54_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_8d23e718-68ce-4e26-a8be-18e97ad8716c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fff5cfa6-d8ac-458b-8bb0-26296e4a6d26_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_701285d0-872a-4250-a1ca-579846f719e2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9c0c9dc8-e296-4694-9779-319c5dafa32c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9fbf7900-7897-4570-a6aa-77bfdfa32bb6_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7f7df2dc-716c-4cba-8873-de39157e24b0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ae29ac2e-d01e-497d-b010-4358205a253f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f9335396-8dea-41d3-90ea-65fa48d7760f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_7491a7ad-324d-44f9-af09-570ea5602528_terseLabel_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner</link:label>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_label_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner [Member]</link:label>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_documentation_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember" xlink:href="natr-20220331.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CompanysJointVenturePartnerMember" xlink:to="lab_natr_CompanysJointVenturePartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2c98a8c8-124f-4126-8933-5dca85aa983c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_10655e07-9ac1-4552-b131-787f30cd584b_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Liability Related to Unrecognized Tax Positions</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:to="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_f5d89838-4227-4b86-a34f-2e64edec6eb1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b987d506-ac4e-474c-9df5-3c8cd86769fe_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_b4e5d748-53b4-4fb9-81cd-7897171fbd08_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ded8d0af-a0ad-4150-b01a-4ccaac843c6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ab27e535-d0c2-45fe-b964-5bbc2ba22f0f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_f9d84e2c-19e8-445d-ac53-89c3c9705287_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3178dfa4-dde3-45ec-a16e-183c994e8ac8_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ImmunityProductsMember_c0917be6-2728-43e4-922a-19c162e749f1_terseLabel_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immune</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_label_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunity Products [Member]</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_documentation_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to immunity products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember" xlink:href="natr-20220331.xsd#natr_ImmunityProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ImmunityProductsMember" xlink:to="lab_natr_ImmunityProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_dfd50f10-8d98-41bd-a372-63bbc8479e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of trading investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a125b18-013f-44c3-bfc4-01dd46adda06_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f80e28b-0146-4015-9a2c-1106fb6669a9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_061750ea-27bb-4423-9caf-fe0de2ac3add_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b1a391e3-0d0a-4e87-9b31-d07b2fc832c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_33ccb084-b04e-4702-892f-728d8050796d_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_af7c7d9d-57d3-41c3-a439-5b7c9cedddd1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9a8ae7b9-eb92-4052-a759-0f435008f15f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares included in the calculation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_da14537f-b69a-4dc9-bde9-4a618624d7e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa34fd1d-a7d8-4a88-a803-1b5a438dfeb1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8ac3585a-f6a5-4604-8b56-d8375669f859_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7b58e2a5-478d-442c-93b2-09852c381bf1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_de32a6d3-a0b3-40c9-9c4f-0b0cc71a9f86_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_76b041cd-1c2c-48f2-bbb4-83fea65f5cd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CustomerLoyaltyProgramLoyaltyPoints_c7c32337-cc36-43a5-9326-3eff7587555d_terseLabel_en-US" xlink:label="lab_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer loyalty program, loyalty points</link:label>
    <link:label id="lab_natr_CustomerLoyaltyProgramLoyaltyPoints_label_en-US" xlink:label="lab_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Loyalty Program, Loyalty Points</link:label>
    <link:label id="lab_natr_CustomerLoyaltyProgramLoyaltyPoints_documentation_en-US" xlink:label="lab_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Loyalty Program, Loyalty Points</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:href="natr-20220331.xsd#natr_CustomerLoyaltyProgramLoyaltyPoints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:to="lab_natr_CustomerLoyaltyProgramLoyaltyPoints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c2f9f19f-9b72-4fbe-bfa6-1c294fa33ae3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_39af9ce6-ca8e-4a42-8a91-2c7a2b46d1a2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4fb8a6f1-e989-42f8-9066-816773c7fb31_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_e50c2165-6007-4ef6-849b-3345fe62fcf2_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_89ae5b71-3769-487f-b19c-74d06725f7cb_terseLabel_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_label_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Volume Incentive and Service Fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_documentation_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the liability that is related to incentives that are payable, due to volume sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:href="natr-20220331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:to="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_3a5fdd0a-62fb-4617-8d76-3344c8ac641c_terseLabel_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital Credit Agreement</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_label_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:href="natr-20220331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:to="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNoParValue_ddf99ff3-07ca-4520-b8e5-31960bb81de8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockNoParValue_label_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue" xlink:to="lab_us-gaap_CommonStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_28957c13-04ca-4629-a9ac-207ed194a40d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Company's hierarchy for assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NorthAmericaSegmentMember_bcf6c268-057f-4d39-abdb-7941705c1c0f_terseLabel_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_label_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_documentation_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember" xlink:href="natr-20220331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NorthAmericaSegmentMember" xlink:to="lab_natr_NorthAmericaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ba20c7e-66ef-4e05-9005-1873860b17ff_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_78f06423-255f-4b10-b1a3-64dbab4c2485_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_583587ee-6e0e-4369-9d99-e8dd89f89a4f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_382f05e6-558d-4e7f-bbaf-be3ce1f5475a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_395394ef-be4b-4a48-a2e0-2220b953661b_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance based stock options operating income margins</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the performance based stock options, which vest upon achieving operating income margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:href="natr-20220331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:to="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_af2deab4-3f66-43f7-8115-232488302dbd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_7ac2cec7-1228-41d1-9c81-ea057f269f85_terseLabel_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_label_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember" xlink:href="natr-20220331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BankofAmericaCreditAgreementMember" xlink:to="lab_natr_BankofAmericaCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IndicativeIndexMember_e6f2863c-9511-4fa9-88e0-cca11ea83559_terseLabel_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_label_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index [Member]</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_documentation_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember" xlink:href="natr-20220331.xsd#natr_IndicativeIndexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IndicativeIndexMember" xlink:to="lab_natr_IndicativeIndexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d2c020a5-d544-4a8c-9fff-95471c888601_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3c1e0b54-28dc-4b7f-8401-bdc07d890e11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3a4b1711-78ad-4a07-95f9-b8bd4b0017fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_19e5140e-7924-483a-b2c6-d78a7ed064c8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5f01b7bb-c03b-4a87-9d14-2310fa869410_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c31370db-06f8-497c-a1df-e85a9f0a49b7_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_bc7652bc-8511-4064-bd02-6754c23149db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Transactions</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8a938eaf-1cc3-48cb-93fa-56a27ccdb4ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_95e6ed24-0aac-4e6c-9713-e05f310a0181_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2bce7aa3-c89b-46c8-9978-24c69c85a31d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4c172040-2bab-47fe-8b24-8773e1e9beb0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted net income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_f256ae6c-ec36-4370-8671-c7a43906b9ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_46e29151-01ec-42de-aea3-e09bc124778a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of related party borrowing</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_bb4fb3c6-51f9-4c31-bf00-b97f5edce409_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_92126bd8-207a-4517-ab28-7508603f4941_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f61a547b-3e35-4f18-b7e7-039d96185f68_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_ff419ba7-199c-45d4-9d6e-7e000aab903e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_78df7d05-3d08-4413-bde4-b1cbec1c8b7b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3ec69c36-107b-4b34-84f3-2f23f7708056_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_1406cbc4-2efd-466c-a0cb-7c6a1ec8ee2c_terseLabel_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock options</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_label_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Stock Options [Member]</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_documentation_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the time-based stock options, which vest over differing periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember" xlink:href="natr-20220331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedStockOptionsMember" xlink:to="lab_natr_TimeBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_a445f433-9de5-498e-9c5d-dbfc44222517_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_65ef5b46-46fc-4d77-a5b7-44f22af8f499_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_04a2bf93-22de-454b-a879-7ae232482b86_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_63eab5de-95b7-4e02-a01d-308ac9cb3d1f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2af45f23-a613-46d3-8f8e-ce8433dab275_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership, noncontrolling party</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6618f64e-7b96-43c8-88d4-2f046e818a54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_31a99db5-f4ad-4f8b-925b-91249aeec51b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes, as a percentage of income before income taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_243acdcc-c2d0-491b-98b2-7d8ca07a80f8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d425a555-2487-448c-9763-1d17f5281d2f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9372d8ce-cfd5-4ca9-ba86-0bc474a3a063_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c871a553-32b8-4a75-ac2e-795215b9fab1_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_de1aa767-010d-4f68-a473-f90c4a20f0c0_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bff45075-c92b-4c6d-94b3-f90b481361b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dfd10024-032b-4c79-9e3b-9b82956e6bf3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_0df5d8f7-4944-4008-9482-30a02dd610a8_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cef6847f-4d6d-4a6c-8e8d-bc318d9028c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0e97e198-c071-4f98-ad61-8f85ab79fca4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMarginAbstract_a4906491-d929-4fc6-9725-ebd28fea68bc_terseLabel_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin:</link:label>
    <link:label id="lab_natr_ContributionMarginAbstract_label_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract" xlink:href="natr-20220331.xsd#natr_ContributionMarginAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMarginAbstract" xlink:to="lab_natr_ContributionMarginAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_23b332ba-ffc3-4edd-a4cf-d59766982b06_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4e59a968-ffe3-46c7-94d0-33a913050b78_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9a53ed7b-8b66-43a3-80fe-4ddf65e9f071_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ad6bb63a-0bd6-4edd-bd59-4336d4da90b4_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d802602-713f-42ae-8252-ec49ba29342d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8e271b3d-e1ea-4b6f-8e3e-ebb702174c22_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b30cc4c-054e-475a-8a98-9af825c66931_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ac879c4f-abb4-4757-b68a-e18572e1b07d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_236430b0-3bdc-44f3-bf5f-9908ca4fc56d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_e60881e0-0deb-4e7c-9b51-0007ce4924a6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9a06747c-136e-41c0-8053-014e54570dde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5a49082c-a0f1-4e80-8bd5-2e35019e6550_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_3bfcbc5d-9dbf-42f5-b8c7-031a2f255ad8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f047db1f-78b7-4a90-a21e-182f948bd7eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_795c1c6c-d35d-4201-96c0-fbfbe1af400a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_65a74655-88dd-4e35-bfb6-50ea8c0d265f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f1e6ad41-6146-4580-86c3-1b6d0cf2f03b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_7da80ef8-c2b6-4433-af89-0ebcec7f707f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_e7896af2-bc11-446c-9066-fbab4bc17f45_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_40a44530-254a-493b-a9a0-d4169b86beb5_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity, per occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_92af9466-8c38-413f-942b-74f214658a1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1d3faad-7eff-4d01-a281-63c63db929c9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_88d2514d-cc70-4f09-8a58-6cae4338823b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a49b220b-5731-4671-b0df-e62765064f28_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_148676b2-8381-4af4-acc9-45d532a61f2e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d9268642-fe35-4232-b82c-193ce42ba8cb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_19a729b4-8e5d-4387-96ad-7ca62cdeafec_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_8c578729-da01-407d-b054-4f79ec757e51_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e08a8ecd-f272-4c99-82a0-1d115ce9f536_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0898bd7b-33af-4f39-b64e-1986542ad109_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_6e5a1b91-bfad-441c-aa0c-22189da7f69f_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c3346968-0afc-4b77-830c-5ad1554766e8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OtherCountriesMember_b9b5e78e-4921-4e33-a904-3bb9b75771bb_terseLabel_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_natr_OtherCountriesMember_label_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_natr_OtherCountriesMember_documentation_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to all other international countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember" xlink:href="natr-20220331.xsd#natr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OtherCountriesMember" xlink:to="lab_natr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a8dc33c3-e287-484a-b994-2f2bd262cc9a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_c532f33f-8633-4b95-84d6-adfc3b88e22a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_560401b8-7c87-4e51-b439-e4f0da1db5da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_efce5e74-0106-4240-ab11-3e76b5499f93_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ed9dfd3f-54ff-47b0-bd1b-6aea1d7489ac_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_a6c95ffc-c486-4eaa-b3bf-872924b9781c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_bf58814e-0673-435b-8df7-41ab481462c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_91074331-3aad-478a-8bd5-5f684eeceac0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CardiovascularProductsMember_75a12043-5c77-4eca-a450-43697856d411_terseLabel_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_label_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular Products [Member]</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_documentation_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to cardiovascular products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember" xlink:href="natr-20220331.xsd#natr_CardiovascularProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CardiovascularProductsMember" xlink:to="lab_natr_CardiovascularProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_91093883-36f4-4013-8d31-54cee9173166_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility and Other Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_14ad1e24-5c32-4129-9dac-b8493b926cdc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_11c0547c-64b8-4af6-9313-869aae582777_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>natr-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d83b1d89-59ad-460c-b981-ed982d081531,g:1654c5a1-86e1-4736-b959-8aea153031a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CoverPage" xlink:type="simple" xlink:href="natr-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1b77dd1e-a5ce-4853-acfe-076a3b9b9973" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentType_1b77dd1e-a5ce-4853-acfe-076a3b9b9973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8a3b05e3-660a-416a-9146-5c058a9b83c3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentQuarterlyReport_8a3b05e3-660a-416a-9146-5c058a9b83c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1c672a15-e9c0-492b-8d3c-3d7f624c36a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentPeriodEndDate_1c672a15-e9c0-492b-8d3c-3d7f624c36a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9ca30d0f-3777-4125-a7ae-8ffd82ee8eea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentTransitionReport_9ca30d0f-3777-4125-a7ae-8ffd82ee8eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3339c536-45e7-4d0b-b1c0-2108daf70c52" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityFileNumber_3339c536-45e7-4d0b-b1c0-2108daf70c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_25f9d1da-197b-41cb-926e-e2799f5b7ad2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityRegistrantName_25f9d1da-197b-41cb-926e-e2799f5b7ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0c086d31-56e7-4ac1-b9da-305755c68c4b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0c086d31-56e7-4ac1-b9da-305755c68c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fa227dd4-4bd1-4761-83cc-5050b0ce3455" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityTaxIdentificationNumber_fa227dd4-4bd1-4761-83cc-5050b0ce3455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c1ab14e4-b452-474f-a104-9de375cc36a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityAddressAddressLine1_c1ab14e4-b452-474f-a104-9de375cc36a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_28cbf32c-f81a-4894-9894-16a47def39c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityAddressAddressLine2_28cbf32c-f81a-4894-9894-16a47def39c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1704086b-6039-4c24-b522-2e079ee3474a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityAddressCityOrTown_1704086b-6039-4c24-b522-2e079ee3474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0a8fee99-0950-49f2-9e8e-1d6cdbe16efe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityAddressStateOrProvince_0a8fee99-0950-49f2-9e8e-1d6cdbe16efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b4643d19-d3df-4ee0-947e-67b5ed8f3398" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityAddressPostalZipCode_b4643d19-d3df-4ee0-947e-67b5ed8f3398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1dd8d487-f5ad-48d4-b701-c39968b6cfac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_CityAreaCode_1dd8d487-f5ad-48d4-b701-c39968b6cfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6c86e01a-c9a3-4208-927f-80a4223fa227" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_LocalPhoneNumber_6c86e01a-c9a3-4208-927f-80a4223fa227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_dc01cd25-aee6-4fa1-81d7-69df6124e3a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_Security12bTitle_dc01cd25-aee6-4fa1-81d7-69df6124e3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f2eda801-296e-48a0-9036-05f6af996227" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_TradingSymbol_f2eda801-296e-48a0-9036-05f6af996227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b08da8b6-01c6-48e5-87d0-685d5af2f76e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_SecurityExchangeName_b08da8b6-01c6-48e5-87d0-685d5af2f76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f83d51cc-804c-4361-8a44-8f31c86e5939" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityCurrentReportingStatus_f83d51cc-804c-4361-8a44-8f31c86e5939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e25e3572-b3b4-4226-83ac-1da5a554613b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityInteractiveDataCurrent_e25e3572-b3b4-4226-83ac-1da5a554613b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_509b4624-c631-4101-a583-4bc32679d960" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityFilerCategory_509b4624-c631-4101-a583-4bc32679d960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6c57fbce-e07c-4bd9-8279-6b568a58c323" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntitySmallBusiness_6c57fbce-e07c-4bd9-8279-6b568a58c323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bd50061a-bf76-46c4-a102-04bcacfe7275" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityEmergingGrowthCompany_bd50061a-bf76-46c4-a102-04bcacfe7275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_812586dd-1cb8-49b4-83f6-d54e12274be0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityShellCompany_812586dd-1cb8-49b4-83f6-d54e12274be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_79e9f876-a945-421d-8772-3d84eb54893c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_79e9f876-a945-421d-8772-3d84eb54893c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f0e4cd98-61fa-4e26-ae3a-2543d0b81dfb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_EntityCentralIndexKey_f0e4cd98-61fa-4e26-ae3a-2543d0b81dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ad219480-9bf7-435e-8749-af8df3fe1920" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_AmendmentFlag_ad219480-9bf7-435e-8749-af8df3fe1920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_12b23254-855b-4188-ae59-8adda43f1023" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_CurrentFiscalYearEndDate_12b23254-855b-4188-ae59-8adda43f1023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bfafd5fd-5138-4ed4-9d19-b6fc5d20ad1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentFiscalYearFocus_bfafd5fd-5138-4ed4-9d19-b6fc5d20ad1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_dada0bf9-a603-4c67-b440-513fe9cfecee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9ef53255-af18-4382-8085-32c7e962762f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_dada0bf9-a603-4c67-b440-513fe9cfecee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_63e35417-1790-4026-a006-b2d0424d9467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63e35417-1790-4026-a006-b2d0424d9467" xlink:to="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2b30ebb-767e-439d-80a6-4e3868e17464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2b30ebb-767e-439d-80a6-4e3868e17464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dc49bfb1-28b6-4be8-9fb6-af676b300c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dc49bfb1-28b6-4be8-9fb6-af676b300c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ed614a66-862f-4bff-bb00-11618262b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:to="loc_us-gaap_InventoryNet_ed614a66-862f-4bff-bb00-11618262b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00695c0f-1d7d-4e6a-a1c3-6f451fb3aeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00695c0f-1d7d-4e6a-a1c3-6f451fb3aeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43d2d577-b1ae-469d-8e9d-05d1fedb757b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0c35a97-eddb-48a2-b4bb-1613ec69f440" xlink:to="loc_us-gaap_AssetsCurrent_43d2d577-b1ae-469d-8e9d-05d1fedb757b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d62478c7-e2c7-47a5-bd49-12d7d097e0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d62478c7-e2c7-47a5-bd49-12d7d097e0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4c527377-aa0c-439b-8d19-b4c49eb71c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4c527377-aa0c-439b-8d19-b4c49eb71c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_29790597-249f-493c-99f7-2c76cd9b98e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_29790597-249f-493c-99f7-2c76cd9b98e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_79a15a81-23e9-4097-901f-821da3b41db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_79a15a81-23e9-4097-901f-821da3b41db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4ea9ae41-f4d5-4a21-8dc0-c0ece5de5b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4ea9ae41-f4d5-4a21-8dc0-c0ece5de5b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_eda7ea2a-30ae-4587-88d0-8ce293f79e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_431bff7f-f8b8-47d3-b6d7-c66ccf10d85d" xlink:to="loc_us-gaap_Assets_eda7ea2a-30ae-4587-88d0-8ce293f79e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63e35417-1790-4026-a006-b2d0424d9467" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e0ad9bff-28a4-4b53-924f-601fc1600ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_AccountsPayableCurrent_e0ad9bff-28a4-4b53-924f-601fc1600ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_6c68e707-2cec-4ac3-8813-b4389a859a0b" xlink:href="natr-20220331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_6c68e707-2cec-4ac3-8813-b4389a859a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dae06df4-4c4b-4e82-a770-979b38048dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dae06df4-4c4b-4e82-a770-979b38048dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b94861a1-4da2-4530-8beb-110949494f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b94861a1-4da2-4530-8beb-110949494f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_d88d2c8c-5907-40b3-b23b-b6cb42b19c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_d88d2c8c-5907-40b3-b23b-b6cb42b19c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e9e38e04-1f61-4d2f-8110-34c07ee9c117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e9e38e04-1f61-4d2f-8110-34c07ee9c117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6e7903ad-9e35-4e0b-8fed-678a8bd14ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6e7903ad-9e35-4e0b-8fed-678a8bd14ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c44ea0fe-405f-4f31-9d48-64217ed94d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c44ea0fe-405f-4f31-9d48-64217ed94d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ab6c6918-e571-49ff-9674-d8a05de4e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0077a55a-c9d1-4e67-8096-670ac3fc2399" xlink:to="loc_us-gaap_LiabilitiesCurrent_ab6c6918-e571-49ff-9674-d8a05de4e26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17e62cb6-563b-4992-8fee-fc21a86885f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17e62cb6-563b-4992-8fee-fc21a86885f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_b40e2774-4626-4833-aa24-73096e98a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_LongTermNotesPayable_b40e2774-4626-4833-aa24-73096e98a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_79fe5ddc-4b63-4f74-8138-5eedb434dba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_79fe5ddc-4b63-4f74-8138-5eedb434dba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_488a2113-2b29-46a8-9dee-04857b3a03d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_488a2113-2b29-46a8-9dee-04857b3a03d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e3b5ed43-d37a-4965-85e0-0609e48f0246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e3b5ed43-d37a-4965-85e0-0609e48f0246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6d037bdb-62f8-4fa6-bf6f-78727c7e830e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_Liabilities_6d037bdb-62f8-4fa6-bf6f-78727c7e830e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1a74f14c-f3aa-4f27-9d96-c0a40e9252af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:to="loc_us-gaap_CommonStockValue_1a74f14c-f3aa-4f27-9d96-c0a40e9252af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_70210f59-01d0-4409-8321-dbe58014daf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_70210f59-01d0-4409-8321-dbe58014daf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6623433c-64fb-49a5-ac77-87f4b531e129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:to="loc_us-gaap_MinorityInterest_6623433c-64fb-49a5-ac77-87f4b531e129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_540135bd-fbb4-4ea5-9122-d77cd3aed9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_540135bd-fbb4-4ea5-9122-d77cd3aed9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3afa50b0-a060-4c67-b05d-1aee31b4f953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6e532cf-22a6-48b6-9dca-30e274620f3e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3afa50b0-a060-4c67-b05d-1aee31b4f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_34c0114d-8932-41fa-a2b2-bdbe512b907f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6fccf06e-5eef-4ef0-b01b-cda0b22d2efe" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_34c0114d-8932-41fa-a2b2-bdbe512b907f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_07c839f8-430e-438d-bea9-c5b8418afcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_07c839f8-430e-438d-bea9-c5b8418afcb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_ce3eb109-bf65-4b9d-a3a8-e5fe4ecffab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:to="loc_us-gaap_CommonStockNoParValue_ce3eb109-bf65-4b9d-a3a8-e5fe4ecffab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_86307c19-5f19-4fca-95e9-6abd2a1fb0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_86307c19-5f19-4fca-95e9-6abd2a1fb0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_686101c2-2f8c-412f-b7f5-c6fd2fed6b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_686101c2-2f8c-412f-b7f5-c6fd2fed6b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b9918f72-eaa2-484d-91e7-c82834f398f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9616d08e-6a4b-4cd7-ae27-2d6c67d2cee5" xlink:to="loc_us-gaap_CommonStockSharesIssued_b9918f72-eaa2-484d-91e7-c82834f398f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a677a62-2221-4755-af7f-fb60cf187d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a677a62-2221-4755-af7f-fb60cf187d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a58a2873-794d-4538-96f6-807eff1fc0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a58a2873-794d-4538-96f6-807eff1fc0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_23509af0-dfc2-43a1-9e63-daacb5ff3343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_GrossProfit_23509af0-dfc2-43a1-9e63-daacb5ff3343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_a332f695-d558-4a3a-8caa-c00b3c4602a0" xlink:href="natr-20220331.xsd#natr_VolumeIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_natr_VolumeIncentives_a332f695-d558-4a3a-8caa-c00b3c4602a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85b2ae12-88d6-4539-9114-e74e3300bd82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85b2ae12-88d6-4539-9114-e74e3300bd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ffad4965-4c83-4acf-a585-2eb80d80f4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_us-gaap_OperatingIncomeLoss_ffad4965-4c83-4acf-a585-2eb80d80f4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4ef1c18c-1b1f-4b62-954f-1e1d0266b7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4ef1c18c-1b1f-4b62-954f-1e1d0266b7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c32ca449-c16e-466b-9221-0b940a39412e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c32ca449-c16e-466b-9221-0b940a39412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_40de0639-e5e8-4709-aa75-7c815a957a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7c59548a-a6dd-4237-9473-58ff22929d3b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_40de0639-e5e8-4709-aa75-7c815a957a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7a49188d-7aa9-4dbe-80b7-38caefe23ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_ProfitLoss_7a49188d-7aa9-4dbe-80b7-38caefe23ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_beeed523-9f26-4ae7-9614-1392f902d91a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_beeed523-9f26-4ae7-9614-1392f902d91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac8a7afa-fed3-45c3-8c9f-a1cd776a025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_NetIncomeLoss_ac8a7afa-fed3-45c3-8c9f-a1cd776a025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0852dd01-11c4-4835-a983-82df0f43735c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0852dd01-11c4-4835-a983-82df0f43735c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cad7414c-b82e-436a-8c40-a88171b4a131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0852dd01-11c4-4835-a983-82df0f43735c" xlink:to="loc_us-gaap_EarningsPerShareBasic_cad7414c-b82e-436a-8c40-a88171b4a131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_dafb97e7-9a28-47b7-bc0b-36f57b2be07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0852dd01-11c4-4835-a983-82df0f43735c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_dafb97e7-9a28-47b7-bc0b-36f57b2be07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f799557d-7c06-429b-bb7a-a3f993c98361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f799557d-7c06-429b-bb7a-a3f993c98361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81170ad8-0f99-4285-b2a2-6b37f04c966b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81170ad8-0f99-4285-b2a2-6b37f04c966b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e053080-4bb3-4c8a-be94-8f3864975b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60a5f7e9-ffdb-4f67-b687-ebe273cfe85d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e053080-4bb3-4c8a-be94-8f3864975b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_beb1016b-ee48-43e1-b0e1-ffe1951df32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_871a9b02-b63f-44bf-aeee-e41a3fcb1cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_beb1016b-ee48-43e1-b0e1-ffe1951df32e" xlink:to="loc_us-gaap_ProfitLoss_871a9b02-b63f-44bf-aeee-e41a3fcb1cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_576e9470-36b2-412e-b077-652257ee8855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_beb1016b-ee48-43e1-b0e1-ffe1951df32e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_576e9470-36b2-412e-b077-652257ee8855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_22e7ab4d-f2f5-4716-b4b0-f6eebaa7bbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_beb1016b-ee48-43e1-b0e1-ffe1951df32e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_22e7ab4d-f2f5-4716-b4b0-f6eebaa7bbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a34a33fa-6756-4cde-a93f-dd31c6cd31a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a34a33fa-6756-4cde-a93f-dd31c6cd31a8" xlink:to="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94a0b3a5-6ba5-4b58-a0fa-487c6fef158e" xlink:to="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_10176005-6a95-4f08-9517-fd10863e0b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_CommonStockMember_10176005-6a95-4f08-9517-fd10863e0b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a3902af-8507-4767-8f14-7e14f0a16f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_RetainedEarningsMember_0a3902af-8507-4767-8f14-7e14f0a16f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_68e3c82b-ba9e-42f9-be32-4bb0e79409e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_NoncontrollingInterestMember_68e3c82b-ba9e-42f9-be32-4bb0e79409e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_80612c6b-23f9-4653-bb79-4e2ad992c121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b94cc27-ade8-4473-a3fa-435481e03bc9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_80612c6b-23f9-4653-bb79-4e2ad992c121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0e821380-5cc5-48ba-a5c0-c31a893f47d0" xlink:to="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2811c25c-55f4-4a2c-9c56-7063438048e2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_aa16d437-05ab-440c-934a-605e077fb7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_CommonStockSharesIssued_aa16d437-05ab-440c-934a-605e077fb7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e3087c9-f8c4-41e4-a3da-7d0689a889bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e3087c9-f8c4-41e4-a3da-7d0689a889bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_71f9194c-03ea-4946-a2ae-d70f1ac49469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_71f9194c-03ea-4946-a2ae-d70f1ac49469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_0af5cf5d-c36b-4998-b40e-b95f4fa05fc4" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_0af5cf5d-c36b-4998-b40e-b95f4fa05fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_bdc5c4b3-d775-4f8c-8ec0-7eb9cfabcfe3" xlink:href="natr-20220331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_bdc5c4b3-d775-4f8c-8ec0-7eb9cfabcfe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6b29e038-bc4d-4d05-be2a-341cf9d5fac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6b29e038-bc4d-4d05-be2a-341cf9d5fac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f1cc85fa-afbb-4f14-9f57-5cba5bdc6dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f1cc85fa-afbb-4f14-9f57-5cba5bdc6dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9cc82469-4c53-498d-9003-e64b06cd8e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_DividendsCommonStockCash_9cc82469-4c53-498d-9003-e64b06cd8e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_692715c8-1ddc-4720-aa04-e4356ed23309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_ProfitLoss_692715c8-1ddc-4720-aa04-e4356ed23309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d43dc42d-a031-4345-ae8a-fd55ea4d6b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d43dc42d-a031-4345-ae8a-fd55ea4d6b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_86674eab-5ce8-44ea-a17d-e17074505fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_CommonStockSharesIssued_86674eab-5ce8-44ea-a17d-e17074505fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942fa2f0-052a-4061-b25d-c2bed7069477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff666308-cedf-4e4a-8ca9-b2d8aab700d2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942fa2f0-052a-4061-b25d-c2bed7069477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d3aac113-8150-4eba-ab4f-c202dc0daab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_99cd6587-2cba-4253-ba36-c55223af6c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d3aac113-8150-4eba-ab4f-c202dc0daab3" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_99cd6587-2cba-4253-ba36-c55223af6c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_66e980b3-ddea-4725-91c1-7003bb940de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:to="loc_us-gaap_ProfitLoss_66e980b3-ddea-4725-91c1-7003bb940de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9ecda3f5-4e27-472c-8d1a-ae2c5d952b80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9ecda3f5-4e27-472c-8d1a-ae2c5d952b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1c4f5f02-ae53-42b1-a06f-9356a64af01a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1c4f5f02-ae53-42b1-a06f-9356a64af01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_567adf08-2e72-4e85-b426-2d54c30f9a11" xlink:href="natr-20220331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_567adf08-2e72-4e85-b426-2d54c30f9a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9bb279ef-054d-4f8b-8b0d-fd96e755d048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_ShareBasedCompensation_9bb279ef-054d-4f8b-8b0d-fd96e755d048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22868537-ffa8-4625-acf2-d5f5e282ea9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22868537-ffa8-4625-acf2-d5f5e282ea9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_634f3748-b633-4e21-a9cd-a0adfcc24de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_634f3748-b633-4e21-a9cd-a0adfcc24de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2fd2db73-48a6-4b9f-8740-26f66f7e61bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_2fd2db73-48a6-4b9f-8740-26f66f7e61bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_48a09d76-e175-4ed4-8e2a-bfd7cbb29c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_GainLossOnInvestments_48a09d76-e175-4ed4-8e2a-bfd7cbb29c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_12dbd1d6-16ee-4dee-9298-0211ee6d7852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_387838ae-9b95-4f29-8eaa-fff73c23c092" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_12dbd1d6-16ee-4dee-9298-0211ee6d7852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bd8b8f4-0dd3-4cfe-a691-1bd69704258a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bd8b8f4-0dd3-4cfe-a691-1bd69704258a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5dd16d16-5ebc-4257-b155-87b2a8ab2865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5dd16d16-5ebc-4257-b155-87b2a8ab2865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d6309902-7458-42ea-91c5-ee4b0292fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d6309902-7458-42ea-91c5-ee4b0292fa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3a92ddb6-42a5-4818-b68c-d74e6492e1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3a92ddb6-42a5-4818-b68c-d74e6492e1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8293022b-16e5-4db4-87bd-3054495aadd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8293022b-16e5-4db4-87bd-3054495aadd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_978eca45-5cd6-4338-a90a-598dd93d978e" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_978eca45-5cd6-4338-a90a-598dd93d978e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8523ff3c-b28c-4059-b4f6-8b8f875072b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8523ff3c-b28c-4059-b4f6-8b8f875072b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f13ecf59-be8e-4758-a9b4-a05e920ce05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f13ecf59-be8e-4758-a9b4-a05e920ce05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_205d2b84-7ad8-4a36-afed-882463e0f6b4" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_205d2b84-7ad8-4a36-afed-882463e0f6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_588653e0-810d-4c4f-9a3b-fd5d8701e8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_588653e0-810d-4c4f-9a3b-fd5d8701e8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_02193174-2e65-4518-85af-f9ca68d4f469" xlink:href="natr-20220331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_02193174-2e65-4518-85af-f9ca68d4f469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_65d01008-4a17-4c77-935b-db0107faf0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eef452d8-f73e-4d47-aa9a-93877adcbe88" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_65d01008-4a17-4c77-935b-db0107faf0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_078941b7-a84a-4134-8615-63476adef4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6384df99-1af5-474d-b98e-a55301a3c0a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_078941b7-a84a-4134-8615-63476adef4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4947c36a-05b5-4cdf-8f09-354a6f08cd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4947c36a-05b5-4cdf-8f09-354a6f08cd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ed551e9c-3f2e-42f4-927b-5ff38a439c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4947c36a-05b5-4cdf-8f09-354a6f08cd25" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ed551e9c-3f2e-42f4-927b-5ff38a439c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6cd7c7dc-3fdd-4cb6-8071-ffed38abb6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4947c36a-05b5-4cdf-8f09-354a6f08cd25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6cd7c7dc-3fdd-4cb6-8071-ffed38abb6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_5ba47904-53dc-4b4f-8009-cd50f7b2e508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_5ba47904-53dc-4b4f-8009-cd50f7b2e508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_87b321a2-bb57-4905-b915-eb894d0be887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_87b321a2-bb57-4905-b915-eb894d0be887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_de12eda6-231d-42db-8883-06773fcc6624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_de12eda6-231d-42db-8883-06773fcc6624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5cd01cb9-cc3a-439d-931d-e466b4f8762b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5cd01cb9-cc3a-439d-931d-e466b4f8762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01ca716c-06b5-4392-8ee1-edd42e97700f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e239374c-1a51-47c0-b835-a9f2279631ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01ca716c-06b5-4392-8ee1-edd42e97700f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8111ab7-45cf-4678-9cc2-5c259290dedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8111ab7-45cf-4678-9cc2-5c259290dedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38790754-1e25-4a50-8bed-82548149e584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38790754-1e25-4a50-8bed-82548149e584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33e99361-13c1-429c-b10e-963f9767a788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33e99361-13c1-429c-b10e-963f9767a788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2c04fab-69c7-4e65-97bb-ad7e6e9b603f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2c04fab-69c7-4e65-97bb-ad7e6e9b603f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_43f7a9e1-b9eb-4e12-86a9-64deac0561ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d302d692-34dd-4def-8443-b6b68e54dfb8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_43f7a9e1-b9eb-4e12-86a9-64deac0561ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_60d13be1-7d66-4dcb-86cc-9059c6f8b622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_43f7a9e1-b9eb-4e12-86a9-64deac0561ba" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_60d13be1-7d66-4dcb-86cc-9059c6f8b622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fbbdeb0c-ec8d-4566-a001-61e813b97069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_43f7a9e1-b9eb-4e12-86a9-64deac0561ba" xlink:to="loc_us-gaap_InterestPaidNet_fbbdeb0c-ec8d-4566-a001-61e813b97069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentation" xlink:type="simple" xlink:href="natr-20220331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_35bd8712-cf66-408f-acdd-472f210e8ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_7e0ec768-4da7-49a8-a5c4-7c9d94e99bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_35bd8712-cf66-408f-acdd-472f210e8ced" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_7e0ec768-4da7-49a8-a5c4-7c9d94e99bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="natr-20220331.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_31b9f719-98cd-472d-8462-4e215d4c0962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17d04f9d-00ac-46ee-ac67-108dcc951d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_31b9f719-98cd-472d-8462-4e215d4c0962" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17d04f9d-00ac-46ee-ac67-108dcc951d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4cb99539-da14-4e4b-97d9-7a9dd25c677b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_31b9f719-98cd-472d-8462-4e215d4c0962" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4cb99539-da14-4e4b-97d9-7a9dd25c677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e6600da0-fae2-46b3-8ba8-ef3418a0d7db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_31b9f719-98cd-472d-8462-4e215d4c0962" xlink:to="loc_us-gaap_UseOfEstimates_e6600da0-fae2-46b3-8ba8-ef3418a0d7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2f61d56e-3639-44ec-9fb6-eca5da3d741d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_31b9f719-98cd-472d-8462-4e215d4c0962" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2f61d56e-3639-44ec-9fb6-eca5da3d741d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ef3dda9b-99bf-4df7-921f-6939719e4550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ef3dda9b-99bf-4df7-921f-6939719e4550" xlink:to="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_847fb543-ee7c-471b-b021-a7e624ad92a4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember_0b38bb41-ba0e-415b-9f47-53c8350975f4" xlink:href="natr-20220331.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_22aa58c4-f94a-4551-9367-d64b866e293e" xlink:to="loc_natr_AccruedSeveranceandRentCostsMember_0b38bb41-ba0e-415b-9f47-53c8350975f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_8321ab29-3d69-44f4-af84-36934372c74a" xlink:to="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_e1c53ab7-23e2-4330-9c0e-c07e1057cb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_e1c53ab7-23e2-4330-9c0e-c07e1057cb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ae4b88bb-eb7e-4a35-808a-db71828a97ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_MinorityInterest_ae4b88bb-eb7e-4a35-808a-db71828a97ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_abd8eea4-8ed2-45a9-ad67-83b5427dad11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_RestructuringCharges_abd8eea4-8ed2-45a9-ad67-83b5427dad11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c47d12fb-6ca2-4ee7-96e1-9128586d786d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_0fd729fe-ee86-4d42-8cc6-3628e77d51b8" xlink:to="loc_us-gaap_RestructuringReserve_c47d12fb-6ca2-4ee7-96e1-9128586d786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/Inventories" xlink:type="simple" xlink:href="natr-20220331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_5de1b294-4d0b-4d8c-883c-eadcb49e5ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_0d93ee01-4379-4017-bbf1-5031781b941d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5de1b294-4d0b-4d8c-883c-eadcb49e5ca6" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_0d93ee01-4379-4017-bbf1-5031781b941d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesTables" xlink:type="simple" xlink:href="natr-20220331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b0250cea-d5dc-472b-939b-48d6076a8da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1020d983-5865-4a9a-ad21-a180a27db501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b0250cea-d5dc-472b-939b-48d6076a8da0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1020d983-5865-4a9a-ad21-a180a27db501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e7940787-5746-4cad-8803-4b988cc29a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_372faac9-79f3-4376-95ee-354a8038298e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e7940787-5746-4cad-8803-4b988cc29a79" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_372faac9-79f3-4376-95ee-354a8038298e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0aa8c0e0-05ed-4792-a02b-5e2a164e5034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e7940787-5746-4cad-8803-4b988cc29a79" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0aa8c0e0-05ed-4792-a02b-5e2a164e5034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a451a1c1-2270-4745-bfcb-34eadecbfd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e7940787-5746-4cad-8803-4b988cc29a79" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a451a1c1-2270-4745-bfcb-34eadecbfd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_96648482-75dd-467f-9ddd-fcbeea1b97d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e7940787-5746-4cad-8803-4b988cc29a79" xlink:to="loc_us-gaap_InventoryNet_96648482-75dd-467f-9ddd-fcbeea1b97d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="simple" xlink:href="natr-20220331.xsd#InvestmentSecuritiesTrading"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4d4b08bb-f468-4b8d-8ad5-af28bcc7a640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ff5be10f-a22e-44e6-ba41-6561c99160b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4d4b08bb-f468-4b8d-8ad5-af28bcc7a640" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ff5be10f-a22e-44e6-ba41-6561c99160b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#InvestmentSecuritiesTradingDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_601abf95-0c22-473b-a727-8e4214f49bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_9dd53166-d56d-4b30-93d7-f9deb726d2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_601abf95-0c22-473b-a727-8e4214f49bee" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_9dd53166-d56d-4b30-93d7-f9deb726d2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_4dc78a75-d217-4bc8-b79f-56323da5cce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_601abf95-0c22-473b-a727-8e4214f49bee" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_4dc78a75-d217-4bc8-b79f-56323da5cce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="simple" xlink:href="natr-20220331.xsd#RevolvingCreditFacilityandOtherObligations"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6acd0b0-e4f0-4cc4-b16b-31425f16a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_b95f1db0-83ec-4ed4-bca6-4368116f66a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6acd0b0-e4f0-4cc4-b16b-31425f16a0de" xlink:to="loc_us-gaap_LongTermDebtTextBlock_b95f1db0-83ec-4ed4-bca6-4368116f66a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fc90c533-09d3-4f41-915a-4ef0c9509980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fc90c533-09d3-4f41-915a-4ef0c9509980" xlink:to="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_41c65941-ccfc-4a2d-8361-7d6819205515" xlink:to="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3381f5bd-b4af-4920-a1b0-8b0fefcb76eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3381f5bd-b4af-4920-a1b0-8b0fefcb76eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_660d1cae-092c-4a1a-abf9-f01feb8caca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e9ebc58d-5b28-40e7-abbf-32ea770c0092" xlink:to="loc_us-gaap_LineOfCreditMember_660d1cae-092c-4a1a-abf9-f01feb8caca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ccc9a03e-64bc-49c7-93f7-2475d5037c19" xlink:to="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f7e9daad-50a2-4678-a35d-b06105ad8bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f7e9daad-50a2-4678-a35d-b06105ad8bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_ccdb2af5-403a-4d9e-b642-5078a1359455" xlink:href="natr-20220331.xsd#natr_IndicativeIndexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1bc6ffe6-0482-461d-94a8-ee39de335ed7" xlink:to="loc_natr_IndicativeIndexMember_ccdb2af5-403a-4d9e-b642-5078a1359455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc5c410-02ba-4834-af4b-20f5d4e8af1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_94b733c8-def8-485f-a01b-80589b86b21a" xlink:href="natr-20220331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_94b733c8-def8-485f-a01b-80589b86b21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e305166d-24bd-4e63-8fa1-cac8e3192b16" xlink:href="natr-20220331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a18621b3-f15c-4a29-b023-3d29d7e6e767" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e305166d-24bd-4e63-8fa1-cac8e3192b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_788d1734-72bc-44c3-9af8-00b8babbde48" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4af0667e-76b8-4151-a885-c233f119be2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4af0667e-76b8-4151-a885-c233f119be2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_a1f5de46-043e-4d79-b1ec-f1cbf0888b5f" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_a1f5de46-043e-4d79-b1ec-f1cbf0888b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_ba0ae5dd-d94e-4553-852d-f895e86e032b" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_ba0ae5dd-d94e-4553-852d-f895e86e032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_0f9208d0-ebae-48ed-88d7-6f06bf3479fb" xlink:href="natr-20220331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_0f9208d0-ebae-48ed-88d7-6f06bf3479fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1d49a92f-d363-410c-b89c-c0a826317069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1d49a92f-d363-410c-b89c-c0a826317069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8190669-79e9-47fc-a468-b0f51a10e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8190669-79e9-47fc-a468-b0f51a10e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_270326cc-4205-44b1-84d1-716c9e021b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_270326cc-4205-44b1-84d1-716c9e021b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b0188949-ce21-48b5-802e-da7ce1da406d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LineOfCredit_b0188949-ce21-48b5-802e-da7ce1da406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_77c72d60-dffa-41b2-9e62-4ca40ad05e2a" xlink:href="natr-20220331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_77c72d60-dffa-41b2-9e62-4ca40ad05e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1549b205-6e42-4228-ab31-d6aaccec882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1549b205-6e42-4228-ab31-d6aaccec882b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_fa1b9694-e7d1-446b-85ce-b104d0d6d791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c1cd1665-f8cb-457b-83f3-133657054530" xlink:to="loc_us-gaap_LinesOfCreditCurrent_fa1b9694-e7d1-446b-85ce-b104d0d6d791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="natr-20220331.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_138a0a99-aa47-4f70-81b2-10d4af9e866d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_33e3464b-dec2-46c2-aaca-a0cde4786d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_138a0a99-aa47-4f70-81b2-10d4af9e866d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_33e3464b-dec2-46c2-aaca-a0cde4786d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="natr-20220331.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3f5cb968-56d3-43cf-b400-46c369f23273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e296715c-62ef-4acf-8ba0-d71ea2b28b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f5cb968-56d3-43cf-b400-46c369f23273" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e296715c-62ef-4acf-8ba0-d71ea2b28b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#NetIncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_42df5891-6455-4f5e-84aa-b411de219b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_42df5891-6455-4f5e-84aa-b411de219b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_57f95419-5df0-446a-9e4d-2735ef928de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_57f95419-5df0-446a-9e4d-2735ef928de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_23cef6b7-2116-402a-a195-45f92f90da68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_us-gaap_EarningsPerShareBasic_23cef6b7-2116-402a-a195-45f92f90da68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b92512-8db7-4591-b1eb-e9b73d99a204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b92512-8db7-4591-b1eb-e9b73d99a204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4f1be286-e164-48ed-8072-bab40f705733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b92512-8db7-4591-b1eb-e9b73d99a204" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4f1be286-e164-48ed-8072-bab40f705733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a3299d30-8ea1-44e1-adcd-0b65b6afd223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b92512-8db7-4591-b1eb-e9b73d99a204" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a3299d30-8ea1-44e1-adcd-0b65b6afd223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8d1495e5-e4ba-4899-bbd8-7d5adc8336b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b92512-8db7-4591-b1eb-e9b73d99a204" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8d1495e5-e4ba-4899-bbd8-7d5adc8336b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_377d0acb-65ee-4f05-a854-24bae7d944d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_377d0acb-65ee-4f05-a854-24bae7d944d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_71ee3cd5-abed-452b-8e3a-ceaea01447c4" xlink:href="natr-20220331.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_71ee3cd5-abed-452b-8e3a-ceaea01447c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_2472e933-ded6-4250-b94d-4ab98330bc35" xlink:href="natr-20220331.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_71ee3cd5-abed-452b-8e3a-ceaea01447c4" xlink:to="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_2472e933-ded6-4250-b94d-4ab98330bc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_e6be10e6-bdeb-4dec-aba7-e39f1d31c609" xlink:href="natr-20220331.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3b42fa4-5399-4317-b78e-01a08d5e097b" xlink:to="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_e6be10e6-bdeb-4dec-aba7-e39f1d31c609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffad158e-5172-46ab-8374-0d1b78d40c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_e6be10e6-bdeb-4dec-aba7-e39f1d31c609" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffad158e-5172-46ab-8374-0d1b78d40c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8985a45b-509b-4e64-b0cc-ea8b153bdd86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_e6be10e6-bdeb-4dec-aba7-e39f1d31c609" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8985a45b-509b-4e64-b0cc-ea8b153bdd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactions" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactions"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_16ae419a-43a5-49dc-9617-d34b7f03441d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_4d57cee1-51bb-4323-894a-00e6c9a20f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_16ae419a-43a5-49dc-9617-d34b7f03441d" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_4d57cee1-51bb-4323-894a-00e6c9a20f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b4c3742d-0ca9-4208-bd44-0379586bb4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ba12d7ed-b61b-4282-a62d-fb1dc8573516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b4c3742d-0ca9-4208-bd44-0379586bb4a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ba12d7ed-b61b-4282-a62d-fb1dc8573516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f18c1781-6da3-4abe-88bb-80d42da0eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b4c3742d-0ca9-4208-bd44-0379586bb4a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f18c1781-6da3-4abe-88bb-80d42da0eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_79505144-7bd3-4642-b3a0-92ddb6b750ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_79505144-7bd3-4642-b3a0-92ddb6b750ce" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_295703a3-ade7-48d5-b323-8b2f47297699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_56ec8bc5-c543-4f4f-8e82-02e869acb0f9" xlink:href="natr-20220331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:to="loc_natr_TimeBasedStockOptionsMember_56ec8bc5-c543-4f4f-8e82-02e869acb0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_395c653d-4a12-4f31-bb8f-0f8bdd3ef1dd" xlink:href="natr-20220331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_dae4e3a6-8abc-4912-9590-65b6303bd7a8" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_395c653d-4a12-4f31-bb8f-0f8bdd3ef1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af63250e-d087-4f2f-abba-caad0f67de55" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember_483502db-1b9f-451c-8a31-0b1ddf5b8f55" xlink:href="natr-20220331.xsd#natr_TimeBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUsMember_483502db-1b9f-451c-8a31-0b1ddf5b8f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_2d42ccaa-9193-4d62-9e70-953bfb6e3a7d" xlink:href="natr-20220331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_130af140-b90f-40d2-8980-d8453760149e" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_2d42ccaa-9193-4d62-9e70-953bfb6e3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_d5cdd95b-ebdf-40c4-8c09-79f6e24e89f3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f460c812-56d1-4c4b-83f2-12e5a29b6fe5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e25db6ac-e39b-4b28-99cc-94cd02a46f2e" xlink:to="loc_srt_DirectorMember_f460c812-56d1-4c4b-83f2-12e5a29b6fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3fd2940e-149e-43dd-8d31-ae9c5ef4f66e" xlink:to="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_110206bc-85ff-4ab7-b843-421493b53a69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:to="loc_srt_MinimumMember_110206bc-85ff-4ab7-b843-421493b53a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_94d62245-e370-4374-94e2-1b725f160df0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3287fa84-169c-457f-8200-520fca35aa55" xlink:to="loc_srt_MaximumMember_94d62245-e370-4374-94e2-1b725f160df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5b514922-82f9-4309-a66a-d63410ca4d02" xlink:to="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_1c4da071-327b-488d-90f9-1b226073544b" xlink:href="natr-20220331.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_69635573-9ae9-45d2-b176-2b234a5ccf42" xlink:to="loc_natr_A2012IncentivePlanMember_1c4da071-327b-488d-90f9-1b226073544b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cee5113-2ce7-4ffe-ba59-383b11983f2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8b8a4c2d-bf1a-4f5a-9b86-be636ea6b4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8b8a4c2d-bf1a-4f5a-9b86-be636ea6b4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_a96e9a3a-64f3-4980-bdbc-a6f17d3daa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_DividendsCommonStockCash_a96e9a3a-64f3-4980-bdbc-a6f17d3daa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d469731-a5ea-4824-a05a-7bf375213f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8d469731-a5ea-4824-a05a-7bf375213f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c4d4d145-c000-474e-8177-46d886f6fbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c4d4d145-c000-474e-8177-46d886f6fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3826aace-caf0-4c2d-9e60-5a0707571c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3826aace-caf0-4c2d-9e60-5a0707571c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_95038e99-282d-4253-b905-9d1fee880f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_95038e99-282d-4253-b905-9d1fee880f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_881b262d-9711-4fe8-b98e-392706c71446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_881b262d-9711-4fe8-b98e-392706c71446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b986aa7-685c-4757-a467-6df0cbf519c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b986aa7-685c-4757-a467-6df0cbf519c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_289391f2-7d82-41a2-ab90-b1dd44093f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_289391f2-7d82-41a2-ab90-b1dd44093f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_d6f98c66-a988-43c5-8557-4f5210de5926" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_d6f98c66-a988-43c5-8557-4f5210de5926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_998e46ac-94f0-4d47-be46-32d31e71cdd0" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_998e46ac-94f0-4d47-be46-32d31e71cdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_cfe30b0c-2e33-4e87-ae52-6888bb94e1bf" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_cfe30b0c-2e33-4e87-ae52-6888bb94e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_32be4d99-b5b5-40b5-b4f8-d6e8ea154966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_32be4d99-b5b5-40b5-b4f8-d6e8ea154966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8de02fba-c5d5-4a45-8005-128e58255653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8de02fba-c5d5-4a45-8005-128e58255653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba398d71-0686-45f8-a86f-0a5769595337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba398d71-0686-45f8-a86f-0a5769595337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_93a96cb2-9d54-4d3f-9687-245d9dd41a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_93a96cb2-9d54-4d3f-9687-245d9dd41a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97f03565-9f29-47bb-a025-e4c97722e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97f03565-9f29-47bb-a025-e4c97722e8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_09572cf5-149e-4888-b9cf-3ea82f40d3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_09572cf5-149e-4888-b9cf-3ea82f40d3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92b0e9d2-e861-4d9e-b99a-347c4d4fe58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92b0e9d2-e861-4d9e-b99a-347c4d4fe58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_41e05d0a-c219-44e5-85b2-8feb404290fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_41e05d0a-c219-44e5-85b2-8feb404290fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3c274e47-12df-44fd-8db9-8921e5d0219c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3c274e47-12df-44fd-8db9-8921e5d0219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_8b14c3bb-14e5-4182-bd99-728c0208e6bd" xlink:href="natr-20220331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_8b14c3bb-14e5-4182-bd99-728c0208e6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_0d8291a5-be34-4f8a-b2f8-8180b1eaf14b" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_0d8291a5-be34-4f8a-b2f8-8180b1eaf14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3d9815fe-87c5-4c35-a66d-7fc69bf5bf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3d9815fe-87c5-4c35-a66d-7fc69bf5bf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7a2252c5-f7af-4d6c-9196-41d5eee55144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7a2252c5-f7af-4d6c-9196-41d5eee55144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_80a28c77-c3d4-40c8-b28f-8b3082bfd78b" xlink:href="natr-20220331.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_80a28c77-c3d4-40c8-b28f-8b3082bfd78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8fcf42bd-7c48-4d89-8aad-b0bfe6b0d08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8fcf42bd-7c48-4d89-8aad-b0bfe6b0d08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5c2a9c16-e252-47bb-bb72-c9e01eb7671d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5c2a9c16-e252-47bb-bb72-c9e01eb7671d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_c3ad336c-8cd2-42b8-a03c-7d5a35d9e312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_c3ad336c-8cd2-42b8-a03c-7d5a35d9e312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_e8dd00db-d7fe-4330-b68e-e3ffe42b4dbb" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_e8dd00db-d7fe-4330-b68e-e3ffe42b4dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_9909b4b3-620d-4b50-970a-94d920ef6064" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_146b12e0-e31f-46e1-8c20-6b3afef76e5e" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_9909b4b3-620d-4b50-970a-94d920ef6064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_51fab14d-234c-4815-873e-388fd559d376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51fab14d-234c-4815-873e-388fd559d376" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:to="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1de205ef-b8f5-4e07-93a0-c96a09496ab1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_92af6dbb-2b34-4a14-9925-52217978e506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_960b6996-4e9c-4cc4-b4f4-8cb5d3478edb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_92af6dbb-2b34-4a14-9925-52217978e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85706ac6-c760-4555-8ba5-fa04886a1050" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8a9422f7-8bd3-41e2-b67f-69ee48218260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8a9422f7-8bd3-41e2-b67f-69ee48218260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3120ee2c-e2ee-4d31-a3f4-ae98890592d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3120ee2c-e2ee-4d31-a3f4-ae98890592d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ecbf48cd-3f62-4f05-b6d8-dae47733207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ecbf48cd-3f62-4f05-b6d8-dae47733207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a88a3a24-423e-450c-b1de-2ebb2e2e7183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a88a3a24-423e-450c-b1de-2ebb2e2e7183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fb24f8a2-a156-44ca-91ab-920914f3be06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dfcb92a1-0308-44c8-ac2d-4560d0589e1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fb24f8a2-a156-44ca-91ab-920914f3be06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f9c3957f-e8ed-4622-937a-95c31455c981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f9c3957f-e8ed-4622-937a-95c31455c981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fb5aac4f-6c9a-4f73-b956-d8f4f1b1d3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fb5aac4f-6c9a-4f73-b956-d8f4f1b1d3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_49b1b157-e779-4de5-995f-2184329955ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_49b1b157-e779-4de5-995f-2184329955ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41d7f54e-be04-4194-9c19-a8b2563072c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41d7f54e-be04-4194-9c19-a8b2563072c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d289577a-fd0f-48e2-b322-423cea5cc90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2efdaa41-96b0-4df4-b988-50d35c6c7449" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d289577a-fd0f-48e2-b322-423cea5cc90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d305364b-d685-4e80-9883-af14271056d1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3c87246a-f705-47fb-9d86-05e250577bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3c87246a-f705-47fb-9d86-05e250577bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f52f645a-4ee5-4211-837c-ca2b2c681553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f52f645a-4ee5-4211-837c-ca2b2c681553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_1bc3c8ea-4aa3-448f-a717-be71346d94e5" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_1bc3c8ea-4aa3-448f-a717-be71346d94e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_886b9292-d3aa-4d41-ab28-144d8b362748" xlink:href="natr-20220331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_886b9292-d3aa-4d41-ab28-144d8b362748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6d1f8400-da57-4464-975e-0f5d8e5b1d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_63d74965-d633-43a0-9514-514605974fb9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6d1f8400-da57-4464-975e-0f5d8e5b1d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ca13290-5f3e-4780-986d-876b2445d4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ca13290-5f3e-4780-986d-876b2445d4fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:to="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0d70ede4-5648-4739-ba75-e5d148e08e47" xlink:to="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_0ebf035f-7c97-48bc-8e6c-1a384befdaa4" xlink:href="natr-20220331.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_92e82db3-59ef-4c83-b2c0-129d4b0e8512" xlink:to="loc_natr_A2012IncentivePlanMember_0ebf035f-7c97-48bc-8e6c-1a384befdaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:to="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_608e75b4-38ab-4932-9ccb-799047043906" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0a1f0340-2bd8-464c-aa74-d93bcd7f57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34949d25-ec6b-4825-952d-da7be664e2c1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0a1f0340-2bd8-464c-aa74-d93bcd7f57c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd25971a-27a3-4158-af40-ba91e481fe49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77fb66d3-eba3-488a-bc7f-7f1edbe261c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77fb66d3-eba3-488a-bc7f-7f1edbe261c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6743fbd-3892-42a7-88c5-767f95c78423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6743fbd-3892-42a7-88c5-767f95c78423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e841fa8a-e302-4411-965c-eb0779d5782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e841fa8a-e302-4411-965c-eb0779d5782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_38b80f70-9b79-4002-8822-5c972a31af98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_38b80f70-9b79-4002-8822-5c972a31af98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1369d8f6-1669-4d82-86c2-a55c23d564bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_98e9ed6a-652a-4218-9002-e05cf20aca78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1369d8f6-1669-4d82-86c2-a55c23d564bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3698ef4-154b-4d9b-a539-3fb5c3e865e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4cd3f76-e9f8-496e-86ae-64f0d9600c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4cd3f76-e9f8-496e-86ae-64f0d9600c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aac38b12-0b2e-48bd-9f54-7392f0e72de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aac38b12-0b2e-48bd-9f54-7392f0e72de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_70e4e29a-2c79-4f6c-931c-4abec2011247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_70e4e29a-2c79-4f6c-931c-4abec2011247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_049d019a-d3f8-497f-bfa3-e1b8e314bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_049d019a-d3f8-497f-bfa3-e1b8e314bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4bbb49b7-faf4-4e70-be97-a2f05dadf4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f50bacb-db41-45af-9beb-9b21cf15758d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4bbb49b7-faf4-4e70-be97-a2f05dadf4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformation" xlink:type="simple" xlink:href="natr-20220331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_afdb08b2-d4ef-46d2-a746-a04ddc7c3750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7f2e8ff5-6889-4b4d-ba18-ef7647f5838b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_afdb08b2-d4ef-46d2-a746-a04ddc7c3750" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_7f2e8ff5-6889-4b4d-ba18-ef7647f5838b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="natr-20220331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9d168dc3-fe81-4420-8358-752fc8a3cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9d168dc3-fe81-4420-8358-752fc8a3cfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_8c3fb2f5-6a91-46e7-8386-a2abd2b5f8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_8c3fb2f5-6a91-46e7-8386-a2abd2b5f8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_d11bbbd5-0493-4d2f-81b9-7a074a1ba85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_d11bbbd5-0493-4d2f-81b9-7a074a1ba85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_d736dea7-3c2a-447c-9e4f-8a1ebe3a7455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_d736dea7-3c2a-447c-9e4f-8a1ebe3a7455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_9400571e-794c-4ea5-a490-a0f753531465" xlink:href="natr-20220331.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3184c7cf-4e2a-4f6e-b4a9-8f6ee0971909" xlink:to="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_9400571e-794c-4ea5-a490-a0f753531465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4cc063ff-070e-4a11-bdc2-dd2e7292385b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4cc063ff-070e-4a11-bdc2-dd2e7292385b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9cc9d0cc-7c9b-4a52-a3f1-6621791877ed" xlink:to="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_da2d9faa-2559-4934-b510-67bf4c6d716e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_CN_da2d9faa-2559-4934-b510-67bf4c6d716e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_863f116a-05d2-46d6-b646-f9cdfc060b6b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_US_863f116a-05d2-46d6-b646-f9cdfc060b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_3c9419be-198a-47cb-b29d-242ef3484c95" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_KR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_country_KR_3c9419be-198a-47cb-b29d-242ef3484c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_5b1401f3-afa1-4fe5-9491-09b39fec4f6e" xlink:href="natr-20220331.xsd#natr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ea3b99b-89a8-4533-abe7-0806a789fad9" xlink:to="loc_natr_OtherCountriesMember_5b1401f3-afa1-4fe5-9491-09b39fec4f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89ac7d55-f9d9-4b22-ae6e-dba5cc87822d" xlink:to="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_ea403b6a-3ce4-4313-9a61-8d34559f6ad4" xlink:href="natr-20220331.xsd#natr_AsiaSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_AsiaSegmentMember_ea403b6a-3ce4-4313-9a61-8d34559f6ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_27b7f0a4-3783-4521-a731-2a85ced85c1c" xlink:href="natr-20220331.xsd#natr_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_EuropeSegmentMember_27b7f0a4-3783-4521-a731-2a85ced85c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_26a2f62f-3092-46ad-91c1-8494aa25933d" xlink:href="natr-20220331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_NorthAmericaSegmentMember_26a2f62f-3092-46ad-91c1-8494aa25933d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_e284edb7-194a-4938-9654-7722694dadaf" xlink:href="natr-20220331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6f8a9af5-29c5-495d-bd99-189282a31f3e" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_e284edb7-194a-4938-9654-7722694dadaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3bbad7db-c7a9-4d17-8e2f-21663614d1e5" xlink:to="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_df3e0a94-c269-4ed6-a9f8-de1706ea09af" xlink:href="natr-20220331.xsd#natr_GeneralHealthProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_GeneralHealthProductsMember_df3e0a94-c269-4ed6-a9f8-de1706ea09af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_17284364-e9ea-4f6a-908f-0cd1b2cd206f" xlink:href="natr-20220331.xsd#natr_ImmunityProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_ImmunityProductsMember_17284364-e9ea-4f6a-908f-0cd1b2cd206f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_511320ab-cfd7-426b-981d-2fad4e5f7ec5" xlink:href="natr-20220331.xsd#natr_CardiovascularProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_CardiovascularProductsMember_511320ab-cfd7-426b-981d-2fad4e5f7ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_2c4deafe-9676-4d67-bd92-4cc080968bd5" xlink:href="natr-20220331.xsd#natr_DigestiveProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_DigestiveProductsMember_2c4deafe-9676-4d67-bd92-4cc080968bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_330c5398-6d8f-4910-8e0b-1cf7092d97a6" xlink:href="natr-20220331.xsd#natr_PersonalCareProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_PersonalCareProductsMember_330c5398-6d8f-4910-8e0b-1cf7092d97a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_e812b8c6-942f-4532-9970-315325c1449a" xlink:href="natr-20220331.xsd#natr_WeightManagementProductsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_469bf8c9-e9b5-4954-8d40-a1dd22bdc05a" xlink:to="loc_natr_WeightManagementProductsMember_e812b8c6-942f-4532-9970-315325c1449a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04ba3a17-a40c-4544-91e1-792f9ef78c42" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_dfc3ce77-911a-4a5e-b160-36d78c88203a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_NumberOfReportableSegments_dfc3ce77-911a-4a5e-b160-36d78c88203a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f9890f-11cb-4859-9634-8bd1cee4413b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_52def3ae-bd57-49cd-9049-1bd46e1a5d4e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f9890f-11cb-4859-9634-8bd1cee4413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:href="natr-20220331.xsd#natr_ContributionMarginAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_4661108a-e2f8-4d4c-9333-813222251ea1" xlink:href="natr-20220331.xsd#natr_ContributionMargin"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_ContributionMarginAbstract_6f484f26-da0c-4ad3-8584-3bf70ffbeafe" xlink:to="loc_natr_ContributionMargin_4661108a-e2f8-4d4c-9333-813222251ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_92299644-2819-48ae-926b-fad1bde62eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_92299644-2819-48ae-926b-fad1bde62eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_74a0a6e7-a0ef-44cf-8edb-9b36ab413f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_OperatingIncomeLoss_74a0a6e7-a0ef-44cf-8edb-9b36ab413f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7deed6ca-dc07-4b2b-823d-04fde7c16774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7deed6ca-dc07-4b2b-823d-04fde7c16774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21958505-2f5a-470b-b5a5-11470e461fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21958505-2f5a-470b-b5a5-11470e461fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_854feb2d-2b43-4a73-b64c-d9b4308696bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_854feb2d-2b43-4a73-b64c-d9b4308696bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6ae4d0e4-09d7-4b29-bf7f-fa24f69f3944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_24167588-1f92-49ef-be6a-51e756d0c093" xlink:to="loc_us-gaap_Assets_6ae4d0e4-09d7-4b29-bf7f-fa24f69f3944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxes" xlink:type="simple" xlink:href="natr-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e9212e66-ddfa-4414-bf50-552e4b1d4a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fcfd0ac5-37c4-4420-a35c-cacfccb91213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9212e66-ddfa-4414-bf50-552e4b1d4a79" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fcfd0ac5-37c4-4420-a35c-cacfccb91213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0c3e5229-09c0-4387-a675-b11195008a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_183019d6-e23e-4590-91c5-358dbb788139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c3e5229-09c0-4387-a675-b11195008a27" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_183019d6-e23e-4590-91c5-358dbb788139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d5de54f8-c4b6-400b-95d0-625a64555715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c3e5229-09c0-4387-a675-b11195008a27" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d5de54f8-c4b6-400b-95d0-625a64555715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="natr-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f21c98c9-d92e-436f-9238-822e6d589a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_461f169a-f3a0-4323-a856-decdd93972e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f21c98c9-d92e-436f-9238-822e6d589a3e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_461f169a-f3a0-4323-a856-decdd93972e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9efc9785-4509-4d48-9725-e62d3b4be7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9efc9785-4509-4d48-9725-e62d3b4be7e3" xlink:to="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_fc4d4b8b-accd-44a5-918d-ec1acb8a10d2" xlink:to="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c14e8b33-27f0-472a-93c9-580e640b01cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_05d426b7-649e-41d5-8193-8e2e3e252e7b" xlink:to="loc_us-gaap_PendingLitigationMember_c14e8b33-27f0-472a-93c9-580e640b01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_74f1005c-0a3b-49f3-a1d1-b6e45cc893b6" xlink:to="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc271060-46b6-4821-aeaa-5e16d6d604d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:to="loc_srt_MinimumMember_bc271060-46b6-4821-aeaa-5e16d6d604d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dc32dfbc-8213-40db-84bd-a530a3d99466" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36106410-68f0-43c3-8b9b-5a6103c1e496" xlink:to="loc_srt_MaximumMember_dc32dfbc-8213-40db-84bd-a530a3d99466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a85c9556-2c9a-4899-aa55-7d8a78997a64" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_8579f8ab-aa4c-42ba-bbfb-cec0743c43be" xlink:href="natr-20220331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_8579f8ab-aa4c-42ba-bbfb-cec0743c43be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_eef314ce-5214-4789-a01b-3620e10f53b3" xlink:href="natr-20220331.xsd#natr_NonIncomeTaxMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89ebafd8-a33f-4a83-a680-25563de18043" xlink:to="loc_natr_NonIncomeTaxMember_eef314ce-5214-4789-a01b-3620e10f53b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_222d0bcf-0d57-4e87-a530-9856675c6a3c" xlink:to="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_1a747fb0-e5dd-4a36-b9a4-4248b48fb2e7" xlink:href="natr-20220331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_1a747fb0-e5dd-4a36-b9a4-4248b48fb2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_edea6e1f-a73f-4ce9-a872-7c82e9e02ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_edea6e1f-a73f-4ce9-a872-7c82e9e02ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_fd98c199-ed9b-4f0d-8a65-f0a4ca98bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_fd98c199-ed9b-4f0d-8a65-f0a4ca98bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_dbc70e51-d016-4c4a-975d-ae7694fff9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8e821c31-166a-4237-946a-183eb350adcf" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_dbc70e51-d016-4c4a-975d-ae7694fff9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="natr-20220331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_76a6612e-17e7-4aa9-8b7a-4bd585616291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_dfd14416-1425-4768-8465-faf3ca2525fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_76a6612e-17e7-4aa9-8b7a-4bd585616291" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_dfd14416-1425-4768-8465-faf3ca2525fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ff0df84c-bf1e-4d5c-bac4-a27bbc56e9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ff0df84c-bf1e-4d5c-bac4-a27bbc56e9d5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7fd73faa-a7c3-487d-8da6-10f560f69f15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_9fb40857-b5b5-4d8d-9061-7af518c94711" xlink:href="natr-20220331.xsd#natr_ChinaJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:to="loc_natr_ChinaJointVentureMember_9fb40857-b5b5-4d8d-9061-7af518c94711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember_6f0b97be-5a23-4f45-a435-b083481889f0" xlink:href="natr-20220331.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_526ed74a-8b5b-4c4f-a2f9-e5450a5e20da" xlink:to="loc_natr_NaturesSunshineProductsChinaMember_6f0b97be-5a23-4f45-a435-b083481889f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_8deb741a-2bd5-4187-814b-8036162746b9" xlink:to="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_52f756cd-ee7f-40f6-9c4a-2a5463948578" xlink:href="natr-20220331.xsd#natr_ChinaJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_a3279bad-a6d7-466a-a829-39196e6bfc44" xlink:to="loc_natr_ChinaJointVentureMember_52f756cd-ee7f-40f6-9c4a-2a5463948578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_edc9f34d-fd74-48d2-8df3-28fe0a996a86" xlink:to="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_3cef1d25-948b-4cb2-8e50-8d4cc0935f0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5ecb42b6-e601-4f6d-bf1c-bd7979545a9b" xlink:to="loc_srt_SubsidiariesMember_3cef1d25-948b-4cb2-8e50-8d4cc0935f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ddef15f5-d2e6-4a02-8bcb-01d50bfa5b90" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_f73544f6-6cdb-48ae-bec0-9fcb2a3d863d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_8d89d14f-b964-4501-8bf2-b45abfc396b8" xlink:to="loc_us-gaap_NotesReceivableMember_f73544f6-6cdb-48ae-bec0-9fcb2a3d863d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_09576a11-ed32-4900-9c49-49ac06facd71" xlink:to="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember_37509442-b7be-42dd-86f8-c9f26a7543d6" xlink:href="natr-20220331.xsd#natr_FosunPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:to="loc_natr_FosunPharmaMember_37509442-b7be-42dd-86f8-c9f26a7543d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember_fd53494b-e305-43dc-8c53-a5318cb83d85" xlink:href="natr-20220331.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3b895bbf-5e82-4cb5-a8ea-5824d4f37cc3" xlink:to="loc_natr_CompanysJointVenturePartnerMember_fd53494b-e305-43dc-8c53-a5318cb83d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1189c17a-734d-44ff-b26f-035f9db4dfce" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a229e8d4-887e-409f-a9cb-a0ef8ed71a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a229e8d4-887e-409f-a9cb-a0ef8ed71a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ae1210f5-3ad4-464b-9487-c06cd8452dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ae1210f5-3ad4-464b-9487-c06cd8452dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ff619d28-56cd-4863-a140-64e0f8f5f818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ff619d28-56cd-4863-a140-64e0f8f5f818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_e50c8278-19dc-4ccf-87fc-8f8829fca868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_e50c8278-19dc-4ccf-87fc-8f8829fca868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_947d55df-2600-4ee0-83bf-c667a7ca9989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5372ed75-9962-42bf-8bd5-fe7416a703f9" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_947d55df-2600-4ee0-83bf-c667a7ca9989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="natr-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b2b0cad7-71a0-43d5-b53c-34aea7ae74ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f77a1951-d119-43d5-9726-4cf47319fbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b2b0cad7-71a0-43d5-b53c-34aea7ae74ff" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f77a1951-d119-43d5-9726-4cf47319fbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="natr-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ada27d51-6c83-484a-8c15-6c65b0041d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_74ac7f05-64ad-4851-97b2-fa987927dc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ada27d51-6c83-484a-8c15-6c65b0041d0f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_74ac7f05-64ad-4851-97b2-fa987927dc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e45a028f-23df-48a4-a52f-e163e687cd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e45a028f-23df-48a4-a52f-e163e687cd23" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_36a4b7a3-e859-4923-936f-05ee81867861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1eea58dc-ac3b-48ec-8374-7211feb01971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a9f19483-60c3-4923-8870-2fe152c205a2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1eea58dc-ac3b-48ec-8374-7211feb01971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_807b073a-35c1-4a1e-8629-537cc23f9b50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f5a6335a-f556-4b9c-a879-65b3fd7f5938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f5a6335a-f556-4b9c-a879-65b3fd7f5938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a75ee01f-d139-4abd-bc6e-a9e5e6fdcef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a75ee01f-d139-4abd-bc6e-a9e5e6fdcef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_52d20e8d-d233-4149-b286-8f82fdde6f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88539846-f206-437f-b47a-8dd018f7244b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_52d20e8d-d233-4149-b286-8f82fdde6f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_8743767e-aec7-4d2b-8f51-31d75199bbe0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1e74abc5-a863-42cc-bebe-590dbc46fbea" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a8324d8-cd56-41c3-8377-2e0caa139746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f445360c-d88f-45fa-bb20-a38a61a01fb0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8a8324d8-cd56-41c3-8377-2e0caa139746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5e5365af-83fe-4e56-ba14-54ad87b2e933" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f8393337-3496-4952-88e1-6b7454c1cee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:to="loc_us-gaap_TradingSecurities_f8393337-3496-4952-88e1-6b7454c1cee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ff799b42-e6f9-471b-addf-d7f2189b78d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_69efff5e-d690-4fbf-8598-4b0922585b63" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ff799b42-e6f9-471b-addf-d7f2189b78d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognition" xlink:type="simple" xlink:href="natr-20220331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9b8132f3-b91b-4b62-b982-190b1e13ca48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_eccd7cc1-9a70-4f53-97f1-d91dd6f00289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9b8132f3-b91b-4b62-b982-190b1e13ca48" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_eccd7cc1-9a70-4f53-97f1-d91dd6f00289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="natr-20220331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_03252bb4-dc58-4e91-bd91-84813ecfa49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_03252bb4-dc58-4e91-bd91-84813ecfa49c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:to="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5a97df81-2f26-4887-bc11-1f4c51890bf1" xlink:to="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8002de99-8671-49d0-a893-51e7e172609b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1839520c-2c42-42b3-a87d-a7f59bed939d" xlink:to="loc_srt_MaximumMember_8002de99-8671-49d0-a893-51e7e172609b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a6214d26-b450-4b3a-a80a-72808c4b1ad3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod_7933d6cc-24d6-42e8-a281-e6a08c445ead" xlink:href="natr-20220331.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_RevenuefromContractwithCustomerRefundPeriod_7933d6cc-24d6-42e8-a281-e6a08c445ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CustomerLoyaltyProgramLoyaltyPoints_71b74a78-c459-417e-820a-322f6ebaea7b" xlink:href="natr-20220331.xsd#natr_CustomerLoyaltyProgramLoyaltyPoints"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_CustomerLoyaltyProgramLoyaltyPoints_71b74a78-c459-417e-820a-322f6ebaea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts_87efe5f0-f818-4c32-b9ee-926768e7721b" xlink:href="natr-20220331.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_NumberofPrincipalCategoriesofProducts_87efe5f0-f818-4c32-b9ee-926768e7721b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_17fbebdf-7b0b-4973-b4eb-7e8c97d24328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_us-gaap_NumberOfReportableSegments_17fbebdf-7b0b-4973-b4eb-7e8c97d24328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm_837c5daa-fec1-4e95-a951-f43a86a8d2a0" xlink:href="natr-20220331.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d6f1d49c-2bca-4e50-9a96-487b3dc3aabe" xlink:to="loc_natr_ContractWithCustomerContractTerm_837c5daa-fec1-4e95-a951-f43a86a8d2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>natr-20220331_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 natr-20220331_g1.jpg
M_]C_X1((17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C @*$UA8VEN=&]S:"D ,C R,#HP,3HR-2 P.#HQ,CHP,P
M  .@ 0 #     0 !  "@ @ $     0  !+"@ P $     0   5@
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   0S@        !(     0   $@
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M_OMG&+E&<JCI6* .T?TBYW7\KIF+TJZSJM9MPG;:[6!I?H]S6!VT?N.]^_\
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M+C  .$))300E       0                     #A"24T$.@      Y0
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M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M $@    !  $ 2     $  3A"24T$)@      #@             _@   .$))
M300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-!         (  3A"24T$ @      !      X0DE-
M!#        (! 3A"24T$+0      !@ !     CA"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -)    !@
M           !6   !+     * %4 ;@!T &D = !L &4 9  M #0    !
M                      $             !+    %8
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   %8     %)G:'1L;VYG
M   $L     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !6     !29VAT;&]N9P  !+     #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!0       0    #.$))300,     !#J     0   *     N
M   !X   5D   !#. !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1"  N * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#U1SFM:7.(:UHDDZ  +DG]9ZW]9,BS&^K[AA]-I=LNZF\2YWBW':?Y/O\
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ML]OZ1$ZEU?"Z8[%;E.(.9<W'JB-'._/?N+?T3?SW_P M8'^+8$="N!Y&4_\
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M62]@SO1<_>&^W<UY9_-S^Z%>Z#]8<;K73W7U17DTB,B@F2Q\:?UJK(_1/_\
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M &\ <    !0 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #
M,@ P     0 X0DE-! 8       < !@    $! /_A#FIH='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-
M,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB
M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N-BUC
M,30X(#<Y+C$V-# S-BP@,C Q.2\P."\Q,RTP,3HP-CHU-R @(" @(" @(CX@
M/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R
M+S(R+7)D9BUS>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B
M('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H
M;W O,2XP+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]M;2\B('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B('AM<#I#<F5A=&]R5&]O;#TB
M061O8F4@4&AO=&]S:&]P(#(Q+C @*$UA8VEN=&]S:"DB('AM<#I#<F5A=&5$
M871E/2(R,#$Y+3$R+3(S5# X.C$Q.C,V+3 W.C P(B!X;7 Z36]D:69Y1&%T
M93TB,C R,"TP,2TR-50P.#HQ,CHP,RTP-SHP,"(@>&UP.DUE=&%D871A1&%T
M93TB,C R,"TP,2TR-50P.#HQ,CHP,RTP-SHP,"(@9&,Z9F]R;6%T/2)I;6%G
M92]J<&5G(B!P:&]T;W-H;W Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W Z24-#
M4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B('AM<$U-.DEN<W1A;F-E240]
M(GAM<"YI:60Z-S<T-35C9C M,F)C-BTT8S,S+6)C-34M9F%D8S8V.3 X9C)F
M(B!X;7!-33I$;V-U;65N=$E$/2)A9&]B93ID;V-I9#IP:&]T;W-H;W Z934T
M83-C-6$M8C-F9"TY8C0R+3DT-S,M9&4W8V0Q9C8U9F$X(B!X;7!-33I/<FEG
M:6YA;$1O8W5M96YT240](GAM<"YD:60Z86,Y,34Q.#$M-&(P-RTT,69F+6(V
M,F$M,#@R83<V834V-3(X(CX@/'AM<$U-.DAI<W1O<GD^(#QR9&8Z4V5Q/B \
M<F1F.FQI('-T179T.F%C=&EO;CTB8W)E871E9"(@<W1%=G0Z:6YS=&%N8V5)
M1#TB>&UP+FEI9#IA8SDQ-3$X,2TT8C W+30Q9F8M8C8R82TP.#)A-S9A-38U
M,C@B('-T179T.G=H96X](C(P,3DM,3(M,C-4,#@Z,3$Z,S8M,#<Z,# B('-T
M179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<" R,2XP("A-86-I
M;G1O<V@I(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C;VYV97)T960B('-T
M179T.G!A<F%M971E<G,](F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]J<&5G(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N
M/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HW-S0U-6-F,"TR
M8F,V+31C,S,M8F,U-2UF861C-C8Y,#AF,F8B('-T179T.G=H96X](C(P,C M
M,#$M,C54,#@Z,3(Z,#,M,#<Z,# B('-T179T.G-O9G1W87)E06=E;G0](D%D
M;V)E(%!H;W1O<VAO<" R,2XP("A-86-I;G1O<V@I(B!S=$5V=#IC:&%N9V5D
M/2(O(B\^(#PO<F1F.E-E<3X@/"]X;7!-33I(:7-T;W)Y/B \+W)D9CI$97-C
M<FEP=&EO;CX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q%
M  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U3
M1E0     245#('-21T(               $  /;6  $     TRU(4" @
M                                                           1
M8W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0
M   4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M
M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,
M9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I
M(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-2
M1T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M     %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                9&5S8P
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="                             &1E<V,
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@
M245#-C$Y-C8M,BXQ                                  !V:65W
M   3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
M %<?YVUE87,          0                        */     G-I9R
M    0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [
M $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D
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M&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[
ML'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZ
MM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7 <,#LP6?!X\)?PMO#6,/4Q%'$SL5+
MQ<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0
MNM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%
MW(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH
M,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.] [\SP6/#E\7+Q__*,\QGSI_0T
M],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X
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M/ZG?]#<?\XY_^72T[_D1>?\ 5#'\KE[E_P!%W97^KQ^1_4[_ *&X_P"<<_\
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M+/\ H;C_ )QS_P#+I:=_R(O/^J&'\KE[D?Z+NRO]7C\C^IW_ $-Q_P XY_\
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M0OT0#:[%78J[%78J[%6.><69/*/FET8HZ:1?,CJ:$$6[D$$9*',.-K#6"?\
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MM>6\C12QL.C(Z$,I]P<2+90G*!$HD@CJ'VQ^37_.<_YF>09[32_/DTOYC>5
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M'_./ODQ(63R1'YHOH@.6H>8I&U O3^:W?C;?=$,PYZO)+K7N>WT7L;V9I?\
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M_P#^39R[3_WD?>Z3VE_XS-1_4/W/YT<WS\YNQ5^C_P#S[=_Y3[\Q?_ ?M_\
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M4=U?QMU8[%(B* ;O4_"NMU6K_AA\WU7V2]C14=5K(^<8'_=2'W1^?<_48
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M9FF?<W8J[%78J[%78JP+\T?/VF_EA^7_ )J\]ZKQ:W\NV+SPV['CZ]RU([:
M'QEE94^G)XX&<A$=7 [4U\-!I9YY\H"_>>@^)H/YM==UK4O,FM:OYAUFY:\U
M;7+R>_U*Z;K)/<.9)&^EF.=!$ "@_-F?///DEDF;E(DD^9W*586I]N?\X)?E
M5_CK\VQYOU&V]70/RVC346+"J/J4I9;%/FA5YJCH47QS#UN7AA74O;^PG97Y
MO7>-(>C%O_G'Z?EO+X)9_P YO_E3_P J[_.&[U_3[;T?+OYC+)K-D5%$2^Y
M7\0]_482^PD [8='EXX5U#5[<=D_DM><D1Z,OJ'];^(?/?\ SGQMF6\:B]/O
M[S2K^RU/3KA[/4-.GCNK&[C-'BFA8/&ZGL58 C$B]F>/)+'(2B:(-@^8?T@?
MDO\ F19_FS^6?E/SU:E$GU>S5=7M4Z07\!]*ZBIU $JGC7JI![YS^;'X<S%^
MD.Q>TH]HZ3'G'.0W\I#:0^?V/4<K=H[%78J[%78J[%78JP7\T/\ R6GYB?\
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M^)=_T.C_ ,XS_P#ES4_[A.K_ /9%C^4R]WW+_HT[(_U;_8S_ .)=_P!#H_\
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M[%7R7_SFS-YL3_G'_P QVOE33[C4#J5Y9VWF$VJ,\L.F<S)-)Q0$\2\:(_\
MDL:[5S*T=>(+>2]MI9QV9,8@39 E72/,GY@ ^1?@RZ,C%'4HZ[,K"A'S!S=/
M@I%+<5?MU_S@;^5W^"ORD/G'4+7TM=_,B<7P9UHZ:9!RCLT^3U>44ZAU\,T^
MMR<4ZZ!]O]@^R_RNA\:0]64W_FCZ?GO+XA]Q9AO<.Q5^<7_.?_YU/Y>\N:?^
M4&@W?IZKYMC%[YKDC:C1:8CD10$C<&XD4D_Y"$'9\S]#AL\9Z/G'_! [:\'$
M-'C/JGO+RCT'^<?L'F_(#-J^/NQ5ZG^3'G#R=Y"_,/0?-?GGRG+YST31Y/63
M2(IDBXW"D&*<I(K+-Z1^(1L5!:E6H*&O-"4HD1-.U[%UF#2:J&7/C\2,>E]>
MA\Z[MO>_>3\K?S]_*O\ .*W4^2_,\,^J!.=SY;O/]&U*$ 5:MNYJX7NT99/\
MK-)DP3Q\P^\]E=OZ+M(?N)CB_FG:0^'Z18\WLN5.Y=BKL5=BKL5=BKL5=BKL
M5=BKL5=BJ%OK&SU.RN].U&UBOM/OX7M[VRG021312J5>-T8$,K*2"#UP@TPR
M0CDB8R%@BB#U#\'/^<K_ /G'>?\ ([SDM[HD4LWY>^:I))?+=RU7-I*/BDL)
M7-36,&L9.[)W+*^;K2Y_%COS#X/[6>SI[*S\4/[F?T^1ZQ/NZ=X\P7RAF2\F
MV"5(925934$;$$8J_?/_ )Q%_.IOSB_*RT.K77K^<O)QCTKS06-9)Z+_ *->
M-_QG13R/=U?MFDU6'PY[<B^^^R';7\I:,<9O)C],O/NE\1]H+ZHS&>J=BK\J
MO^?BWY7K'-Y3_-S3;8#ZQ_SK_F=T'5U#364K4[E1(A8^"#PS9:#)SA\7RK_@
MB]ET<>LB.?HE]\3]X^3\N,V3Y:[%7]%'_.-GYAM^9_Y+>1_,]S/Z^K)9?HW7
MF)JYO; FWE=_>7@)?DV:'48^"9#]%>S7:/Y_L_%E)N55+^M'8_/G\7NF4N]=
MBKL5=BKL5=BKL5=BKL5=BKL5=BK\%/\ G-[_ -:5\^_\8-'_ .Z7:YN]'_=#
MX_>^">W'_&ME]T?]Q%\G9DO)HJQ_WML_^,\?_$AB66/ZA[W]1-[96FHV=UI^
MH6L5[87T+V][9SH)(I8I%*O&Z,"&5@2""-QG-@T_4<X1G$QD+!V(/4/P[_YR
MS_YQ>N_R9UE_-OE.WEN_RRURXI =Y'TFXD-1:S,:DQM_NIS_ *C?$ 7W.EU/
MB"CS?#O:WV7EV9D\;"+PR/\ I#_-/E_-/P._/QAF6\6[%7V;_P XH?\ .4=]
M^3&KQ^5/-<\U]^66LSUN(]Y)-)GD.]U HJ3&3_>QCK]M?BJ'Q-3IO$%CF]G[
M)^U,NS)^%E-X9'_2'^</+^</B-^?W#T_4+'5K&SU/3+R'4-.U"%+BQOK=Q)%
M-#(H9)$=20RL""",TY%;%]QQY(Y(B42""+!'(A)O.?\ RA_FO_MC7W_4.^&'
MU!IUO]QD_JG[B_F(SHGYA=BK[0_YP(_]:$TW_MAZG_R;7,36_P!W\7M/8'_C
M4']63]S,TS[F[%78J[%78J[%7Y1?\_$?S8^L7WES\G=*N:Q:>$USS:$/6:12
MME U/Y4+2D'8\HSVS9Z#%SF7RC_@B=K<4H:.!Y>J7O\ X1\M_B'Y@9L7R]V*
MOZ!O^<3/RJ_Y53^3/EZPO;;ZOYC\RC].^90PHZSW:*8H&KN##"$0CIR#'OFC
MU67CF>X/T#[)=E?R?H(1D*G/U2]YY#X"A[[0/_.7_P"5'_*T_P FM<2QMO7\
MR^3ZZ]Y>XBLCM;(?K,"TW/JPE@%'5PGAATN7@F.XL/;#LG^4-!+A%SQ^J/PY
MCXB_C3\!\W;X"[%7Z2?\^\OS7_1'F?7ORDU2YXV/FE&U;RRKG9=0MHZ7,2CQ
MF@4-_P \O?-?K\5@2'1])_X'G:WAYIZ29VGZH_UAS'QCO_FOUXS5OKSL5=BK
ML5=BKL5=BK!?S0_\EI^8G_@,:O\ ]04N3Q_4/>X/:G^*9OZDO]R7\SN="_,S
ML5?:O_. G_K0-K_VP-3_ %1YB:[^[^+VOL!_QIC^I+]#]Q\TS[D[%78J[%78
MJ[%78J_)?_GY1_RD7Y4_]LW5/^3UOFT[/Y2?)?\ @E?WN#^K+[P_,O-@^9.Q
M5^]7_.$/_K-7D+_C/K'_ '5+K-+K/[T_#[GWOV'_ .,G%[Y?[N3ZRS%>L=BK
ML5=BKL5?BQ_S\4_\GAY>_P# +L?^H_4,V^@_NS[_ -3XK_P1?^-&'_"A_NI/
M@K,UX)V*OZ*?^<9O_) _E+_X#EI_Q$YH=1_>2][]%>S/_&9@_J![GE+O78J[
M%6%?F3_Y+KS]_P" YJO_ %"2Y/']0][A=I?XKE_J2^XOYF,Z%^978J]I_(3\
MX&_([\P(O/2>7AYF,5A<V/Z+-U]3!^L!1S]7T9_L\>G'?*L^+Q8\-T[KL#MC
M^2M5X_!Q[$5?#S\Z/W/N#_HI;/\ ^69C_P#"@/\ WC<POY/_ *7V?M>X_P"3
MEG_E&_V?_''?]%+9_P#RS,?_ (4!_P"\;C_)_P#2^S]J_P#)RS_RC?[/_CCO
M^BEL_P#Y9F/_ ,* _P#>-Q_D_P#I?9^U?^3EG_E&_P!G_P <8CYJ_P"?CGGS
M4;*6W\H^0M(\KW,JE1J%[<RZF\=?VHU$=JG(=N2L/;)QT$1S-N)JO^"/J9QK
M#BC ]Y)E^B(^=O@KS?YS\T^?M=N_,WG'7+KS!KE[3U[^Z?D0HKQ1% "QHM?A
M1 %'89FP@("@*#P.LUN;69#ES2,I'J?QL/(;,9R3C-@%B%4%F8T &Y).*OW:
M_P"<-/R-G_*'\N&U;S!:&V\[>>C%?:Q XI):6J*?JEHU=PRAR[CLS<3]D9I=
M7F\25#D'W?V,[#/9NDX\@K)DHGR'\,?TGS-='V#F*]@[%78J[%7B/_.2?_DA
M/S;_ / 9O_\ DV<NT_\ >1][I/:7_C,U']0_<_G1S?/SF[%78J[%78J[%78J
M[%7]&G_..A+?D/\ E$6))_PKI@J? 6Z@9H=1_>2][]&^SG_&;I_^%Q^Y[1E+
MNG8J[%78J[%78J[%4IUO0=#\S:;<:-YBT>RUW2;L<;G3;^".X@D'^5'(&4_=
MA$C$V&G/I\>>!ADB)1/0BQ]KX'_-O_GWYY'\QK=:K^5>IOY'UE@SKH5VTEUI
M4K]:*Q+3P5/<%U'0(,SL6ND-I;O!=K_\#[3Y[GI9>'+^:=X'],?M'D_+/\R/
MRL\]?E-KK>7O/>@S:->,&>RN#22VNXU-/4MITJDB[BM#4=& .V;+'DCD%Q+Y
M7VEV5J>SLGAYX&)Z=Q\P>1_%O/<FZ]V*OV _Y][_ )M7GF+ROK_Y5ZS=-<W7
MDP)?^6GD/)_T;<.5EAJ=^,$Q!'@) O11FJUV*B)#J^P?\#WM:6;#/2S-G'O'
M^J>8^!^]_]/[^8J[%78J[%78JA+JPL;Y>%[9P7B4IPGC604^3 X0:83QQG]0
M!][";_\ *7\JM5E6;4_RS\J:C,K!EFN=&L96!&]0SPDY,99CD3\W"R=D:+(;
MEAQGWPB?T,]BBB@BC@@C2&&%!'##& JHJBBJJC8 #8 96YX  H<E3%+L5?SV
M?\Y2:9^847YU>?\ 6//NCWMB^I:S<+HE]-"ZVL^GPGT[+ZM*1P=1;H@^$UK7
ME1JC-[IC'@ B_/7M3BU0[0RSU$2+D:-;&(VC1Z^FO[7SME[SKL5=BJ(M+NZL
M+F"]L;F6RO+5UEMKN!VCEC=3561U(*D'H0<2+90G*!$HFB.H?>7Y,?\ .>GG
MSR7]4T7\S()/S!\N)1!JW)4UFW3Q]5J)<T\):,?]^=LPLVBC+>.Q^Q[WL7V]
MU.EJ&J'BP[_XQ\?XOCO_ $GZN_EO^;'D'\VM&&M^1/,5OK,"!?KMD#Z=W:.W
M[%Q;O1XSUH2*'JI(WS69,4L9J0?5^S>UM-VCCX\$Q(=1U'O',?BGHN5NQ=BK
ML5=BKL5=BKL5=BKL5=BKL5>:_FY^66B?F]Y U_R+KBJD>J0EM-O^/)[.]CJU
MO<IWJC]0#\2EEZ,<LQ9#CD)!UO:_9F/M+33P9.HV/=+H?A]VS^<KS1Y;U?R=
MYBUORKK]J;/6?+]Y-8ZE;G<++"Q4E3W4TJI&Q%",W\9"0L=7YQU6FGILLL60
M5*)(/P2+"T/K+_G"_P#,:^\A?GEY<T]/4ETCSZZ^7M7M$J:M<L/JLO'I6.8+
M4]D+^.8VKQ\6,^6[UGL7VE+2=HPC_#E]!'O^D_ _9;]ZLTC[V[%7DOY[>0$_
M,[\I//7DP0B:]U+3)9=&7N+^UI<6E#U%9HU!IV)&6X9\$P74=N]G_G]#EPUN
M8[?UAO'[0_F^(*DJP(8&A!Z@YOWYO:Q5^J?_ #[>\[,T/YB_EU<35$36_F+2
M8*_STM+QJ?1;YK>T(<I?!]5_X&^MVS:8GNF/]S+_ 'K]2<UKZD[%78J[%78J
M[%78J[%78J[%78J[%7X*?\YO?^M*^??^,&C_ /=+M<W>C_NA\?O?!/;C_C6R
M^Z/^XB^3LR7DT58_[VV?_&>/_B0Q++']0][^I+.;?J5*=>T'1_-&C:EY>\P:
M=#JVBZQ;O:ZEIUPO*.6)Q0J1U'B"-P=QOAC(Q-AIU&#'GQRQY )1D*(/5^#7
M_.3G_..&L?D1YG]>R$VI_E]KTSGRUKC#DT3;L;*Z(%!*@^R>DBCD-PRKN]/J
M!E'F^#>T_LWD[)S7&SBD?2>[^C+S'VC?O \O9D/+NQ5]W_\ .(G_ #E9/^5M
M];?E]Y]O7G_+G4IJ:?J$A+MHL\K;N.I-N[&KJ/LGXU_:#86JTW'ZH\_O>\]D
M/:L]GR&GU!O"3L?YA_XD]1TYCK?V#\V3P77DCS+<VTR7%M<:'>2V]Q$P=)$>
MV=E966H((-01FJC]0][[#JY"6GF0;!B?N?S&YT3\Q.Q5]H?\X$?^M":;_P!L
M/4_^3:YB:W^[^+VGL#_QJ#^K)^YF:9]S=BKL5=BKL58]YM\SZ5Y*\L:_YMUR
M;T-)\N6$^H7\@IR,<"%RJ@]6:G%1W) R48F1 '5Q]7JH:7#/-D-1@"3\'\V'
MGOSCJOY@^<?,GG76WY:GYEOYKZX4$E8Q(WP1(3^S&@"+[ 9T$("$0!T?FO7Z
MR>LSSSS^J9)_9\!L&)Y)Q'TG_P XG_E5_P K7_.;R[IM[;?6/+GEQOT[YF#"
MJ-;VC*8X6KL1-,40CKQ+'MF/JLOAP)ZEZ7V3[*_E#7PC(7"'JE[AT^)H>ZW]
M!.:-^@G8J_GO_P"<J/RI_P"52?G'YBT>SMO0\N:ZWZ;\K<11%M+MF+0KX""4
M/&!UXJI[YO=-E\2 /5^>_:KLG^3M?.$14)>J/N/3X&P^<\O><9!Y4\S:KY,\
MS:#YLT.;ZOJ_EV^@U"PDWIZD#APK 4JK4HP[@D8)1$@0>KD:34STN:&6!J4"
M"/@_I/\ (?G'2OS!\F^6O.NB/RTWS+80WL"5#-&9%_>0N1^U$X9&]P<YZ<#"
M1!Z/TIH-9#6:>&>'TS /[/@=BRW(N6[%78J[%78J[%6"_FA_Y+3\Q/\ P&-7
M_P"H*7)X_J'O<'M3_%,W]27^Y+^9W.A?F9V*OM7_ )P$_P#6@;7_ +8&I_JC
MS$UW]W\7M?8#_C3']27Z'[CYIGW)V*NQ5V*NQ5V*NQ5^2_\ S\H_Y2+\J?\
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M4HZK5CU#>,#T_I2\^X=.N^P^G&:Y].=BKL5=BKL5>(_\Y)_^2$_-O_P&;_\
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MLI_.8N_["[S_ $$]K_ZC_LX?\4[_ *$I_P"<FO\ RVG_ '.=&_[+L?SF+O\
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MNK]"?^A#/^<>?^K/K/\ W%)LP?SN1]"_T!=E_P V7^F+O^A#/^<>?^K/K/\
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MXAEPR$HGK^@]Q\BRO(N6[%78J[%78J[%78J[%78J[%78J[%78J[%78J_&?\
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MJVEO-0O)#1(H($,DDC'P55).$"S089<L<4#.1J,023W <W\WGYP_F-??FO\
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M?^2T_,3_ ,!C5_\ J"ER>/ZA[W![4_Q3-_4E_N2_F=SH7YF=BK[5_P"<!/\
MUH&U_P"V!J?ZH\Q-=_=_%[7V _XTQ_4E^A^X^:9]R=BKL5=BKL5=BKL5?EA_
MS\JTV2OY0ZNJDP@:U9S-V5O]"DC'TCE]V;+L\_4/<^5_\$O&?\'G_7'^Y_:_
M++-D^6.Q5^V?_/OKS-!J_P"2%UH/J#ZWY2UZ\MW@KN(+L)=1O3P9Y) /=3FH
MUT:R7WA]M_X'VJ&3LXX^L)D? ^H?>?D^Z<PGNG8J[%78J[%7X1?\YS>9H/,7
M_.0GF"VMI!-#Y6T^PT;U%-1ZD<9N95'^I)<,I]P<W6CC6,>;X1[=:H9NU)@?
MP 1^RS]I?(&93Q[L5?TA?D)ILFD_DE^4UA,I2:+RGI+S(>JO+:1R,I^18C-!
MG-Y)>]^D.P,9Q]GX(GGX<?N!>M94[=V*NQ5A7YD_^2Z\_?\ @.:K_P!0DN3Q
M_4/>X7:7^*Y?ZDON+^9C.A?F5V*ON7_GWQ_Y/F\_\!74/^3]KF'KO[OXO<_\
M#W_C2/\ PN7WQ?MOFG?;G8J_%/\ YSS_ "@_P3^9$/Y@Z3:^GY>_,;G->\!1
M(=7B ^L@TZ>NI$HKU;U/#-OHLO%'A/,/BGM[V/\ E=6-1 >C+S\ICG\^?OM\
M'YFO!NQ5^Y'_ #A#^<__ "LG\L$\IZQ=^MYL_+I8M/N#(U9+C32"+*??<E54
MQ-_JACN^:?68>"=CD7W+V'[:_/:/PIG]YBH>^/\ "?T'W>;[4S#>U=BKL5=B
MKL5=BKQ'_G)/_P D)^;?_@,W_P#R;.7:?^\C[W2>TO\ QF:C^H?N?SHYOGYS
M=BK]'_\ GV[_ ,I]^8O_ (#]O_U%+F!VA](][Z1_P-O\9S?U!][]?<U3Z^[%
M78J[%78J[%78J[%78J[%7RG_ ,YF>3?/GGG\D=2T;R!!/J%[#J5I>ZWHMKO/
M?:=;B1GAB0;NRR^E+Q&[<* $T!R=).,<ER>4]L]%J=7V=*&G!)X@2!SE$7L.
M_>C7D_!*6*6"62">-H9H6*30N"K*RFA5@=P0=B#F[?!""#1YK,4.Q5V*NQ5V
M*O1_RL_*KSC^<'FNS\I>3M.:ZN9BKZAJ#@BUL;>M'N+F0 A47PZL?A4%B!E>
M3+'&++LNRNRL_:688<(L]3TB.\GN^_D']!GY2?EAY?\ R?\ (FB^1O+JF2WT
MU#)?Z@ZA9;R\EH9[F2E=W;H*GBH51LHS1Y<AR2XB_0?9'9>+LW31P8^0YG^<
M>I/O^P;/_];J/_.5G_.2/YKK^<'G3RCY6\\ZGY8\K^6+E=,L[+1YVLW:2*)/
MK$DD\/&5F,I8?:H   .I.WTVGAP D62^*>U?M)K?SV3#BRRA"!X0(GAY#>R-
M^=OBC5_,OF/S!(9=>\P:EK<K&K2W]W-<L3XDRLQS,$0.0>*S:G+F-Y)RE[R3
M]Z2X6AV*NQ5V*IUI'F3S%Y?E$V@Z]J.B3 U$NGW4ULU?&L3*<!B#S#=AU.7"
M;QS,?<2/N>U^6O\ G*S_ )R#\K%/J'YH:M?QIUAU@QZJ&'@6O4F8?00<IEIL
M<NCN]-[5]J:?Z<\C_6J?^ZM]*>4/^?C7G_3S%#YV\D:/YE@6BO=:=)+IMP1W
M9N7UF-C[!%'RS'GH(GD:>ET?_!'U,-L^*,QWBXG_ 'P^P/KSR)_SG/\ D3YQ
M:&UU75+WR)J,M%]'7(.-N7[TNK<S1A?>0IF+/19(\MWK]![==FZFA.1QG^D-
MO],+'SI]:Z3K.CZ_80ZIH6JV>M:9<BMOJ-A/'<P2#Q62)F4_0<Q2"-B];AS8
M\T1/'(2B>H-CYA,L#:[%78J[%7R/^>__ #A_^7?YQ)>:WID4?DKSY*"X\P64
M0]"[D\+ZW7B)*]Y%H_B6 XYE8=5+'L=P\CV]['Z7M*YQ_=Y?YPY'^L.OOY^_
MD_&K\T_R>\_?DYKS:#YXT9[)I"QTW5H:RV-[&I^W;3T ;J*J:,M1R49ML66.
M07%\:[5['U/9F7P\\:[C_#+W'\$=0\PRQU;L5>S_ )*?GIYV_(WS(NM^5[KZ
MSIEVR+Y@\L7#-]4OXE/1@*\)%!/"115?=2RFK-ACE%%W78G;NH[*R\>(W$_5
M$\I#]![CT]VS]W_R?_./R;^=7E2#S/Y1O*LG&/6M$F(%WI]P14Q3H.QH>+#X
M6&X[@:7+BEC-%]W['[9T_:F$9<)]XZQ/<?T'D7JV5.V=BKL5=BKL5=BKL5=B
MKL5=BKL52'7O-/EGRK:_7O,_F+3/+EG0GZWJ=W#:1[=?BF=!DHQ,N0MHU&JP
MZ>/%EG& [Y$#[WSGYH_YS3_YQX\L>K&OG5O,=W%6MIHEI/=5I_+.4C@/_(S+
MXZ3)+I3S>J]M>R\&WB<9[H@G[=H_:\ \P?\ /R/R?;EQY5_+36-7[))JMY;Z
M=])6%;W[JY?'L^74N@U'_!)P1_NL,I?UB(_=Q/B+_G(?_G)35_\ G(1_+/Z4
M\JV'ER+RJUX=/-K-+/*XO?1]19'?BI ]!2**,S,&G&*Z-V\/[1>TN3MG@X\8
MAP75$D^JN?R[GS3F0\T[%7].7D75&UOR1Y.UISR;5]#T^]9O$W%M'(3_ ,-G
M.S%2(\WZ=T&7Q=/CG_.C$_, LJR+E.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*OP4_YS
M>_\ 6E?/O_&#1_\ NEVN;O1_W0^/WO@GMQ_QK9?='_<1?)V9+R:*L?\ >VS_
M .,\?_$AB66/ZA[W]26<V_4KL5=BKL5>._G=^2WE?\\?)ESY7\P1BVOX.4_E
MSS!&@:?3[NE!(O3DC4 D2M&'@P5EMPYCBE8=-VYV+A[5TYQ9-B-XRZQ/ZN\=
M??1?S^_F-^7?FG\K/-VJ>3/-]@;+5M,?X9%J8;F!B?3N+=R!SCD J#\P0&!
MWF/()BP_/_:79V;L_/+#F%2'R(Z$>1_&[!\FX+L5=BK[0_YP(_\ 6A--_P"V
M'J?_ ";7,36_W?Q>T]@?^-0?U9/W,S3/N;L5=BKL5?!'_.??YL?X0_+:S_+S
M2[GT];_,20K?A#\<6DVK*TU:;CUI.$8_F7U!F;H<7%+B/1X'V_[6_+:0:>)]
M67G_ %!S^9H>ZWXM9MWQ9V*NQ5V*NQ5V*NQ5V*NQ5V*OV6_Y]^_FO_B?\O\
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MT/Z.6(M*UZ;D$,94<"@@VH.^8NJU!Q50YO7^R?LYB[8EE&24HB'#RK?BOO\
M<^WXO^?<OY- #U_-WG.0]REUIR?KT]LP_P _/N'X^+W _P"!SH.N3)\X_P#$
MK9_^?<OY.L#]6\W^<HCV,ESI\@_"P3'\_/N")?\  XT'3)D^<?\ B6*:E_S[
M9\JRJWZ'_-'5;%C]DWFG078'S$<MO7)#M ]0XF3_ (&N$_1GD/?$'],7E>O?
M\^X/S"M0[>6OS T#6>.ZIJ$-SI[,/;TUNQ7YGZ<MCVA'J"ZO/_P-]5'^ZRPE
M[P8_=Q/ ?-7_ #AU_P Y#>5!)++Y GUVTCK2ZT.>'4"U/Y8(G,_WQY?'5XY=
M7G]7['=J:?<XC(?T2)?8/5]CYTU71M7T*\DT[7-*O-&U"'^]L;Z"2WF7_6CE
M56'W9>"#R><RX9XI<,XF)[B*/VI=A:W8J[%4WT'S!KOE?5;37/+>KWFA:Q8M
MSM-3L9G@FC/>CH0:'H1T(ZX)1$A1;L&HR:>8GCD8R'(@T7Z6_D=_S\!N(39^
M7?SNM/K,)*Q1>?-.A D7MRO;2, ,/%X0#_Q6>N:_-H>L/D^E]A_\$ BL>N%_
MTP/]U$??'Y/U"T+7M$\SZ39:[Y=U6UUO1M1C$MCJ=E*LT,JGNKH2-CL1U!V.
M^:V43$T7U#!J,>> R8Y"43R(W";8&YV*J4\$-S#-;7,*7%O<(T<\$BAT='%&
M5E-000:$'%$HB0H[@OR2_P"<K/\ G#)_+::E^9/Y0Z<\WE].=SYD\E0 L]BO
MVGN+)14M".K1]8^JU39-IIM7?IGS[WR/VK]C/ XM3HQZ.<H#^'SC_1[QTZ;<
MOFKFP?-78J]1_*#\W/-?Y,><K'S?Y6N*M'2'6-(D8BWO[0D%[>8#QI56I56H
MPRO+B&2-%VG8_:^;LS4#-B/O'20[C^-G] _Y6_F=Y6_-WR;IGG3RG=>M8WR\
M+NS<CU[.Z0#U;:=03Q="?D11EJI!S1Y,9QRHOT%V7VIA[1T\<^$['F.L3U!\
MQ^WD]$RMV+L5=BKL5>-_FI^?GY6_DY:L_G3S+##JAC]2U\M6=+G4IP15>-NI
MJ@;L\A5/\K+<6">3D'3=J]OZ/LP?OY^KI$;R/P_2:'F_,7\U_P#G/_\ ,7S4
M;G3/RWL(OR^T5ZH-3;A=ZK*O2OJ.OI0U'9%+#M)FQQ:&,=Y;OF':W_! U6HN
M.F'A1[^<_P!0^ OS?"FLZWK/F+4;C5]?U:\UO5;MN5UJ5_/)<3R'Q:21F8_2
M<S0 !0>%S9\F:9GDD92/4FS\REF%J=BKL5=BKL597HGD+SSYFXGRWY,UWS '
M^P=-TZYNZ_+T8VR)G&/,@.7@T&IS_P!WCE+W1)^X/3M,_P"<7O\ G(+5@#:_
ME/KT7+I]<A6R^_ZTT5,K.IQC^(.SQ>R_:>3E@G\1P_[JF96/_.$__.2EZ\8?
M\ODL(G8 SW6JZ8JJ#W94NG>@]ER!UF(=?O<W'[$]K2_R5>^4?^*M^V_Y8>5+
MKR+^77D?R;?74=[>^5]#L=-O+J$$1R2VT"QN4J >/(&E16G7-/DEQ2)[R^V]
MEZ0Z32XL,C9A$ GS 9UD'/=BKL5=BKL5=BKL5=BKL5=BKL5?@I_SF]_ZTKY]
M_P",&C_]TNUS=Z/^Z'Q^]\$]N/\ C6R^Z/\ N(OD[,EY-%6/^]MG_P 9X_\
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M\EI^8G_@,:O_ -04N3Q_4/>X/:G^*9OZDO\ <E_,[G0OS,[%7VK_ ,X"?^M
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M&$C&0HC8H?%B]%_*;\QM6_*?\P?+7GO2"SRZ)=!KVS#<1=6<GP7-NW;]Y&2
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M$G8&-D?'B%_)+/\ HFE/_P"7FC_\)\_]Y+#_ "A_1^W]C5_R;0_\I/\ L/\
MC[V3\DO^<%O+'Y5^<M/\[Z_YPE\\:GH;^OH-D+!;"U@N *+/(IGN&D9.J;J
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MD9/PJ\B7T2N0.I"+7P&;$=H?T?M?,<G_  - 9'AU%#I<+/SXA]P0O_1-*?\
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M "A_1^W]B_\ )M#_ ,I/^P_X^[_HFE/_ .7FC_\ "?/_ 'DL?Y0_H_;^Q?\
MDVA_Y2?]A_Q]W_1-*?\ \O-'_P"$^?\ O)8_RA_1^W]B_P#)M#_RD_[#_C[O
M^B:4_P#Y>:/_ ,)\_P#>2Q_E#^C]O[%_Y-H?^4G_ &'_ !]W_1-*?_R\T?\
MX3Y_[R6/\H?T?M_8O_)M#_RD_P"P_P"/KX_^?:3^HGK?G*#$&'J!/+]&*]P"
M=1(!^C'^4/Z/V_L2/^!IOOJ/]A_Q]^DOD7R?I?Y?^3O+?DK16EDTSRS80V%I
M-.0TL@B6ADD( ')VJQH *G8 9KYS,Y$GJ^DZ'1PT>"&"'TP  OFRO(N6[%78
MJ\._YR _)#3?S[\C0^3K_7)_+LUAJ46JZ9JT,*W CN(HI8:20L\?-"DS;!U-
M:&NU#=@S'%*^;H_:#L.':^F&&4C B0D#5[@$;C:Q1/4/AW_HFE/_ .7FC_\
M"?/_ 'DLS/Y0_H_;^QX;_DVA_P"4G_8?\?=_T32G_P#+S1_^$^?^\EC_ "A_
M1^W]B_\ )M#_ ,I/^P_X^[_HFE/_ .7FC_\ "?/_ 'DL?Y0_H_;^Q?\ DVA_
MY2?]A_Q]W_1-*?\ \O-'_P"$^?\ O)8_RA_1^W]B_P#)M#_RD_[#_C[O^B:4
M_P#Y>:/_ ,)\_P#>2Q_E#^C]O[%_Y-H?^4G_ &'_ !]W_1-*?_R\T?\ X3Y_
M[R6/\H?T?M_8O_)M#_RD_P"P_P"/N_Z)I3_^7FC_ /"?/_>2Q_E#^C]O[%_Y
M-H?^4G_8?\?3#2O^?:UE#J-I+K7YMRW^EQRJU[96FBBVFEC!^)$F>^F"$C]K
M@U/#$]H;;1^ULQ?\#6(F#/47'J!"B?CQ&OD7_]/E'YRZ4=$_-S\S])*\%L/-
M6L0Q#QC%Y+Z9^E:'.@Q&X ^0?FKMG%X6NSP[LDO]T7FV6.M?=7_/O;61IWYY
MW^G.U%\P>6+ZUC0]Y(9[:Y!^A86S#UPO'[B]U_P/<W!VB8_SH$?(@_H+]LLT
M[[:[%7CWY[?FW;?DG^7.J^>Y](DUV:UF@M+#2TD]%9;BY?BGJ2\7X(HJ2>)Z
M4[Y;AQ>)+A=/V[VN.R])+.8\5$ #EN?/H'Q1Y:_Y^2Z%,T<?G#\L;_3U!I+=
MZ/?Q7A/N(;B.VI\O4.9DNSST+Q.F_P""3C/]]@(\XD'["(_>^GO)7_.7_P#S
MC_YW>*WMO/4'EZ_EI_H'F"-M.()Z#UY?]')]A*<QIZ7)'I?N>HT7MAV9JMAE
M$3W3]/VGT_:^D[6ZM;ZWAN[*YBO+2X4/;W4#K)&ZGHRNI((/B#F.13TD9B8N
M)L%7Q9.Q5V*J4\$%U!-;7,*7%M<(T=Q;RJ'1T<4965J@@@T(.*)1$A1%@OS5
M_P"<BO\ G!/3M72_\X_DG;Q:5JPY3W_D(L([2Y/4FP=B! Y_WVQ],_LE*4.P
MP:TC:?S?-/:+V$ADO-HAPRZPZ'^KW'RY=U/R?U+3=0T>_O-*U:QGTS4]/E:"
M^T^ZC:*:&5#1DDC<!E(/4$9M 0=P^3Y,<L4C"8(D-B#L0@L6"(L[R[T^[MK^
MPNI;*^LI4GL[R!VCEBEC8,CHZD%64@$$&H.)%LH3E"0E$T1N".C]J_\ G$K_
M )ROM_S8L[?R%Y[N8K3\R-/@_P!"O3QCCUJ&):M(@% MPBBLB#9A5TVY*NHU
M6F\/U1Y?<^U^R7M8.T8C3YS68#8_SQ_Q7>.O,=:]TYA/=.Q5 ZEINGZSIU]I
M.JV<6H:9J<$EKJ%A.H>*:&52CQNIV(9201A!(-AAEQ1RP,)BXD40>H+\"O\
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MECY"7,P]_?'[1YC9^Q%C?6>IV=KJ.G7<-_87T27%E>V[K)%-%(H9)(W4D,K
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M\XXZ4J?6/)]WKDJ=)M0U2]J3XE;>6%#_ ,#E)UF4]7=8?8;LK'SQF7OE+]!
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MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\
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M/^B[LK_5X_(_J>O^2O/OD[\Q=&_Q!Y(\PVGF32!,UO)>6C$^G,@!:.1&"LC
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M_P!4,O\ RN7N='_HN[*_U>/R/ZER?\Y:_P#..DCI&OYIZ8&<A06ANU6I\6:
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MV-WKEI;VQMF>)S'(\2R7*2,BD&A*@GL.F9D=#,B]GAM3[?Z##FEBX9GA-&0
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MS+^7GGQE)5E\NZH58;$$6DM"#D\?U#WN%VE_BN7^I+[B_F6SH7YE=BK]>?\
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MZ4#AU&RYH]3A\.7D>3] ^RW;@[5T@E+^\AM/W])?YWWV.CZ4S'>E=BK\WO\
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M,\Q_\_'OS$N[I&\J>0] T2Q5P6BU.2YU&9U!Z>I$]FHKW^#,J.@CU)>2U/\
MP1]5*7[K%"(\[D?LX?N?JE^7?FJ3SSY"\F^<Y; Z7+YJT:RU633BW/T3=PK*
M55J#DHY?":"HH:9K<D>&1'<^J=G:LZO38\Q'#QQ$J[K%LRR#FNQ5_./_ ,Y#
MZV/,/YY?FMJB/ZL3>9M0MH)!N&BM)C;1D>Q6(4S?X!6.(\GYQ]HL_C=HYY?T
MY#Y&OT/&\M=,^S_^<"=).H_\Y"Z9>!.0T#1-4OV:GV0\2V=?^GFGTYB:TUC]
MY>T]@L/'VI&7\V,C]G#_ +Y^YN:9]S=BKL5=BKL5=BKL5=BK\U/^?@/YVW6A
M:5IOY-^7;PV]YYDMQJ'G*>)J,MAS*P6E1T]9T9G&QXJHW5SFPT.&SQGIR?-/
M^"!VW+% :/&:,Q<_ZO2/QZ^0[B_([-H^1NQ5Z5Y&_)W\T?S*5I?(_D?5?,-J
MC%'U&&'A:*XZJ;J4I"&]B]<KGEA#ZC3LM#V-K-=O@Q2D.^MO],=OM9[K7_.)
M_P#SD3H%JUY?_E9JLT*CDRZ>]MJ,E/\ C%933O\ \+D!JL9_B=AF]D^U,(N6
M"7PJ7V1)+P*]L;W3;N>PU&SGL+ZU<QW-G<QM%+&PZJZ. RGV(R\&WGYPE"1C
M($$=#L4+BQ1%G9W>H7=KI]A;27E]?3);V=I"I>2665@B(BBI+,Q  '4XDTRA
M"4Y",19)H#O+^BO_ )QX_+O4_P JOR=\E>1]:N1<ZQI=M-/J85N213WMQ)=2
M0(=P5B,O"HZTKWS0Y\@G,R#]%^SO9T^S]!CP3-R -^1D3*OA=/:<I=T[%6*^
M>O\ E"/./_;#U'_J&DR4/J'O<77?XOD_JR^XOYC<Z)^8G8J_6W_GVS_RBWYI
M?]M73O\ DQ-FK[0YA];_ .!K_<Y_ZT?N+]+\U[Z8[%78J[%6%?F3_P"2Z\_?
M^ YJO_4)+D\?U#WN%VE_BN7^I+[B_F8SH7YE=BK]=_\ GVY_RA/YE?\ ;<M/
M^H8YJ^T/J'N?7O\ @;?XOF_K#[GZ2YKWTEV*NQ5\D?\ .<?_ *S;YU_YB](_
M[J-OF5H_[T/(^W/_ !DY/?'_ '0?@UFZ?!E6WN)[2>&ZM9I+:YMI%EM[B)BD
MD<B$,KHRD$$$5!'3%,9&)!!HA^U7_.(O_.5<'YJ6%M^7_GR\CM_S'TV&EA?R
M$(NM6\2U+KT N$45D4?:'QK^T%U&JTW!ZH\ON?:_9#VK':$1I\YK,!L?YX_X
MH=1UYCK7NW,)[MV*NQ5V*NQ5^.7_ #\=_P#)I>1O_ 57_J.N<VV@^@^]\<_X
M(_\ CF+_ (7_ +XOSPS.?.WKO_./_P#Y//\ *#_P,=%_ZC8LJS_W<O<7;^S_
M /QHZ?\ X9#_ '0?T?YH'Z0=BKL58UYR\UZ3Y&\J>8?.&N2^EI/ENPGO[TBG
M)EA0L$0'JSFBJ.Y(&2A$R( ZN-K-7#289YLGTP!)^'Z^C^<+\R_S"\P?FGYU
MUWSQYEG,NHZU.7CMPQ,=M;KM#;1 ]$B2BCQZG<DYO\>,0B(A^<.T^T<O:&HE
MGRG>1^0Z >08+DW 1FG:;J.KWMMIFDV%SJFI7CB.ST^TB>>>5ST6..,,S'V
MQ) W+/'CGDD(P!)/( 63\'T'I_\ SB+_ ,Y&ZG9K?6WY6ZA%"R\@EW<V5I-3
MWAN;B.0'V*US'.JQ#J]#C]D>U<D>(8#7F8@_(D%Y?YS_ "J_,C\O&'^-?).L
M>7(F;A'>WEK(ML[>"7 !B8_ZK'+898SY&W5ZWLK5Z+^_Q2AYD;?/E]K ,FZ]
MV*OOS_G '\KM=U[\SS^9X,EGY9\BQ7-LUQ0A;R^OK9X!;+T!$<<IE?P/#^;,
M+79 (</4O?\ _ _[+R9M9^:Y0QV/ZTI BO@#9^'>_:#-0^T.Q5V*OB[_ )SW
M_P#6>]1_[;FF?\G&S+T7]Y\'B_;[_C+/]:+\-,W+X8[%7]%W_.-G_DA/RD_\
M!FP_Y-C-#J/[R7O?HSV:_P",S3_U!]SV[*7=NQ5V*NQ5V*OPI_YSN_\ 6BO,
M'_;*TK_J&7-SHO[L/A/MY_QJS_JQ^Y\<YEO'/J?_ )PI_P#6FORT_P"WS_W1
M;[,;6?W1^'WO5>Q/_&OA_P __<2?OKFD??78J[%78J_G:_YR?_\ 6@?S8_\
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MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MT,[A7<^+?\$+L_P=;'.!MECO_6CL?LX7P-F:\"GWE7S#>^4O,_EWS3IQI?\
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MZEYCECJW8J[%7V=_S@O^7,_G/\[-.\Q7%H\FA?E_;R:M=7)0F(WC PV<1:E
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MJ[%7\[7_ #D__P"M _FQ_P"!!<?J7-]IO[N/N?G;VH_XT\_]<O",N="^Y?\
MGWQ_Y/F\_P# 5U#_ )/VN8>N_N_B]S_P/?\ C2/_  N7WQ?MOFG?;G8J[%78
MJ_F'\Y?\I?YK_P"VQ??]1#YT4/I#\PZW^_R?UC]Y8WDG&=BKL5?I3_SAQ_SE
MG_AR33?RE_,W4_\ G7I66V\F^9[E_P#>!B:)9W+M_N@G:-S_ '9^$_NZ<-?J
M]+?JCSZOI7L;[6^ 8Z352]'*$C_#_1/]'N/3ERY?7/-6^NNQ5V*ODW_G-[_U
MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MTP/"G4_YIVE^WWBWO&4.^=BKL5=BKL5=BKL5?%W_ #GO_P"L]ZC_ -MS3/\
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M*'?NQ5V*OS__ .?C/_DF?*7_ (&EI_W3M0S.T'UGW?J?/_\ @C?XAC_X:/\
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M_P 4/MY][TW_ )S>_P#6:O/O_&?1_P#NJ6N5Z/\ O1\?N=I[<?\ &3E]\?\
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M5_1=_P XV?\ DA/RD_\  9L/^38S0ZC^\E[WZ,]FO^,S3_U!]SV[*7=O!/\
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M]1_[;FF?\G&S+T7]Y\'B_;[_ (RS_6B_#3-R^&.Q5_1=_P XV?\ DA/RD_\
M 9L/^38S0ZC^\E[WZ,]FO^,S3_U!]SV[*7=NQ5V*NQ5\3_\ .5?_ #BEI'YM
MZ3?><O)EC#IOYG:?$9?W8$<>M1QK_<7'0":@I'(?9'/&A3,TVI.,T>7W/$^U
M?LI#M&!S80!G'^S\CY]Q^!VY?$">":UGFMKF%[>XMW:*X@D4JZ.AHRLIH001
M0@YN'P^43$T=B%+%#ZG_ .<*?_6FORT_[?/_ '1;[,;6?W1^'WO5>Q/_ !KX
M?\__ '$G[ZYI'WUV*NQ5V*OYVO\ G)__ -:!_-C_ ,""X_4N;[3?W<?<_.WM
M1_QIY_ZY>$9<Z%]R_P#/OC_R?-Y_X"NH?\G[7,/7?W?Q>Y_X'O\ QI'_ (7+
M[XOVWS3OMSL5=BKL5?S#^<O^4O\ -?\ VV+[_J(?.BA](?F'6_W^3^L?O+&\
MDXS]4_\ GVC_ '/YS_Z_E[]6I9K>T/X?C^A]5_X&G+4_YG^_?J3FM?4G8JQ7
MSMY*\M_F'Y8U;R?YLTY-4T/683%=6[;,IZI+$_5)$:C*PW!&2A,P-CFXFNT6
M+6X98<PN,N?ZQYCH7X"?\Y ?D/YD_(CSC)HFI!]0\N:D7F\J>9 E([NW4[H]
M-EFCJ!(OR8?"P.;S!G&6-]7P'V@[!R]DY^"6\#],N\?K'4?H>$9<Z%V*NQ5V
M*OZ'O^<6O_6>_P J/^V''_R<?-%J?[R7O?HCV6_XR\']5[]E#OW8J[%7Y_\
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M!$DAL)$GE*)(:(\[PQR) K=C*RBF_3+88)S%@;.GUW;^AT.48L^41D>FY^=
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MVVDL[)J?1,X_XQ^^;+0X?XS\'RS_ ((/;G+0XSW&?^]C_OC_ )K\P-(UC5=
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MY]Q>0+B75O/7YG74!6TM+5/+FCS,-I)IG2ZN^/O&L<0_V>:[7SV$?B^G_P#
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M ?QCO'](?:/.GXV,K(S(ZE64D,I%"".H(S;/C1%-8J]=_P"<?_\ R>?Y0?\
M@8Z+_P!1L659_P"[E[B[?V?_ .-'3_\ #(?[H/Z/\T#](.Q5V*L)_,?SYHGY
M8^2?,7GGS!)QTWR_:-.800'GE-$AMXZ_MRR,J+[G?;)XX&<A$=7![2U^/0:>
M>?)RB+]YZ#WD[/YP_//G+6_S"\W>8/.GF*?ZQK'F*\>[NV%>*<MDBC!K1(T
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MK_UGO\J/^V''_P G'S1:G^\E[WZ(]EO^,O!_5>_90[]V*NQ5^?\ _P _&?\
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ML:A)J?F'RU; FXNXA$4CFB0;R&"K'@-R&J 2M,S-%DC"6_5XCVZ[-U6LT<?
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MJ]^RAW[L5=BK\_\ _GXS_P"29\I?^!I:?]T[4,SM!]9]WZGS_P#X(W^(8_\
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MPQ^41?VV^5<R7E7TA_SB-Y<7S/\ \Y$?EI:2Q\X--OY=7F-*A3IMO+=Q$_\
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M0Y1'TCW_ ,[W<O>_1I555"J JJ**HV  [#,!]';Q5V*NQ5\B?\YPZ%J^O?\
M./VOQZ-IT^IS:=J.GWUW!;(9)%MXI:22<%!)"<@6H-A4G8',K1R R"WD/;C!
M/-V9,0!-&)-=P.Y?A1]1O?\ ECG_ .1;?TS=6^$^'+N*Y-.U"1UCCL;AW<A4
M18G)).P  &Y.-A(QR/0OZ-/R#TC4M!_)7\KM(UBRET[5+'RW81WMA.I26&3T
M5)213NK"M"#N#L<T&<@S)'>_1O8&&>'L_!"8J0A&P>FSUS*G;NQ5V*NQ5V*O
MQ"_YSU\O:Y;_ )\7NKRZ5=#2]9TC3VTS4!$QAF]"+TI55P*<D9=Q6HV/0C-Q
MHI#PZ?$/;W3Y!VD9F)X91C1Z&A1?%7U&]_Y8Y_\ D6W],S+>)\.7<7UM_P X
M0>7M=N_^<C/)6J6^DW4FG:#!JMQK%Z(F]*WCFTRZMHVD<B@Y2RJH\2<Q=9(>
M$1^.;UWL/I\DNU<<A$U$2)-<KC(?>0'[N9I7W=V*NQ5V*OY]O^<K_+>O:7^?
M_P"9+W^D7=O%JNJ-?Z;,T3^G/;3HK))$]*,.QH=B"#N#F\TT@<8?GWVLTV7'
MVGFXHD<4K&W,'J'SM]1O?^6.?_D6W],R+><\.7<7WK_S[U\N:Z_YQ:UKWZ*N
M5T;3?+=W;WFIO&RPI/<3VWI1<R*<V",0O6@)[9@ZZ0X*\WOO^!YILAU\LG">
M$0()Z62*'O?L[FI?9W8J[%78J_FB_,CRWK^A^?O.6F:MH]Y87UMK-Z);>:%U
M:C3N58;;JP(*L-B-QMG0XY Q!#\T=I:;+BU.2,XD$2/3S85]1O?^6.?_ )%M
M_3)VX/AR[B_6'_GV]Y?UK3M$_-36[_3+BSTO6;K2+?2[R:-D2>2S6],XC+ <
M@GKI4CN:9K.T) F(][ZS_P #?3Y(8\\Y1(C(Q /?7%?RL/TQS7/ICL5=BKL5
M=BKL5?)?_.4W_.-&F?GEY=_2VBQPZ?\ F3H$##0]1:B)>Q+5C8W+?RDDF-C]
MAC_*S9E:;4'$:/)Y+VJ]F8=JXN.%#-$;'^</YI_0>A\K?A/JVDZGH.IW^BZS
M8S:9JVESO:ZCI]PA26&:)BKHZG<$$9N0018?"<V*>&9A,$2B:(/,%_0C_P X
MN(Z?\X^?E0KJ4)T*)@&%#1G=@?I!J,T>I_O)>]^A/985V7@_J![WE#OW8J[%
M7PK_ ,_!]"UC6?R3T:?2=-N-1CT3S5:7VJFW1I#!;?4[R$S.%!(422HI/:HS
M-T,@,F_<\)_P0L&3+V?$P!/#D!-=!PR%_,A^*_U&]_Y8Y_\ D6W],V]OBOAR
M[B[ZC>_\L<__ "+;^F-KX<NXN^HWO_+'/_R+;^F-KX<NXN^HWO\ RQS_ /(M
MOZ8VOAR[B[ZC>_\ +'/_ ,BV_IC:^'+N+OJ-[_RQS_\ (MOZ8VOAR[B[ZC>_
M\L<__(MOZ8VOAR[BF.D>6O,&O:G8:-HVC7FHZIJ<Z6]A8P0N\DDDAHJJ /'
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M(?RZ\]+>6$]OH5QKT5SHM[(I6.XF:W$=UZ9/V@@BC!(VKMVS5Z^N(=]/KG_
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9L5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627536216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 22, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0327982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2901 Bluegrass Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">341-7900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NATR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,474,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000275053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484629930296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 66,541<span></span>
</td>
<td class="nump">$ 86,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $148 and $143, respectively</a></td>
<td class="nump">7,272<span></span>
</td>
<td class="nump">8,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">63,928<span></span>
</td>
<td class="nump">60,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">10,896<span></span>
</td>
<td class="nump">8,760<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">148,637<span></span>
</td>
<td class="nump">164,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">49,587<span></span>
</td>
<td class="nump">50,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">18,960<span></span>
</td>
<td class="nump">18,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Restricted investment securities - trading</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">9,836<span></span>
</td>
<td class="nump">13,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">10,754<span></span>
</td>
<td class="nump">10,447<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">238,662<span></span>
</td>
<td class="nump">258,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,434<span></span>
</td>
<td class="nump">9,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_AccruedVolumeIncentiveandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="nump">22,513<span></span>
</td>
<td class="nump">23,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">26,621<span></span>
</td>
<td class="nump">31,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">3,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Related party note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="nump">2,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">4,537<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current installments of long-term debt and revolving credit facility</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">68,370<span></span>
</td>
<td class="nump">76,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">16,475<span></span>
</td>
<td class="nump">15,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Long-term debt and revolving credit facility</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation payable</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred income tax liabilities</a></td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">88,884<span></span>
</td>
<td class="nump">97,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, 50,000 shares authorized, 19,461 and 19,724 shares issued&#160;and outstanding, respectively</a></td>
<td class="nump">125,417<span></span>
</td>
<td class="nump">133,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">32,075<span></span>
</td>
<td class="nump">35,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">3,466<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(11,180)<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">149,778<span></span>
</td>
<td class="nump">161,404<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 238,662<span></span>
</td>
<td class="nump">$ 258,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AccruedVolumeIncentiveandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the liability that is related to incentives that are payable, due to volume sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AccruedVolumeIncentiveandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627475016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">19,461,000<span></span>
</td>
<td class="nump">19,724,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">19,461,000<span></span>
</td>
<td class="nump">19,724,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484633051496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 110,494<span></span>
</td>
<td class="nump">$ 102,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">34,460<span></span>
</td>
<td class="nump">26,979<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">76,034<span></span>
</td>
<td class="nump">75,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_VolumeIncentives', window );">Volume incentives</a></td>
<td class="nump">34,102<span></span>
</td>
<td class="nump">34,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">40,623<span></span>
</td>
<td class="nump">33,552<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">7,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss, net</a></td>
<td class="num">(314)<span></span>
</td>
<td class="num">(1,933)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">5,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">3,681<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,686)<span></span>
</td>
<td class="nump">4,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="num">$ (2,950)<span></span>
</td>
<td class="nump">$ 4,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and diluted net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic common shares outstanding (in shares)</a></td>
<td class="nump">19,573<span></span>
</td>
<td class="nump">19,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted common shares outstanding (in shares)</a></td>
<td class="nump">19,573<span></span>
</td>
<td class="nump">20,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_VolumeIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_VolumeIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627488488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (2,686)<span></span>
</td>
<td class="nump">$ 4,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation loss (net of tax)</a></td>
<td class="num">(975)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (3,661)<span></span>
</td>
<td class="nump">$ 4,031<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627087192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,697,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 157,234<span></span>
</td>
<td class="nump">$ 139,311<span></span>
</td>
<td class="nump">$ 26,030<span></span>
</td>
<td class="nump">$ 1,848<span></span>
</td>
<td class="num">$ (9,955)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">$ (914)<span></span>
</td>
<td class="num">$ (914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">$ (19,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">4,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 141,498<span></span>
</td>
<td class="nump">$ 139,402<span></span>
</td>
<td class="nump">10,188<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
<td class="num">(10,076)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">19,724,000<span></span>
</td>
<td class="nump">19,724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 161,404<span></span>
</td>
<td class="nump">$ 133,382<span></span>
</td>
<td class="nump">35,025<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">$ 801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">$ (795)<span></span>
</td>
<td class="num">$ (795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(451,000)<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (7,971)<span></span>
</td>
<td class="num">$ (7,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,950)<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">$ (975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(975)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">19,461,000<span></span>
</td>
<td class="nump">19,461,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 149,778<span></span>
</td>
<td class="nump">$ 125,417<span></span>
</td>
<td class="nump">$ 32,075<span></span>
</td>
<td class="nump">$ 3,466<span></span>
</td>
<td class="num">$ (11,180)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484629832440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (2,686)<span></span>
</td>
<td class="nump">$ 4,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,766<span></span>
</td>
<td class="nump">2,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_OperatingLeaseNonCashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">3,844<span></span>
</td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities', window );">Purchase of trading investment securities</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of trading investment securities</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized losses (gains) on investments</a></td>
<td class="nump">58<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange losses</a></td>
<td class="nump">402<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="num">(2,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(3,489)<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(2,518)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(946)<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="num">(464)<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(5,386)<span></span>
</td>
<td class="num">(6,248)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(1,632)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(191)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Deferred compensation payable</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(7,924)<span></span>
</td>
<td class="nump">2,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Principal payments of long-term debt</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(397)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Principal payments of related party borrowing</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Proceeds from the exercise of stock awards</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(7,971)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(9,374)<span></span>
</td>
<td class="num">(1,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="num">(827)<span></span>
</td>
<td class="num">(1,257)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(19,643)<span></span>
</td>
<td class="num">(816)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">86,184<span></span>
</td>
<td class="nump">92,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">66,541<span></span>
</td>
<td class="nump">91,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">2,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_OperatingLeaseNonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_OperatingLeaseNonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484633778664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632773896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2022, and for the three months ended March&#160;31, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates due to the uncertainty around the magnitude and duration of the COVID-19 pandemic, the current conflict between Russia and Ukraine, inflationary pressures and supply chain challenges as well as other factors and those differences could have a material effect on our financial position and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.3 million and $0.1 million for the three months ended March&#160;31, 2022 and 2021, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, noncontrolling interests were $3.5 million and $3.2 million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Related Accruals and Expenses</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $0.3 million and $48,000 of restructuring related expenses during the three months ended March&#160;31, 2022 and 2021, respectively. Accrued severance and restructuring related costs were $0.1 million and $0.2 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria, that have contracts, hedging relationships, and other </span></div>transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632611064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631669512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investment Securities - Trading</a></td>
<td class="text">Investment Securities - Trading&#160;Our trading securities portfolio totaled $0.9 million at March&#160;31, 2022, and $1.0 million at December&#160;31, 2021, and generated losses of $58,000 and gains of $16,000 for the three months ended March&#160;31, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631703016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Revolving Credit Facility and Other Obligations</a></td>
<td class="text">Revolving Credit Facility and Other Obligations<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#8220;Credit Agreement&#8221;).&#160;On June 11, 2020 the credit agreement was amended to extend the term to mature on July 1, 2023. The amendment also allows for additional borrowings of $15.0&#160;million or up to three separate increases of no less than $5.0&#160;million each. On March 8, 2021, we signed an amendment to the credit agreement that eliminates the Index floor from the calculation of interest. Interest under the amended Credit Agreement is at the LIBOR daily floating rate, plus&#160;2.25 percent&#160;(2.71 percent as of March&#160;31, 2022), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. At March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance under the Credit Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments, of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2022, there was $2.1&#160;million outstanding balance under the Capital Credit Agreement, of which $1.3&#160;million was classified as current.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631697688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income (Loss) Per Share<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted earnings (loss) per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted-average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632832536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Capital Transactions</a></td>
<td class="text">Capital Transactions<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a special non-recurring cash dividend of $1.00 per common share in an aggregate amount of $19.9&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2022, we repurchased 451,000 shares of our common stock for $8.0&#160;million. No shares were purchased for the three months ended March 31, 2021. At March&#160;31, 2022, the remaining balance available for repurchases under the program was $29.6&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no share-based compensation expense for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 and December&#160;31, 2021, there was no unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 143,000 shares of common stock was $0.6 million. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase 172,000 shares of common stock was $1.1 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022 and 2021, we issued 29,000 and 2,500 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 and $11.98 per share, respectively. The aggregate intrinsic value of options exercised during the three months ended March&#160;31, 2022 and 2021, was $0.3 million and $19,000, respectively. For the three months ended March&#160;31, 2022 and 2021, the Company recognized $0.1 million and $9,000 of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, we did not have any unvested options outstanding.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to revenue and earnings growth, earnings-per-share, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At March&#160;31, 2022 and December&#160;31, 2021, there were 95,000 and 88,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we granted 2,000 time-based RSUs under the 2012 Incentive Plan to new members of the Board of Directors. The RSUs were issued with a weighted-average grant date fair value of $16.35 per share and vest in monthly installments over a period less than one year from the grant date. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately 12.9 percent for a common share.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, no share-price performance-based RSUs were issued. Historically, share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three months ended March&#160;31, 2022 and 2021, was approximately $0.5 million and $0.4 million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $1.0 million and $1.6 million, respectively. As of March&#160;31, 2022, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.5 years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three months ended March&#160;31, 2022 and 2021, was $0.3 million and $0.4 million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would, and expect to, recognize up to $2.0 million of potential share-based compensation expense. </span></div>The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 60,000 and 75,000 shares for the three months ended March&#160;31, 2022 and 2021, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632772776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy&#174; WorldWide brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,702&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $4.9 million and $2.8 million for the three months ended March&#160;31, 2022, and March&#160;31, 2021, respectively. These service fees are included in selling, general and administrative expenses. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March&#160;31, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631697688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 369.9 percent and 27.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets which are expected to expire before utilization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2021, was primarily attributed to transfer pricing adjustments and non-deductible executive compensation, partially offset by favorable deductions for stock compensation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three months ended March&#160;31, 2022 compared to March&#160;31, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets which are expected to expire before utilization. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2018 through 2020 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, we do not have any amounts accrued for unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632678632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $0.2 million and $0.2 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $3.1 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $0.5 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.5 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632828264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party TransactionsDuring the three months ended March&#160;31, 2022 and 2021, our joint venture in China, owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $0 and $1.2 million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $0 and $0.3 million, respectively. These notes were payable in less than one year and bore interest of 3.0 percent. The notes between NSP China and the Company eliminated in consolidation. In March 2022 the outstanding principal and interest amounts were repaid.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632677192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632766568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at the point in time in which the customer obtains control of the products, per the agreed shipping terms in the respective market. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Amounts received for unshipped merchandise are recorded as deferred revenue. Membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Liabilities - Customer Loyalty Programs</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have offered loyalty point programs which allowed customers to earn loyalty points on personal orders. Loyalty points were recorded as contract liabilities in deferred revenue. These programs were accounted for as a reduction in the transaction price and generally recognized as points that were redeemed for additional products. During the year ended December 31, 2020 these programs were discontinued. As of March&#160;31, 2022, there were no outstanding loyalty points.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy&#174; WorldWide brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense volume incentives when incurred because the amortization period would have been one year or less.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our contracts with customers have a duration of less than one year. The value of any unsatisfied performance obligations is insignificant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627449064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2022, and for the three months ended March&#160;31, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates due to the uncertainty around the magnitude and duration of the COVID-19 pandemic, the current conflict between Russia and Ukraine, inflationary pressures and supply chain challenges as well as other factors and those differences could have a material effect on our financial position and results of operations.</span></div>The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria, that have contracts, hedging relationships, and other </span></div>transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632762040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of composition of inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632638200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted earnings (loss) per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632702824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of restricted stock unit activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631350184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of reportable business segment information</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,702&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div>(2)&#160;&#160;&#160;&#160;Service fees in China totaled $4.9 million and $2.8 million for the three months ended March&#160;31, 2022, and March&#160;31, 2021, respectively. These service fees are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of consolidated net sales revenue by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March&#160;31, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of revenue generated by each of the Company's product lines</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of consolidated property, plant and equipment by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock', window );">Schedule of assets per segment</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Segment Reporting Information, by Segment1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632613192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of the Company's hierarchy for assets measured at fair value on a recurring basis</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627110136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Increase (decrease) in noncontrolling interest</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">3,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember', window );">Accrued Severance and Rent Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632910120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 25,192<span></span>
</td>
<td class="nump">$ 22,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">36,916<span></span>
</td>
<td class="nump">36,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 63,928<span></span>
</td>
<td class="nump">$ 60,852<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627615592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Trading securities portfolio</a></td>
<td class="nump">$ 888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss', window );">Debt securities, trading, realized gains (losses)</a></td>
<td class="num">$ (58)<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484628987464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations (Details)<br></strong></div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 11, 2020 </div>
<div>USD ($) </div>
<div>borrowing</div>
</th>
<th class="th">
<div>Jul. 11, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings', window );">Potential increase in maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases', window );">Number of separate increases | borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence', window );">Potential increase in maximum borrowing capacity, per occurrence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Annual commitment fee</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | LIBOR | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_DebtInstrumentNumberOfMonthlyPayments', window );">Number of monthly payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit, outstanding, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Indicative Index | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DebtInstrumentNumberOfMonthlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Monthly Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DebtInstrumentNumberOfMonthlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Number Of Separate Increases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityNumberOfSeparateIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=natr_IndicativeIndexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=natr_IndicativeIndexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632934504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="num">$ (2,950)<span></span>
</td>
<td class="nump">$ 4,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">19,573<span></span>
</td>
<td class="nump">19,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Diluted shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,573<span></span>
</td>
<td class="nump">19,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock-based awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,573<span></span>
</td>
<td class="nump">20,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract', window );"><strong>Dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings', window );">Share-based awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract', window );"><strong>Anti-dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Share-based awards (in shares)</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive shares included in the calculation of diluted earnings per share</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedfromComputationofEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484622389880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 05, 2021</div></th>
<th class="th"><div>Apr. 05, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 10, 2021</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Common stock, dividends (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends, common stock, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,858,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember', window );">2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of shares authorized under the plan (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.17<span></span>
</td>
<td class="nump">$ 11.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic values of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit from the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember', window );">Time-based stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne', window );">Operating income margin, one (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo', window );">Operating income margin, two (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree', window );">Operating income margin, three (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested stock options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability', window );">Discount for lack of marketability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">RSU issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which the remaining compensation cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements', window );">Minimum withholding requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Director | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_RestrictionPeriodForIssuanceOfShares', window );">Restriction period for issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber', window );">Nonvested subject to restriction period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUsMember', window );">Time-Based Restricted Stock Units (RSUs) | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share based compensation potential compensation expense to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RestrictionPeriodForIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the restriction period before shares will be issued related to a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RestrictionPeriodForIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the first operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the three operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the second operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484628971688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Stock Option Activity (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or canceled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the end of the period (in shares)</a></td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted&#160;Average Exercise Price&#160;Per&#160;Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 12.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">9.17<span></span>
</td>
<td class="nump">$ 11.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">12.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted&#160;Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">5.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627452936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - RSU Activity (Details) - 2012 Stock Incentive Plan - RSUs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(57,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="num">(220,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">555,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">16.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">3.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">8.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484622767240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">$ 110,494<span></span>
</td>
<td class="nump">$ 102,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">41,932<span></span>
</td>
<td class="nump">41,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">40,623<span></span>
</td>
<td class="nump">33,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">7,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss, net</a></td>
<td class="num">(314)<span></span>
</td>
<td class="num">(1,933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">5,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">49,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">238,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">46,110<span></span>
</td>
<td class="nump">35,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">21,939<span></span>
</td>
<td class="nump">15,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">93,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">12,986<span></span>
</td>
<td class="nump">11,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,344<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">13,630<span></span>
</td>
<td class="nump">9,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">9,036<span></span>
</td>
<td class="nump">6,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">2,543<span></span>
</td>
<td class="nump">2,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">6,571<span></span>
</td>
<td class="nump">4,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">21,777<span></span>
</td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">4,373<span></span>
</td>
<td class="nump">6,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">9,196<span></span>
</td>
<td class="nump">9,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">2,633<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">5,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">35,981<span></span>
</td>
<td class="nump">37,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">12,719<span></span>
</td>
<td class="nump">15,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">122,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">15,314<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">4,872<span></span>
</td>
<td class="nump">4,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">3,842<span></span>
</td>
<td class="nump">4,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">8,594<span></span>
</td>
<td class="nump">9,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">1,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,184<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">6,626<span></span>
</td>
<td class="nump">6,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">2,901<span></span>
</td>
<td class="nump">3,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,818<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">33,229<span></span>
</td>
<td class="nump">34,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">45,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_KR', window );">South Korea</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">13,653<span></span>
</td>
<td class="nump">14,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">63,612<span></span>
</td>
<td class="nump">$ 52,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">$ 3,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMarginAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMarginAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_ImmunityProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_ImmunityProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_CardiovascularProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_CardiovascularProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_DigestiveProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_DigestiveProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_PersonalCareProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_PersonalCareProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_WeightManagementProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_WeightManagementProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_KR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_KR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=natr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484631632744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision (benefit) for income taxes, as a percentage of income before income taxes</a></td>
<td class="nump">369.90%<span></span>
</td>
<td class="nump">27.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627549272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember', window );">Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover', window );">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Provision for losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember', window );">Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484632955160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=natr_ChinaJointVentureMember', window );">China Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Joint venture ownership</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=natr_ChinaJointVentureMember', window );">China Joint Venture | Fosun Pharma Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Joint venture ownership, noncontrolling party</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_ChinaJointVentureMember', window );">China Joint Venture | Subsidiaries | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Notes receivable, related parties, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries | Company's Joint Venture Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Notes receivable, related parties, current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction, rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=natr_ChinaJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=natr_ChinaJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=natr_FosunPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=natr_FosunPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=natr_ChinaJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=natr_ChinaJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=natr_CompanysJointVenturePartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=natr_CompanysJointVenturePartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484629956824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Recurring basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">$ 888<span></span>
</td>
<td class="nump">$ 964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 - Quoted Prices in Active Markets for Identical Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 - Significant Other Observable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 - Significant Unobservable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140484627538104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>segment </div>
<div>productCategory </div>
<div>loyaltyPoint</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_RevenuefromContractwithCustomerRefundPeriod', window );">Refund period</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_CustomerLoyaltyProgramLoyaltyPoints', window );">Customer loyalty program, loyalty points | loyaltyPoint</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_NumberofPrincipalCategoriesofProducts', window );">Number of principal categories of products | productCategory</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_natr_ContractWithCustomerContractTerm', window );">Contract with customer, contract term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContractWithCustomerContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Contract Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContractWithCustomerContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_CustomerLoyaltyProgramLoyaltyPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Customer Loyalty Program, Loyalty Points</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_CustomerLoyaltyProgramLoyaltyPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_NumberofPrincipalCategoriesofProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Principal Categories of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_NumberofPrincipalCategoriesofProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RevenuefromContractwithCustomerRefundPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Refund Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RevenuefromContractwithCustomerRefundPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>natr-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:natr="http://naturessunshine.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="natr-20220331.xsd" xlink:type="simple"/>
    <context id="ife753c21309348fa8d87e87158807672_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e35948f90de4e4bb885b253907321af_I20220422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-04-22</instant>
        </period>
    </context>
    <context id="i134f93f3e1e140309cddc401f5a3e5fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibd8f983b74df47e39a31782e54a1f453_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i31118a41ac734f62a4a1b223c11d6388_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iafc00c0e066e415d97d748896c5b8293_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0f80a190c774d68a92e8b1a2f88a5f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i970a18ecde554037990417bc451e2bc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5f415b4db8b944d0bed042261b480afe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52ca8da5fb054fc793d0133a79547e2c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id0a816cff4a849aaa6899e1a2e2b5469_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia64394d8f9e149c48e32b4bf254c70b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5959344c8c8242509d2162698de11ad8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i319e38ef94554c4bbee57b4e16105332_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i986b0412b49f48f7af2e01731e0207b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2815e28e436f4c61a00dc75c638b512e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i526c00954e5344319ba34979f1995514_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifbbf75a7daef4a46879cb80474d10c34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4dda98afbcfa4f93969fa231b6d7ad7a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1ac093d990f747789ddc5622c8faa200_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8da7b722ce504d7796cf25d0a7d834cc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i809568b0c3fe4247b38fd5463e2a656e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5065f6df791f4c01b3fd8c6ab8e971b1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib43f287504274318bf963d9a1d66f50f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idcbc2254a9ff457793b34cf0b849506d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia1a3638bc5e548b6aa731778d987df88_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i58339cf767784484935089232da792c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-07-11</instant>
        </period>
    </context>
    <context id="i2e3b028273b4499fa40faa68a39ebd4c_I20200611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="i9eebe4f1416a42e29600fbc080b00ddd_D20210308-20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <context id="id926898d6fa64913b3ef9123f02f63cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id69bfe93049647898e279137e36c29b1_D20210308-20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <context id="i32456aa4ccc64830b04647560160366a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab0f1c76f2c54a56b68ab99720f974d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic6a5b6c9fc5c4a5c86741daebd2c055c_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="ia98eed0936e6455f8174af8a8890d1db_I20201119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-19</instant>
        </period>
    </context>
    <context id="ie8d4e839e771459aa39d3689d857e1a9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62c09354038642f186df2d18e5450419_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="id76496067c7b4d3f8bd85db3b5f95257_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if98b729b54f5451a829590e8adb58f29_D20210405-20210405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-04-05</startDate>
            <endDate>2021-04-05</endDate>
        </period>
    </context>
    <context id="id691a4ef66cf4da3b988bfbf06a2e811_I20210310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-03-10</instant>
        </period>
    </context>
    <context id="i78adc08e7232473a933e1ecb19fbb047_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="i555b079af2a941c182b57bfc82a439aa_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="ie914eddd4e9943539c51b78d2f72072b_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i2c8f4fc34bae44f3a7053951f910b3b8_D20210505-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="i7bf0a2bb87c04726b85a12b3aaf47333_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2766fa78dc664de49f98b43876ee0fd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i402b0314d6b84b1480d0e6192c468f66_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i398a4c632e9146b6a4117e9a80bd1b33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i402ed898554945f59d3dcb7c9d4b63e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3fb365d93fed48cdb727939977fc3c22_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iccd7c968f4df4cc0aa01a09c2a2a9125_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if832daaf3a78404e9c159a19b9debf45_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia72899eeeac6488c866c2c21e97909de_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b74d788af4647368d8064fe930b3af7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9f4ec581d7e641179b6e6d5671e479cc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i84a5b39487154954983fee65eae72369_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3da7c00ee4b94166b3df419f56670028_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iabbe644ac11048d2b710f145d0c3929c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib87d18bc3f9040428d9eb9ea8d77994f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i348578201c544d8e9d4c3798b278b2fb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22cc4557e1f545e1bc22ad3695e0973d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i448f69feb8bc4e458720f20bcf268a47_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba97bd86e7444e189f6fc7c93415f216_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i92527f12c51f48969241c6c015177b7e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i831c92eb3b70497eb880571439797b1d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia99ab0f2e60446ec842d8b9c7ecedda2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3dc50e572e4748939b523aac9f92ce3d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3833f589148a4227b4f5c984f8f200b8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4aaa533e28334f489d7076c39dd1673d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2d1d57f3f4a34ccdb3dbce4533de6401_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idadda0b851c948ef9359bd2d2b89e394_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib8b65a6d4edb47548db956eb75ac2c69_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i348e6e2f93764613b3bd554e1ef83f4b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a0bf1d17dbb48cbb44d363a39cecd6c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17bade993e50434bb25d5592094f26be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8912512957214830a709fb3a0e5f6bca_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i923224bdda5a44f6b1fd81e1e95c68ad_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie9a2377c670243d1a78c141cc8e41170_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia60c19c5ef2943ab9963e5ff0b52a2c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1318988169ff4f8fa5244b15ab3b8c19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7d7e87cbccf44fda7f9f4bb20e905bb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i910fb20292ee451c8d13d76fb72f1bc6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29ee274469924f98ad71b11264e3aac2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib2afe0a2304a4456866df0c569f0b79b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i94732c9a5ab84a539cf8295a1bee383e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4e28facca7c94a3bb9ef0cbef288a9b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf9d61c288624d7199064cf8381fb74c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia7c4bae86f8b4368a604018a81f2ec34_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i70cbed7bb9954b1f8cd165f5e0ec7a32_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i14fe7c8a0e454ba181e8aa0117c5fe76_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i902dbfce0d3d416f9e765b1c3e2da20f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2a00e56648394275b3210882faf90e94_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id0c3f3a5a15141889d6b30d587478d20_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibcc88af59d684d87a1010641a53f8b29_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia25d2edee7b64a6ebb0b481f7c617554_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia2358ce4157b4456ae0ba519086bc059_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i40834fd02559432dae656ae4e9cde9f0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9ec47376a16843fe8b7959468e821063_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i40ea609d840d4bfcb6ac425813487379_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i767402ab744647ed99b96582c5beb3a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8732a9aa67884481b06822950adac68e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic15ce45b151e4a20adb9f451c3673c19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7f5284ee739d4941a2c520f0a501c89e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie9c8d01d2a81452f8df2e915edc4269e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4bf5d682a21749498e82089f8cad3646_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4908295d328c4841a2ee03a0b1ffd3d7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7de4b6373eea45468e42ddd4316cd664_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i378b6704092a4d50ac575936de66eff3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d963c459ab44b6e925d88b0342277cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i325b7a5fd36c4fe28941bfaf3f5e55f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2c0ce3a35074fb4a5417b00b210d23e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb2e0b295afa4d06a33d1a682c00dbbf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2418e36a7c6d4b968097a27d457f9a08_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if4e927aab10b4984bee8f3006640dc63_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68972e27e09c468e998db2ff4a112ecd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1ce4108dd6004d9f97aa7f7a7ed76e7d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0b0ebd208da4867a5672633b3762f8d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic33417330f8f488c995347b902948643_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i15e313090407494ba9488fe56934f695_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i23f702f0295049a28cbcdc8b4d1ef74a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5f14deead68345519312a61e7ae03e71_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i86021b8e2ac744dbb42d13876c378755_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i95ba4d14830043cfa540bfed1414f780_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i004217ff71f5450a9f97499b3ad9bcf9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b1e426e6e414937a5f77169261c768c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0831f06411dc477198d772b8a9a9e543_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6ea186633b504a27ba220e6cfcd61edb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47363d5359bd46939ab4fc9af1589e6b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac919f4f48d240ed91a334c82ccd8334_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfaaa60da1b043588f9fae53b220069c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4376d08163e3452aa8513d7ff8613dc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i281b77f20968487b8373b3b9e315c30b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e8dbc545c204454955aab73bf9e460f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2dff93085c7f44fa956bd391f58b99df_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1aa91f25a9b349ef8fdaee1bfeda71ee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6e4dd6c147114968863a0c8456478780_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f362c72e29e4ee8ad5ec7c2dfb61c74_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib89e37a274af4cee94ebef8056298d53_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac3fd88adf7d4e73bafc50be57cbaef2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i492c57a6f9d046bda2bbdd0115e8fa08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icefc00db041a48d4a92bfbe7b4e5ad25_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09a9560c1ee743039cb31edafc3294ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id57f2be0493944f4be377552827b560e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idf7ca29b6fc94c6dbdc1652525619cd1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3f9df89d786a41e0b3d144f941fc5d32_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d3d962215954cc8a9171fdd8505b3ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i72fa1124277f415fb68c710bb5c87c6c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3ffa4204f2244033a6387741823b1eea_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6210ad9bf96e4639909b9ee6ec5f0dee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9172a343a5724170828bcc1c87deb05b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieae5488b942241ffb6afa51639ffba10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if4e1cf8cd79b489185a71063b36e1414_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie78f626536d54b3ca22aa7de05ba6475_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5c874d0d851496d8d0b2cad723434c2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd0d3c071a9749e19577e2b5b5623c3f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5996eefda0d54ab59124aeaee9125db4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibaaf9feba842448992af5440ff1e9ca4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if60740a0aa42458e9145ad1c8f41c4a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i11fc7a1040844bd1a53ed85f210878e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i444dd1d44ce74fcb94a32f106266e541_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i067bf9020abe410db4a9808337bf4f61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21defeb3de3d4f229983ffbf2177bdbf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i838fe1c774584db3baff30093827a885_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="borrowing">
        <measure>natr:borrowing</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="payment">
        <measure>natr:payment</measure>
    </unit>
    <unit id="segment">
        <measure>natr:segment</measure>
    </unit>
    <unit id="claim">
        <measure>natr:claim</measure>
    </unit>
    <unit id="loyaltypoint">
        <measure>natr:loyaltyPoint</measure>
    </unit>
    <unit id="productcategory">
        <measure>natr:productCategory</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xLTEtMS0xLTI2NDEy_c659d8f2-ff6c-4ff4-bba4-5bd004983f4e">0000275053</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M180LTEtMS0xLTI2NDEy_dc5417ef-5eb5-49a3-aac5-3933babff88b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xMi0xLTEtMS0yNjQxMg_1e0ff08f-0475-43c0-a594-cac27c9d69fe">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGFibGU6YzQ3MDFkNTAzY2ZmNDM2ZTliODBhODUyMGI3MTA1OTMvdGFibGVyYW5nZTpjNDcwMWQ1MDNjZmY0MzZlOWI4MGE4NTIwYjcxMDU5M18xMy0xLTEtMS0yNjQxMg_9dabb3d8-2289-4c20-bed3-cc109e7e5a25">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180L2ZyYWc6YjFlNjUyNGY4MzAwNDliMWEwZTFlZTI3MGVjNDgzNWIvdGV4dHJlZ2lvbjpiMWU2NTI0ZjgzMDA0OWIxYTBlMWVlMjcwZWM0ODM1Yl8xOQ_3d2940bb-b113-452b-853a-00db962e52e2">--12-31</dei:CurrentFiscalYearEndDate>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="i448f69feb8bc4e458720f20bcf268a47_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181NS9mcmFnOmRhODc3M2U4Njg0MDQ1NDM5NGRhY2M3MTUyMGQ4MzQxL3RhYmxlOmQ4YzEwYTUyZGY2NjRhMTI5ZDU2ZmIzYzhjY2Q5OTRkL3RhYmxlcmFuZ2U6ZDhjMTBhNTJkZjY2NGExMjlkNTZmYjNjOGNjZDk5NGRfMS0xLTEtMS0yNjQxMg_9775ccef-1f10-4d37-a78d-0580e0d6208d">P1Y</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="iba97bd86e7444e189f6fc7c93415f216_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181NS9mcmFnOmRhODc3M2U4Njg0MDQ1NDM5NGRhY2M3MTUyMGQ4MzQxL3RhYmxlOmQ4YzEwYTUyZGY2NjRhMTI5ZDU2ZmIzYzhjY2Q5OTRkL3RhYmxlcmFuZ2U6ZDhjMTBhNTJkZjY2NGExMjlkNTZmYjNjOGNjZDk5NGRfMS0yLTEtMS0yNjQxMg_5921de9b-14a6-417d-9f3a-16e43ae768d2">P1Y3M</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <dei:DocumentType
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNTM_7ae6eec9-a419-4bfc-97f4-2c61b7ecf9aa">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNzA_09462d8a-2f14-4bf3-84b2-6b39c1265967">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yOTc_26462779-5edf-476c-9331-03b1a26ddcdf">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8zMDg_98f32ccd-815a-40a3-b9e7-3cdd34075adc">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF80OTI_667d84c3-3caa-4dbd-bbaa-83acc88c864e">001-34483</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF80OTg_b43beb0b-5119-4704-9b94-143bc936deaf">NATURE&#x2019;S SUNSHINE PRODUCTS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ODMzYzgzMjI1YjFjNDc1NGE1ZDAxNmYyY2YwODE2MjgvdGFibGVyYW5nZTo4MzNjODMyMjViMWM0NzU0YTVkMDE2ZjJjZjA4MTYyOF8wLTAtMS0xLTI2NDEy_ed837950-e7d7-4647-804b-3a1c8258eb74">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ODMzYzgzMjI1YjFjNDc1NGE1ZDAxNmYyY2YwODE2MjgvdGFibGVyYW5nZTo4MzNjODMyMjViMWM0NzU0YTVkMDE2ZjJjZjA4MTYyOF8wLTItMS0xLTI2NDEy_db7854ce-43de-4729-98a7-6cc3ad87249a">87-0327982</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NjA_40abeaa3-d1cd-4743-8d15-2e176499a465">2901 Bluegrass Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NjQ_d7258744-7961-4dda-96a1-3500eb487aa1">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81Njc_f9fb570f-2e2c-457b-bfa1-7f40b77dd4ef">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NzE_f3430beb-4bd8-45b4-9c3c-e55f2acfb8fd">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF81NzQ_d3a99486-6966-4314-bb35-734a271999a1">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF82MzQ_cd8360a7-e5b0-4587-b1a7-92e9f11cdf02">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF82Mzg_08588c83-132d-4e64-b3ac-38ce89d63d5a">341-7900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTAtMS0xLTI2NDEy_51384170-7017-4296-9cbb-d5c61b89fb62">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTEtMS0xLTI2NDEy_19c13c85-d11d-42d5-9c94-6552f9bfc6d7">NATR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6OWZiMDk2N2UxODhiNGQyY2E5OTNhYmM3MmIyODQ2MGQvdGFibGVyYW5nZTo5ZmIwOTY3ZTE4OGI0ZDJjYTk5M2FiYzcyYjI4NDYwZF8xLTItMS0xLTI2NDEyL3RleHRyZWdpb246ZTc5MDYwMmM2ZWVmNGQxYzhlNDYzM2E3M2JmMjJiMjlfNA_28c3bb6f-306e-4c1a-8f62-ffdaecae4623">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xMTMy_2e5e50e9-860a-4223-84a0-d996c7e67256">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8xNDU4_70441151-89e7-46ec-95b4-b89af0bb13e9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml8wLTItMS0xLTI2NDEyL3RleHRyZWdpb246YzI1MWVkNWU5NGNhNDhiOTk3MDA4MjhiZmZkMDMwODBfNQ_97a3e2cf-5c4e-48f7-b50b-9d88f2ff61b6">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml8yLTItMS0xLTI2NDEyL3RleHRyZWdpb246YzYwNmJjZjQ0YjU2NDI5ZmExZDQ3MGEwOTE3NWYzZDlfMzE_183ba83c-b621-4f66-b266-e6031df2d55b">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGFibGU6ZDE2YWIwMTM4MjAyNGI5NmJiNGM2YzJiYmQ2ZWIwODIvdGFibGVyYW5nZTpkMTZhYjAxMzgyMDI0Yjk2YmI0YzZjMmJiZDZlYjA4Ml80LTItMS0xLTI2NDEyL3RleHRyZWdpb246MTgzMThhMWYxMDA5NDhkZWI3ZDUwMTZmOTY4NDc1MDVfMzA_8c78b5cc-93a8-4ac7-a54d-36c5ec91ad99">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yMzAy_cc3ce416-f97c-4999-ad6d-1d32c163a5fc">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1e35948f90de4e4bb885b253907321af_I20220422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xL2ZyYWc6ZjMyNDdhMDRjN2I3NDJjNzgwMjNjYTJjZTNkZWE1N2QvdGV4dHJlZ2lvbjpmMzI0N2EwNGM3Yjc0MmM3ODAyM2NhMmNlM2RlYTU3ZF8yMjkx_9d941b53-97d0-42fc-aa13-bc7d86e3bf9e"
      unitRef="shares">19474806</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMy0xLTEtMS0yNjQxMg_d67cdeb7-059e-4a76-a402-79a91d8538be"
      unitRef="usd">66541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMy0zLTEtMS0yNjQxMg_679ed119-5751-430c-b0fa-49e492750df4"
      unitRef="usd">86184000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0wLTEtMS0yNjQxMi90ZXh0cmVnaW9uOjFkNGZhNjIzMjgxZTQzZDA5Y2U4OGUwMWYyY2YwOTMyXzY3_aa1a8b87-b17b-408f-a6ae-9cd5fffee7ac"
      unitRef="usd">148000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0wLTEtMS0yNjQxMi90ZXh0cmVnaW9uOjFkNGZhNjIzMjgxZTQzZDA5Y2U4OGUwMWYyY2YwOTMyXzc0_32822031-3ed0-4983-8175-bf8c19610526"
      unitRef="usd">143000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0xLTEtMS0yNjQxMg_9588d517-afa4-4e48-9c88-9d4993443dce"
      unitRef="usd">7272000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNC0zLTEtMS0yNjQxMg_d7e99f65-e36d-4554-ac75-9ea70e51bdbe"
      unitRef="usd">8871000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNy0xLTEtMS0yNjQxMg_976165a8-3345-40fa-b516-0c421e7f3553"
      unitRef="usd">63928000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNy0zLTEtMS0yNjQxMg_f7b9c587-dc5e-4761-bfc9-4d6e585b44c1"
      unitRef="usd">60852000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOC0xLTEtMS0yNjQxMg_0c76eb80-68eb-4b57-b033-45cd033408be"
      unitRef="usd">10896000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOC0zLTEtMS0yNjQxMg_3f4ebaa0-398f-4cb4-af11-991bcdb93263"
      unitRef="usd">8760000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOS0xLTEtMS0yNjQxMg_1f19f7c9-249b-425b-9d54-32903467afbb"
      unitRef="usd">148637000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfOS0zLTEtMS0yNjQxMg_b9665b13-781e-4ec0-b257-995d010a0b12"
      unitRef="usd">164667000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTEtMS0xLTEtMjY0MTI_36225e4a-b882-4bca-b418-075b1d57a58f"
      unitRef="usd">49587000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTEtMy0xLTEtMjY0MTI_7bd173d1-c8f7-4107-b0ec-90679bcfb0c4"
      unitRef="usd">50857000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTItMS0xLTEtMjY0MTI_d2a05a7f-029b-4c22-8801-df375f106c0e"
      unitRef="usd">18960000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTItMy0xLTEtMjY0MTI_89f99c0d-7fdb-4b17-b625-15c5057eea3f"
      unitRef="usd">18349000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTMtMS0xLTEtMjY0MTI_2940915b-8085-4978-98db-2aedefc65a03"
      unitRef="usd">888000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTMtMy0xLTEtMjY0MTI_af07bae2-c69f-472a-adb3-52e035b76261"
      unitRef="usd">964000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTUtMS0xLTEtMjY0MTI_8217b49f-c5bd-4168-a654-50b6c02d7640"
      unitRef="usd">9836000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTUtMy0xLTEtMjY0MTI_745b2392-40dd-4bc7-b2ce-51ddcb303420"
      unitRef="usd">13590000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTYtMS0xLTEtMjY0MTI_f6147668-d499-453f-9f54-11dafbaa694d"
      unitRef="usd">10754000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTYtMy0xLTEtMjY0MTI_e9c02d6d-33a1-4d11-bb6b-905957364c9d"
      unitRef="usd">10447000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTctMS0xLTEtMjY0MTI_3946c213-a275-49a0-9d2b-4840f6c57860"
      unitRef="usd">238662000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMTctMy0xLTEtMjY0MTI_a66bb994-d864-424b-af95-5bad5f341be3"
      unitRef="usd">258874000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjEtMS0xLTEtMjY0MTI_effd3d13-4410-488f-b13a-5fc8f42389a3"
      unitRef="usd">8434000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjEtMy0xLTEtMjY0MTI_309b8736-9c32-4168-9e0c-b7fce0062a92"
      unitRef="usd">9702000</us-gaap:AccountsPayableCurrent>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjItMS0xLTEtMjY0MTI_f1c86ac7-e6c8-4a86-b72d-187a9acfb24b"
      unitRef="usd">22513000</natr:AccruedVolumeIncentiveandServiceFees>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjItMy0xLTEtMjY0MTI_e3958bd2-442d-4894-a7f1-1384fe95f611"
      unitRef="usd">23131000</natr:AccruedVolumeIncentiveandServiceFees>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjMtMS0xLTEtMjY0MTI_5f7764e5-b15f-4d79-b347-237d5ae1e2b2"
      unitRef="usd">26621000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjMtMy0xLTEtMjY0MTI_dc155d88-25fc-49e9-bdc5-03f3913ced7b"
      unitRef="usd">31600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjQtMS0xLTEtMjY0MTI_4bcc1c71-6a0b-4951-bbce-442bf6ccdbbd"
      unitRef="usd">2036000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjQtMy0xLTEtMjY0MTI_2c72fb2f-d011-4dbc-a249-481979828bf4"
      unitRef="usd">3694000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjYtMS0xLTEtMjY0MTI_0df78b30-78f5-410c-9fc8-f18e7672a6e6"
      unitRef="usd">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjYtMy0xLTEtMjY0MTI_223f1152-01ac-4ff7-b19d-deda46be2e62"
      unitRef="usd">302000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjctMS0xLTEtMjY0MTI_1db202d1-1939-4c4e-af86-662834b86069"
      unitRef="usd">2976000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjctMy0xLTEtMjY0MTI_8a1062a2-cb54-4f6b-ae42-7b952620a7e3"
      unitRef="usd">2647000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjgtMS0xLTEtMjY0MTI_2aa54291-e375-4a5a-b12d-c44de1a1b89e"
      unitRef="usd">4537000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjgtMy0xLTEtMjY0MTI_c995590c-20a8-4c1f-bcd2-f8668ee6cfde"
      unitRef="usd">4350000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjktMS0xLTEtMjY0MTI_929d3536-5702-41d1-b179-08019f488fce"
      unitRef="usd">1253000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMjktMy0xLTEtMjY0MTI_56e5a0ee-88e8-4aed-9aa7-c95d12bbf91f"
      unitRef="usd">1244000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzAtMS0xLTEtMjY0MTI_1982da5e-5024-4fb1-b63e-90c9a3f2b270"
      unitRef="usd">68370000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzAtMy0xLTEtMjY0MTI_76781082-9a85-4011-9caa-7443355f2b71"
      unitRef="usd">76670000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzMtMS0xLTEtMjY0MTI_228de190-2d67-447f-a707-1471a18fff66"
      unitRef="usd">16475000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzMtMy0xLTEtMjY0MTI_0fd8cb1f-3ff4-4b30-adc3-68875dfd0919"
      unitRef="usd">15919000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzUtMS0xLTEtMjY0MTI_0d29d14d-5878-4726-abb7-b9b25eb79d66"
      unitRef="usd">857000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzUtMy0xLTEtMjY0MTI_a0dcc3bd-05fd-4292-90d5-480673253f5e"
      unitRef="usd">1174000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzYtMS0xLTEtMjY0MTI_59553de0-860d-4bc4-98a3-9f9b947401f7"
      unitRef="usd">888000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzYtMy0xLTEtMjY0MTI_07b0078c-6df4-415a-9ac3-34ce02a78a9d"
      unitRef="usd">964000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzctMS0xLTEtMjY0MTI_77e78ab4-f703-4a7b-b9d7-14e73c9e7666"
      unitRef="usd">1131000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzctMy0xLTEtMjY0MTI_0b221b30-dadf-4243-922c-ed92703c3685"
      unitRef="usd">1566000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzgtMS0xLTEtMjY0MTI_93454b47-49db-45a5-a5e2-6bc47f14704d"
      unitRef="usd">1163000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzgtMy0xLTEtMjY0MTI_90a725fa-9ecd-4886-84ca-2bc04694e725"
      unitRef="usd">1177000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzktMS0xLTEtMjY0MTI_3b9c8255-ad43-4c8f-978e-56d9eeafd39a"
      unitRef="usd">88884000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfMzktMy0xLTEtMjY0MTI_249e76f2-20dd-4010-b7e4-cc1e50382a79"
      unitRef="usd">97470000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8xOA_725c982c-fd21-4d46-9d6e-c44b2d546460"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8xOA_83f5fd96-3b8e-497c-ad23-993f49dff336"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8zMg_944d39c0-1db8-46df-be0f-e39e59ff46ef"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV8zMg_e315809b-ecf3-4423-b5d9-529aeb02c666"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV81NA_1e9a5a53-6f7c-4c9f-a6b9-1159af5d8505"
      unitRef="shares">19461000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV81NA_7674fe22-6d68-43e0-a59f-44f2b3848490"
      unitRef="shares">19461000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV82MQ_05b39b5f-8df8-4d48-816f-6d8ded5a8f3b"
      unitRef="shares">19724000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMC0xLTEtMjY0MTIvdGV4dHJlZ2lvbjo0NjI3NDk5MDc4MTc0YmIyYjk0YjVmN2JlYmQ1OWQ4YV82MQ_58fdcc9c-bbe7-41af-b608-32ef914b9878"
      unitRef="shares">19724000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMS0xLTEtMjY0MTI_a9531793-70f1-4cc6-8159-4f66b7de5190"
      unitRef="usd">125417000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDQtMy0xLTEtMjY0MTI_242d09d1-a54d-46dd-86af-dfc8312c379b"
      unitRef="usd">133382000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDUtMS0xLTEtMjY0MTI_ca15f49d-f3c5-4d21-984f-7b22fc3fa5d9"
      unitRef="usd">32075000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDUtMy0xLTEtMjY0MTI_5a235fc0-8ffd-4a07-8e0d-1d9ea3535abb"
      unitRef="usd">35025000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:MinorityInterest
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDYtMS0xLTEtMjY0MTI_b43f398a-8864-4bd2-9c2c-1492ca6cfa86"
      unitRef="usd">3466000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDYtMy0xLTEtMjY0MTI_8247a0a0-9628-4908-b248-20defd19db6d"
      unitRef="usd">3202000</us-gaap:MinorityInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDctMS0xLTEtMjY0MTI_88ac25fd-af1a-452b-8881-e2fb4173024e"
      unitRef="usd">-11180000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDctMy0xLTEtMjY0MTI_c30f3720-951a-49df-8cf2-3d5d7e7ca1f7"
      unitRef="usd">-10205000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDgtMS0xLTEtMjY0MTI_68da4a42-e1f4-4206-9639-41c0a3fb400a"
      unitRef="usd">149778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDgtMy0xLTEtMjY0MTI_d30d7363-db11-430d-8da3-e6924cf21b57"
      unitRef="usd">161404000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDktMS0xLTEtMjY0MTI_2c8f5295-4173-47f6-a599-f70a20bd67ae"
      unitRef="usd">238662000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18xOS9mcmFnOmFmYThmZmZlMGYxZTQ1Y2M5OWY4OTVhYTI1YjliNGMxL3RhYmxlOmY1NTMxZWQ0ZTZjNzQ1Y2Y5ZDgyOGRlOWQ3MWE4YTkyL3RhYmxlcmFuZ2U6ZjU1MzFlZDRlNmM3NDVjZjlkODI4ZGU5ZDcxYThhOTJfNDktMy0xLTEtMjY0MTI_763f3fa0-e002-40c2-867e-164213fad1d5"
      unitRef="usd">258874000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMi0xLTEtMS0yNjQxMg_cac361a9-e31a-4271-9130-d04bf4360807"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMi0zLTEtMS0yNjQxMg_c9c0ab8e-e6fc-4e54-b0ff-32e249f900d7"
      unitRef="usd">102421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMy0xLTEtMS0yNjQxMg_842e4e4f-2a27-4d33-8aa9-890818304058"
      unitRef="usd">34460000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMy0zLTEtMS0yNjQxMg_e0edeac7-5b08-490f-b8fe-5ba112f4ee49"
      unitRef="usd">26979000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNC0xLTEtMS0yNjQxMg_5a7f361f-8179-4768-820e-d4d99bb1bc83"
      unitRef="usd">76034000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNC0zLTEtMS0yNjQxMg_25ef8312-4df6-456e-8773-bb0f7d79a9a4"
      unitRef="usd">75442000</us-gaap:GrossProfit>
    <natr:VolumeIncentives
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNy0xLTEtMS0yNjQxMg_a2eb7f26-652b-4905-b8b0-e8dabc8e61f8"
      unitRef="usd">34102000</natr:VolumeIncentives>
    <natr:VolumeIncentives
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfNy0zLTEtMS0yNjQxMg_f9c4ec16-6870-4bc0-aaf6-16c7ead359df"
      unitRef="usd">34255000</natr:VolumeIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOC0xLTEtMS0yNjQxMg_5c6995d4-a937-4ae4-b794-2444c4ffdc5c"
      unitRef="usd">40623000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOC0zLTEtMS0yNjQxMg_850a7a0d-102e-4dcb-868c-55f4fa00ac03"
      unitRef="usd">33552000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOS0xLTEtMS0yNjQxMg_bd587f2a-02a4-430e-acf5-625238fbe765"
      unitRef="usd">1309000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfOS0zLTEtMS0yNjQxMg_dc474afa-4abc-4118-af73-cd9190960c3b"
      unitRef="usd">7635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTAtMS0xLTEtMjY0MTI_2c9ab3b1-6c94-4ec8-9930-85bab654900d"
      unitRef="usd">-314000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTAtMy0xLTEtMjY0MTI_92dd5ff2-e32b-4474-a713-baf58bf435ed"
      unitRef="usd">-1933000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTEtMS0xLTEtMjY0MTI_3684f313-ce1e-46b8-b713-9e6b43b9406b"
      unitRef="usd">995000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTEtMy0xLTEtMjY0MTI_67b415f3-8cb4-438e-8f9a-6d92faeb6ea3"
      unitRef="usd">5702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTItMS0xLTEtMjY0MTI_84de36bf-bcd1-40ef-90ef-633148502043"
      unitRef="usd">3681000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTItMy0xLTEtMjY0MTI_520b3ee3-fcc5-45dd-8db2-b513bb7505e6"
      unitRef="usd">1550000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTMtMS0xLTEtMjY0MTI_35484f3c-babf-4e66-8f91-5a997a009245"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTMtMy0xLTEtMjY0MTI_b6792b65-a69c-47b8-bf6d-99ac98adc106"
      unitRef="usd">4152000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTQtMS0xLTEtMjY0MTI_e1a7c4b9-2093-455c-b1ea-ea71558e1b1b"
      unitRef="usd">264000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTQtMy0xLTEtMjY0MTI_dced22cd-570c-4cf4-a1c5-7c63463d8d09"
      unitRef="usd">136000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTUtMS0xLTEtMjY0MTI_2ffb4d3a-dd60-40a1-a830-ac048a093a2f"
      unitRef="usd">-2950000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMTUtMy0xLTEtMjY0MTI_9f8756e0-87b6-414f-80ae-0ead90e2eb20"
      unitRef="usd">4016000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjItMS0xLTEtMjY0MTI_a3f245d2-f30b-4983-8489-5a21e779d16f"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjItMy0xLTEtMjY0MTI_ec424b7e-e904-415d-a4d5-c704bcf03644"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjctMS0xLTEtMjY0MTI_a3221c3a-f6fe-4044-9ab1-b3d70637f2c5"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjctMy0xLTEtMjY0MTI_9a40eb95-52dc-4434-bf19-0c0dba573d3e"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjktMS0xLTEtMjY0MTI_02a2f040-dad1-430b-9276-bd25c41b7822"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMjktMy0xLTEtMjY0MTI_d2b9967b-986f-4bb4-ba0d-ba7a3621b624"
      unitRef="shares">19794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzAtMS0xLTEtMjY0MTI_c3e3001e-cf3e-4fef-864a-70b2a3cce133"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzAtMy0xLTEtMjY0MTI_8d6c2517-8c8c-4c40-9ca9-da7b589b1e13"
      unitRef="shares">20236000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzItMS0xLTEtMjY0MTI_bfe66a7d-468b-48a0-bb60-4f17dd96745f"
      unitRef="usdPerShare">0</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yMi9mcmFnOmM3NDljYTdiZTQ2NDRiNTc5YzQyY2U0ZjM2YTI2ZmFjL3RhYmxlOjYxMjMwMGFlZDllOTQyZTI4N2FmYzA5NmFiMDBjYjU4L3RhYmxlcmFuZ2U6NjEyMzAwYWVkOWU5NDJlMjg3YWZjMDk2YWIwMGNiNThfMzItMy0xLTEtMjY0MTI_ce1d88f9-8e67-4668-a82e-d586878a81ba"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMi0xLTEtMS0yNjQxMg_c807112d-d4af-42d9-94ff-8f9aa7a823dc"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMi0zLTEtMS0yNjQxMg_bb3accd5-0809-4413-a68d-04bd5a5cc68a"
      unitRef="usd">4152000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMy0xLTEtMS0yNjQxMg_826586bf-859e-4620-b975-4cb2778fd34c"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfMy0zLTEtMS0yNjQxMg_8977d63b-1144-4d52-8ce5-331032d0eee1"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfNy0xLTEtMS0yNjQxMg_2e5d1942-0762-49d4-b85d-78766902e250"
      unitRef="usd">-3661000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yNS9mcmFnOjVkMTVhODU2NjM5MzQ3MzQ5OTM1MjQwZWFiZGY3YjdlL3RhYmxlOmRjNTE2ODM3OWYwYTRhNGRiNjQ3MGRjOGFhMTdlMDdlL3RhYmxlcmFuZ2U6ZGM1MTY4Mzc5ZjBhNGE0ZGI2NDcwZGM4YWExN2UwN2VfNy0zLTEtMS0yNjQxMg_75a702a8-4c4a-4c7a-8da7-a3d128fd5c5c"
      unitRef="usd">4031000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i31118a41ac734f62a4a1b223c11d6388_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0xLTEtMS0yNjQxMg_d069761c-023f-4627-af04-6be404dba436"
      unitRef="shares">19724000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31118a41ac734f62a4a1b223c11d6388_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0zLTEtMS0yNjQxMg_cbb76be4-da6d-4187-bb19-5d6f2395179a"
      unitRef="usd">133382000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafc00c0e066e415d97d748896c5b8293_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi01LTEtMS0yNjQxMg_f4503e5a-86da-4467-bbe3-4337f6bcca28"
      unitRef="usd">35025000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0f80a190c774d68a92e8b1a2f88a5f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi03LTEtMS0yNjQxMg_d3629eaf-b922-4042-a7fe-72b7c67cd27d"
      unitRef="usd">3202000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i970a18ecde554037990417bc451e2bc6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi05LTEtMS0yNjQxMg_277ac2ba-2546-4bb3-8540-d88b4113f920"
      unitRef="usd">-10205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMi0xMS0xLTEtMjY0MTI_f75db0a9-9792-4359-9a81-df35d9e8cd25"
      unitRef="usd">161404000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMy0zLTEtMS0yNjQxMg_cc35a446-ee61-4f79-a67f-f161d01daa0f"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfMy0xMS0xLTEtMjY0MTI_d406a19c-8495-4110-b105-7907d6f15bb0"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0xLTEtMS0yNjQxMg_7a671045-120a-4b69-9f9b-866e47f4f02b"
      unitRef="shares">188000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0zLTEtMS0yNjQxMg_b29fe60e-27a5-4701-bee0-07236415e8dc"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNC0xMS0xLTEtMjY0MTI_f6b2039c-8861-44f0-9cc7-8eb4ba6d29aa"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0xLTEtMS0yNjQxMg_b0b6f9cd-f827-4f2d-83f6-39c65f89abbb"
      unitRef="shares">-451000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifa1fff8be5144906a812b225f7b5d8b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0zLTEtMS0yNjQxMg_8272825b-78e7-4b43-9c02-f44de56ddc32"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNS0xMS0xLTEtMjY0MTI_c6793705-ad29-4f9a-aed8-7f646fc2e293"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i5f415b4db8b944d0bed042261b480afe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi01LTEtMS0yNjQxMg_873d6e15-cb0b-453e-b129-0a1f35016034"
      unitRef="usd">-2950000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i52ca8da5fb054fc793d0133a79547e2c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi03LTEtMS0yNjQxMg_685c7284-4add-45a7-9998-41c9c2524f22"
      unitRef="usd">264000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNi0xMS0xLTEtMjY0MTI_55a8a1b5-7580-4903-8958-54fc4983459a"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id0a816cff4a849aaa6899e1a2e2b5469_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNy05LTEtMS0yNjQxMg_f9691d48-f2bd-43ff-a0cc-949ecf5d7ed8"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfNy0xMS0xLTEtMjY0MTI_dd6c6bae-7a6c-409d-b40a-a725a5aaf604"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia64394d8f9e149c48e32b4bf254c70b1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0xLTEtMS0yNjQxMg_30c1090f-4312-4153-91d8-f8295eca423c"
      unitRef="shares">19461000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia64394d8f9e149c48e32b4bf254c70b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0zLTEtMS0yNjQxMg_ed7d858f-8207-406f-b6e8-00bf0fb6e1cf"
      unitRef="usd">125417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5959344c8c8242509d2162698de11ad8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC01LTEtMS0yNjQxMg_ac83cc24-ad31-494e-b952-410954da8abb"
      unitRef="usd">32075000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i319e38ef94554c4bbee57b4e16105332_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC03LTEtMS0yNjQxMg_602c08fc-1a1d-4332-ad61-1eeb935df5e3"
      unitRef="usd">3466000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i986b0412b49f48f7af2e01731e0207b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC05LTEtMS0yNjQxMg_2a99d23f-a0dd-440c-b54b-1564ab5a5448"
      unitRef="usd">-11180000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjJjNTc5MDBiM2I0MjQ0ZThhMmYzYzk1ZDUyNmNlMTJkL3RhYmxlcmFuZ2U6MmM1NzkwMGIzYjQyNDRlOGEyZjNjOTVkNTI2Y2UxMmRfOC0xMS0xLTEtMjY0MTI_d39f728b-8613-4a97-a6de-bfa35a0b3b5f"
      unitRef="usd">149778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0xLTEtMS0yNjQxMg_b32520f0-60bd-4761-9369-13db39bc1da7"
      unitRef="shares">19697000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d2ba59fdcf45a1b86c9db966d936af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0zLTEtMS0yNjQxMg_ea7e40ed-a699-4c64-9a22-2bf19ed0e17b"
      unitRef="usd">139311000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2815e28e436f4c61a00dc75c638b512e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi01LTEtMS0yNjQxMg_a7dd7b40-195d-40ad-8fbe-97bd68451f02"
      unitRef="usd">26030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i526c00954e5344319ba34979f1995514_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi03LTEtMS0yNjQxMg_b91feab3-9438-4c24-9844-d99161006245"
      unitRef="usd">1848000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbbf75a7daef4a46879cb80474d10c34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi05LTEtMS0yNjQxMg_55760c6a-2b32-4b7b-952e-3584f7dd5a69"
      unitRef="usd">-9955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMi0xMS0xLTEtMjY0MTI_a702d322-9ee4-486c-bba4-a8c82bbf60d8"
      unitRef="usd">157234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMy0zLTEtMS0yNjQxMg_b6468bb9-6754-4030-9cf8-acb83aac4eaa"
      unitRef="usd">1005000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfMy0xMS0xLTEtMjY0MTI_67bac0f4-2b1b-474c-a8f8-c23f48db7f72"
      unitRef="usd">1005000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0xLTEtMS0yNjQxMg_51e65296-8ff9-4200-9d8a-ba0796aa5576"
      unitRef="shares">218000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i40f68ed6696145f8b53a30bb8806a306_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0zLTEtMS0yNjQxMg_b1635ee1-7498-4b45-9a40-262be4b39171"
      unitRef="usd">-914000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNC0xMS0xLTEtMjY0MTI_25cabd4a-ea24-4ef1-8955-659438b63beb"
      unitRef="usd">-914000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0wLTEtMS0yODI1MC90ZXh0cmVnaW9uOjMxNTg4ZDU3ZjE4MDQ0YjBiMWZhNGNkMTYzNWUwZTE3XzEyNjQ0MzgzNzE5NDY1_e7b4182c-a75b-47d7-8a01-e80b06983ce4"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS01LTEtMS0yODI1MA_78d328d2-b7ba-48b2-ae1f-6f5f4ef06d6c"
      unitRef="usd">19858000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0xMS0xLTEtMjgyNTA_f0e246b6-7e11-44f8-970d-2a9f60a00da7"
      unitRef="usd">19858000</us-gaap:DividendsCommonStockCash>
    <us-gaap:ProfitLoss
      contextRef="i7edfb8595fcc4835a43067091a9dd2a7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS01LTEtMS0yNjQxMg_5378575b-55d4-42ec-ad06-e5b706a20a8d"
      unitRef="usd">4016000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4dda98afbcfa4f93969fa231b6d7ad7a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS03LTEtMS0yNjQxMg_1b6f4903-35ab-4e9f-86e3-806e3e03ac83"
      unitRef="usd">136000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNS0xMS0xLTEtMjY0MTI_b93b010b-f7b7-4aff-82bb-ad21a890379a"
      unitRef="usd">4152000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ac093d990f747789ddc5622c8faa200_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNi05LTEtMS0yNjQxMg_0d23b9f7-448f-451f-a9bd-ecb85dbf763f"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNi0xMS0xLTEtMjY0MTI_ad074ed7-bd79-4a69-8d42-15a576b47c83"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8da7b722ce504d7796cf25d0a7d834cc_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0xLTEtMS0yNjQxMg_455cfeaa-5f78-4322-a852-07e0d12b9a1f"
      unitRef="shares">19915000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8da7b722ce504d7796cf25d0a7d834cc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0zLTEtMS0yNjQxMg_da4950dc-b862-40ba-b260-366e4a4bb9ee"
      unitRef="usd">139402000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i809568b0c3fe4247b38fd5463e2a656e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy01LTEtMS0yNjQxMg_f34bbd5a-f8c0-47e7-ad9f-463fdc658fa6"
      unitRef="usd">10188000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5065f6df791f4c01b3fd8c6ab8e971b1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy03LTEtMS0yNjQxMg_6e9313d2-da54-42cd-b5d0-59683a87a1a4"
      unitRef="usd">1984000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib43f287504274318bf963d9a1d66f50f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy05LTEtMS0yNjQxMg_b73a8675-8d2b-4d64-a1a3-c7cd8c8b9ce1"
      unitRef="usd">-10076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idcbc2254a9ff457793b34cf0b849506d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18yOC9mcmFnOmEyYTk4ZDVkNjM4MjQzNzViMmEwNjg4NGQ2MTMxZjg5L3RhYmxlOjk1OThmNDE0YTk4ODRmMTI4NzViZTJhMzg1NTIyOGQyL3RhYmxlcmFuZ2U6OTU5OGY0MTRhOTg4NGYxMjg3NWJlMmEzODU1MjI4ZDJfNy0xMS0xLTEtMjY0MTI_8d8cfd8b-97cc-48ad-9421-5d8010cc8176"
      unitRef="usd">141498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMy0xLTEtMS0yNjQxMg_6a5e0736-9b1c-4e7d-af72-92dc2a2387e9"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMy0zLTEtMS0yNjQxMg_c7855323-7f40-45e5-b59d-c179bd274510"
      unitRef="usd">4152000</us-gaap:ProfitLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNS0xLTEtMS0yNjQxMg_991974db-7880-41c6-9ad5-b318432f4279"
      unitRef="usd">6000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNS0zLTEtMS0yNjQxMg_13b7256e-d780-4b81-bf01-33d2cb60f4c7"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNi0xLTEtMS0yNjQxMg_8519aed4-3ff4-4b9f-8c31-a6a812f39019"
      unitRef="usd">2766000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNi0zLTEtMS0yNjQxMg_158f8f06-55db-4090-820c-ef84d21e75a3"
      unitRef="usd">2736000</us-gaap:DepreciationDepletionAndAmortization>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNy0xLTEtMS0yNjQxMg_440a87e9-c94b-4814-92bd-ca4d69dba6bd"
      unitRef="usd">1173000</natr:OperatingLeaseNonCashLeaseExpense>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNy0zLTEtMS0yNjQxMg_c0fde6f7-cc6e-4ce7-84fd-bb93ca6ac0e6"
      unitRef="usd">1311000</natr:OperatingLeaseNonCashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfOC0xLTEtMS0yNjQxMg_d7f39df8-0c68-42a4-9eab-3dd12710f7c4"
      unitRef="usd">801000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfOC0zLTEtMS0yNjQxMg_9ceeaabf-d776-48ec-9930-01fa5460500e"
      unitRef="usd">1005000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTAtMS0xLTEtMjY0MTI_2022929c-3431-484d-9f4a-752384b29129"
      unitRef="usd">3844000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTAtMy0xLTEtMjY0MTI_8dc228c7-943e-4cb6-9802-f6a75975ee40"
      unitRef="usd">561000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTEtMS0xLTEtMjY0MTI_6b669e22-dbd4-40ea-9a9a-931ecff66acc"
      unitRef="usd">12000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTEtMy0xLTEtMjY0MTI_91c5ecc0-0ed2-44f0-afad-1044df2b1962"
      unitRef="usd">16000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTItMS0xLTEtMjY0MTI_b629c1f1-b8ea-4293-be84-93d0079165ac"
      unitRef="usd">35000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTItMy0xLTEtMjY0MTI_7e9c7ca8-7084-44e9-a452-1a03d7f630d3"
      unitRef="usd">175000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:GainLossOnInvestments
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTMtMS0xLTEtMjY0MTI_4e346005-18b1-4ccb-9fd0-b591e738e96a"
      unitRef="usd">-58000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTMtMy0xLTEtMjY0MTI_bb186700-b8f2-4d58-922e-a8409bd735a0"
      unitRef="usd">16000</us-gaap:GainLossOnInvestments>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTQtMS0xLTEtMjY0MTI_d836ffec-edbd-4140-8555-71c1079ce4fd"
      unitRef="usd">-402000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTQtMy0xLTEtMjY0MTI_a8083e8d-08a9-412e-a657-83a2f9781830"
      unitRef="usd">-1529000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTYtMS0xLTEtMjY0MTI_2a2a20ca-9286-44d7-bd94-58d2c39b68b8"
      unitRef="usd">-1447000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTYtMy0xLTEtMjY0MTI_455bc7b8-38bb-4dd6-9153-b557346e3878"
      unitRef="usd">2689000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTctMS0xLTEtMjY0MTI_5b52cc60-9a30-4363-919b-1b26d502939e"
      unitRef="usd">3489000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTctMy0xLTEtMjY0MTI_edc76e41-e748-48f1-b1f1-82455d1e4465"
      unitRef="usd">-536000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTgtMS0xLTEtMjY0MTI_93d45556-d2a7-4a5c-9eb3-bd9f68face56"
      unitRef="usd">2518000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTgtMy0xLTEtMjY0MTI_81de6494-f956-4718-ba16-d362c1e79607"
      unitRef="usd">272000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTktMS0xLTEtMjY0MTI_ff9cc4a2-b688-4e8c-9449-c6e3451fec11"
      unitRef="usd">20000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMTktMy0xLTEtMjY0MTI_daf6b524-44f9-4b98-bd40-4d20c6a0239a"
      unitRef="usd">-24000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjAtMS0xLTEtMjY0MTI_4ebb44f5-423c-40a9-a974-45fbb43062ca"
      unitRef="usd">-946000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjAtMy0xLTEtMjY0MTI_29749c17-e525-448a-b850-7c6281c5bd19"
      unitRef="usd">598000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjEtMS0xLTEtMjY0MTI_f4115863-14fa-4b3d-9c58-21544eb1bfdb"
      unitRef="usd">-464000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjEtMy0xLTEtMjY0MTI_c7be380f-2352-4a46-af80-27e1faba04c6"
      unitRef="usd">1644000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjItMS0xLTEtMjY0MTI_ecabf0ef-c0fc-4248-b73a-75724d4153da"
      unitRef="usd">-5386000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjItMy0xLTEtMjY0MTI_beb3837c-c22e-4f7a-829b-c53f4f7e9978"
      unitRef="usd">-6248000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjMtMS0xLTEtMjY0MTI_587a033f-21cf-405c-b375-f4c1e564b2ba"
      unitRef="usd">-1632000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjMtMy0xLTEtMjY0MTI_44320f7f-2ce4-4066-b88c-b988699f94ec"
      unitRef="usd">-394000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjQtMS0xLTEtMjY0MTI_717326bd-3200-422b-88a0-8e2df1fdfd92"
      unitRef="usd">-1031000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjQtMy0xLTEtMjY0MTI_c825d988-a429-410b-9140-44462cab48a5"
      unitRef="usd">-1170000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjUtMS0xLTEtMjY0MTI_91d93e0d-46e3-4c64-a24e-7ef97c6de440"
      unitRef="usd">-191000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjUtMy0xLTEtMjY0MTI_51f58c6e-4bbc-47c0-a69b-c63c6ecbeb8d"
      unitRef="usd">-699000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjYtMS0xLTEtMjY0MTI_95f6a07d-fe1c-48e1-90b4-070e1a064551"
      unitRef="usd">0</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjYtMy0xLTEtMjY0MTI_313fa516-a0cb-410b-826b-36433d467541"
      unitRef="usd">-10000</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjctMS0xLTEtMjY0MTI_83b7cb30-d312-4827-80cf-7aee6b4c2457"
      unitRef="usd">-81000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjctMy0xLTEtMjY0MTI_53719d70-eb94-43da-86d6-9cf082e30460"
      unitRef="usd">-22000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjgtMS0xLTEtMjY0MTI_6dfa124f-241e-4e09-8e15-237f5ef63b36"
      unitRef="usd">-7924000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMjgtMy0xLTEtMjY0MTI_38ffe57e-bd7a-4792-a41b-6f14794f13b0"
      unitRef="usd">2735000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzAtMS0xLTEtMjY0MTI_6485d124-ac97-47b1-9491-a486b4f69499"
      unitRef="usd">1518000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzAtMy0xLTEtMjY0MTI_77dbcf29-5b1c-42c1-9171-586446b331f8"
      unitRef="usd">983000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzQtMS0xLTEtMjY0MTI_aabae32e-9dde-4554-9ff8-4ae782f349a1"
      unitRef="usd">-1518000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzQtMy0xLTEtMjY0MTI_a2b62ae9-4f9a-484a-87d8-3e2efb0f1daa"
      unitRef="usd">-983000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzctMS0xLTEtMjY0MTI_6765f516-43ac-4dc7-a6d9-92a541e954ac"
      unitRef="usd">308000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfMzctMy0xLTEtMjY0MTI_489c6a21-f67b-47d2-8f85-bb1c9fd24457"
      unitRef="usd">397000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDAtMS0xLTEtMjY0MTI_3f70bfb2-3b04-435c-b496-c03c72cb416c"
      unitRef="usd">300000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDAtMy0xLTEtMjY0MTI_dd259b29-0777-4d1f-910b-8798ffd078fd"
      unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDEtMS0xLTEtMjY0MTI_d069d869-34b9-44d3-9636-d4c07107e96d"
      unitRef="usd">795000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDEtMy0xLTEtMjY0MTI_aa473446-fafb-442d-8b30-b074f454cfb9"
      unitRef="usd">914000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDQtMS0xLTEtMjY0MTI_24ee6aa2-cdd4-4811-b146-9eef0b256826"
      unitRef="usd">7971000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDQtMy0xLTEtMjY0MTI_61b37bd5-89a6-4ec8-8b36-58b5cc0bcaea"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDUtMS0xLTEtMjY0MTI_fb926dd3-308e-4771-a631-9c7c623109b0"
      unitRef="usd">-9374000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDUtMy0xLTEtMjY0MTI_c99d6dde-f927-4a39-9530-534c39fb1e09"
      unitRef="usd">-1311000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDYtMS0xLTEtMjY0MTI_5196bdce-6405-40da-9687-9fce7516df4e"
      unitRef="usd">-827000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDYtMy0xLTEtMjY0MTI_f468d007-e0af-4ead-87ce-442a5b9345e1"
      unitRef="usd">-1257000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDctMS0xLTEtMjY0MTI_76b9b848-ff59-4392-b9c0-724700206e42"
      unitRef="usd">-19643000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDctMy0xLTEtMjY0MTI_b0888567-19e9-4f9c-bca2-040ddc3d9902"
      unitRef="usd">-816000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDgtMS0xLTEtMjY0MTI_332fc5ef-ebc9-4518-b045-dbd6bb2f19ff"
      unitRef="usd">86184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09e7a48b6f81498ba063aca4ad0fcbe2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDgtMy0xLTEtMjY0MTI_462e732e-076c-460b-a706-8b6e80ede68b"
      unitRef="usd">92069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDktMS0xLTEtMjY0MTI_59895253-d37d-43fb-94b8-ee94e40a66a3"
      unitRef="usd">66541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idcbc2254a9ff457793b34cf0b849506d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNDktMy0xLTEtMjY0MTI_bb386d59-c451-4089-be76-fe87b078355b"
      unitRef="usd">91253000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTEtMS0xLTEtMjY0MTI_c764f7d0-f49e-46ce-b223-0a194a0e4e7d"
      unitRef="usd">1809000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTEtMy0xLTEtMjY0MTI_897675e4-5ee9-4963-94c4-b631a73ece10"
      unitRef="usd">2026000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTItMS0xLTEtMjY0MTI_e5b92ea7-2a19-467d-8eaf-ed107c721678"
      unitRef="usd">45000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zMS9mcmFnOjIxNTRjMTJmYzNjNDQxYzNiODFmMzM1ZTA1MzBjNDNjL3RhYmxlOjIxNDI4ZTkzMTE2YTRmM2ZiYzMxNjk3OTY0Yzk3NmQ0L3RhYmxlcmFuZ2U6MjE0MjhlOTMxMTZhNGYzZmJjMzE2OTc5NjRjOTc2ZDRfNTItMy0xLTEtMjY0MTI_e8327cf7-2bec-49a2-a480-a404c5351e7a"
      unitRef="usd">50000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5MQ_1ef32da3-1ab4-42e6-b58f-2e1eefe77ebc">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5Nw_6f8818d6-1c02-47bd-9c29-c9c5cc78e4c3">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2022, and for the three months ended March&#160;31, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates due to the uncertainty around the magnitude and duration of the COVID-19 pandemic, the current conflict between Russia and Ukraine, inflationary pressures and supply chain challenges as well as other factors and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.3 million and $0.1 million for the three months ended March&#160;31, 2022 and 2021, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, noncontrolling interests were $3.5 million and $3.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Related Accruals and Expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded $0.3 million and $48,000 of restructuring related expenses during the three months ended March&#160;31, 2022 and 2021, respectively. Accrued severance and restructuring related costs were $0.1 million and $0.2 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria, that have contracts, hedging relationships, and other &lt;/span&gt;&lt;/div&gt;transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM4Mw_d66d6edb-ff3d-4557-8a50-8746252b7eb8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2022, and for the three months ended March&#160;31, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTM5NA_5cb74e89-1086-4698-83dd-ff79a21c8ab0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates due to the uncertainty around the magnitude and duration of the COVID-19 pandemic, the current conflict between Russia and Ukraine, inflationary pressures and supply chain challenges as well as other factors and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</us-gaap:UseOfEstimates>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzIwOA_a8fb093e-5ab2-4eb7-9a45-88e39bebcbed"
      unitRef="usd">300000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMTA5OTUxMTYzMzI5Nw_3152f0a6-eac9-42f9-a8de-9c619e6344c9"
      unitRef="usd">100000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterest
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzQzOQ_2ea37f53-a3b2-46aa-b978-d7851a52f8f0"
      unitRef="usd">3500000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzQ0Ng_879fcb40-22bf-440f-9ec3-36d430f7e082"
      unitRef="usd">3200000</us-gaap:MinorityInterest>
    <us-gaap:RestructuringCharges
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzUyMw_0cf116af-9b0c-4c6b-af64-d48283d0fbf1"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMTA5OTUxMTYzMzE4Nw_0f21ddee-6361-423e-9ff6-ed3ad192cf85"
      unitRef="usd">48000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="ia1a3638bc5e548b6aa731778d987df88_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzc2OA_ce1af384-a60d-45a8-abea-dab5786c18fb"
      unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i58339cf767784484935089232da792c0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfMzc3NQ_a91398a2-fb1a-43cb-8032-ae7f43e4127e"
      unitRef="usd">200000</us-gaap:RestructuringReserve>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN18zNy9mcmFnOmJjNGIyY2Q0NTVlNDQxNjFhY2Y4MmE3YzZjYjNlYTc2L3RleHRyZWdpb246YmM0YjJjZDQ1NWU0NDE2MWFjZjgyYTdjNmNiM2VhNzZfNTQwNA_768a34c3-d076-479b-9c38-332c1d061785">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria, that have contracts, hedging relationships, and other &lt;/span&gt;&lt;/div&gt;transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RleHRyZWdpb246YzM1ZGY1NTBhZTQ2NDI2MGEzYzg5ZDE3ZTc3NDM5YjJfOTk_de7b0b5e-84c9-40ea-bdfd-b3688250e24d">Inventories&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RleHRyZWdpb246YzM1ZGY1NTBhZTQ2NDI2MGEzYzg5ZDE3ZTc3NDM5YjJfMTAw_aa7c3e41-5ed7-44d2-8b2e-4ac9ee24a9f1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMS0xLTEtMS0yNjQxMg_9d3dfb9e-60a2-4a37-8fb8-dccaa0d4106d"
      unitRef="usd">25192000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMS0zLTEtMS0yNjQxMg_9249bce0-69ee-4211-acb8-4ecf382a84a6"
      unitRef="usd">22494000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMi0xLTEtMS0yNjQxMg_bfc04e93-00fd-4f55-8b42-960264d01f42"
      unitRef="usd">1820000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMi0zLTEtMS0yNjQxMg_feed5340-423d-4d27-88e1-4efb316317a5"
      unitRef="usd">1746000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMy0xLTEtMS0yNjQxMg_d6d33452-6b2f-4b32-a2fd-a32a93caf975"
      unitRef="usd">36916000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfMy0zLTEtMS0yNjQxMg_0d21c239-3c6e-47f9-9322-91512a0472a6"
      unitRef="usd">36612000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfNC0xLTEtMS0yNjQxMg_ea8492d0-f794-419b-994b-7006c3ef1de0"
      unitRef="usd">63928000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180MC9mcmFnOmMzNWRmNTUwYWU0NjQyNjBhM2M4OWQxN2U3NzQzOWIyL3RhYmxlOmFkYmZjZDllNzIzYTQwZTZiNGVlYmMxNjU3ZDZhNGYxL3RhYmxlcmFuZ2U6YWRiZmNkOWU3MjNhNDBlNmI0ZWViYzE2NTdkNmE0ZjFfNC0zLTEtMS0yNjQxMg_f8b7fb32-bba2-45ea-bf75-b8fb0f3c240d"
      unitRef="usd">60852000</us-gaap:InventoryNet>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMjg4_cc011d82-dcb2-4ff9-9e65-fa06ec45bc56">Investment Securities - Trading&#160;Our trading securities portfolio totaled $0.9 million at March&#160;31, 2022, and $1.0 million at December&#160;31, 2021, and generated losses of $58,000 and gains of $16,000 for the three months ended March&#160;31, 2022 and 2021, respectively.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfODQ_b9c3f27d-07e2-4f75-8d83-9b90932dd635"
      unitRef="usd">900000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfOTg_8acea92f-1c93-4e47-ac2d-f2a25e159a06"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMTMy_bfdd29bb-a840-40ed-a0bc-2c6587dec415"
      unitRef="usd">-58000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180My9mcmFnOjgzZGQ1NmY4ZWM4NTQ0MjliYjIwN2YyZjRlMDUxNzU3L3RleHRyZWdpb246ODNkZDU2ZjhlYzg1NDQyOWJiMjA3ZjJmNGUwNTE3NTdfMTQ4_c9f1544c-3638-4c72-a5a8-fc3bcde35e3b"
      unitRef="usd">16000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjYyMQ_0f18aca8-1685-4d2e-adc8-e17bd4398839">Revolving Credit Facility and Other Obligations&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#x201c;Credit Agreement&#x201d;).&#160;On June 11, 2020 the credit agreement was amended to extend the term to mature on July 1, 2023. The amendment also allows for additional borrowings of $15.0&#160;million or up to three separate increases of no less than $5.0&#160;million each. On March 8, 2021, we signed an amendment to the credit agreement that eliminates the Index floor from the calculation of interest. Interest under the amended Credit Agreement is at the LIBOR daily floating rate, plus&#160;2.25 percent&#160;(2.71 percent as of March&#160;31, 2022), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. At March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance under the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments, of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2022, there was $2.1&#160;million outstanding balance under the Capital Credit Agreement, of which $1.3&#160;million was classified as current.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTc1_0686106c-ff29-4375-821d-a17ef605a0fb"
      unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings
      contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMzU1_7c978e75-ad02-4342-9b34-3fde8f16eb13"
      unitRef="usd">15000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings>
    <natr:LineOfCreditFacilityNumberOfSeparateIncreases
      contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMzY3_f6b265de-be21-4657-93bb-7ca1c2d26bd6"
      unitRef="borrowing">3</natr:LineOfCreditFacilityNumberOfSeparateIncreases>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence
      contextRef="i2e3b028273b4499fa40faa68a39ebd4c_I20200611"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfNDA1_dc14b2fc-24d3-4cd3-a515-561c9952404e"
      unitRef="usd">5000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9eebe4f1416a42e29600fbc080b00ddd_D20210308-20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfODYx_42b25379-7ec7-42f3-aeca-b041ad2c8e46"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id926898d6fa64913b3ef9123f02f63cf_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfODY1_9ed6966f-cc95-46dd-9b1e-9adf2ca47cb4"
      unitRef="number">0.0271</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="id69bfe93049647898e279137e36c29b1_D20210308-20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfOTEx_9a9984bd-04ec-4c1d-80b3-57c9299ca181"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCredit
      contextRef="i32456aa4ccc64830b04647560160366a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTE4Ng_61e6f0ad-6f99-4329-94bf-2bcb0d4ad6b3"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iab0f1c76f2c54a56b68ab99720f974d0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTE4Ng_7e388bce-e9ac-41cd-b22d-e3166935a071"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic6a5b6c9fc5c4a5c86741daebd2c055c_I20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMTk3Ng_104d030f-998a-4a18-a5a6-335dad082015"
      unitRef="usd">6000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ia98eed0936e6455f8174af8a8890d1db_I20201119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjA5Mg_0e12bfde-cff8-4cd2-b2c7-fabdee724751"
      unitRef="usd">3700000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ie8d4e839e771459aa39d3689d857e1a9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjI4MQ_673110c3-3935-417b-8c12-6f4adad4fff6"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <natr:DebtInstrumentNumberOfMonthlyPayments
      contextRef="i62c09354038642f186df2d18e5450419_D20200421-20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjM3Mg_e8d16c0e-1b1e-4632-a11e-fe7e632a236f"
      unitRef="payment">36</natr:DebtInstrumentNumberOfMonthlyPayments>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i62c09354038642f186df2d18e5450419_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjM5Ng_7762e3d1-97d2-4b79-a4a7-2e4033901ef9"
      unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCredit
      contextRef="id76496067c7b4d3f8bd85db3b5f95257_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjUxOQ_69d4fc84-80d5-4daf-8148-b62338fe4da9"
      unitRef="usd">2100000</us-gaap:LineOfCredit>
    <us-gaap:LinesOfCreditCurrent
      contextRef="id76496067c7b4d3f8bd85db3b5f95257_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180Ni9mcmFnOmIzNTM4ZTkzYThhYzQxNWRiNTNhOGVhZDkxYzdmN2I0L3RleHRyZWdpb246YjM1MzhlOTNhOGFjNDE1ZGI1M2E4ZWFkOTFjN2Y3YjRfMjU4Nw_9e7869fc-68c5-4879-a9b3-58acb4a55def"
      unitRef="usd">1300000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMTM5NQ_a338696f-981f-4700-9975-5e07fd456091">Net Income (Loss) Per Share&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per common share (&#x201c;Basic EPS&#x201d;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#x201c;Diluted EPS&#x201d;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted earnings (loss) per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted-average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMTM5MA_dd0cf9d8-2def-46ac-a63a-5dd8b08f3118">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted earnings (loss) per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNS0xLTEtMS0yNjQxMg_12043be7-ec6d-4016-a65b-edc91eac6d83"
      unitRef="usd">-2950000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNS0zLTEtMS0yNjQxMg_e310416d-2ac1-44f5-b8d4-d2fde0337f03"
      unitRef="usd">4016000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNy0xLTEtMS0yNjQxMg_785c77f9-417f-4217-87bd-be231890789a"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfNy0zLTEtMS0yNjQxMg_daf45a7b-2e1e-43bc-bc85-458a57db6439"
      unitRef="shares">19794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTItMS0xLTEtMjY0MTI_8e017ed9-f1d7-46fd-8f2e-ab688851ece1"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTItMy0xLTEtMjY0MTI_d9c80f65-dabb-4726-b2fe-77f606b9c1fc"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTUtMS0xLTEtMjY0MTI_839a3b42-0bb5-465b-83a5-fee2df946170"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTUtMy0xLTEtMjY0MTI_0ffdeaef-126a-4adf-90e6-8977419ff009"
      unitRef="shares">19794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTYtMS0xLTEtMjY0MTI_2f3bde38-a252-4f5b-9543-54f0113ff634"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTYtMy0xLTEtMjY0MTI_7738b3fd-eed5-4e0a-9607-3c4a80f9a6f4"
      unitRef="shares">442000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTctMS0xLTEtMjY0MTI_d7d3ffdf-9c31-41f0-a24f-143f9de86ac4"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMTctMy0xLTEtMjY0MTI_bf16cea1-f8bd-47c8-917b-ba7a0cee074f"
      unitRef="shares">20236000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjItMS0xLTEtMjY0MTI_0a6e8e01-d813-441f-b927-802171b90069"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjItMy0xLTEtMjY0MTI_fbb66f42-b59e-440c-9667-379935de46be"
      unitRef="usdPerShare">0.20</us-gaap:EarningsPerShareDiluted>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjUtMS0xLTEtMjY0MTI_58e64a49-3ce0-4348-9541-3b7d7d82c66d"
      unitRef="shares">0</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjUtMy0xLTEtMjY0MTI_3c7b8ae9-e7ac-4c10-bece-dd8ca7934f8b"
      unitRef="shares">629000</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjgtMS0xLTEtMjY0MTI_92e86fd2-b1fd-4a46-ace5-3e0f554187ef"
      unitRef="shares">282000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RhYmxlOmY0M2RiYmZhZDk0MjQzNTJhNzdlNDRjYTYyNGM2OTM5L3RhYmxlcmFuZ2U6ZjQzZGJiZmFkOTQyNDM1MmE3N2U0NGNhNjI0YzY5MzlfMjgtMy0xLTEtMjY0MTI_c1f03752-7711-4ab4-bf47-da29fd51c8b6"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMzg0ODI5MDY5OTM0NA_6143ccb7-3212-46b1-a606-18d1436d0642"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN180OS9mcmFnOmNlNmM0MmRkYjc5NTRlMWM5ZGIzZWE2ZjAzNjFkOTA4L3RleHRyZWdpb246Y2U2YzQyZGRiNzk1NGUxYzlkYjNlYTZmMDM2MWQ5MDhfMzg0ODI5MDY5OTM0MA_a293f7ee-521e-4e29-8171-9b3b51235617"
      unitRef="shares">282000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYzNA_5bce7acf-ac38-4157-9b3a-daf6e36c0865">Capital Transactions&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2021, we announced a special non-recurring cash dividend of $1.00 per common share in an aggregate amount of $19.9&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2022, we repurchased 451,000 shares of our common stock for $8.0&#160;million. No shares were purchased for the three months ended March 31, 2021. At March&#160;31, 2022, the remaining balance available for repurchases under the program was $29.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#x2019;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no share-based compensation expense for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 and December&#160;31, 2021, there was no unrecognized share-based compensation expense related to the grants described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 143,000 shares of common stock was $0.6 million. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase 172,000 shares of common stock was $1.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022 and 2021, we issued 29,000 and 2,500 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 and $11.98 per share, respectively. The aggregate intrinsic value of options exercised during the three months ended March&#160;31, 2022 and 2021, was $0.3 million and $19,000, respectively. For the three months ended March&#160;31, 2022 and 2021, the Company recognized $0.1 million and $9,000 of tax benefits from the exercise of stock options, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021, we did not have any unvested options outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding restricted stock units (&#x201c;RSUs&#x201d;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to revenue and earnings growth, earnings-per-share, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At March&#160;31, 2022 and December&#160;31, 2021, there were 95,000 and 88,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, we granted 2,000 time-based RSUs under the 2012 Incentive Plan to new members of the Board of Directors. The RSUs were issued with a weighted-average grant date fair value of $16.35 per share and vest in monthly installments over a period less than one year from the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately 12.9 percent for a common share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, no share-price performance-based RSUs were issued. Historically, share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to time-based RSUs for the three months ended March&#160;31, 2022 and 2021, was approximately $0.5 million and $0.4 million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $1.0 million and $1.6 million, respectively. As of March&#160;31, 2022, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to performance-based RSUs for the three months ended March&#160;31, 2022 and 2021, was $0.3 million and $0.4 million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would, and expect to, recognize up to $2.0 million of potential share-based compensation expense. &lt;/span&gt;&lt;/div&gt;The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 60,000 and 75,000 shares for the three months ended March&#160;31, 2022 and 2021, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="if98b729b54f5451a829590e8adb58f29_D20210405-20210405"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTE2_3b69ac03-f7bd-4141-a6cb-b2e0b6b653f5"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="if98b729b54f5451a829590e8adb58f29_D20210405-20210405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTYy_ebc218ed-7b66-444c-8734-a422940d1ab1"
      unitRef="usd">19900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="id691a4ef66cf4da3b988bfbf06a2e811_I20210310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTEzNA_9dab5a6d-09fa-4be3-ac4e-13efb55e38fd"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i78adc08e7232473a933e1ecb19fbb047_I20220308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQzMjg_3095441b-f07f-481d-8faf-15d8b1d289ea"
      unitRef="usd">30000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ1Mzg_53285e0b-0086-4e83-967b-3884425d8eed"
      unitRef="shares">451000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ1OTA_a165c3ab-0ae0-4ed0-9902-a45293a6098b"
      unitRef="usd">8000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTI2NDQzODM3MzQ2ODQ_9c04b6a7-9c66-4acb-9bef-ef334a196051"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMTA0NDUzNjA0NzM5Njg_0671f6f5-633b-4f4a-9c25-04e3dc7a856c"
      unitRef="usd">29600000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i555b079af2a941c182b57bfc82a439aa_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjA3Ng_5ae983ea-9873-4cb7-a315-0b13c5956715"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ie914eddd4e9943539c51b78d2f72072b_D20150101-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjM0MQ_e1fe149f-fb39-4f2c-8fb3-26bfbd083e58"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i2c8f4fc34bae44f3a7053951f910b3b8_D20210505-20210505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMjU0OA_1f932d1f-85c6-42d6-9de7-4b8b12402491"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7bf0a2bb87c04726b85a12b3aaf47333_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzQyMA_c0eb030a-29d2-4d33-b9f5-8bef70bed183">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne
      contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU1Nw_c41ef245-dfc1-48b5-82c6-8c463858075e"
      unitRef="number">0.06</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo
      contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU2MQ_3148f7a4-3649-4647-b120-176b1277a068"
      unitRef="number">0.08</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree
      contextRef="ica0cca9b01cb431182d51bb45fe43150_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzU2OA_7df44196-3663-49a7-8449-f93c96537472"
      unitRef="number">0.10</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYyMg_1acbf1e5-e896-4949-9dca-be3082dc6132">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS0xLTEtMS0yNjQxMg_f45caef1-cc44-4486-a01a-4e1243338220"
      unitRef="shares">172000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS0zLTEtMS0yNjQxMg_c2dd3ffc-64c8-4ea0-99cc-df431b79a260"
      unitRef="usdPerShare">12.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMS01LTEtMS0yNjQxMg_69019931-543b-4449-89c0-e43eb17b0555"
      unitRef="usdPerShare">5.05</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi0xLTEtMS0yNjQxMg_abdf9f1a-a94d-49d1-96d7-7c52047e8179"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi0zLTEtMS0yNjQxMg_2ea8cef5-8326-4fb1-8817-32adcb67d4a8"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMi01LTEtMS0yNjQxMg_336f9a2c-2290-4183-9b92-3119c89ef942"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy0xLTEtMS0yNjQxMg_94acd22b-4cc4-454e-9631-1fa1fe27c2cb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy0zLTEtMS0yNjQxMg_229f6304-734d-4cde-94ba-a82fe8b77a4f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfMy01LTEtMS0yNjQxMg_9ce6d456-a59a-44c9-9120-72150a836374"
      unitRef="usdPerShare">0</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC0xLTEtMS0yNjQxMg_7ac2cb58-6520-4e08-9b6d-f944687ebe00"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC0zLTEtMS0yNjQxMg_8f6203d7-38fa-4207-8270-251277ff348c"
      unitRef="usdPerShare">9.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNC01LTEtMS0yNjQxMg_ace0938c-af8d-4005-856a-fd227cacedfe"
      unitRef="usdPerShare">3.92</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS0xLTEtMS0yNjQxMg_17ab3d66-861a-44bc-9979-5d87e111dfec"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS0zLTEtMS0yNjQxMg_1f200c04-b4a7-448f-ad76-aa6e527c2e24"
      unitRef="usdPerShare">12.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjkzODIwYmM2ZGI2OTRjY2FiZDM3YWI1NTJlZTZhODlmL3RhYmxlcmFuZ2U6OTM4MjBiYzZkYjY5NGNjYWJkMzdhYjU1MmVlNmE4OWZfNS01LTEtMS0yNjQxMg_0b602caa-a5e3-4bf1-893e-fd97ea9a7eae"
      unitRef="usdPerShare">5.28</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzc5Ng_7cca0651-9cc6-4a4b-964d-f3c77b6b3ce0"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzc5Ng_a27dbc5f-b281-4a5b-8f31-4a4644c4e740"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzkxMg_5166c266-e6c7-4bbb-b069-b52fae1c64a3"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzkxMg_6bc66fb7-114b-4e87-8559-3136ea1e2283"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDQxNg_ae49936a-e17c-4a01-9e3c-71d61f67b8ff"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i402b0314d6b84b1480d0e6192c468f66_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDQ0Ng_8d6aff05-b856-4e62-b432-44f242f47989"
      unitRef="usd">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDUzOA_d4529102-9870-4888-b76c-ae3d63ba96ae"
      unitRef="shares">172000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2766fa78dc664de49f98b43876ee0fd0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDU2OA_c2604f94-5c33-47cb-a2e4-815dc2eb383c"
      unitRef="usd">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDYyNQ_3c790816-8cd8-4c6e-b03d-ba3ce7af2db5"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDYzMg_67863da4-a173-4940-9310-6e7d4a6d3255"
      unitRef="shares">2500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDcyNQ_2400334c-8513-4110-8620-9150be1a98fa"
      unitRef="usdPerShare">9.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDczMg_70631688-be50-4e2c-bbbb-d56554a89b40"
      unitRef="usdPerShare">11.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDg2MA_59c9ec8f-4752-4707-bb87-fa63ec716929"
      unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDg2Nw_427ff19c-77ab-43f9-9b36-7a94cc93ae19"
      unitRef="usd">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDk1MA_0a2edca9-e405-4591-9132-b7019df9ce1e"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ic242446ce9644a6988e6e99cdf077932_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNDk1Nw_875803d7-f731-4033-b1e3-6c0b42d7ff2e"
      unitRef="usd">9000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i398a4c632e9146b6a4117e9a80bd1b33_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTA1MQ_5ee9ad4c-b698-4167-ae47-39f50a0eedae"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i402ed898554945f59d3dcb7c9d4b63e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTA1MQ_fee9bd14-4cb3-40c5-8a63-3f26b4184106"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3fb365d93fed48cdb727939977fc3c22_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTI3NA_e4438171-c77e-44da-9f85-f38e20a38ef4">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iccd7c968f4df4cc0aa01a09c2a2a9125_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTI4Ng_4ecb2931-7d93-4159-9160-c437a7d5b853">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:RestrictionPeriodForIssuanceOfShares
      contextRef="if832daaf3a78404e9c159a19b9debf45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTU5MQ_f8143c57-8d4b-448d-929f-4515bcb2dd55">P2Y</natr:RestrictionPeriodForIssuanceOfShares>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="ia72899eeeac6488c866c2c21e97909de_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTYzNA_4ebb7167-eff2-4bca-a0ac-b7edcf84caa3"
      unitRef="shares">95000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="i8b74d788af4647368d8064fe930b3af7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTY0MQ_f95b5973-6e3e-48a5-a6cf-cc1e3c38bb34"
      unitRef="shares">88000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTYxNg_0694e3ec-cd84-4203-b9e4-a0165af8746d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the three months ended March&#160;31, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMS0xLTEtMS0yNjQxMg_568dc22e-28a3-410d-aab4-ac94b9bee831"
      unitRef="shares">830000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i75cc11a2a0bd4cec985a661aa5a5572a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMS0zLTEtMS0yNjQxMg_b82a6328-8d2f-473d-9684-0faf3965c820"
      unitRef="usdPerShare">9.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMi0xLTEtMS0yNjQxMg_71879726-a593-4fa4-ab45-fb2df04c0fed"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMi0zLTEtMS0yNjQxMg_efcf0eca-2c8f-448e-92aa-75d2f59476c9"
      unitRef="usdPerShare">16.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMy0xLTEtMS0yNjQxMg_7801b331-e247-42ee-b3b9-ed89e9e962d7"
      unitRef="shares">57000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfMy0zLTEtMS0yNjQxMg_1fcd4226-0cf7-4a5e-80f7-5d94568879f3"
      unitRef="usdPerShare">3.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNC0xLTEtMS0yNjQxMg_56f07474-2fc3-476b-8483-da9aafaf4cdf"
      unitRef="shares">220000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNC0zLTEtMS0yNjQxMg_485b527d-7615-4af8-b16d-5c2e15997842"
      unitRef="usdPerShare">8.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9f4ec581d7e641179b6e6d5671e479cc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNS0xLTEtMS0yNjQxMg_f436158a-5bee-44c0-a89f-95d575dd7a6b"
      unitRef="shares">555000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9f4ec581d7e641179b6e6d5671e479cc_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RhYmxlOjhjYjI4ODE1MGQ0NDRkN2VhMGNmNjZhMDU2ZjExYjQ0L3RhYmxlcmFuZ2U6OGNiMjg4MTUwZDQ0NGQ3ZWEwY2Y2NmEwNTZmMTFiNDRfNS0zLTEtMS0yNjQxMg_e1c19a18-5096-443f-8a96-82c8d02c541f"
      unitRef="usdPerShare">10.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3a34944a924e4066b3c1da802052a5c5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNTkzMQ_9c57d53b-9666-445f-b537-0367707c6f2e"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i84a5b39487154954983fee65eae72369_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNjIwMw_2a6b3ac0-7ec4-4d97-9ef8-d9a1d0d9771e"
      unitRef="usdPerShare">16.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability
      contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzE0NQ_7d199c2b-b3b8-4af0-8d8d-44859f620be5"
      unitRef="number">0.129</natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfMzg0ODI5MDcxMjYwOA_b1742702-9296-4807-a674-b8287cbb1d13"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzY0NQ_f18ff9e0-6868-46a6-82c0-f521af9232fd"
      unitRef="usd">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzY1Mg_2fb164bc-b5d7-4a0d-af07-a97dec54972b"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i3da7c00ee4b94166b3df419f56670028_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzk1Mg_3ffb0f71-986b-4d23-9b8d-a97a1bb6730b"
      unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="iabbe644ac11048d2b710f145d0c3929c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfNzk1OQ_2e13d73b-5ec2-472c-9482-1ce12741d20a"
      unitRef="usd">1600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODA5MQ_b778c15d-51e7-49d2-a4db-a5a610daa3ab">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib87d18bc3f9040428d9eb9ea8d77994f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODIxMw_88eb2e52-c809-419d-a5f6-5ac455a9ff20"
      unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i348578201c544d8e9d4c3798b278b2fb_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODIyMA_9d0ab07b-5ba8-421b-b2dd-53117597c3c5"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i22cc4557e1f545e1bc22ad3695e0973d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfODQ5NA_33612f62-53fa-41f0-872e-938d975ccd08"
      unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="ie376d38b072e4fefb28248f25e8aa24b_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTI1MA_1449962b-3dad-4d2c-9356-3519fe19f021"
      unitRef="shares">60000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="ib31fa40d12bc4d7dbfe3eb1dba1a52b7_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181Mi9mcmFnOjI5Y2FiYjkyYzJkMDRiODM5OTMzMjI1YmMwNTY4ZmFkL3RleHRyZWdpb246MjljYWJiOTJjMmQwNGI4Mzk5MzMyMjViYzA1NjhmYWRfOTI1Nw_bea54a97-b63d-4c08-baf5-c061360be1d6"
      unitRef="shares">75000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk2Mw_71a48531-c356-471c-9120-98f78906defc">Segment Information&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy&#xae; WorldWide brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $4.9 million and $2.8 million for the three months ended March&#160;31, 2022, and March&#160;31, 2021, respectively. These service fees are included in selling, general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March&#160;31, 2022 and 2021, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMzk_c8013bd2-1182-4ebe-8c81-f9399a6b433a"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk2MQ_3bb45829-2a59-4903-8d53-990b00c28a3a">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $4.9 million and $2.8 million for the three months ended March&#160;31, 2022, and March&#160;31, 2021, respectively. These service fees are included in selling, general and administrative expenses.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMy0xLTEtMS0yNjQxMg_45769c76-8459-4f07-bb14-769bc916a5d0"
      unitRef="usd">46110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMy0zLTEtMS0yNjQxMg_a1bef39f-d23e-4fbe-95bf-a968c22b43a6"
      unitRef="usd">35755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNC0xLTEtMS0yNjQxMg_72fff09d-6077-4995-ae1c-fa7243721fd9"
      unitRef="usd">21777000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNC0zLTEtMS0yNjQxMg_3dac81a9-371f-4a74-84d4-30f703deaa2d"
      unitRef="usd">22200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNS0xLTEtMS0yNjQxMg_80d2bb7e-c8c0-4f3f-af39-b98fd678ccc4"
      unitRef="usd">35981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNS0zLTEtMS0yNjQxMg_e9d7430f-b24a-4017-9f51-7e56007df55e"
      unitRef="usd">37762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNi0xLTEtMS0yNjQxMg_0e87b6b7-40a0-49cd-9586-bfaa11535cd4"
      unitRef="usd">6626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNi0zLTEtMS0yNjQxMg_6f81a7e2-fb32-4586-8bc2-1bdf763fd716"
      unitRef="usd">6704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNy0xLTEtMS0yNjQxMg_20181deb-8270-4879-844c-f3dacac4f6ab"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfNy0zLTEtMS0yNjQxMg_ebf76803-1231-46af-b956-1bc73cae7c2d"
      unitRef="usd">102421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <natr:ContributionMargin
      contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTAtMS0xLTEtMjY0MTI_84ac82b4-04ea-4b87-b35f-290915dee14d"
      unitRef="usd">21939000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTAtMy0xLTEtMjY0MTI_563cb17f-ffb3-4da2-8718-8683812c2674"
      unitRef="usd">15319000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTEtMS0xLTEtMjY0MTI_faaf27cd-825d-412f-b66c-2f1a4c427e10"
      unitRef="usd">4373000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTEtMy0xLTEtMjY0MTI_537677e7-1cb4-4a28-a708-d860fc9fec01"
      unitRef="usd">6796000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTItMS0xLTEtMjY0MTI_6ad67ba5-50a6-4f63-a0da-f9d19efcc3bf"
      unitRef="usd">12719000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTItMy0xLTEtMjY0MTI_fe7aebd4-8f94-49a5-9f9c-6c8488f310de"
      unitRef="usd">15440000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTMtMS0xLTEtMjY0MTI_a790ce10-dce7-41aa-ac33-d7155f87c1ed"
      unitRef="usd">2901000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTMtMy0xLTEtMjY0MTI_b83ae878-aef4-4de3-b748-cee009f378c7"
      unitRef="usd">3632000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTQtMS0xLTEtMjY0MTI_fe5a337b-3e15-4e7d-9405-8bbb84da2cf7"
      unitRef="usd">41932000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTQtMy0xLTEtMjY0MTI_ff5dba52-a07a-4a76-acc1-f30c8bfe06b0"
      unitRef="usd">41187000</natr:ContributionMargin>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTYtMS0xLTEtMjY0MTI_76c5be05-1b10-4245-ad94-4ef268b6aa04"
      unitRef="usd">40623000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTYtMy0xLTEtMjY0MTI_34be9952-6e46-4e0e-91bd-931144a99e9b"
      unitRef="usd">33552000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTctMS0xLTEtMjY0MTI_bac5d7b2-73ec-42de-b825-2901129575c5"
      unitRef="usd">1309000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTctMy0xLTEtMjY0MTI_8166c15f-d16e-4973-8727-2dba9dd904aa"
      unitRef="usd">7635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTktMS0xLTEtMjY0MTI_60319e70-e070-4a98-b79a-0c5ee2839fad"
      unitRef="usd">-314000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMTktMy0xLTEtMjY0MTI_9b887d3e-0e10-484d-9164-534706570c10"
      unitRef="usd">-1933000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMjAtMS0xLTEtMjY0MTI_49558254-0287-4a76-bf16-5f2f5d8dab90"
      unitRef="usd">995000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmNjOGZjY2Y4Mzk5MDQ3ZjE5ZDg4NDViN2FjNDFkN2RmL3RhYmxlcmFuZ2U6Y2M4ZmNjZjgzOTkwNDdmMTlkODg0NWI3YWM0MWQ3ZGZfMjAtMy0xLTEtMjY0MTI_abe7cccd-1376-42c5-90ab-2dde9a320312"
      unitRef="usd">5702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia99ab0f2e60446ec842d8b9c7ecedda2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTE3NQ_fe519836-424c-46b2-9b08-79c133495dbc"
      unitRef="usd">4900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3dc50e572e4748939b523aac9f92ce3d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTA0NDUzNjA0NjU4NzQ_cad0f75b-0a9a-4b2e-811a-4dc109b8ea8f"
      unitRef="usd">2800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk1Ng_7f32157d-a3ce-478c-ab49-428f99de6f4e">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three months ended March&#160;31, 2022 and 2021, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3833f589148a4227b4f5c984f8f200b8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfMy0xLTEtMS0yNjQxMg_368b1b21-3cbf-46a1-bf35-5395c028a99d"
      unitRef="usd">33229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aaa533e28334f489d7076c39dd1673d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfMy0zLTEtMS0yNjQxMg_de3981e2-9066-4dc6-a0fb-63859a473ee2"
      unitRef="usd">34920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d1d57f3f4a34ccdb3dbce4533de6401_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNC0xLTEtMS0yNjQxMg_33a48256-68f6-4777-8a27-2a9fe6484631"
      unitRef="usd">13653000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idadda0b851c948ef9359bd2d2b89e394_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNC0zLTEtMS0yNjQxMg_5d7e509e-be15-4dd2-a019-ecd2bc9ba5a5"
      unitRef="usd">14809000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8b65a6d4edb47548db956eb75ac2c69_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNS0xLTEtMS0yNjQxMg_b1a7cae5-c979-467e-9911-f793cdb01030"
      unitRef="usd">63612000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i348e6e2f93764613b3bd554e1ef83f4b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNS0zLTEtMS0yNjQxMg_5e8a2940-bf85-47f1-b526-ec6ad997f846"
      unitRef="usd">52692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNi0xLTEtMS0yNjQxMg_581c5678-9103-4473-bee9-c4e8633eeef5"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmE5NGVlODBiNjgyZDRlNzM4NjAzNDlhN2ZmZDVjNzc0L3RhYmxlcmFuZ2U6YTk0ZWU4MGI2ODJkNGU3Mzg2MDM0OWE3ZmZkNWM3NzRfNi0zLTEtMS0yNjQxMg_1439803b-7059-4608-9aab-fc16d9ccf386"
      unitRef="usd">102421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk3MQ_667c71ac-0ff0-48dc-9f42-50d0e3c86542">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0bf1d17dbb48cbb44d363a39cecd6c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMy0xLTEtMS0yNjQxMg_16009aa0-c2ca-4e6f-9687-460987cb905e"
      unitRef="usd">12986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17bade993e50434bb25d5592094f26be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMy0zLTEtMS0yNjQxMg_3635a77a-0d4e-4f58-8c80-bdbd1e9cae89"
      unitRef="usd">11292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8912512957214830a709fb3a0e5f6bca_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNC0xLTEtMS0yNjQxMg_42833ecd-c89b-49de-8a1f-2cd0c95ce388"
      unitRef="usd">1344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i923224bdda5a44f6b1fd81e1e95c68ad_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNC0zLTEtMS0yNjQxMg_e7234975-07ef-4573-8821-ec517cfbba9d"
      unitRef="usd">203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9a2377c670243d1a78c141cc8e41170_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNS0xLTEtMS0yNjQxMg_f2a83684-ca9b-4c61-8b21-8151dbb63745"
      unitRef="usd">13630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia60c19c5ef2943ab9963e5ff0b52a2c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNS0zLTEtMS0yNjQxMg_7bfbfb17-818a-4bbd-96f9-b5a99af4684b"
      unitRef="usd">9903000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1318988169ff4f8fa5244b15ab3b8c19_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNi0xLTEtMS0yNjQxMg_1ebb8d79-aea3-44fe-99d7-55a244e47535"
      unitRef="usd">9036000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7d7e87cbccf44fda7f9f4bb20e905bb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNi0zLTEtMS0yNjQxMg_dfe1aa20-927f-4dc9-a882-1bfe0eee30d4"
      unitRef="usd">6871000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i910fb20292ee451c8d13d76fb72f1bc6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNy0xLTEtMS0yNjQxMg_8bd120f4-a4db-4c5a-b021-cf370efc481a"
      unitRef="usd">2543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29ee274469924f98ad71b11264e3aac2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfNy0zLTEtMS0yNjQxMg_350eba26-4a3b-44fa-bacc-799e0b56623b"
      unitRef="usd">2524000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2afe0a2304a4456866df0c569f0b79b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOC0xLTEtMS0yNjQxMg_05888027-df4b-49b4-9059-2212344a7f9d"
      unitRef="usd">6571000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94732c9a5ab84a539cf8295a1bee383e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOC0zLTEtMS0yNjQxMg_6dd35fc7-9bf9-4d3f-86d3-24e44256bc92"
      unitRef="usd">4962000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21312f640f5c490a892e96b5d8692f61_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOS0xLTEtMS0yNjQxMg_778c9f2c-c30b-4605-9557-e89bf01432c5"
      unitRef="usd">46110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ac6759ab017403994e25748267d7ef7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfOS0zLTEtMS0yNjQxMg_7e93e657-0dbd-4c7c-ac28-c24877fd856c"
      unitRef="usd">35755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e28facca7c94a3bb9ef0cbef288a9b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTEtMS0xLTEtMjY0MTI_7a39909f-11c8-4256-af87-49b9912b3a74"
      unitRef="usd">9196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf9d61c288624d7199064cf8381fb74c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTEtMy0xLTEtMjY0MTI_0ed6b857-7062-45bc-aa68-b0ee9f9ef23d"
      unitRef="usd">9472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7c4bae86f8b4368a604018a81f2ec34_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTItMS0xLTEtMjY0MTI_897dee2b-e749-4f60-8a01-52d06983470a"
      unitRef="usd">2631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70cbed7bb9954b1f8cd165f5e0ec7a32_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTItMy0xLTEtMjY0MTI_e37694e6-f1ad-4a00-a727-ec63b0c7a9c3"
      unitRef="usd">2016000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14fe7c8a0e454ba181e8aa0117c5fe76_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTMtMS0xLTEtMjY0MTI_698b536f-8fca-415c-bbf7-6988e91c6c34"
      unitRef="usd">2633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i902dbfce0d3d416f9e765b1c3e2da20f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTMtMy0xLTEtMjY0MTI_7832dde0-e8ca-4d59-8e4c-7cca0f3a71fc"
      unitRef="usd">2992000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a00e56648394275b3210882faf90e94_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTQtMS0xLTEtMjY0MTI_45ae3a6e-2940-49eb-8fa1-79f486e83029"
      unitRef="usd">5591000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0c3f3a5a15141889d6b30d587478d20_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTQtMy0xLTEtMjY0MTI_c82e0e0b-b0c5-4f88-808a-4d10b111d677"
      unitRef="usd">5540000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcc88af59d684d87a1010641a53f8b29_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTUtMS0xLTEtMjY0MTI_66001779-b7b1-4fb0-aab6-0ee8b27e2868"
      unitRef="usd">1233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia25d2edee7b64a6ebb0b481f7c617554_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTUtMy0xLTEtMjY0MTI_ae073959-394e-465d-887c-ef9d10c148b0"
      unitRef="usd">1426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2358ce4157b4456ae0ba519086bc059_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTYtMS0xLTEtMjY0MTI_5385bb3b-1a8f-4375-927c-a88b8316fa28"
      unitRef="usd">493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40834fd02559432dae656ae4e9cde9f0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTYtMy0xLTEtMjY0MTI_9ecb384c-b295-4642-8bfa-a5eb4ecd5fc7"
      unitRef="usd">754000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f15dc0d739c48d7add91ac6aa4a4921_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTctMS0xLTEtMjY0MTI_7f0930a3-3a67-46e1-8870-85f5cd1a0000"
      unitRef="usd">21777000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92527f12c51f48969241c6c015177b7e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTctMy0xLTEtMjY0MTI_092a2099-4181-4401-bbf8-f8d09b86271f"
      unitRef="usd">22200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ec47376a16843fe8b7959468e821063_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTktMS0xLTEtMjY0MTI_1f1076b1-7958-48a5-8397-b667d4261cb7"
      unitRef="usd">15314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40ea609d840d4bfcb6ac425813487379_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMTktMy0xLTEtMjY0MTI_6ba2fe1f-a405-4023-8c8d-ddd505f1b834"
      unitRef="usd">16270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i767402ab744647ed99b96582c5beb3a2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjAtMS0xLTEtMjY0MTI_a43d181d-f7cc-4c72-86e6-0c6057d44ab7"
      unitRef="usd">4872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8732a9aa67884481b06822950adac68e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjAtMy0xLTEtMjY0MTI_270d990e-7a02-40ab-a776-21778dd5dbe2"
      unitRef="usd">4874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic15ce45b151e4a20adb9f451c3673c19_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjEtMS0xLTEtMjY0MTI_006addd8-6c4d-4772-b039-d6f91754c7da"
      unitRef="usd">3842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f5284ee739d4941a2c520f0a501c89e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjEtMy0xLTEtMjY0MTI_1aab3d52-62e1-43bd-b5c6-5dde7275139b"
      unitRef="usd">4225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9c8d01d2a81452f8df2e915edc4269e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjItMS0xLTEtMjY0MTI_c39d61b3-1fb1-48b1-9f95-3f488dbe4469"
      unitRef="usd">8594000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bf5d682a21749498e82089f8cad3646_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjItMy0xLTEtMjY0MTI_d4e9aeb2-71a7-4f81-a904-3e41c05d2a97"
      unitRef="usd">9463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4908295d328c4841a2ee03a0b1ffd3d7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjMtMS0xLTEtMjY0MTI_579669d4-e87a-427e-8bf8-69d6425442af"
      unitRef="usd">2175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7de4b6373eea45468e42ddd4316cd664_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjMtMy0xLTEtMjY0MTI_47dfbddc-4c2e-467f-abee-a539e450828f"
      unitRef="usd">1819000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i378b6704092a4d50ac575936de66eff3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjQtMS0xLTEtMjY0MTI_e145f9b7-c5ef-4db3-8ae5-3a0d52e4f87e"
      unitRef="usd">1184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d963c459ab44b6e925d88b0342277cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjQtMy0xLTEtMjY0MTI_6a7306f4-7c4b-404f-9979-2621dd079396"
      unitRef="usd">1111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43b6f2ca655e47da80feab67edf851d2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjUtMS0xLTEtMjY0MTI_01cce19c-b5cb-4ed8-b880-7b7ae2160694"
      unitRef="usd">35981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i831c92eb3b70497eb880571439797b1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjUtMy0xLTEtMjY0MTI_3209ed6b-004c-4d95-9aee-cdbd7c876315"
      unitRef="usd">37762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i325b7a5fd36c4fe28941bfaf3f5e55f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjctMS0xLTEtMjY0MTI_951caa25-43c1-447b-8954-1abc6bde4343"
      unitRef="usd">1818000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2c0ce3a35074fb4a5417b00b210d23e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjctMy0xLTEtMjY0MTI_1ac919a4-285d-49b0-9a4a-23050e820419"
      unitRef="usd">1976000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2e0b295afa4d06a33d1a682c00dbbf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjgtMS0xLTEtMjY0MTI_71611633-9ba8-4be9-9ebf-1b6c6f7a615d"
      unitRef="usd">761000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2418e36a7c6d4b968097a27d457f9a08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjgtMy0xLTEtMjY0MTI_803c3cee-c069-4127-8f1d-392a363a7b1a"
      unitRef="usd">811000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4e927aab10b4984bee8f3006640dc63_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjktMS0xLTEtMjY0MTI_17565d03-0f49-4af5-b867-0a0a2fa1cae4"
      unitRef="usd">357000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68972e27e09c468e998db2ff4a112ecd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMjktMy0xLTEtMjY0MTI_d698946b-b738-4354-aec5-3a0e26950e2c"
      unitRef="usd">478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ce4108dd6004d9f97aa7f7a7ed76e7d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzAtMS0xLTEtMjY0MTI_3d0b2c92-b557-4962-8334-884e8ecb3632"
      unitRef="usd">2841000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0b0ebd208da4867a5672633b3762f8d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzAtMy0xLTEtMjY0MTI_6d408fca-62d9-497c-95a8-7223515cef5e"
      unitRef="usd">2870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic33417330f8f488c995347b902948643_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzEtMS0xLTEtMjY0MTI_bf128203-44a0-485c-87ad-9c1f2097115b"
      unitRef="usd">641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15e313090407494ba9488fe56934f695_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzEtMy0xLTEtMjY0MTI_1c1486e3-8a12-44b8-8b68-35f4ade8683f"
      unitRef="usd">345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23f702f0295049a28cbcdc8b4d1ef74a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzItMS0xLTEtMjY0MTI_f006fac3-cc3a-400a-8792-c86350a0bb19"
      unitRef="usd">208000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f14deead68345519312a61e7ae03e71_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzItMy0xLTEtMjY0MTI_2efeb951-3502-4757-8cd6-dbf9eaca0738"
      unitRef="usd">224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5f959dd7fb44e78aca4d3cbba8c1897_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzMtMS0xLTEtMjY0MTI_27e50ec4-ebdb-4e89-859d-b165f48b560a"
      unitRef="usd">6626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6763f9bc11b540fcafe6cfc60b288aba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzMtMy0xLTEtMjY0MTI_0218e3c6-16aa-49df-904c-766df8bdf83d"
      unitRef="usd">6704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzQtMS0xLTEtMjY0MTI_1ee27e1c-a7c5-4ca9-96b6-8a19002db5e7"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOjhjMzNhMDk5YmVlNzQ0MjA5ZjJmNGI3Yzk0MDNlODBjL3RhYmxlcmFuZ2U6OGMzM2EwOTliZWU3NDQyMDlmMmY0YjdjOTQwM2U4MGNfMzQtMy0xLTEtMjY0MTI_227c6989-735d-4025-8e29-9205ee19b7e0"
      unitRef="usd">102421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk1Mg_fc9cee3d-35c4-4650-82a8-570a303d4037">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i86021b8e2ac744dbb42d13876c378755_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMi0xLTEtMS0yNjQxMg_9accddcd-ef2e-4ee3-a91a-2dc2aae83b12"
      unitRef="usd">45769000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i95ba4d14830043cfa540bfed1414f780_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMi0zLTEtMS0yNjQxMg_52bb2a4b-f4cf-4591-ae35-65a9436539e6"
      unitRef="usd">46595000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i004217ff71f5450a9f97499b3ad9bcf9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMy0xLTEtMS0yNjQxMg_55ac564b-2b45-45f7-90ee-840b0470b2e3"
      unitRef="usd">3818000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8b1e426e6e414937a5f77169261c768c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfMy0zLTEtMS0yNjQxMg_7a71591d-6484-41a2-8cab-fa6310e29ba5"
      unitRef="usd">4262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfNC0xLTEtMS0yNjQxMg_e9734360-8876-4871-9efe-971b111ec444"
      unitRef="usd">49587000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmRmMTJjOWFhZWQxNzQ4YWNhMzMwNzk3OTliNDBhODQ1L3RhYmxlcmFuZ2U6ZGYxMmM5YWFlZDE3NDhhY2EzMzA3OTc5OWI0MGE4NDVfNC0zLTEtMS0yNjQxMg_0c3f0ffc-18b4-4b77-ad08-7affe42961ff"
      unitRef="usd">50857000</us-gaap:PropertyPlantAndEquipmentNet>
    <natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RleHRyZWdpb246Yjc0OWZmOGExNmZhNGViYjg1MTk4NmY5ZDllMWZhN2VfMTk3Mg_7bc0913c-7d2f-4da5-bcbf-bd20962b7ed4">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock>
    <us-gaap:Assets
      contextRef="i0831f06411dc477198d772b8a9a9e543_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMi0xLTEtMS0yNjQxMg_35168607-61c6-44b2-8b6c-9e8e949f806b"
      unitRef="usd">93957000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ea186633b504a27ba220e6cfcd61edb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMi0zLTEtMS0yNjQxMg_6e20b50a-6a52-49cb-ac39-cbfae02da25f"
      unitRef="usd">104659000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i47363d5359bd46939ab4fc9af1589e6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMy0xLTEtMS0yNjQxMg_89f67d69-7b82-4cbb-8f83-4cc0c91b076d"
      unitRef="usd">14233000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iac919f4f48d240ed91a334c82ccd8334_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfMy0zLTEtMS0yNjQxMg_8a38c1b3-461f-4382-9013-bf252ee609fc"
      unitRef="usd">15486000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibfaaa60da1b043588f9fae53b220069c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNC0xLTEtMS0yNjQxMg_f2fcb269-0458-4d50-9016-e232dddaf354"
      unitRef="usd">122779000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4376d08163e3452aa8513d7ff8613dc3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNC0zLTEtMS0yNjQxMg_aab82536-0325-4270-83dd-fc255b4593fa"
      unitRef="usd">131207000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i281b77f20968487b8373b3b9e315c30b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNS0xLTEtMS0yNjQxMg_7a917e7d-4692-4181-a4c9-eb81d67bbaa7"
      unitRef="usd">7693000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e8dbc545c204454955aab73bf9e460f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNS0zLTEtMS0yNjQxMg_1d78ddba-7d13-4f10-bfe1-407139c74bc4"
      unitRef="usd">7522000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNi0xLTEtMS0yNjQxMg_ba877516-70f0-4bbc-a2b0-426070aeabb4"
      unitRef="usd">238662000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN181OC9mcmFnOmI3NDlmZjhhMTZmYTRlYmI4NTE5ODZmOWQ5ZTFmYTdlL3RhYmxlOmJkZDQ1NWE1MDg5NjQzYzNiZmI5OWRjNGNjZjg0YTMzL3RhYmxlcmFuZ2U6YmRkNDU1YTUwODk2NDNjM2JmYjk5ZGM0Y2NmODRhMzNfNi0zLTEtMS0yNjQxMg_3e3cef3b-4408-4b7a-9347-39c4073e4f3c"
      unitRef="usd">258874000</us-gaap:Assets>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMzM4NQ_ed30dc75-e07d-4736-ad2d-789cf02cc361">Income Taxes&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 369.9 percent and 27.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets which are expected to expire before utilization.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2021, was primarily attributed to transfer pricing adjustments and non-deductible executive compensation, partially offset by favorable deductions for stock compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate for the three months ended March&#160;31, 2022 compared to March&#160;31, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets which are expected to expire before utilization. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. federal income tax returns for 2018 through 2020 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021, we do not have any amounts accrued for unrecognized tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMTU0_4c63731f-1d1a-4410-b77e-7d307adf64dc"
      unitRef="number">3.699</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i342bcedeedeb493d928313b1a67661c2_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMTYx_6b9746f0-d22a-41d8-ab11-c0e05db88c88"
      unitRef="number">0.272</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMjE5OTAyMzI2MTQzNw_654ad8fd-e8c3-49a1-ab58-7af0875415ad"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibd8f983b74df47e39a31782e54a1f453_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182MS9mcmFnOjcxNTkzMjdmZjU0YzQ3ZDM4Zjk1YjNlOGM2YzcwMDY5L3RleHRyZWdpb246NzE1OTMyN2ZmNTRjNDdkMzhmOTViM2U4YzZjNzAwNjlfMjE5OTAyMzI2MTQzNw_ed0904ee-5746-4a01-ba45-f90502366e54"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY4Nw_3c3c4601-a98f-4fbb-bb57-553a3c253f37">Commitments and Contingencies&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Income Tax Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#x2019;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $0.2 million and $0.2 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $3.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2022 and December&#160;31, 2021, accrued liabilities were $0.5 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.5 million.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover
      contextRef="i2dff93085c7f44fa956bd391f58b99df_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfODc2_5869fdff-aca2-4a08-bc98-19b2fa4d1084"
      unitRef="claim">1</natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i1aa91f25a9b349ef8fdaee1bfeda71ee_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMTcyMw_7fc805bb-17c2-4e63-b7b2-bfd2d4c98ffe"
      unitRef="usd">200000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6e4dd6c147114968863a0c8456478780_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMTczMA_d2907687-aac1-498d-a048-ac25154d51e7"
      unitRef="usd">200000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i1f362c72e29e4ee8ad5ec7c2dfb61c74_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjAzNw_5158315d-d611-4adf-b920-b384b3241501"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ib89e37a274af4cee94ebef8056298d53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjA1Nw_19e4b81c-cddf-4e66-8396-aba8dd43c709"
      unitRef="usd">3100000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="iac3fd88adf7d4e73bafc50be57cbaef2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjIzNQ_9b7ea729-85a3-415d-8a46-e678de27af0b"
      unitRef="usd">500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i492c57a6f9d046bda2bbdd0115e8fa08_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjIzNQ_e979a653-2e59-44de-a444-7fec4eb67df0"
      unitRef="usd">500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="icefc00db041a48d4a92bfbe7b4e5ad25_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjU0NQ_ba0047ae-c776-4b2b-bbe2-50d4c383da58"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i09a9560c1ee743039cb31edafc3294ab_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY1Nw_844e4c92-eda8-4b55-b2a2-7f9208d1488b"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="id57f2be0493944f4be377552827b560e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182NC9mcmFnOjY3ZWVhNDg5YjllNTRiM2FiMDMyMDljZjZiOWVkZWEzL3RleHRyZWdpb246NjdlZWE0ODliOWU1NGIzYWIwMzIwOWNmNmI5ZWRlYTNfMjY3Nw_400bbcbd-7b38-420e-a7a1-e6bc550722dd"
      unitRef="usd">500000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNjEz_36c79b02-8614-4cac-9c09-84863da5c105">Related Party TransactionsDuring the three months ended March&#160;31, 2022 and 2021, our joint venture in China, owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $0 and $1.2 million, respectively. As of March&#160;31, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $0 and $0.3 million, respectively. These notes were payable in less than one year and bore interest of 3.0 percent. The notes between NSP China and the Company eliminated in consolidation. In March 2022 the outstanding principal and interest amounts were repaid.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="idf7ca29b6fc94c6dbdc1652525619cd1_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTIx_6015c34d-6b0d-4284-8378-2a695be87eb6"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i3f9df89d786a41e0b3d144f941fc5d32_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTIx_eedbb422-668d-4fb1-8654-3b60ee0a4223"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i8d3d962215954cc8a9171fdd8505b3ba_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTM0_b9cc73d5-7116-4f22-bb95-fff2932bdfd5"
      unitRef="number">0.20</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i72fa1124277f415fb68c710bb5c87c6c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTM0_be63222b-4b93-4535-8682-08ae7e3209f4"
      unitRef="number">0.20</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i3ffa4204f2244033a6387741823b1eea_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTg3_ae6a17fb-9829-40d9-9e49-c5833ee30b89"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i6210ad9bf96e4639909b9ee6ec5f0dee_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMTg3_b1148e56-70c5-4517-ba23-548f0e7379c1"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="i9172a343a5724170828bcc1c87deb05b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMzMx_a88604db-6bc8-4a9a-8e81-09cd90d91f09"
      unitRef="usd">0</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="ieae5488b942241ffb6afa51639ffba10_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfMzM4_4bd33d23-f6c2-4313-a5c7-7a8c84396a1e"
      unitRef="usd">1200000</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="if4e1cf8cd79b489185a71063b36e1414_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNDQ0_c3d27fbf-0834-4c9d-9c5f-ba64c50c8f7b"
      unitRef="usd">0</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="ie78f626536d54b3ca22aa7de05ba6475_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNDUx_d4cdebc4-8f9a-48b6-aba0-fd38b2ed5dd7"
      unitRef="usd">300000</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="id5c874d0d851496d8d0b2cad723434c2_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN182Ny9mcmFnOjQ4YjRlMzI0ZmEzODQzNWNhOTNiYWFlYWZiMmExMGM4L3RleHRyZWdpb246NDhiNGUzMjRmYTM4NDM1Y2E5M2JhYWVhZmIyYTEwYzhfNTM2_7e126d81-e536-4790-a6d3-a08b61dfae32"
      unitRef="number">0.03</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RleHRyZWdpb246ODIzOTVkN2U3OTQzNDc5YWJlM2YxOTVhYTgxZmZlMjJfMjE2NQ_3cd5a404-2415-47e1-963c-450fb7459545">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs that are not corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment securities - trading&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022, and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RleHRyZWdpb246ODIzOTVkN2U3OTQzNDc5YWJlM2YxOTVhYTgxZmZlMjJfMjE2Mg_3fb127de-61c3-4522-be47-26ad71f24e94">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:TradingSecurities
      contextRef="icd0d3c071a9749e19577e2b5b5623c3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi0xLTEtMS0yNjQxMg_06ab6e1e-1587-4863-8e01-74c93e0c98e2"
      unitRef="usd">888000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i5996eefda0d54ab59124aeaee9125db4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi0zLTEtMS0yNjQxMg_de517eb3-696c-4d57-9d38-e57b0868c625"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ibaaf9feba842448992af5440ff1e9ca4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi01LTEtMS0yNjQxMg_b18696a0-7e79-4878-a607-138d02c179c4"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="if60740a0aa42458e9145ad1c8f41c4a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMi03LTEtMS0yNjQxMg_3acfc5cf-4a03-4ef7-88be-dd6e9ccec16e"
      unitRef="usd">888000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icd0d3c071a9749e19577e2b5b5623c3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy0xLTEtMS0yNjQxMg_e8b965f1-182a-490b-972c-8db153210644"
      unitRef="usd">888000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5996eefda0d54ab59124aeaee9125db4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy0zLTEtMS0yNjQxMg_c4adc597-b795-465e-a36b-160c0f3ef197"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibaaf9feba842448992af5440ff1e9ca4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy01LTEtMS0yNjQxMg_86fcd6f5-9d47-46bf-9295-c96bf7d8b732"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if60740a0aa42458e9145ad1c8f41c4a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOmQ2MGZhZmEwOWE5NTRmYTk4YTg2MzlkYjI5ZWY3OGYzL3RhYmxlcmFuZ2U6ZDYwZmFmYTA5YTk1NGZhOThhODYzOWRiMjllZjc4ZjNfMy03LTEtMS0yNjQxMg_809c2640-7f91-42c3-925a-ac5fef9639b5"
      unitRef="usd">888000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i11fc7a1040844bd1a53ed85f210878e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC0xLTEtMS0yNjQxMg_2f506aca-fa90-4bdb-9753-4a9ae4dba3ff"
      unitRef="usd">964000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i444dd1d44ce74fcb94a32f106266e541_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC0zLTEtMS0yNjQxMg_3d844df9-6b0d-4d08-928f-c3ce29d85868"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i067bf9020abe410db4a9808337bf4f61_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC01LTEtMS0yNjQxMg_7649fa8a-ec07-48e2-ad7f-443327e6c285"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i21defeb3de3d4f229983ffbf2177bdbf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNC03LTEtMS0yNjQxMg_b62fa650-02e3-474b-8b3f-b21d321226e4"
      unitRef="usd">964000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i11fc7a1040844bd1a53ed85f210878e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS0xLTEtMS0yNjQxMg_7ca9cc6a-03a6-4e33-a249-ef50bed32d25"
      unitRef="usd">964000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i444dd1d44ce74fcb94a32f106266e541_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS0zLTEtMS0yNjQxMg_36ca2a65-fa57-448a-957f-972f3e916d86"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i067bf9020abe410db4a9808337bf4f61_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS01LTEtMS0yNjQxMg_b7957540-1f8b-4254-8943-e92052bd7de7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i21defeb3de3d4f229983ffbf2177bdbf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183MC9mcmFnOjgyMzk1ZDdlNzk0MzQ3OWFiZTNmMTk1YWE4MWZmZTIyL3RhYmxlOjgxZTUzMjdkNTIzMTRjYTU5ZDAwZDc5YWMzOGI0Zjg3L3RhYmxlcmFuZ2U6ODFlNTMyN2Q1MjMxNGNhNTlkMDBkNzlhYzM4YjRmODdfNS03LTEtMS0yNjQxMg_14729de8-a388-4c60-a463-3404d621926a"
      unitRef="usd">964000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfNDA1NA_df83aef7-88a0-494d-8bb7-95740f0a26ff">Revenue Recognition&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at the point in time in which the customer obtains control of the products, per the agreed shipping terms in the respective market. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Amounts received for unshipped merchandise are recorded as deferred revenue. Membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Liabilities - Customer Loyalty Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, we have offered loyalty point programs which allowed customers to earn loyalty points on personal orders. Loyalty points were recorded as contract liabilities in deferred revenue. These programs were accounted for as a reduction in the transaction price and generally recognized as points that were redeemed for additional products. During the year ended December 31, 2020 these programs were discontinued. As of March&#160;31, 2022, there were no outstanding loyalty points.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy&#xae; WorldWide brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally expense volume incentives when incurred because the amortization period would have been one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of our contracts with customers have a duration of less than one year. The value of any unsatisfied performance obligations is insignificant.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <natr:RevenuefromContractwithCustomerRefundPeriod
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMTQxNA_e7edbe3b-8807-4dad-bdf6-2e4242dd53c8">P90D</natr:RevenuefromContractwithCustomerRefundPeriod>
    <natr:CustomerLoyaltyProgramLoyaltyPoints
      contextRef="i134f93f3e1e140309cddc401f5a3e5fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzAxNg_129ce1f1-8fbe-416d-968b-0c683c3196f2"
      unitRef="loyaltypoint">0</natr:CustomerLoyaltyProgramLoyaltyPoints>
    <natr:NumberofPrincipalCategoriesofProducts
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzEwNQ_bd48a613-3a4a-4233-a568-2b0b0c942e49"
      unitRef="productcategory">6</natr:NumberofPrincipalCategoriesofProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="ife753c21309348fa8d87e87158807672_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzIyNg_9e1ccab8-be2e-4379-9727-5451f2efabf4"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <natr:ContractWithCustomerContractTerm
      contextRef="i838fe1c774584db3baff30093827a885_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkOWM0OGI0MjEzOTRmYTlhMTgyM2Q5ZWNiYmNmMzM3L3NlYzphZDljNDhiNDIxMzk0ZmE5YTE4MjNkOWVjYmJjZjMzN183My9mcmFnOjk1ZThlZDg3ZTIxODRhOWZiOTZlNmZlYzg5OWZjNmExL3RleHRyZWdpb246OTVlOGVkODdlMjE4NGE5ZmI5NmU2ZmVjODk5ZmM2YTFfMzk3OQ_4fa27199-4e93-484c-96c0-4e3828e58b8f">P1Y</natr:ContractWithCustomerContractTerm>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>53
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,"M%GC42>9/)0;X!0KJ6JG+CU^ ,/0^*9,A@A)^#8>Q*J6>-I-Z->!B249K
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MUC+*+C>"^T*9 ?!^):4^WI@/%!W@P7]02P,$%     @ B8FE5(3Z-$6V!@
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M7$"4V<VF2M&)Y*X0=OP>!G4UP</EI./D#A%XET*XY!>HB"<A$V8.?J<47Y#
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M8W"L*+K^8J#X+F^<5UQ!&YX_1HS"R=,"\'[#N3H-] +5MY?9/U!+ P04
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M<X4CRBP3_(E0H1WP?,&YVALZ0/5;\O\ 4$L#!!0    ( (F)I53('PWBG@4
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M(-O))[ <MFT1R;1+%R)X;BXEW<IQ.KDAV.M=-VX5N/NS!ZYK!%?3_UA=EB=
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M+=I+<4Q@7J#5&_ITR.$AR3XCB%Z2%4FVJ99_4B0\=_DPJ$4&3A\N5&ME9(+
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MAX4QT.]KSM5!, ZZ!1K]!E!+ P04    " ")B:542D]9260(  !0%0  &
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MDCQ/6C0K?MK0A@ ^7Q'YO1,2=(_E_#=02P,$%     @ B8FE5,Y$@D!G @
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M,ILOL,UGYOE*(UUXLTW$SBABV3LT:NM,>R5T_/+[;1WV'(ZR%QR*K4,1=,=
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M4B'WT7G-+=8V+RU(]-J>QDX#O9+6DH2[JC8Z=5,B3,$O*=TI-RP)">'EP?C
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;+57:6_;.!#]*X1WL4@
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M:&5E=#$T+GAM;,U:67,;-Q+^*RBN:M>NHD8D)=J2KRK93C9Y<.*RXLW#UCZ
M,R")&',8P(AB?OU^W<!</"0YWH>MLD7.#-!W?]V-X:M-:;^XM5)>W.6F<*]'
M:^^K%V=G+EVK7+JDK%2!)\O2YM+CTJ[.7&65S'A3;LYFD\FSLUSJ8O3F%=_[
M:-^\*FMO=*$^6N'J/)=V^U:9<O-Z-!TU-S[IU=K3C;,WKRJY4C?*?ZX^6ER=
MM50RG:O"Z;(05BU?CZZG+]Y>T'I>\"^M-J[W79 FB[+\0A<_9Z]'$Q)(&95Z
MHB#Q<:O>*6.($,3X&FF.6I:TL?^]H?XCZPY=%M*I=Z7Y76=^_7IT.1*96LK:
M^$_EYB<5]9D3O;0TCO^*35@[ \>T=K[,XV9<Y[H(G_(NVJ&WX7)R9,,L;IBQ
MW($12_E>>OGFE2TWPM)J4*,OK"KOAG"Z(*?<>(NG&OO\FW>RTEX:\9N5A9-L
M*??JS(,R/3]+(Y6W@<KL")5S\:$L_-J)'XI,9</]9Y"H%6O6B/5V=B_!#](F
MXGPZ%K/);'8/O?-6S7.F=WZ$W@]?:^VWXM_7"^<MU/S//30O6IH73//B.TUW
M+Q5*NA>NDJEZ/4)6.65OU>@@:?%>W^I,%9D3OQ8"!DK78CIA"\%.&R5D491U
MD:I,2.$JE6H0*,KBU*JTME87*Y%*MQ99)"/*I3B9)I.)J)05:9GG2!*WEE8)
MC6S!O]7*JI7TH)R#L \;KI(KQ*$QE%)^+;W82"<JJ4&O$->5U4;,&Z%\&0BN
M2Y,IZX@ A"DMKPT:S*["XD3\3"E*#R5T0!;X->@K4=GR5CLV +:7M<7RZ4S<
M^#+]@CVI*BBMQ4<#B9_0AA$_'SX9/1T+B"G!WB%=B1(M;:S4FH2L"/VM0KA8
M&!(*Y/*+"H)(ZW6J*UGX?T 6JU>ZP-X57 0C0$4E%EN(JVZ),:RMH (LFVE3
M,P"55JC"2+M2 +56AH4JU%)[HBBJTM->4&WOZ@*WD%-$FY8/^2;B-]P[H' P
M6Z8<6^Q=F0/$G60Q<)%K[U7/QIEVJ57\E#2F6N#7VC5V('$3<8,=R]I&G1RP
MB8%9%TSBAOQ\^A;XF W9N0B_K"YH_@(=@]B92F$-V3Q=UKZVJO4%5'<H%8L_
ML)^DVI$SQL+;4EJ.Y/>0,_4E@DR2'Q&@H%^13^L*RV^EU67MQ%+RHC'$3DV=
MD9N(C)*VP'?<7\*X!0=%6A:9)EYCBAIO=4Q#G5>E"PZ1Q1:$,K7P*BN4<R$A
M<KF%_T#7.P]A0'<<,J]G3N(4](6C* Q]$+QD\T8IH0$69]AGU"U%&5@>5CH)
M]A>?5%4CJ^ %\=&6")'\$5AQ,ITGDS:G!T!@.WI5H)=T!"\#.N^00Q9#P8Q#
M/+KM&"TA#7H"\@&MZCV':D0G"_:'+T[.)ST1F9X+0=3M<HWA<YDA4FV9"X_V
M@86@3TD+[!?$=NM9!_"RG+]D>Q*R%W# OMI(6'=+&QR",L0J&*,?8)']VB(I
M\E#Z0IH&TS25BVW=B9B)B_ET/ 'D!A6:*&YLSIB&1DN<7';J)DB99OU&4<2T
MU):/E /H>NWW1 M&I\:-7+"0AH%7WDIMY )H1M3[YJU!V#:8S/XCZ#^9727/
M.EF/XL#[VC:>WB+=HICO5:KR!<@&L:80BPPRJ!HR*RO/H87_%0$;(3/H_"(I
M@_[^M\O9]/E+)V[JPJU172GTLSJE' ,H)L?KQ2/0L[%P0'FX2[<+@[<@&L7$
MF"LM\MW7'#$[#\,E"4\%A^UAJ5UT';9 )UZU?P>&U[2RK5($([?24(8U5%#"
MN4%G#R*HLXXI7_7 A6^?+MA#X6&PPY$B$<O4 :!=4T6M_1HER6^9P;".9,HK
MFY-#.$:W54AL8LG5>(-6G#[I:>@P$)/8$83M)2EV*8G0Y:V],#S@N?%NR3 :
M>LB6SI%MR ]LH(X+:Z;C^63R4)9R)C;%V&P;0_S9RTJ.&:XPR\8+]\K.+1#N
MSP_E0!/WA_#UH!WP#+&*.<T%^Q<UYQEDZ;0::!2;SR"_=J[F8$+)V;5'+ ';
MKL\[+BYQOLY#KI-7/RG*$5P<34I YEJ3LR'9*H9LJW$HW*Q4]IU:S4BC@5:_
M':(WA,,FM7:B-T0MATE;\[NUP[(BLS\PU;'[J'$.0),U;=1Q6^T@%$D3-'25
M87@(5VW[1#B2AC%"_QD3H <"2 M#*$S-*K4/O/G7@%?B5_BSK\H S6+KI+BJ
M1AS9@;O@P5O(+Q %U"XNEXKA'SBERRRD(A5EI,B*[H=R32T>S1N$LXVK8+*Z
MHK\7ETV%:Q<'AA&<:>>85>R!X7WRK26,*0T=96Q96!6;16"-5K><N147?7R#
MTF5.O86%O"R_TW=CP4,_,T6;3HS3Z%@4SM+ZX-@EY0=UN.0]ZB4PD+$GO]:8
M*7@PNHVP0)'4X%04MW%.5):/,0AP'UO\45+124NJ9=1N.?$D@*T+,8>N6'*X
MJ+M459Z'P68*#&<^X/KTA?BES8S?66FPN8;4<J7V;S1Q-$@'OUOL9U,Q?3X3
M)V(Z2Z;G^$0;.A?_)&>"%I?UV<N]3_1>2TQ66 ']4_*QN6?U#W=PB:80>#*[
M>BJNDNES<9Y<S8Z).+2<F%Z<!_E8SGDRNR24@&VH\REB6Q9C+.W73W5'W]7C
MG<0Q%%LU#J\#C_?LQSU<)TU=T'2]*K@*/2@:I@I&EUA$.(EHY$ )UPN"H 6B
M\FCCV!T.8$)%:CN=8L@RM=J#06I8@A<81H=8 N9MUP]C[U3=8<6E9G/2[S6O
M#X34=TIW4*[GLP?EFB;33JY'CP>MTWE.(,@CM+]B;OR(*N\QO@Q5Q";*S[H-
MK2L]]PLQ*]MU%;I+7GW"^4"<3J;3Y.JR2W[N0FDL!4R9;:B-]QLULE1MPF5=
MP_]-A@AN/F^GO2 >&V57JK]B:!];79K=>^D"EM,AR^ &PF)YUYW'M+7GJ-5W
MA?R6=-[0&4>&7/:Q.D'(NHBUJ=R'K(2;A#@LA#+QF8:%O0I^>*803P@G9Y.7
MGVX^._XZ??ET?*C TX*_7-?1O43?M,7\_-E>,0>+827O>JS]@KXGST[A]G3,
MYET .;Y! SV:G5J%G(\'/N!8;OQZW-XX!:_3F )8>-:V62%I#&@8E&3B'Z2-
MIX3LR7;$.# MH>Y[20>K_=.D:#>JQ$&7]KC$<=](@1!A 15;&^$W)8_/>+Q$
MK\"Z<QSLP?0#%8/^7,U;I+F\Y*\QTH)U^V$\[BM[1$,^3I3A%)?SJQ]XG;*#
MF.V"\?^QL3F27 ^V-9?G$[0+5\G%L[:=02_Q+#F?]]J7)_/G3ZD7>29^#AY^
M@DQ\*BZ3R>4C&>\X?#Z?BRD*Y*1_UO*X(ZK&N:'0[>3]_5,K!42A-@]G0"@B
M3)"C+\9UB!K<"K8_;:I5!P5B*;7M*LU),&3G3HI?Q@"XG14U="H+0QG#,V/
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MESE_72N)4D,+\'Q90IEX00S:GU"]^2]02P,$%     @ B8FE5%+M@>RC!P
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M>;76P?@<E17+U8$E1ZM-7.5$<:+>:X=NY3RJTL[Y!%L85DFEEA2:P:!72&$
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M. N@P UKA+U1[0?LZSEU?+D2QO]#V^6FE)PWQJJJ!Y."BLONR1Y['T: L_@
M(.D!B=?=;>157C#+YE.M6M NF]C<P)?JT22.2_=2;JVF*"><G=^@8!8+6#-M
M=W"GF33,^V6FD25^EQ7E/=>RXTH.<*5PK:0M#;R7!19/\1'I&L0E>W'+Y$7"
M:Z9#2"?'D,1)\@)?.A2;>K[TCXN%KXO,6$VS;R_L<S+L<^+W.?DGIOXMUT6C
MN=R"+9%^&A&JSGUT[@-YEY>O7TW>Q._V#@*3A1O05#4:OBLN+3R@M(U&X!)6
M)9>,8JTD_%D,->J<HI#MH#$]>+S(H"V5$+L>89K,\(+3U0:U@4ME&@GKDM'5
M.8:"%R 5H91V7C))Z$HUTAK8:%7Y(E:JJEU Z6?DU52^1#H."^/8#U5W@3E6
M&>HGH0GQ66,I[OSJ)-#(N!H^WJZ[NG_7T2+M>Q1[WJ-)F-#U$X*,/Z9F9&KT
M[43L_K>B@U8\U1>'Z2%]=R4:=.ZCZ3 UV[%,^%<NT!@JFDE0$F&'3'LZ4N3"
MEK*-==6EX?#F/6%/EZ%M$>5(LT./343!J6OY$TS;Y71LE> %<P<XA"O9V=:Y
MY6!C6VHZWCFOF?"D@YK]N?&E:*P9+\+G[FPT:HH5ZJUO_88D$+KKC\/J\'59
M=$WU5WKW:2*16TY-0N"&H''X]C0 W;7[;F)5[5MLIBPU;#\LZ0N)VB50?*/(
MKG[B-AB^N?.?4$L#!!0    ( (F)I50&D7],6@4  *H.   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;,U7;4_D-A#^*]:VJNXDV(5=[DHI(,%1="<5
M'3VXZX>J'YQX=F.1V,%V6/9^?9^QDY#EM>U)53^P),[,,S//O-C>7UIWY0NB
M(&ZKTOB#41%"O3>9^+R@2OJQK<G@R]RZ2@:\NL7$UXZDBDI5.9EN;;V=5%*;
MT>%^7#MWA_NV":4V=.Z$;ZI*NM4QE79Y,-H>=0N?]*((O# YW*_E@BXH?*[/
M'=XF/8K2%1FOK1&.Y@>CH^V]XQV6CP)?-"W]X%EP))FU5_SR01V,MM@A*BD/
MC"#Q[X;>45DR$-RX;C%'O4E6'#YWZ*<Q=L2224_O;/F[5J$X&.V.A**Y;,KP
MR2[?4QO/&\;+;>GCKU@FV=G.2.2-#[9JE>%!I4WZ+V];'@8*NUM/*$Q;A6GT
M.QF*7I[(( _WG5T*Q]) XX<8:M2&<]IP4BZ"PU<-O7!X*K437V39D#@CZ1M'
M8#SX_4D .(M,\A;H. %-GP":B3-K0N'%+T:16M>?P*G>LVGGV?'T6< SZ<9B
MMKTAIEO3Z3-XLS[26<2;O1SIB?9Y:3E8+_XXRGQP*(X_G[&QT]O8B39VOIW-
M?P4D+@L2<_YV$[_9N9!BKHTTN9:ET :A-"PIM!<!LK*R#=Y"(8/(;5,JD1%Z
M*2>T@A)-C;Y@,2_+!(8V\1ZCP#I12ZU$L +D&#\G!TNEEIDN=5C!$LM:I\B5
MJR0B4YME%)9$!C7JK@!42Q=TKFO)WLL0K55W$0DE XW%:1]"- ])1PDANI#!
MD]KI'.F21@T"[AS2=%_%SMGEI 3\.\JJ(9W*"F-!ELG+1M%:'+GUF';B:$AW
MH<E)EQ<KIK?QR1)L6 <7OE(,[KJ1D2%VU-$=8V"7/VN3!BF;Z! 4!7+H[6%J
M/2N0S(M'TSL6[\#; G:_)JBE#H5.N7S*7YY=2K0)QRPF'T1)-U2R)6WJIBT3
MB'J],'JN<\FE8^^C#A@<WR_(-8L8C@A* ;P#L24,:[/ FR,2>1L$^3WQ:W1E
M>T_\UM@ I:Y^4MIU-[_;=0\L)[2"#W"S+QNL#4IBW().]\3'S).[D5G9 6PF
M.F+<4:\Q]DZF78Y\<%WEUCF;62?9LVS5.8?BE9V1V9[X_!P$U]FS,)?K!$40
M[+,^%JIMW(!;CIU74M0;7484-]AP.H T;O;&.89$Q!K",I;6&2/UXU6\4K L
M73LO(M^AL(U'%?O7?7(Z/KN0NUR=IR1=#,IF^'QI U+TP=R@Y&+3>_8I=>TF
M-YUB][X7N[N[^/WAN]WI]O3GM2?^DE#:1/^#B%\&_D^)/\'PK3+,II;[[?\'
M]S^]W7F"(O[R#=P_#_R28YWT1Y#>K=76!>1+6_03#H<^1%YO).9PX]N>BDD<
M(/9M&'W%SN<9Z3I1^-2,P;Z!?//@2N.J2@<<X@/.O0;:2!M3*[XBI#.)/4CW
M!DO D27%H?#$8/6MA\-);%E1/!PQK]K*>,UC;*CPV$AKA6>OT\#)I7,K-M05
M'\[$?&"^VRG ,:8LSTIF&[2K-+UDB5T)'//),TWC7/HBTA ?Z+K1"(MC 3EY
MWL'ST8,=2HSU'VJYBF[*NG;V5F.'7-M7%/[2)H(E7Z "-GG/%$8&,'8OEOYL
MQ*VJ* M#5/\(K&X] V<RA]]>IQL#'(RV4!"!*VDU%B>-2_O7WRB*")!ROH0M
M'&)X$R@D*DR:%2QNKF4<#AMK-N</SD(/VPQR]SO--\CU=4/]E@T-;1 (@"!K
M%R8&-7[LE#L9W!\J<HMX2_(BIB9=)?K5_B)VE.X?=^+I%@<&%CBGX&0QA^K6
M^,<W(^'2S2B]!%O'VTAF ^XV\;' 99(<"^#[W*(GVQ<VT%]/#_\"4$L#!!0
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M6\BDA@!W.].[L>PN/*84EVBMWF&V\C2;%O=C/O!= )BQC(!!A#7FFXP)K/M
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M=:J@&CL4MU$W<.<[YS.^C0$8ESS[1IH[K.U:78GU10I&\ '%/ZDQ0UD^S B
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M08<)H<+8,X*@;H4GJ!0#$8T?#6;0AF3'N^,-^EF5.^6R$ Y/C/HJ$Y^-@T$
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M&3F= 5+&]9FQ/<UGY/3DC)P0)LAC+BM-1:HC'XT.R^8G3<Q)'3,X$+-/[J3
M7),;D4+Z$>\;_6T2P2:)27"4\(ZJ"]+O=4C0#8(]>J9?A_?VP&?'X3-(#L$_
M9--O6])W?/W_MD1WR P62$R9R<U+Q?!MNTF_KQ<:E;DX?XX$#=N@H0L:'@BZ
MZ;=^YR^EPJ7D3.[K<,TV=&QVM*SBT6@4^:OMLGWV^38,6Y\/,@>MS,%1F:X<
M[QH[!&O='3."*&=_(269F76:G'*I->BS?=H'GW2=#W:T3S_[](8[TOVM6U>
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M,F!0$/$X_Z1O)A![ -PX 2 &0-X!2/L$P#, [ST GP T#*!Q*< W /]20-,
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M^+7>YE_%Y/^JOA+.I?)K$&NM/S\XD@TN5R",1(<PD;>8Y= YT4:*#"6%*WI
MH%=2ST3.M>HJ3__8R_RP.[F-R1]*[M)@5W8WB R#28N?CFW1CSK]], U[27_
M@;..7<WO;FL_X:SSUA2,@U-WG0MY+<XZ-B^_NWLMA2;@+\S8=W3J,Q@N"I\!
M=IT2%&,6YPS;Z5QL#DX\%E]5.XT,AQ?!N[4I-R-R:X=_!24+D2FFP&JWNF \
MV+'Z9']A+AYV>CZ:*6XM,.-M*5>(D0V8]/HCP".+BT"QT&)G9^FUT#"9V\<4
M+D]$&@%XOQ'@L')A#JBN8_-_ %!+ P04    " ")B:54 ^/A!S((  "I+@
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M?LC;MH;0>65@V#N V7O.BDB?DB*5\R@EF@<6>L5_HY(\L93)5RMPV*GKG<]
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M0AL]<</*/!$HK8-9+X706\,&Z!^=Y"]02P,$%     @ B8FE5+_5R$:< P
M2PX  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULM5=M;]LV$/XKA#!@
M+;!&(OT2I[ -)$Z'%6@&HUG;S[1TMHGRQ2,I.P'ZXW>D%,FM;34K8G^028GW
MW-USIT?D>&?L5[<&\.1!2>TFR=K[S=LT=?D:%'<79@,:GRR-5=SCU*Y2M['
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MT@3@\YG 3U4U,&?"^C_ X!]02P,$%     @ B8FE5($Z"9[* @  I <  !D
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M(? TX@BF #1@2!1UY^#!>11LSJE@^P^"V2]02P,$%     @ B8FE5)>*NQS
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ B8FE5/(CKTE=!0  #18  !@              ("!#0@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (F)I52$^C1%M@8  -4:   8
M              " @: -  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    " ")B:54U+7=>=0"  "<!P  &               @(&,%   >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ B8FE5%_T@U'3!
MAQ$  !@              ("!EA<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    ( (F)I51$>\P^N@(  *(&   8              " @9\<
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " ")B:54R!\-
MXIX%   E&   &               @(&/'P  >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ B8FE5)T&T9O)!P  NA\  !@
M ("!8R4  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (F)
MI50]/]93=0(  $P%   8              " @6(M  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    " ")B:542D]9260(  !0%0  &
M        @($-,   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ B8FE5$$H=@EV @  . 4  !D              ("!IS@  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " ")B:54SD2"0&<"  "+!0
M&0              @(%4.P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    ( (F)I519\Q'B; 4  $X-   9              " @?(]  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ B8FE5#\$JJWZ
M!   ! X  !D              ("!E4,  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    " ")B:54N_JV]EL,  !.)0  &0
M@('&2   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( (F)
MI512[8'LHP<  ,(2   9              " @5A5  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ B8FE5 [P=@VW!   W0L  !D
M         ("!,ET  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    " ")B:54>?RI"GP%  #0#   &0              @($@8@  >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( (F)I517E.Z,# ,  '\'
M   9              " @=-G  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ B8FE5 :1?TQ:!0  J@X  !D              ("!%FL
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " ")B:54K*\K
MS@((  !T$P  &0              @(&G<   >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    ( (F)I53^-_1D#@<  *\1   9
M  " @>!X  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
MB8FE5+T8B.B' @  4 4  !D              ("!)8   'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    " ")B:54X[)+D*@#  #7"0  &0
M            @('C@@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    ( (F)I5182IH ( ,   <(   9              " @<*&  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ B8FE5+G#I0U'!@
MA!$  !D              ("!&8H  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    " ")B:545MJ.T-4"  "F!P  &0              @(&7
MD   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (F)I53H
MDX8CU0(  $8(   9              " @:.3  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ B8FE5('' ?UF @  ,P8  !D
M     ("!KY8  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (F)I52+2304I@,  )(.   9              "
M@02M  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ B8FE
M5$-1&!(V P  QPH  !D              ("!X;   'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    " ")B:54.2O3[0(*  #B/0  &0
M        @(%.M   >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   ( (F)I509T \/B (  ( &   9              " @8>^  !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ B8FE5+_5R$:< P  2PX
M !D              ("!1L$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    " ")B:54]RC:V'8#  #;#0  &0              @($9Q0
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( (F)I51Q;?B:
M*0,   \,   9              " @<;(  !X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ B8FE5($Z"9[* @  I <  !D
M ("!)LP  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " ")
MB:54/!M5P00#   M$   #0              @ $GSP  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( (F)I527BKL<P    !,"   +              "  5;2
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (F)I51&>J&NE0,  /P:   /
M          "  3_3  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ")B:54
M/&'U&HT!  !/&   &@              @ $!UP  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " ")B:54F,0A):(!  "F&   $P
M        @ '&V   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ,  P  <-
(  "9V@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>183</ContextCount>
  <ElementCount>238</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>50</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Investment Securities - Trading</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTrading</Role>
      <ShortName>Investment Securities - Trading</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Revolving Credit Facility and Other Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</Role>
      <ShortName>Revolving Credit Facility and Other Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2114106 - Disclosure - Capital Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactions</Role>
      <ShortName>Capital Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2126110 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2128111 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2131112 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/Inventories</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Capital Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsTables</Role>
      <ShortName>Capital Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CapitalTransactions</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/BasisofPresentationPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InventoriesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Investment Securities - Trading (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails</Role>
      <ShortName>Investment Securities - Trading (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InvestmentSecuritiesTrading</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails</Role>
      <ShortName>Revolving Credit Facility and Other Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Net Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomeLossPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Capital Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails</Role>
      <ShortName>Capital Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Capital Transactions - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails</Role>
      <ShortName>Capital Transactions - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Capital Transactions - RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails</Role>
      <ShortName>Capital Transactions - RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CommitmentsandContingencies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/RelatedPartyTransactions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2430414 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="natr-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="natr-20220331.htm">natr-20220331.htm</File>
    <File>natr-20220331.xsd</File>
    <File>natr-20220331_cal.xml</File>
    <File>natr-20220331_def.xml</File>
    <File>natr-20220331_lab.xml</File>
    <File>natr-20220331_pre.xml</File>
    <File>natr2022331-ex311.htm</File>
    <File>natr2022331-ex312.htm</File>
    <File>natr2022331-ex321.htm</File>
    <File>natr2022331-ex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>natr-20220331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="503">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>59
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "natr-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 183,
   "dts": {
    "calculationLink": {
     "local": [
      "natr-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "natr-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "natr-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "natr-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "natr-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "natr-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 391,
   "entityCount": 1,
   "hidden": {
    "http://naturessunshine.com/20220331": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 7
   },
   "keyCustom": 30,
   "keyStandard": 208,
   "memberCustom": 26,
   "memberStandard": 23,
   "nsprefix": "natr",
   "nsuri": "http://naturessunshine.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://naturessunshine.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Inventories",
     "role": "http://naturessunshine.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Investment Securities - Trading",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTrading",
     "shortName": "Investment Securities - Trading",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Revolving Credit Facility and Other Obligations",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations",
     "shortName": "Revolving Credit Facility and Other Obligations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://naturessunshine.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114106 - Disclosure - Capital Transactions",
     "role": "http://naturessunshine.com/role/CapitalTransactions",
     "shortName": "Capital Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Segment Information",
     "role": "http://naturessunshine.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - Income Taxes",
     "role": "http://naturessunshine.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - Commitments and Contingencies",
     "role": "http://naturessunshine.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126110 - Disclosure - Related Party Transactions",
     "role": "http://naturessunshine.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128111 - Disclosure - Fair Value Measurements",
     "role": "http://naturessunshine.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131112 - Disclosure - Revenue Recognition",
     "role": "http://naturessunshine.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://naturessunshine.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Inventories (Tables)",
     "role": "http://naturessunshine.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://naturessunshine.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Capital Transactions (Tables)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsTables",
     "shortName": "Capital Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Segment Information (Tables)",
     "role": "http://naturessunshine.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Basis of Presentation (Details)",
     "role": "http://naturessunshine.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Inventories (Details)",
     "role": "http://naturessunshine.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRestricted",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Investment Securities - Trading (Details)",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails",
     "shortName": "Investment Securities - Trading (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i134f93f3e1e140309cddc401f5a3e5fa_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Revolving Credit Facility and Other Obligations (Details)",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails",
     "shortName": "Revolving Credit Facility and Other Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ic1c6c198e5a343b5ba0b67d15c5e7357_I20170711",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Net Income (Loss) Per Share (Details)",
     "role": "http://naturessunshine.com/role/NetIncomeLossPerShareDetails",
     "shortName": "Net Income (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "if98b729b54f5451a829590e8adb58f29_D20210405-20210405",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Capital Transactions - Narrative (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
     "shortName": "Capital Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "if98b729b54f5451a829590e8adb58f29_D20210405-20210405",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i2766fa78dc664de49f98b43876ee0fd0_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Capital Transactions - Stock Option Activity (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails",
     "shortName": "Capital Transactions - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i4f0037d3e1f447bebd497eae42e09eb5_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i75cc11a2a0bd4cec985a661aa5a5572a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Capital Transactions - RSU Activity (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
     "shortName": "Capital Transactions - RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i75cc11a2a0bd4cec985a661aa5a5572a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Segment Information (Details)",
     "role": "http://naturessunshine.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "natr:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Income Taxes (Details)",
     "role": "http://naturessunshine.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i2dff93085c7f44fa956bd391f58b99df_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i2dff93085c7f44fa956bd391f58b99df_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestOwnershipPercentageByParent",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i3f9df89d786a41e0b3d144f941fc5d32_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Related Party Transactions (Details)",
     "role": "http://naturessunshine.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestOwnershipPercentageByParent",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "i3f9df89d786a41e0b3d144f941fc5d32_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "if60740a0aa42458e9145ad1c8f41c4a2_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430414 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "if60740a0aa42458e9145ad1c8f41c4a2_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - Revenue Recognition - Narrative (Details)",
     "role": "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ia1d2ba59fdcf45a1b86c9db966d936af_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ia1d2ba59fdcf45a1b86c9db966d936af_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://naturessunshine.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220331.htm",
      "contextRef": "ife753c21309348fa8d87e87158807672_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 50,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_KR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KOREA, REPUBLIC OF",
        "terseLabel": "South Korea"
       }
      }
     },
     "localname": "KR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "natr_A2012IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to 2012 incentive plan.",
        "label": "2012 Incentive Plan [Member]",
        "terseLabel": "2012 Stock Incentive Plan"
       }
      }
     },
     "localname": "A2012IncentivePlanMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AccruedSeveranceandRentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Severance and Rent Costs [Member]",
        "label": "Accrued Severance and Rent Costs [Member]",
        "terseLabel": "Accrued Severance and Rent Costs"
       }
      }
     },
     "localname": "AccruedSeveranceandRentCostsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AccruedVolumeIncentiveandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the liability that is related to incentives that are payable, due to volume sales.",
        "label": "Accrued Volume Incentive and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "AccruedVolumeIncentiveandServiceFees",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]",
        "terseLabel": "Anti-dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_AsiaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Segment [Member]",
        "label": "Asia Segment [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaSegmentMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Banc of America Leasing and Capital, LLC, Credit Agreement",
        "label": "Banc of America Leasing and Capital, LLC, Credit Agreement [Member]",
        "terseLabel": "Banc of America Leasing and Capital Credit Agreement"
       }
      }
     },
     "localname": "BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BankofAmericaCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank of America Credit Agreement [Member]",
        "label": "Bank of America Credit Agreement [Member]",
        "terseLabel": "Bank of America Credit Agreement"
       }
      }
     },
     "localname": "BankofAmericaCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_CardiovascularProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to cardiovascular products of the entity.",
        "label": "Cardiovascular Products [Member]",
        "terseLabel": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ChinaJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Joint Venture",
        "label": "China Joint Venture [Member]",
        "terseLabel": "China Joint Venture"
       }
      }
     },
     "localname": "ChinaJointVentureMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_CompanysJointVenturePartnerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company's Joint Venture Partner [Member]",
        "label": "Company's Joint Venture Partner [Member]",
        "terseLabel": "Company's Joint Venture Partner"
       }
      }
     },
     "localname": "CompanysJointVenturePartnerMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ContractWithCustomerContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Contract Term",
        "label": "Contract With Customer, Contract Term",
        "terseLabel": "Contract with customer, contract term"
       }
      }
     },
     "localname": "ContractWithCustomerContractTerm",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.",
        "label": "Contribution Margin",
        "terseLabel": "Total contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_ContributionMarginAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution Margin [Abstract]",
        "terseLabel": "Contribution margin:"
       }
      }
     },
     "localname": "ContributionMarginAbstract",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_CustomerLoyaltyProgramLoyaltyPoints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Loyalty Program, Loyalty Points",
        "label": "Customer Loyalty Program, Loyalty Points",
        "terseLabel": "Customer loyalty program, loyalty points"
       }
      }
     },
     "localname": "CustomerLoyaltyProgramLoyaltyPoints",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_DebtInstrumentNumberOfMonthlyPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Monthly Payments",
        "label": "Debt Instrument, Number of Monthly Payments",
        "terseLabel": "Number of monthly payments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfMonthlyPayments",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_DigestiveProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to digestive products of the entity.",
        "label": "Digestive Products [Member]",
        "terseLabel": "Digestive"
       }
      }
     },
     "localname": "DigestiveProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_DilutiveSecuritiesExcludedfromComputationofEarnings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.",
        "label": "Dilutive Securities Excluded from Computation of Earnings",
        "terseLabel": "Share-based awards (in shares)"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedfromComputationofEarnings",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_EuropeSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe Segment [Member]",
        "label": "Europe Segment [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeSegmentMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_FosunPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fosun Pharma",
        "label": "Fosun Pharma [Member]",
        "terseLabel": "Fosun Pharma Member"
       }
      }
     },
     "localname": "FosunPharmaMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_GeneralHealthProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to general health products of the entity.",
        "label": "General Health Products [Member]",
        "terseLabel": "General health"
       }
      }
     },
     "localname": "GeneralHealthProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ImmunityProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to immunity products of the entity.",
        "label": "Immunity Products [Member]",
        "terseLabel": "Immune"
       }
      }
     },
     "localname": "ImmunityProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.",
        "label": "Increase (Decrease) in Liability Related to Unrecognized Tax Positions",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Liabilities",
        "label": "Increase (Decrease) In Operating Lease, Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.",
        "label": "Increase (Decrease) in Accrued Volume Incentives and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IndicativeIndexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicative Index",
        "label": "Indicative Index [Member]",
        "terseLabel": "Indicative Index"
       }
      }
     },
     "localname": "IndicativeIndexMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LatinAmericaAndOtherSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America And Other Segment [Member]",
        "label": "Latin America And Other Segment [Member]",
        "terseLabel": "Latin America and Other"
       }
      }
     },
     "localname": "LatinAmericaAndOtherSegmentMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "terseLabel": "Potential increase in maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "terseLabel": "Potential increase in maximum borrowing capacity, per occurrence"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityNumberOfSeparateIncreases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Number Of Separate Increases",
        "label": "Line Of Credit Facility, Number Of Separate Increases",
        "terseLabel": "Number of separate increases"
       }
      }
     },
     "localname": "LineOfCreditFacilityNumberOfSeparateIncreases",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.",
        "label": "Minimum Number of Claims Companies Insurance Coverage May Not Cover",
        "terseLabel": "Minimum number of claims that the Company's insurance coverage may not be sufficient to cover"
       }
      }
     },
     "localname": "MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_NaturesSunshineProductsChinaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natures Sunshine Products, China [Member]",
        "label": "Natures Sunshine Products, China [Member]",
        "verboseLabel": "NSP China"
       }
      }
     },
     "localname": "NaturesSunshineProductsChinaMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NonIncomeTaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to non-income tax matters, including value-added taxes.",
        "label": "Non Income Tax [Member]",
        "terseLabel": "Non-Income Tax Contingencies"
       }
      }
     },
     "localname": "NonIncomeTaxMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NorthAmericaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Segment [Member]",
        "label": "North America Segment [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaSegmentMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NumberofPrincipalCategoriesofProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Principal Categories of Products",
        "label": "Number of Principal Categories of Products",
        "terseLabel": "Number of principal categories of products"
       }
      }
     },
     "localname": "NumberofPrincipalCategoriesofProducts",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_OperatingLeaseNonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Non-Cash Lease Expense",
        "label": "Operating Lease, Non-Cash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseNonCashLeaseExpense",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to all other international countries.",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedRestrictedStockUnitsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "label": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsRSUsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the performance based stock options, which vest upon achieving operating income margins.",
        "label": "Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]",
        "terseLabel": "Performance based stock options operating income margins"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PersonalCareProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to personal care products of the entity.",
        "label": "Personal Care Products [Member]",
        "terseLabel": "Personal care"
       }
      }
     },
     "localname": "PersonalCareProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_RestrictionPeriodForIssuanceOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the restriction period before shares will be issued related to a share-based compensation plan.",
        "label": "Restriction Period for Issuance of Shares",
        "terseLabel": "Restriction period for issuance of shares"
       }
      }
     },
     "localname": "RestrictionPeriodForIssuanceOfShares",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_RevenuefromContractwithCustomerRefundPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Refund Period",
        "label": "Revenue from Contract with Customer, Refund Period",
        "terseLabel": "Refund period"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerRefundPeriod",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Segment Reporting Information, by Segment1",
        "label": "Schedule of Segment Reporting Information, by Segment1 [Table Text Block]",
        "terseLabel": "Schedule of assets per segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegment1TableTextBlock",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "terseLabel": "Award performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements",
        "terseLabel": "Minimum withholding requirements (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number",
        "terseLabel": "Nonvested subject to restriction period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the first operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One",
        "terseLabel": "Operating income margin, one (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the three operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three",
        "terseLabel": "Operating income margin, three (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two",
        "terseLabel": "Operating income margin, two (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability",
        "terseLabel": "Discount for lack of marketability"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.",
        "label": "Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.",
        "label": "Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_TimeBasedRestrictedStockUnitsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-Based Restricted Stock Units (RSUs) [Member]",
        "label": "Time-Based Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Time-Based Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "TimeBasedRestrictedStockUnitsRSUsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_TimeBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the time-based stock options, which vest over differing periods.",
        "label": "Time Based Stock Options [Member]",
        "terseLabel": "Time-based stock options"
       }
      }
     },
     "localname": "TimeBasedStockOptionsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.",
        "label": "Value Added Tax Assessments And Other Civil Litigation [Member]",
        "terseLabel": "Value-added tax assessments and other civil litigation"
       }
      }
     },
     "localname": "ValueAddedTaxAssessmentsAndOtherCivilLitigationMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_VolumeIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.",
        "label": "Volume Incentives",
        "terseLabel": "Volume incentives"
       }
      }
     },
     "localname": "VolumeIncentives",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_WeightManagementProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to weight management products of the entity.",
        "label": "Weight Management Products [Member]",
        "terseLabel": "Weight management"
       }
      }
     },
     "localname": "WeightManagementProductsMember",
     "nsuri": "http://naturessunshine.com/20220331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r46",
      "r48",
      "r100",
      "r101",
      "r236",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r235",
      "r256",
      "r297",
      "r298",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r474",
      "r477",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r235",
      "r256",
      "r297",
      "r298",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r474",
      "r477",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r176",
      "r276",
      "r279",
      "r428",
      "r473",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r176",
      "r276",
      "r279",
      "r428",
      "r473",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r235",
      "r256",
      "r287",
      "r297",
      "r298",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r474",
      "r477",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r235",
      "r256",
      "r287",
      "r297",
      "r298",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r474",
      "r477",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r47",
      "r48",
      "r100",
      "r101",
      "r236",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r177",
      "r178",
      "r276",
      "r280",
      "r476",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r177",
      "r178",
      "r276",
      "r280",
      "r476",
      "r485",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r295",
      "r406",
      "r407",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r182",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33",
      "r415"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r17",
      "r183",
      "r184"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts of $148 and $143, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r13",
      "r445",
      "r461"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r51",
      "r52",
      "r53",
      "r462",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r53",
      "r59",
      "r60",
      "r61",
      "r104",
      "r105",
      "r106",
      "r362",
      "r478",
      "r479",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r300",
      "r321",
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r21",
      "r185",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Share-based awards (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r158",
      "r165",
      "r172",
      "r188",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r356",
      "r364",
      "r384",
      "r413",
      "r415",
      "r443",
      "r460"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r45",
      "r95",
      "r188",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r356",
      "r364",
      "r384",
      "r413",
      "r415"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r301",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r30",
      "r90"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r82",
      "r90",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the period",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r82",
      "r389"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r218",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Common stock, dividends (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)",
        "verboseLabel": "Cash dividend (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r104",
      "r105",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Common stock, no par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r415"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, no par value, 50,000 shares authorized, 19,461 and 19,724 shares issued\u00a0and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r56",
      "r58",
      "r66",
      "r355",
      "r368",
      "r453",
      "r469"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r265",
      "r266",
      "r277"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r73",
      "r428"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r94",
      "r102",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r400",
      "r444",
      "r446",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r38",
      "r250",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r39",
      "r94",
      "r102",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r39",
      "r94",
      "r102",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r254",
      "r259",
      "r260",
      "r261",
      "r262",
      "r398",
      "r399",
      "r400",
      "r401",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesTradingRealizedGainLoss": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Realized Gain (Loss)",
        "terseLabel": "Debt securities, trading, realized gains (losses)"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesTradingRestricted": {
     "auth_ref": [
      "r425",
      "r486",
      "r487"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Restricted",
        "terseLabel": "Restricted investment securities - trading",
        "verboseLabel": "Trading securities portfolio"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRestricted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r88",
      "r96",
      "r340",
      "r345",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r88",
      "r153"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r276",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends",
        "terseLabel": "Dividends, common stock, cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Basic and diluted net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r67",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r118",
      "r121",
      "r127",
      "r128",
      "r129",
      "r133",
      "r134",
      "r371",
      "r372",
      "r454",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic earnings (loss) per share attributable to common shareholders (in dollars per share)",
        "terseLabel": "Basic earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r67",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r121",
      "r127",
      "r128",
      "r129",
      "r133",
      "r134",
      "r371",
      "r372",
      "r454",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)",
        "terseLabel": "Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Provision (benefit) for income taxes, as a percentage of income before income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which the remaining compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share based compensation potential compensation expense to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit from the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r59",
      "r60",
      "r61",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r136",
      "r189",
      "r258",
      "r263",
      "r325",
      "r326",
      "r327",
      "r341",
      "r342",
      "r370",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r478",
      "r479",
      "r480",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of the Company's hierarchy for assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r374",
      "r416",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r373",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r373",
      "r374",
      "r376",
      "r377",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r241",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r241",
      "r288",
      "r289",
      "r294",
      "r296",
      "r374",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 - Quoted Prices in Active Markets for Identical Assets"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r288",
      "r289",
      "r294",
      "r296",
      "r374",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 - Significant Other Observable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r374",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 - Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r241",
      "r251",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r416",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r378",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r89",
      "r387",
      "r388"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r75",
      "r88",
      "r186"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedLabel": "Realized and unrealized losses (gains) on investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r71",
      "r95",
      "r158",
      "r164",
      "r168",
      "r171",
      "r174",
      "r188",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r384"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r158",
      "r164",
      "r168",
      "r171",
      "r174",
      "r441",
      "r450",
      "r455",
      "r471"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before provision for income taxes",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r336",
      "r338",
      "r339",
      "r343",
      "r348",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r98",
      "r115",
      "r116",
      "r156",
      "r334",
      "r344",
      "r349",
      "r472"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r87",
      "r427"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r129"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock-based awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r80",
      "r84",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r22",
      "r192"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r44",
      "r415"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r24",
      "r192"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r23",
      "r192"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r442",
      "r456",
      "r484",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investment Securities - Trading"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTrading"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r95",
      "r166",
      "r188",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r357",
      "r364",
      "r365",
      "r384",
      "r413",
      "r414"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r95",
      "r188",
      "r384",
      "r415",
      "r448",
      "r465"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r95",
      "r188",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r357",
      "r364",
      "r365",
      "r384",
      "r413",
      "r414",
      "r415"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r14",
      "r446",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "verboseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Annual commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r12",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of credit, outstanding, current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current installments of long-term debt and revolving credit facility"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Revolving Credit Facility and Other Obligations"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Long-term debt and revolving credit facility"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r212",
      "r216",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Provision for losses"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r43",
      "r95",
      "r188",
      "r221",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r384",
      "r447",
      "r464"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Joint venture ownership, noncontrolling party"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Joint venture ownership"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Increase (decrease) in noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r43",
      "r72",
      "r354",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r82",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r54",
      "r57",
      "r61",
      "r64",
      "r89",
      "r95",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r125",
      "r158",
      "r164",
      "r168",
      "r171",
      "r174",
      "r188",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r372",
      "r384",
      "r451",
      "r467"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r54",
      "r57",
      "r61",
      "r115",
      "r116",
      "r360",
      "r367"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r118",
      "r119",
      "r126",
      "r129",
      "r158",
      "r164",
      "r168",
      "r171",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r263",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r32",
      "r99",
      "r408"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Related party note"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r42",
      "r99",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).",
        "label": "Notes Receivable, Related Parties, Current",
        "terseLabel": "Notes receivable, related parties, current"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r158",
      "r164",
      "r168",
      "r171",
      "r174"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r402"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r103",
      "r117",
      "r144",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r49",
      "r51",
      "r385",
      "r386",
      "r390"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation loss (net of tax)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r55",
      "r58",
      "r59",
      "r60",
      "r62",
      "r65",
      "r258",
      "r391",
      "r396",
      "r397",
      "r452",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other loss, net",
        "verboseLabel": "Other loss, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Payments for Purchase of Securities, Operating Activities",
        "negatedLabel": "Purchase of trading investment securities"
       }
      }
     },
     "localname": "PaymentsForPurchaseOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "terseLabel": "Proceeds from the exercise of stock awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r301",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from sale of trading investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r54",
      "r57",
      "r61",
      "r81",
      "r95",
      "r107",
      "r115",
      "r116",
      "r158",
      "r164",
      "r168",
      "r171",
      "r174",
      "r188",
      "r221",
      "r222",
      "r223",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r355",
      "r359",
      "r361",
      "r367",
      "r368",
      "r372",
      "r384",
      "r455"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income (loss)",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r195",
      "r415",
      "r457",
      "r466"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "verboseLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r68",
      "r191"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r295",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r406",
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction, amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r295",
      "r406",
      "r407",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party transaction, rate"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r295",
      "r406",
      "r410",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r404",
      "r405",
      "r407",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-term Debt",
        "negatedTerseLabel": "Principal payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedTerseLabel": "Principal payments of related party borrowing"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r88",
      "r197",
      "r201",
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r199",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r263",
      "r328",
      "r415",
      "r463",
      "r481",
      "r483"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r189",
      "r325",
      "r326",
      "r327",
      "r341",
      "r342",
      "r370",
      "r478",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r149",
      "r150",
      "r163",
      "r169",
      "r170",
      "r176",
      "r177",
      "r180",
      "r275",
      "r276",
      "r428"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net sales",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r278",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of consolidated property, plant and equipment by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of revenue generated by each of the Company's product lines"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r25",
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of composition of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r408",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r70",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of consolidated net sales revenue by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r158",
      "r161",
      "r167",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r158",
      "r161",
      "r167",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of reportable business segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r301",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r305",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r145",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r200",
      "r205",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r147",
      "r148",
      "r158",
      "r162",
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Net sales:"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in shares)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant\u00a0Date Fair\u00a0Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Issued (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic values of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited or canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r307",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at the end of the period (in shares)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the end of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted\u00a0Average Exercise Price\u00a0Per\u00a0Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r299",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Unvested stock options outstanding (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the beginning of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r264",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Capital Transactions"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r145",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r194",
      "r196",
      "r200",
      "r205",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r41",
      "r59",
      "r60",
      "r61",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r116",
      "r136",
      "r189",
      "r258",
      "r263",
      "r325",
      "r326",
      "r327",
      "r341",
      "r342",
      "r370",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r478",
      "r479",
      "r480",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r136",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r258",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "RSU issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r263",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r60",
      "r95",
      "r104",
      "r105",
      "r106",
      "r108",
      "r114",
      "r188",
      "r189",
      "r263",
      "r325",
      "r326",
      "r327",
      "r341",
      "r342",
      "r353",
      "r354",
      "r366",
      "r370",
      "r384",
      "r391",
      "r392",
      "r397",
      "r479",
      "r480",
      "r507"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r449"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Investment securities - trading"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r331",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Potentially dilutive shares included in the calculation of diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r120",
      "r129"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted common shares outstanding (in shares)",
        "totalLabel": "Diluted weighted-average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Diluted shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r118",
      "r129"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Basic weighted-average shares outstanding (in shares)",
        "terseLabel": "Weighted average basic common shares outstanding (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r501": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r502": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r503": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r504": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r505": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r506": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>60
<FILENAME>0000275053-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000275053-22-000010-xbrl.zip
M4$L#!!0    ( (F)I524MSW2GGT! *)J$  1    ;F%T<BTR,#(R,#,S,2YH
M=&WL?6E7&TF7YO?^%1IZ9KKJ'!+'OKBJ/(<RV"_5EK !VPU??&)%B;7PIB1
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M3E"2?$QAA6$8RZ"-0M9C2Q=@*^M%PBF/8^<0"5YIQ3G3 #2Y]M0[F\[G8U:
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M[>;?9YLCLDSQZ&@E/5;6T:@10XPHKX/5P:BTU[-F<7'MV*VSML\)HE"FN%1
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M>X*/^[5>MY7[6LD,0,3Q\W[W^"6Y\?#8^+0$[R6JX?(3W]KPHARG>Q+B#K&
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M^WU0D:$%.J_H=A)@;0UK <#KL+:5S&LZ9>HDU#9,WXS6CEXS ]_JN!P5W1E
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MK+<L5/+TY"2+A0[['FQLDOW/6Z?UO3K4O3YLO-WBC?8_.4!@LG_^#[3K SF
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M']3%^=[C^L_\[&6GVWE3+B_N=FJ#3M[?27'.0<^OE D5T/KR1HXIBYI&&G#
M#%&DG?>.(1RYH8%'\V4K@51$*5XI-W)JFU;OKY4,1*)CVB'5F!T:<_PR<=)Z
MQZ=_-K^QT7K_M2F*(0S;IY1UME(;Y0+ =\_Z+SN#=N:[96 V50M"!L,72G$K
M SR>?AK:C>[).[)SLD_K W^T>7+P5A]MM]]\W?Y<1]MOMU#]:/-\>V^GO;_7
M:M;W#H=U\H$??&[D^^U&NWY>I^]HH[5_?MP\V&@=-3::>6-CZZQ^_A4=M#?Y
M_MXFJQ\UH*Y/1_OM?XX.CNKG#:S.MG=UV[7?=. [4&^S?= ^:-7?[I\=['W
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M8%)(0 7F0!LC@%$&,V^$<HG]2%:G.,M\*EA3ZG.SAF:V4Z'ZSC9H@LY:8AR
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M4"0(Q#35/T8-).<#R/Z3W1K/0</OSSVRAM=0PV<XBB4P$($C1V%)PY4+0-J
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MQ2"O@==1C$QZ9)!)I>&J*L"4?24UU./*24C6XZ7K\0P=<5%^&%L'F("1CMA
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MG^Y?+_?TM^Z,?*E-?R9EVKFF2Z_[96W,O-7<?:N9SS2VEC!-(_/VGB- @U!
M<Q% B)N+@\AI#</&EH0/SC/.RIPQ-XLIBRF+*8NI'@SFX?6M,H-Y @8S9RP[
M&NDG4A9(JAB@"$%@$&1 *"@<#X@9 ^M&82J*JUX=6WA0M$O-*$*_=UX,3WVT
MA'W?M@=E@8-!4IVB=Y&D,BATUQ6?_6"8ZIK$-Y.[J=^VJ8K)^'-)J0>-8E+B
M>QR '"]G3W7W8[I#KU]\:0]/DX\K76*HOSXDDOLYH>"-P=H/-.6N16UW];!_
M&PR.5T'YYN%8SMM==W0EVO*-O<F2<!D3%\#$YLY<"+>(-AR"E &$H0;4< 54
M4 ;(%(HE @T0FXTM)&5%OL,:G9P\<]5>J(+GPWTT,^>J/U/P,<_)^KT,_9YK
M6H)5\!QZ@(6.E$=$"1KO(8 "$TX1\S+U8A*J@A/3K-KU-C&SF+*8LIBRF%94
M3$];D3SSF2>R5^8"'KB)\DH^')F.H:*! I2U DAOJ-'<8:5UC0C-.H4R'/F+
M4=^>ZK&GQI8)V6-'S)H%,=P.54MSJ_PLK/6[7&[PLV1 6@20CN<<* 8:'I1U
M($@L  W8 4D"!Q&B. M2:6/,QA9E->F.E ^':N@[N;O.EE0C1U16J,]SW<ZP
MP!(S X3T49\-)9%?0 P"I<XS[IPE./*+AA)9HU=(H_.I?!93%E,6TUJ)Z9%=
M)IG&/*%9,NLGL5PH(B #VF$5[1*E@?9. A$XY<%BCQ6I%8]9IT"7IA_^O#GG
M,_?E9I=[%E,6TU-L\RQ0Q QU1AH5+5IHO(,48XX,E5 '?_]>K6_[O= >OBGC
M5//&7M'&/E] 20KBN$<,6 ,-H(QX8%#<X:%&@3 8-970C2W<4 S6XP0DZW#%
MX>@,V\C.-0L&,AILI'D.(D*T4(P*C^W"3/VZYF;E7$0Y9XOX<,FLP)("&E=@
M5$XM@%)* HJLLIAA&C".RLFKRL3.^IFI4!93;8)$,A5:*MK.^3@8TU(CPX!@
M$@*J( %2,0G2MDB5))2E,KNXP26O!Q=:IVB0LBE.6=+BJB%.T?E9,YSGZ8/-
MKO(LIBRF+*8LIBRFNHEI$;;LH):(VQ"HEE1IK;E4RB.-/3:,<G5_MEP2A1\:
MY^V71R.)/S?]\#"T]-=,E1>ARI=SM3.#X@HY*D' Q@%*0@ :6@L45=X&YH1W
M<F-+B8=$36?UK;'Z+L_8S>I;O?K.5ZYPW'*C/1":6T"A<L!0J($6F&FF=>"0
MUDA_UZD9X('NV]-I)T!<02? \52^(''N76]D.KZLK7E[U<U5A*[%$B0TIT31
M5-76(ZHLE9Y@0TW C%H!#2H+VOZLW$1N$OA(V'4X7V&"0(N@@B&R#H0!18R
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MGY%Q99%Q+B):."<,A0 I%BDCU [(8#Q0PC@N*4,!EJ4/&Y#,!XUD8,S N%;
MR#"W,*4*>$8H)4@93:@2*K((Q1BB&1A7%AAG YB-0L%K0X"B1$;*B"-EE)0"
MIU0*5X<<4Q8I8T/2BJ,\,B[6"Q[6%A<7JE-C3! LD@GM ]642Z&LD9 *ZA"T
MY"? F..-5P4A9^.-&1,<6JZC%4TPH$88H!CV@#!)0Z25+!K;&UNJ$7?&RL*-
M,SC6"R/6%AP7P$:HO-!4&AXDHDH:#3G15E/M8+#&XTP:5Q82YZ*#M8#8$8R!
M\IX"*KD%QF@*=$HNCWLDAZE@'V*B@4E5W026#HWK5/ZZ/*L$)G6^*XM@^^Y
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MG^>T<]@Z^'K02LU+3KY]B.,Z^+:'#UN6-<^.SN*_^,/N4=F$>C;T1#,/!>%
M&60!]<(!'00&"CN+-291G"HRBP:7#SD&K5_:; :EU0*E7._JV4'1;&J'%9(Q
M@@D0@4) F6? ,!47+1+*."PH0["B<E?U2P->&;JW[<Y&@V%YEI>._OH^ZIYM
M=WS9T_X''IC>3B_:U&_MHM]+%?%=82Z+WT;IJ+#=_4_1N_#I5*7[L4AR_-P>
MMOW@0;9:7:V'ASIWEFF.K?R<56EQ(55W!7R;-&F0]L"X%Y6Q#<,PZI0G\Z/R
M6/%YE)Y; C&HP%B9(P9C4;SJ]7<G@MB>R"&S@0780/-XSC!1"BE!G0$B2@=0
M9*.)HEVD! 1)2G"@6$3#Y,'UA>MGF62%72J3_XG"7N?VH?W5._#-]WM9D1=3
MY%E:'P4F,.,>.)$4V4@$3(@2(\1A:S@,U(JK:GHU4N<JB7W]6<6NOXA4OEV&
M.!6ZZPI]GH)HOY4O/)=^/:O *:X+(O[>\64D<]=M7Y-'=D-4AE?M.>(A&5+:
M.PI("#3B56IM8 D"FFN)<" *HM(C&K>@&E7=7O.J^:M /K)F/[)FSS$1)H,,
MD*>V0@90J""0&%K@@Z0.HXCDFI2:7:NV)>OEW6CVNJ!T&':\'OC"?[U(B079
MJ;%\ M+5P_Z+PZE#]DV:_BB,U+2T_'UO+(D,4)4!U UE!"G4Z< 56$4C0$E$
M@<(F+FA-'5?.:&Y<J@. !*F1H93]'K6E'EFG'UVGYTXU87">!P&LY1Y0ZP60
M-#A@C"(VVA06^I0"V2!HOJYQ=GX\CFJ6=7*!T>,,QO.D%&-'R$/HQWI8297[
M/TI9_)E$L7--$AF%%D"APYTY9N%$(,H%":#E$E"L([/PV@#B',("P2 LW=B2
M\,$8E%T:-5;6RET:MREKYA.5:?(LGU!QI6IM G!"\&@C> N4(A! %#2C'#((
M4P'<!H1551I_!#XQS9>,@_4_5__'^N1Z>5UV??#]?AF4509P#?57GR-)'O74
M9RR <5N9EOXZ,<W^]%T?VJM1I68E$/6@M3V<K5*31*2PLH!0@B*D4@=4H!H(
MAHFD!BN$U<86:4CZX/*+V>U28ZU>PHG/+[0Z*^YBBGLY6U[*8BRM (J2Y%LQ
M'"@),0A<"Z8$\Y["C2W&LV?ER8)51WU[F@YR>J$8]G5Z@L@Q/OMQ!'DQ\';4
M+Z.^U\W%\LA)=C-A</JR#.!_U>M/!708CJ]D<>4PWKX*RL]0M1!4[<UQ#&XX
M5QYCX(RC@$*O@=(J_B#(VQ XU]:FYG8/KS6:72^U5.+J8UFS$B]=B6?XAD*6
M>6LA@-YA0&F 0 ?M (*4NH -4AQ'):Z@8' .'+E'6DR<.C<H0K]W7@QT9TF<
M8SU,H66DRI3B>16E<QR%DZ&J2JC:G^,;AF-E44# R$@U*%8$&"]IY!L.0J$0
M9SKR#?)@'W%V:-18BY>1/Y.U>)E:/$,XA%=66"V!@%%W*?4*:,HP0!H2)P(G
MT*66V*).:KQ>#HXC'T?QS;LR9V;4[4__3!GP\3:_?=3M[N _1=33[Q1D[9P=
MM2@H]#I*(M7P..SN?Y=$1JB%$.I@CF=03RB'D $D#0+46@-4<#!5[D!>$.D5
MUQM;K*KB_MFYL1[.C:RLE2CK#)TP!DDN8-1.&3"@CDF@,/9 2PJ5<8(P#;/_
MXFG4[56O'_],(:?V5'<_^@F#R#Z*)Z *$UGLC/I]W[67K7Y\HO%XIKCT_HKI
M95!:")3>S3$()PD/P5O@G7& (@J!9(P!@2R"0EE/@]O8JJ";>W95U%B9*V 0
ME2ASCK.J4--GZ(>64!(O'8!2JZCIB7EP)H D&@<E))(DT8\&PZI&NKYN!?YV
M2OI1MH_1D8$,!Z5KH]/6IMUYO@7ZZEPO?>7G;+V8_+2@5*J-Z=N?4^^?S.*?
M@,7O=VT_9;GN^O&_^]VI9(ZN!),W_.HV_)/YP&H=_P>M!I'-<4"I$\ X10&3
M#ENB#)=&I@V?4E&C#3^3^_K[![-N/[INSY!YRIBQPDA I$D-U!T'"C$"#&."
M4.Z)%'+<.&">S#])XX#U.I=,;O/NL-?/H=6/&^<T#TS7))$1J3I$LG-L@QF&
MK>40*$T@H(23B$C* &0P=PQB191/:5ST08B4#R)K;$PLSXOX"[W.JKN8ZLZ0
M">^LX)XBX 65( (Q B8%+TH<:89#GE+.-K98KLOWA.'5_D*WW;0BSM@IV!N>
M^GYA2\_Z<.(M7#=71\W8QD1.T\S32<+I=M<=)EEMER+*-*0Z+/LX1T/BMA-!
MBW'@L!: :F:!\H8DST?@4>C6,YX,(X;F@Z)6N:-:5O1']7?<3=&S+B^FR[,)
MYLAY3A4%046%I@))8#2*JDTXML@+Q:&(NBP>DK:971SW5,ARH3^$=:RP350S
MUE&*XGL"2 :?Q<'GTQR1"$%92S4&ALMH%'D9B02E"ECN"64H>(M0:OJ>G1DK
MI+@U=69D!:Y"@6?8@].!&X93XE90J9-(9 \NM39U&%JN(29*1P5^<%&I[-1X
M:*3&A;Y<QS"->G1ZO_TL]^U8+!F(%@&BL_D"=]0;$S&( 8J)!11J!;02$9=8
MB&\0&(V9"$2*/J\6[\]=>^OEC\@Z^T"=G2$/."JHLD@ SW!47"HU,))!("S'
M$EEF7&I#QM2#,RNS_^'^[*$_\J[XW.N,SGTJG>N[P_;GR=E(O.KGMO5%\#D"
MXW%Y1=GT9!:@VMV)N/XNI;5_):PHJ^.QJ%[Y?)*[(&S-U[D+%$71<0(0#3K:
M/,0!99D$&#$::0@RP9F-+<KGC9[LM:BO0C]9[Z)[JW$^X:Q0QV>HB17&$PD#
MP(1A0#7E0 <) 18>!6TTI+9L:<0?7B\[NS8>2$ZNY6UE[T9MO!M)-&^^2R;#
M575P-5\*SUMM O0!6!@LH)A*8 1)Y?T%IHXB1EPJ4=,@,OL_GJM^/^992M;O
M)>OW;%4;;X@DP@*;:MG0(#206!E@&0GQ+Z]4RD3AC:CX]=#O]7*37/46ZOO/
MOCM:NV:*=:4A._'&:4C_M(>G.Z-!G"'?GV+694:LZA!KOF@>DT)'V44#"MD
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M^!01FU=5-%KZ:RIL?MKKI(E\U>L?G^J^_U,/<O+K W!KOK6C@UPYR14@U"A
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M[]A;9LHQLP<>G6!+<'2"/>?1B:I]P4YK.]C>5LOOFLZ/D)?I_?_ZC=[%E]3
M()_L@3??E4<;]SLFR<-6/@.TA,<N!F>[3XXNOW_\1.JG!_S[MUU>W_\$]VLV
M#DYVSNOTX.+[R>?F[O;77_7+KVP\Z7QON_[C^_97^OWD&.Y_1.K;GR[VOOVG
ML7NRQ;Z?_.>T_O'K>7W_/0-5C[LG1_S0.4R(5Q1YEXJ&Q>38!E& R& 1'"^L
M*\3XN0NIF<'&%-1RR1UW.F#!L''$J*)@;*(;WM5ZU:Z6I89JU7K<?!9C^<Y4
M3#\><OND7)_$@&G!L.124,*9T(HX#1^3A2;&X,BOSFX\])36<LS/[<^[U^^D
MQBFY<T;W2D[2$><(N-ZN]9*G/V?UJT55(DPP<R6\E>3FLB2-=$CO110C>7*$
MV=O^=&BU8Y%*C[ ,"6" , #D,Z2M!@M O1>L2)5(] V52'JS6\4\1[7"E2S<
M1Q;VCPZ5<<%H&E'2?<0#E\@XZE&DAA:!%!J,SMHFV9A2!&M$%F:5GDGB4/;0
M2H=@P;9WPY-76DY.-G ]^.V.0@/4\#+XC\!._@L#?A$5U9Z>J.SO7AS:Z#W5
MUB*CT@8_#AX9;!VB3A1*PA1Q CA2S*BAEF4#)GEN@5AX(;V5'#Q #CX!8=61
M%)P[E(K((>XD12:5,HN.6><#*P)PK4TBILO!8NHKW[>6_Q(>!+ZCORF6P-_D
MS^5O_K?=.MH/G=.DNLOB+-8;@QC2SF7J7?I]_\?EP?[Q\<'EIU_U;Y\;]?WZ
M\=['?^":/WX=7/K3.MW!$R>43W;)[N5Q<R]_]@/<^SWY_G&'[-+WH,<P_GUX
MC1ZP@Y//X"P>7.Q^.L21@!$'=2-"%2G#*O46<0H%(JWG3"O%]+BG S2?%9(I
M#CR?&T$ Q*53GD0?"UD4?-Q=_!Q^MIL_DQ?PKA-\HS<H\U2V8MS+]4/V;+-Q
M5-8?NM5]O+&TW*2C<NMPE]'GVFO5_M-O7M1(1BXBUVOGH6R;DOO1Y:;+G>&\
MNG)>S1& 8';+<[.6OTSK1S*/6WD>S7JMOK&UL5Z^9VJVW>FTS].W<_DK^&"I
M>_,84T><<$2K ,X79[:P8,&%]*1P19 PZ8F $XDEN69#=^H?)C02)F OEN(Q
MD(Y=\ZMQVC_]:S#.=^8,WNE=O PZ_N3ZO._((19*$"P<BI%JQ%GRS2@!8D5D
MB (7X)?;=#KM)D+^6S*G51/:2E^W!G(U:$B[48I*%M)6J(0T5\<)4V0Q]5@Y
M+6UR*JGVJQ>J9F"I<4_922UW.&\/9#Y?C8U5ZZF![+3+AD15;Z*JG5&JR3:0
MD;GI( 5V@:FBDEG.M8Z&XVA,JHZH P"@RRXDQH+,<"%;IM>92WH'S3@^=-JG
M6\,G&'[L913>?GKIOOQ*#J734H'U!PN%*4AWRNNWC",6?5"1B& ) Z8X3;I+
M>1V(. A/_RP)WDQ!&0K40L1E!/!FR@M8.W"!]^*7LJ%9&,C)=8$ <^*24)RW
M.[X;6DOC.3R]/!RPPR@L%84/R 9*$!>%1)J!0RF= 4?.4V$]T-SL&4S"7;>:
MY]3JJ9SHLEMRK9GZBO6.P>2_:!S9;;32]_X&F7)E3S/W,BHL/[DLU;>WR*%W
MA%L:':+<,_!"X8<I2($*09S6!>68 Y.]'5J"<<<;M;U!:50UB&6=E^WL4L>Q
MUHA-JQK@3=C,7&YOV&,\MR2N[8 %_56+S7;[JOMF#9;,#;JVY[(]9;^5C6'_
MMEJNAU@V':^,\+A5SP5^RB:E95T_;U+?;+B3R85$DYJLU\Z:_>XU[VQ2+5H9
MP\8T0X=@ X^$$V$X#50+#"S$884MQM[[*N#"L$*#7VXAB\EMV\DM[M/H_TK-
M"K^<I0[0>ZW4?C#M&:;ZL.1NXH[H&Y/WO>V#7X><6EHPJ9$,3J;65B#OP1ED
M,2?&4Z=""A'0#3JEN=!9Z+A,!I,P_#:?-'A-A=+*BV@$UX19%J(FE$5,HV N
M3M^^X3>+P$#6TZJ_']1O_+L<I3FZ(^R]13D@ASIXH86(R#D-_K_P'C@5"4@;
M'ZDS7#K+DQS(*4T$*CF875C^]S*&GQ"O;)WNVJ?@:F;,B2$,7<XY14AH&X-F
MF&O!)0A3H!(D208F'(7!SP\HT^SNUU:_&_S VKX;#OQ#6$G6K9*U__[7H39:
M*VX] LN9FN2 &PJ0SU !-)YJ#1Q-Y28YMR),NU4UE$X+DG>/1ZJ#7TG41FUK
MZK;BC=T-4NPI9 ]UGBT$R@MA#'?.":X8V#$.@E@(#-=F0ICIVXZWR-UU48J-
M7\&CR]!IOUV*#^.H'QT*$D3$QB,1=0II4(TTMQ%1ZRSVW'AAV5QIBL;B2)P4
M &\%-X6P0-*MUI+BJ"7W>+H%6JW>O58/0%DIZP(*V@ ($.>1I=2CP(@0FA4&
M2P"!5GL" J9T3>KWNCW0Y<1(JW+0(]QVG-,NK ?>DL6%]Z<\:Y;OO!?J^MT>
MW*-S,=)3P+5_!O@]%<DNNZ#G?@63;U<- %+C@G8N0=UM-^$M=U'U%$_]HX["
M6"/Q:5-?=I=JI+8'PQ8$YJS1JWIMIP;:_4X8UNR^_EI933S-L^T%WP)?'#[7
M"&F?MS4L]GW4!]<=5#I?I&VJ%N/&_\PUPM=KL&P-6"@/OYZ&SE'HI,;JPX+:
MPY[DN<!YA'>3,:D:LH=?+IQE2G.6NHKW>CG</D/$IBY&+EW>3!VU.N4><,U>
MY/F$M>^G!NAETZU8\8SU01N)M  N-'XF]V7]6OW5JU8,Y2!O: >;'<W<P2O-
M>OOTK-G(BI)C_F6K==L;67.X7$(N>'/60[Y.-0('?>NLTV@.RK?C:?LK,W=5
MW,BN2NV_(,5I0=,JO2OE?+WVW_^^NV&C9:[(DA.FL,+IZ H']LHI(3GQ)ECP
MTG!1#")+G*[V6![?J/U@8-0(!IK 4I=6K0SB0&13QH) C!7>>*PH3IDKXM98
M4=YI6:MD9D+SUG[/<:0ZZ&JNMDKTJ*3^"JZ?L*DBQ[,NDJ6R%, Y\RP-^%7!
M8\U$$+PHHB*2FZB,4AI[XFTI=H00?6^:M!*KP5;\5I&.) =";?0!N1A3(HRG
MP)6<! "T/@1)P<4@J0VPO%FL-FK?0NIX,8P%9LO9NAC=)!OA33,%!_Y7RT2V
M[,T!J#6?FQZ4YT$Q':0DO-#&,.V94-JK0@9B])UY]IRQGK?J=.^>[/#=3X="
M,D)PZAX-]!H8M[1(.4+!?0)?R7@>8TP'VS>F)5,- SJ)3752/Y;_]1N=<ML6
MF$(O-<@!(C.?( &QF"DX(*89ZJY+C@##!H/GF"G!:21*^$@]4:'@!>9$YP!/
MMGCH%M.7=U6NR\]@GVTWI8HU+_XN1]!]NX[:R2Y+IVF5)\+A@$B*_G&1ZIL0
M^"T&&> /0YF(J1["E+R!<B)KU5HF#C\?P7G@<D]/Y[Y:\+]S4[>&JU;Z;V#?
MKG&6S,W*%DT5AR+Y[5+0P#Q!6H(9XE9J9+B1B 98)J8Q"5%/;RT[9HOV;X2&
M::Y2,E4M8/D)>\[RQ\[ZX.>8%/P;V<NZ\L)N<(:NPGOS"*27@FN!A732<L^B
MLF"SO&6VB+J@95;3 R-$*W$;B-O77WM@M#08)J<X4MBG+$03D2)<(2LH8RH&
M>$6G78A;Q.VV&-$,.<R(=7[<<,?/)R;=@9Q4W7-6XC)#7%+[=>"42H!#C(1R
M("XJH9-.6PO*. L^<N%#3,=.V"WBDH#!-4VWVXB-M#.? FAY]L>B'K<?"%YX
M*S6]!/G9Q7/E9[\WG5:BEV"ZOQR;Y3G0N_=E(.[U)EP%[YY^_G%PXHKZ_N?F
M[K?= L3V\ONW]_3[R=9E_22)[A:?$'?ZE8)Z7'S_".IQ^8/4/WX%U6C^*)L[
M?S_=W=ZEN]\^%;O;Q^F<3)%Z?P,&"BTBTHI$Q&&UD-:R0$7 ,GI>"*S)1+-F
MPX61V =1%"!AH"BXB#8(Y\& DSAQI+<>>K6=EFN?AMIOZ<#*[S68_%J>_7NT
M5KO][M='ZU.Y7H-Q82/GI-":*T*-*\ 1EMYZ]DI:L3W'*%-ZC -"E1RQ<GF;
M>7G!U\N;I[!DW;3*M=^JG-_R"^___C)(]ETO>=KI60XX 4/+X?5D8D>N"B\G
M$UL.)6%IN5U0*T,#R<".WJQ[S5+[,B*>VRQGLKY1VVXT\]U&[C!SP(//C@PY
M=1)MYL;+UWLW^_311HZ9F5[58;2=TN-JC0@+ PA3]8CNIAS1,N8^;)6<O.#<
MVWHXC/R%'&T/O\!U;B2*VL[?2"4H!H'DT4^7A+B<S&'2UL@#U'P[E-U"P2J!
MO@TO?'7=;O6MD1/5^6G.\].4C453P*?70.7C_APT-4V!H!LF]!&-WEMN!TW&
MIG75#OI5M8.>:O_N8,^>JBWG.)?*\+[5\A7H+%67SN?@5[M;A]YC%[57B(+?
M@("Y.&0$,ZCP7EFL(B-$3?3I7#Y+_R$WZ$R6-.7SIMWD=BOM\IG1?*E6$CC3
MRYV[/;BEK79.,6YG$STT_8.\Y!L_/6JV[GD,]ZJ9*+Q06O5I;477!]ORZ3;)
M;)4?;;1*'QD>[[D:CP+P;N 2?.?N/$HVJ%"/TLR3BH5W'J4;A92/,UB]R,ZC
MSUMM\$[],Z=73AL^DWZ974'WL^;OEIK_/FE^YH)7G5/G:!#Z>A9SI$;G'(7M
MEGNE[]C^]DX/?(?>N*]JXN;JDSLP4L 3P\US]%2?7 WXF0?\PGK'3->#^D0P
MRO1ZG8;ME]QM)&22:-YQNPGZ/W>+Y==<A'C:(RYW&>'9I\2>LF07"%X9XTX1
M[JV?IM',WF_[71:W+RE 5TE;]H1>1O'A>SK-5?'A [Q+/\/]OZ<].AC?I\OZ
M_G^.ZY>^6=_^?'*P?W!1_[A+]\!1'B\^_!T^^_WC?QK?T_/M?[JH;^^2W=/W
MK$Z_XOK'^G']9 <?7!X4NY?-6)]LI P^*V<V2!2<\(AC(L#I+BP*WFD2#+RH
M&)C,=5U,)BK]_H);Z:QPZR7AUG,6EENAU?.AU7BI], (Y@2 BAI'$.<Q54GW
M''D:?8"EE!$#6O%UO%3=ORHR.;;]0G@&I$4W';W#-49<N2FEWQ=QAV<:Y5M@
M[65P>&*#=W(_=]4,LK0(Y<PLGMQ>MQ+?J@79*M=C6$8HWWSO:E56-F*Q-F*R
M1:14A9.ID1PG,B).B41*6I^J$S&B-)9*F[5-HM<+.2LQ[07SVI66/R877&GY
M<VGY.!/T)O+"2(MH2 <EF'7(NE0ZM5"FD-X*SG36<JGY$FGYLE'!I;[&:XL:
MKP:\BLO?F>&'*F%H-%&T2LU81>E?=[3KQBC]((%LL0X-G1FLGYJXMC3'-%\"
M>]G=WTG,I?133N">^SN'*F B@]<H$B\1%]$C%5/1=RN44@4)+N2J7&2R*M<J
MZKY,NOJ:<>@>,/1 CXNNT.=1T.?B.OIX[12.HD#>6(NXI )9&@.2,@HLK'8D
MNEP3<%;IE)7KM(JBOVB./4B:G@R;_W&7G+I[3,%3PON=T/WN*9/WCD&^_AF;
M6U?&5'L4$&5YE&@YU&;Z#%S??$(+WGR:,C>O,BR]VGQZ+=3JZZ1CE[J?6DX1
MMC85\BXL4LP4*(9 ?=1<$(D7M?MT Y8\EG]W5V:R4O/5[M.K4O,Q#PK'Z(,)
M$1$J4NU)'Y'&02"EI>1$QXCQPK:?%JCF"Z+V+X6NY.0\9'/-*G-N.GXB,+[:
M+G],7I*;(Z723J9994OFVVZ-;&#LMP=QG>"KTG!;G8YI'86J'N M!=U7 '87
M #N8X"DT,NL#4\C0(K6/!YZB"\Y0P2,FA,4H&$\>CZ*$_KE$4:!5FLP+("J+
MT/N5?L^GWV,$14JF+(L>P:J"'Q*P05I@B9CC1N&HC8B@WYS3)=+M-Q9,&<0@
M'SF<<N>#NZ\2VYXJUE(MYH0OMG+#%H=R;H+%>.F!JB3GRS&".(D8^ P'KXRS
MJ'U0PCB^X&C+/.?@7THHYFU#Q%/%:580\200,4:$;"3"!4-0*@R,N'0*Z52-
MWQII,' 7+'E,-2'6Z92JZDL*$0O9"G^$3;REO,9KRW%=#?CILXBG.QI+XEW<
MG.'P-'G$=]W363HG[.[Y>],><;EIT%+G$5?RN<KEFX??G$QF$F,C0LHF1EX1
MACCX0,AJ*I$"JBJ)U1@+_>!,XN7;:5XAT4M"HB7,)%[ASSWQ9\R_BM8*$3E%
MMM !\ <[I(60B$FM6>$#%S8L)I=X\?O@2^- /6(N\?..\LTP[53>OXK;AU^I
MO3-0[]AIGY:]#H)'P+O1M=+*]TLTOGU^7D+:[#.>,'ZA,_;6,G>2IJPR=YY\
MEZOLU%D!VI=A:Y/W%:0E1'MWU36E/6QKL,K360B]FLPG+E00W'"-F L8<5C=
ME*=#$+/22Z^H$\*O\G3>AI8O;*/J_EJ^TN;YM'G,66).6F6"1D$:A[@C&-G@
M O)>.2,!NZ.R:YN"ZB72Y&4[=[G4UW@+9R>WKO4T>PJGYW6<%5R=KER=KGP*
MI^>MG*]:>&I? C8_DQ5]N,Z*)ENZ;66(6W&DN3C2T83'HVE0(GJ*+(D>I1:V
MR+A0(!9P+,#U@45."3OJP9G+S[^I=4=K?]KPOAD6K9-W:Y;S&YG8)5R!T&,F
M#RX(A%;AF,6 TY@#YTC$3!8424D(@)/ER$8ND3=41U\0IZQ86#AFT1M>_\JI
M/IM/U]!^>H/,P[O^WT0#XSMU-ZZF"R4DS7U _QQM#(J>L3,H8&FM%(')GUME
MK]!NO]D;]@@-O5K*V;JUJV=MT-!SO;:,AR-FY3UO^9-^MY>.>]T*5R]T<_[^
M'7$OC_#>]@[\?E  C.'ZUJ$@G#EG)6( +8@+2Y 16""B/+PC/!:<KFVVVA.@
M<]5WO7E1NW+;K]J6ESU<*_<]]WL--9AVUV\.6];Z6Y,);7"FWX7K]D$>JS[G
M92MT&ZYW0=^H_7W+@.XL[X-A/[?8KQR'10K[[M8A6%,690BHH*FZ=Z :*2()
MTI;9@E!6""*G^P )0WN=ALO%O=+Q_RP+W8VQGN'7VG[?W;8L28OIZ0HT5R!N
MJ#KP3@;?EAN$'MIG:2:[*27XK _J9KI71Q+C,$LXSVW2U//C!JBD _9A #R&
M"'$:TC)T:\<&QM9J]P '0JMFW'$C_ S^.@B8!T04AP\"A.<8;M1"_^L# XJ-
MH0 ,GB<UM^ZWT@#AK0<]]GD#;A5^A8YKP(?.X#GA0T>=8'HA(9<I,73ZN<[R
MXS4/(-$ZRI^#H33:_JKW=C==8A9Z#EJ"NRM &07HUE5/QRML3JL48.8'Q**\
M81=&$KJI.ZN?HAT),!NM?K[!3!5@XME48(Q*#Q4U(Z?QVG%E.4"\YM%H0Q0%
MURPX:UUD3!X6=.T):?"$9UVR0?'[+#+X[VOPM #C==U<?1G)\'__OWZC=['5
M\A/'\;O[<,^_FB#OSVN/R&ZCLD<G.\4!_= X./EQ<7#YGQ^[VY\;>]N[R69<
M[I[LD(/3W?/Z_@%/OMVX/=H]:9X<?/M/8V__/R>[IY_.ZQ]W.-P7_+S=B]V3
M?QH'EUND?G)\>O#M<]S;/[@$PE6 7R^-B\@XIA GA4SFQX"K%T5@PF$EBI)8
M@)X Y4WLU1,3(B%!"Q9X885A3)% 1!' :#G'UVH!C/Q94J-./ZQMOC-GC9YI
MUO8[($BE!>M.&*=K,CZFFM7*W'K;Z\,D7!@AB0RN$/"KUM9;H[37G#%,I%E[
M01K_/,J[W?C9@ D9B=#?3!4V6#&<N)?!,?9:%=DF.)-MH-SGR1:UP.JZM$%1
MZYX!)0;A33:WDUAOMFC.=(_!')73DRS._[W/*12MK*3:%CP6O"!&45UH')3Q
MME"1ZBJJQG&!!K_<F/P]TJMQN'*#6[^# ?]M&DN3"?[D>+>[_YX>,BNT<9BA
MF'IE<<*3>^DLLC1@*ZPH6"S6-LD&GDSCSDQC]/!8<B)!8,T14*(CX$055;M5
M&!8K!*@8EX+ATH^(0UK]NQW %F].+ XN#H,%JJ& PTHK!.*<.Z0DX\AP2C7'
M8'@L2046-F9EK  R-=,ZEY36 .D$5:O!"UO @YNU8H M0&M'#QXF60%,:7?R
M9TL@HKK\\$9M)SD2Z<U$WTLVGGEMI_VST<TD'K[>[G?@XX36\CK#=USR-X!!
M_]T$X?PM?6$MOW_]G;7?UVMF,A@W +LALB4P!%'O!"!0'<!#>(!3\R.4 S$I
M%-L U.[]?S"63N.HT8+O'H&5ATF 1P1OY2+1[Y_IQ@": 1X!E*@D^8G1 V%O
M-4VGK(8T&(,-K1#!F4UO#X,Z5Z\V0'=RD 2NG3Y^_;X;M7UX;<H#E]/F<\&9
M3BT%*@)PD3R,I">-7B^,S+%O=%TGY'?3$P?P-WK'C>Y@'M)P-VI?X!NQWZF>
MJ>OZW6[F*J5?5&YS9ZIY_7;=X ;^3+YF'9YQ8UX[.9=U'37+3VU@TW( QL J
M#[VXV._U.V$H8["DW5JW;T]2,*WR^T;FOY+QO]JFDPWM-LR_Z[4[I:=[#HH'
MUS]+LMH_@X__-.#U];NU:/*'UBO'.8E?NLS <5^O11":5A9V@&/?2/=:'X95
MLG8U3L_:W5+03.NBEJ;3@AO9"MW*=STU%\ES':E@M%X2@Q$Q27<JGQ<$,*E7
MKQQX.XM--4IX OBPA^\UP\^D/7#+Z0]]%Q_V3A)2+1*G9<((/&F>@C]@""8I
MS9_G#=\['FP6CGRQW''Y U]]Q=AN._GE,[\RLHF35#)TGDD6"1V;O9&?QYVK
MG96C@&PGF!_(1!CL'Z9Y;BZZ:_^Z]DRGC18:F\/QQY_YD#$^VD.6NT ^V90L
M$'_T06H[Z5,P)K,T8ZD==Q+Y^3^WQS D0$@^N@]:\"[Q)E"I?__+;$Y;R:E>
MXZU>X)C7R'!DF!DML!"<6FXPCR%*KXABEGM^R]H^JC^6;4KM<QA&[O[NM,'L
MG=YO"W%YC,3M7M@\C-H+30P/40@7N3?,:J5LM!$+0X,BY'"GS%$@>)1([]0_
M3$20$J6ZFNUJLK?ZO6,@'9<@+YGPDQ6QGN%OI?B2]L861GB$=32(V\"0<3P@
MPD*T11&8BAZ0N=B8=7!V0*VON5Z=*Q4X*U=EHS84(E5MFUT7(2#38(]]9IH5
MRYAUK9II-MOG@\#UR/N 0>DZOJ0+0!WF$4L)+IW#*DC**)> ,(P% D!'=+06
M<YG%DF*&U4HL'U,L=VA]^],E7)OM7GZ":Q\=,JP+SHE%$:=>VHJD-G4F(E)X
M98FG2@>SMLGPK3):;FR4/LB5V'0'1/'4^%#N\_0 /;,4IG]-^D#G!_@80R;:
M!2>RD_VHQ!63E(X0Y$XX2IO6[<Y%^D(72'1I7^'&'V[94RZ'>Y5(<3XZ3O^T
M&\RW2[;?SMM'?^>-G"_5$.XBU&\OMG5-J,GNY=%AP:@J K8(8R40#XHA+:1%
M3"G.*4AV" "\O"#K>%JTZVI/,#DB$]NA<T6X'IB(,!'ANDE,_C'-?EA!WUVD
M9&]_Z] 043AF0$I,.G@9/$9:8XH,+ZAF1F"=CFJIVY!O8T[H>& ^Z0*@8_G2
MKYY;'NC>]J=#[3"WPDBD78J$&F>1MB&B ,X8-P2\HH*L;=:GY%]5@'$>4JAC
M:%'NFN1$-FI;O>DVJN1@IZ:1 C<U:YHY'&I^FD8S.X;I%J/&-GN9@TAIIG,I
M(#L/8!'&HV8QT3/"@9!IY[WCF,3"L%!$,V!J<^)41=0^#Y[EBK%=?6;%W6X4
MV"U<W_YZ63^!?R]WBSIP-PR^?12Q0((QBWCD!D27%@CSP+R31A7"K6U2O3&K
M[.D P>;SH9_1_Y\24[Z3B[]\F]I+MA>\?96L=!%,IX*I[>!"RN\=A24"L)1H
MT;6]'./;9[U09CB9L[3=D/9+X&)UD^*_.5M>_MFM?>FWNL=P\Q2\\7W7ZZZ7
ME]YIN8W96SD;Y8=NW=T8 &ZY"P/TK3'\X+4\L?6\H=WMP=BR)S'V9OEG>HRT
M(90!,^??=]<G4@\G7RF3$=>O=I%2./PG0!:,:'"5D<RTZA3@\*;YKY$@>7>B
MO]'(9,S8R:GVDJ;L&ARG;:\2>7L7^2[7-WM\Z(7.:5J?;+<NSDJW/]TW;YF=
MAV8S_9O>+7=\P43!-\H1CWAP\*V<CI:_.F*5IBS?^OC^1[,!SV&&UYGQ-;"9
M\(6460.?F8^ %45AL=0F4J,Y<4116T@;G:*&,VVRB2.4T-MYUS"A:G0E1IJ<
M_'4QV0(ES<CUOFY7MG#EX4TU?2=;K Y.G0E:L0 V3DF&>$J4-XR M;.$N4(7
M8 Q3_L)Z@?'<;EUF;H/=U)2N.ER2ZZ"2M]+B0$UOE.N\APVO%]/@<@"1TR)S
M4W4$WFNDECLI$I=/CF0)2F.9D<":$C\[/ZOQ-[K=?D8;>S&GK@1-P#'RG@>M
M.2N8=@6Q4GD:)<62VN2LD*)R5DCQ%$JS-0Q!KM3G;NJSBW<_'082@='KB*)E
M&L@B=4C!KX@*&ZW'H%F%NH/Z5+'FBZN\CMG2G01UZ[2D$LE ? [)YL(?,RW]
M>I5K#L8E:5HV@4,%*3>TLP[X)U4"ZE3DT3%N3> \,B,Q:$)!HB;8,JLJC[T8
MI"D5U].45DJP#$KP%>]M'<*2,>I)1*IPX.)3+Y#V02)NE2648\HUN/@T*<#-
M2K _3?RN^^4#9C?&FTJ^E(W0,'7BZK/7H]UF>'XN?;OBN<,37+-5:XP@I]&4
M"M$]:V9V6OXUS$))--:5B<J-2W-UEJ+BH$#(FLDG2+E,XUD8+\;A>K3!Y"O^
MD>?.W6%X)>SMG569X"]R+I?,>=T#"S2J3=</!0U.#Z7]ILJ3&G/X2IOS$U2H
M!G8K);3%&+(_/#A'D_R0M%V5\#F]7FYDI62ME/R:/,V!<0&M[9^EGS>=\ !O
M QMJK9(.<PD66!6&4,N,B5PRQNYZPN,^%B3_^ >>=1@BOAYQ@T5P?_A^)\<K
MWYJ5N/QTL;MUZ'"PF&&#J/84<<\8LCH62-D0);;!$\76-KD:/\<QB/$.I:.4
ML"H>D41E/</JY,FTJ0*9S]69)A >?Y&E,U1Y?N41N^R+G.7]3_BM.A)V:CH@
MH-T;G>+2;HUQ'&>P<T9;3)SEC(!3[('I6U[$ '\6^.X;FKGTX+W%<V_P1+OE
MD^RUPJ1XPA.<M\%@AM:0T"#ZYF3U*ZF?'SI.0J2\0#XZ@KBR(*84N(UR7#!5
M*"R+L+;9;?R:X#(WE!)X41*R?]Y>2<@,":'@^#'"592&(R8X.'Z"2P1<%R,B
M!?PKI<$"'+]L3R?Y;H*K5R(F:1=N)2BS! 6<(^DCYT0+$!3!$-=&(L5!9,!G
M<EH43 )56=OLA=;4\T&N\E(ZX:S=Z95>2DRQ@93UGER1E*\37'G$^7]] Y])
MAT!^5A&TY!8-PKV5'7RIGL8-[/B13_VZX^#[S5 %EB>T)KL>E>>Q!2OWL]&[
MR G&;_@<\,7NT2$QSD82"A042#_7(//:.X-L8!C@RPG"Z/BYWF<1N"\C-+%F
MJA6\-<]@/*F@T4UZ&MLIT;-;^^VJR@)<H=V'\:6 0/CEPEEOI,1 HU5")]SZ
M]V&-U[*SW/!T1&X> I/1-&?=\,?@ES\'#?H:K?Q(^4M_EDP554<JTAF"L?)6
M67W*MZ^.%VS@\HA!53*TNG/U]D9^:ZSH5OE>(3<H8S/?QAMDYGLW79:0#4;%
MO2Y[\WM,\<4/EFYH5KRDP:H[7?:6&K++47CY3J48[UQ2^(9G*D\9/<U3W:W
M9!FS+I^M'7-.21FTGN-![U B^47-R:",6E4:KBP?DZ?F?55T)O_Q=ZHD4W[F
M[\$4YKE;3=V4J?N8XRS;IE?^^<$T.K6<$_L8?7:6NLYT1?*N[S'TIN;S4/*0
MOCMONZ\\E4)$(Q501,%]X#H5-.!,21$"CAZ7IZW&-\4GJ\L]P,G-ZSQ2<K%>
M^>3+46GNOHR^K )[\N-R;WOG'-ZCWS_N4!C;2;K&]^U==O!MA]3W_]/\OO_]
M>&^[>3I>!1:N"^/Y"]C^]Q\')P=%_6,]>04_=B_]\<')5[)[^D^S?OJ>[WW[
M'H?EJ;_@B_K)IU_@$41>N%1P!SG'.>)<"60P,8@'0CEC3($#MK9)Y(,K5,^K
M1L_<K.=QX6#I8/3N#5OG?OX7"H.S"_K<#PLGZO@L$ K'2M4.B%7F5"\]$>*I
M ?)R#" =]9[%Z)#@3@$LFG1VQCGD(V?$2FVH2 !)-PA;0>0*(E<0N6B(M+=#
MI)T!D?5VJ]Q-'@/([#XE[RDY3M59PA5*SH.29 PEA<9$:T90P=,!G;29HK3#
M*' 6+)$6%T6QMEELX.*E@.0;Z]>452+X57^4&YQ@'C%FTK- (N?2!NNYEL$$
M3@/6P19SUUI_* 7,B];=:9793<O>*.5E8%MCPD4VUD<=P2<VFGO$M2=("R^1
M= 7%7 9%I%[&/BF+[B/YQB!@-KMY( [,[PEVY\*!F[W!UWD\_JDQ8MQ+I,$H
M%U+F)*,"\6@)4H +B%'CG172<Z-6&+'"B,?#B(= Q#1_:(43B\")<3^),1&U
MH0Y1JC'B)-7KL9HB1HAV2H>H4^>CY<.)!6TEOA1OZ$.[$T,CY?:U.S67TM>;
M]_2-ILS#2P>]E^$;54O83T<&6_[]K[-&53]MY2XM$N(N)MPES8WSE%K$G>.(
M%SR N\0((M&0&*ATU-F%0=P-,/-,4?&WB@HOAPK=B@PK!^KQ46/"@:(Z"H8Y
MDBP%69P'U.#6(*-H#,I*:7A<H<8*->9&C8>>K1F%C.#W.N\J-KARH9X(*<9=
M*.V"\+P0R!3:(,Z=1CJ=\I*4%-@H)ICDRX@4;VQ#:6 UW]J6TF_/[3>EDS,[
MW6Y_6G74T7-1PP5:.3QS %+]W83#(TUR:0J%1$%3=5VLD+;"HZ@Y%TH&&S!.
MQ2DGL.CW5<1W6;7X);@YM^T*#13\CG[-BI7, P+C_HN* I;42\14ZH!!L42*
M2HQHD4Z>Q\BX<FN;>H/()8KJKK!@R;%@(<[+T-"OLN 6# +CKHEQL+Q,.62B
M\@BDJ4"J$ 9%3ZET\*Z/86V3;>@'GZ98OJV=I79&9IP2NU:<GB[@=%AUQGLR
M(_%MGQ[CF%K,"/?"*FX)5]CC((BF#@AR%&)&J?W5Z;'E KS)TV-$&LN\$$B)
M=&:,6X>TEAH5J:0'(03P#E@/X0L^&O%P-5ORHQ-OX'3$ZSX <3_$6YT1>QDP
M..[\D4@Q=I@CRXU,AV@C,EX*9(P(1=KQ#I3G,V(+.T:[PK(5EKU$+%L=YEI"
M.!MW8[$5F#ICD"D"0]Q&@I1F =S8%,30)D4RTF$NJI8(S;(;^Z]<<6MSO%SM
MG>LYS]5+^=FJ\>T?IR8>J=_9'.W.'.64<^&"%IP;H94*(FCM?,12:G:/9GQ;
MS6;;I5+LTUG*^U_IUU>[#?Z &I2NJ!\=2N<,%@5!VJ4"_89;!"OC461.2BLL
M<P'?#->+C3FN%GC!"VRH]-85$5FJ""QP89&*+/W&00,=#Y+# K<FFRS.Z,50
M%=!VHZVP0KD$<Q9&S+5NJW:,N8#VK,],KZ*4FS7.#T#W.Q,^12S?GYXUVQ<A
M? F=G^"\3!?.(5O(%**[GQIHC;[_KMWMU=N]@P"C<^VC5FHH,KH[OI+J":G^
MD;A!081P5 @4A$O=1*Q%%@N-;$&C"<0);MA\L'4O=KD2B^42"V%!JZ.5B! P
M9#PHB511:,0($\&00&EJ)' GL.NW.L.IOQWY.J&9N\%4+<5R X(N"$K7=1HV
MM8RQ[9_A;O657QP/O*F7KCDZZH2CU+.CT>IU&JUNP]5^)N=HHB%/ZMQ8!H.J
M$K>C+45@6@=-:^=L);7$,?]5VZA)/:YO?_J52 O89<V$08%(!U0%R*(.S"%)
MO"!12*MBS ']VQH/7F\Z.&=KYGO*SF1KYL7)SLY BU:MYV^2(0PRI+PP,>("
M656 9Q,$1<#S*.(\@@\:N=1*KVWB*;V::\-&\UNS2G@^$-T>CFM+7 ESA6O3
M9/+KY=[6H><%U033U%(5(ZZ40E8*ATQ@7C!KM$@A+2+IH^+:/65GA6O/+D.I
M:PBX/9A'S5'A&$-<.HL,#1PI4GA'@V6*I<WN#3(;UUXG#_UPO^C#>NT\Y'9R
MX8;..X^1-#^M3>D]LN97<#M-50XNZI\.F9,:*Y*:<WF%N!/@PV'FP9%C+D@3
MJ;=%2HF?CK8WMF*:*A"+#VZO!&)A G&9X@-2">8-1X:DEN::8Z09P4B$5!I'
M>$93?4":>C+?V?KF#H$)=RJ"E\G?=??5]'+C\7*C\.IS9RGI(7WZ1N.]RO-_
M78+H$C)1,&&,<8=404 0"<B@$A2DD138!F*TBF9&GG[&I?M(S /1:24QSR8Q
M";HD%HR(Y#"$(AWOH@[9%/;VA2@*;I2V:1^'D T]N1U^U54J-9[NGH74R2HT
M+\JVVC=[L16$#4#+UWRV0_=D6O-&8!YX+''A+LN$R.;0_<I[N8L8']'=K<-"
M.QV<BN"X%!1^8(E26V;P" 0+3A*A:8[*3*;J#KR7V_%OL;BW^)C)XH3H[6'A
M$:V?'W(J8R3:(2F-19Q%C;1E DFCN7.:F4! B,AT7C\.@?=V&].7D@"8UD5M
M9*_H6?'M3KN/^^;77Z$58J/WH=,^'4CC7IR]P[@"L8'\_2  8MC0X)W1*'!<
M(%YH L2-460E)MI'[0()"<1FAV">'\2>6%+>'E+]2-W"E2Q4/H\;9<JYP:FS
M/0D,"8<MIQY@C(*DS A I.Z\YE?-EBLPTN9^IJ<YAFVO,\YWOV2A\U#SC7D#
M.DPKPYU@-&C"A14&/#49M%'8>F(9NW.RT,*RCLM-EJKA\"H/9$+M]K?([J?#
M(L B>7"O+2 EN-="(C"J$C$="VQP"#[ML\R=21"\T@J\+<V+6&C/O+/2:<\M
M<%=RYPRAE2P\J2Q$D 705HZXLPP@V!5(@;.!6*3"<J(XP>)N.4&]VK'Y"?XR
M\+U^M01#_WADMW<,=M-5DB U6GU37G<$4BM@X[2LI'36[C;29_[(^40 XE>-
MF-.AB9$O5F</\=57C.VVF_W>[*],-!E])OQ.':JN3=#(S^/.58O4HX!L)Y@?
MR$08[!^F>6XNNFO_NO9,IXT6&IO#\<>?^9 Q/MI#EH<&  7:94W'/_I@-3OI
M4S FLS1CJ8'+ ]#V?QK&:\<5,!+"-(]&&Z(H\^"H6^LB8_)0KFWNEYD+$7P>
M$)Y6K_OO?YG-:2LY)N\EZ# <&69&"RP$IY8;S&.(TBNBF.6>EV +WPE^*T$8
M+0H6/24Z,B#91&M-I88O6>R!<Q=JBFA7S(2)9V,F8\=.!OSIT0:3K_A'HP=*
M[>XPO,\ 69V&2[!5-K;_"@:O>R>ZMWR3NF2D=*_?N9;QT[F:ZVJ;*,UU[;=4
M$)#B/S]_^=K-OY(_?U^O-5JNV?>AUH,155FFZ0- 6H\;[KB63$VM_3-T@,'&
M&'+X]2P'CC(33M^J)?*07L\^PK^OG3L:H[31,E%XS6+P7#EO)2@6TUK*Z)BC
M=&K(84'QK_SC'WB:X48FN<9:8/+='[[?R4&8-\=6=EA]ZS!PSA21!#DI ^+<
M&Z2C*E!D*E!LX&?,9WC'SY8- E>]=JU_EG[>) /.>>"M0D7N(W<.F]1K%VM'
M#36:T.EAIY4,/(4,\/K1(0>[2U,7.PEJ"MY+D4J+"HP<9])(7UA5L+5-)F;)
MP#!. "!2IJ+7O.F%]9KI@AO<;*9_ 3_RI+?<3,3)&]O&'3?"S[SA8SI' 2"L
MI*;IA3;\_C. R2[S&TVG!2]WX8[M\][Q^O %!/="U>X3?/!?[4X%B>7^=Q.N
MT>QNY/N7HRWSZ$^S&U\B'#S+7VV0F_3'=J,37*\-[R29-@T8XQ!M$]THD1$P
MM7J6].5JZQY^U%KMWB#;IP^$HWFCHD3%J#<F,B,5QSQH!XMAB+;:!QOY38J2
M:V9]OAI7*>L?VIV4S9&F?:K?-I#^\W;'=T/KS<G_UR)Y;(IPY@J)E$^G.+CR
M2%,=$2](84$UO$]9&KWS=NT"9*P[H0;97\@RG+RQVO3S"7<Y699^S!<D,)(J
MK4,(Q@FNE%/IF)*C)&BI,0C-K4&"AY5:>_^_?J-WL=,"J>OG'?B]]"3[QZ8U
M'COXTK<GH$;[[0D17:7QWB2@!Y=@I'FP5J:@4HB1(FZ=008;AZP,WD7%G4FG
MSW2QJ+PR927W4BD3N>"2">45%N _:88M,U'>&H9<2=622Q5.L*<+6VC)D @,
MJ)\R!3+"1>0<"<PQ92T#ZJ?4=*FJXE&E%1_=!5@?-:HS+.EYHW><4]2<*S<T
M1UV8*Z/Z!!L*-QGC( OP4 C#FG$5C4K5O90DA5)8"GDGS\4=!]]O#FSOA#)<
M><C90<[^<<E:TV2"$N0@R#X,Z:\FO/_&Y'1O_R =SL)"<Y!0AYQ7/-689<CJ
MP $"B2A,5)(+OU8+H,QG:8T[_?!,/OGG:3YXS51+.>=I=?#2NXDXQW:SV3X'
M3]Z<MOOID&<C97^V^S!0#YH7?KEPUKM*N(*W2\@#Z?K]CX$F]*HSCE4H-U>+
M@UEIFK-N^&/PRY^^T3UKFHL_&JW\;/E+?YX"#6^T!K7G4L!SK!Y)5JKR[2H6
MJO6&Q#*%0ZOZFM6-JTCI1HZ4CA5)*=^39$-0.?-MO$%FOG?390G98(+=Z[(W
MOU>P^UWUQL'2#2WO-@>WU#!=CE*E8ZHCI]9GFEY 9[YG*C<9GN:IU)V>JB0A
MY;.U8[9-I0\VQX/.K#K]0N=DD'-;SDJ5>9NG)E>T*E].=:WR:ZFX5?E2SE*[
M-F]OH8+O]!#Z>$'?Z6[E @K[OM'"O;( #DP,-=AZ[H+3JC!"$&,*4Q22FD<_
M['IW#^A5%?0]/CDXV>%[V^_)[L=/N+[]^4>=_G.\^[%^6C_Y?KR[_95^/WG_
MZ^#D$YXH_?:QWM@].>*[^U_/OZ?SV!\_L>_?WI\?T -:/WT/]_I^NKO_ 9[A
M<]R=+.A;@(OK* V(*I,BH-@C8RQ03*>YU38$!4N]J=BD'_2@@KXOOF#OPV!B
MZ=!V[@J8=W_^%PJ/LT_WW \C%U?J]^X0^58*9SX9>H[7 ;:*&L&H0LK3=-""
M>:0%N.HXFLBT*)RB.!TNXY.E+Y84/M]8T[J/9<#NC;6LFS,UUS"N.3>:\L"Q
M2)4JB3<*4UQ04[@G[/1]*_+EY1QI^+WBAG='M\9DGSNBI)8T-]X$;AC3:6[+
M"Q0M]1%SAV/P:YO+U-IFU=_JD3C/ S'@"<G/=0A8,: %8\0X PK111R<030?
M->4J($V-0;( 1E1H+H5+!P3%!BN6""<6%$![*2QGV,WZ(8&Q%PAT<[;F?4%$
M9[BB*ZYS'QR[F.0Z"J=C9@0%RB7B- 1DF=4H'40*\/^">KFV64P6";E[3]_E
MZ^3RRM7_5?.<"@'Z &,KDK-@<)AL]^0\I^ (81=EJNP?D,+P6^$U+X0"+RFR
MW.9S46&>521G;F4O2[>]L4#.ZR4X_^0 ]HK=W / ZN^F[/)%++GDB$:7*ID*
MBQ17#'FCC8DF<N?CVB:L^ /HS2J,LZ(WCZ7_*X:S8( 89SA<%;:@TB,I2 $,
M)RIDB?"H<#200FNI.%W;5!OXP1W@EB^*L]2TYFYI4*N^YD^S%:8C#ZY0Q,L@
M4H$:;440OA"2!"ZU<X_>XV25'O68N#B9'A4Y T!4!A4VI$/"#B.C=$2Z\(4L
MO)=&V+7-HGAP</N5]3M?19;&J=?]H&.5-?0*0&5BSXPXD@J_H )K :#"(E(&
M?E/4*8^I*SA)/9?PAEA4UN7S]MM=E32Y993;\Q9ZSD7V!H<-GS0&-*O*VI.D
M\ZR.M$X[TOKC<O?3H7:%] 5+/85%PI34AK9@$F$FI,32B5S^<D:WH[%J.+5<
MMRJ+(P@"K>VTTF&:QL]0^[L)RM%KUUH@][=6C2AKGN<+YO/]52V(\@1L[;RR
M,FC0K.&J?$8M@J6Y*HQ^GPK\*K7?99JG0ZM<P_\4BR&((I@@*1/ZR0(=;S,K
MY?[2?+)SOGM^2(%6,P-D6P;'$?=:(AVB0A[,IL?PITQE?Z=GE8R<"$WG_W.!
ME4:KA-3F!?P*CG.SF?&F+/5D!H5,FJ';!5D&$6^W0JYX<57@Y4HZ-VJOL]CK
M^_(\;3JK6S9AS45C_&C]FNK,>U;I-+]917T*0)R:SH_0&^ALV:4EJS+H;YZZ
M0;V;1G=L.JNE*BO4^$;7I;.^<-$TCM3S-8<^8+8:,#\PF%*UNJ.]$:KR(X.3
M\[G,>(DZ"6G.VMT>&GQDY* ]/(>I?6BT6L!Y+FJ[;1^:N6E"O]=HYNKB '.@
M@ZZ?VLW"1].CE57V!H.\$H[K3W_5M::LA=,)L9E*!%3#'3WLGR#4)QO?: W*
M"'5A*E*MG^'GNZ8L!IA^+PL*YIH!@QXYI00[>(I4H*>2Y*I6V4;M:S='B !Y
M3ZORF>GJC7:_"ZK@0R]T3D$0_/"$MCD[:P(#S(.K[EG6W<P+E*YUFF<*ECQ/
M_=6DY+)'Z;6Q.;V:+;A%TZ0*RK&:,&-AJN&#Z;CWV5FG_0O0MQ=@8#,!OU4%
M-:YA?6!2>*8LEC2D4H>6*LI5I$50QE!N;\%Z-EFZXZ:2L79&R=@A=F]=3?9V
M]>SPZ/^%)V_'W='GOAN?0?2MF8#+][C^Z5!ZHK6C-J7AJ!21QDAYY5.*8:&C
MH-B&(I5GV]!3+4!B+%GDS#5M?*6%NN_A0,SG-3Q0Q^;MMS96'20KV,=.N[LJ
MO3S9COT([VWO%+O;[M?NR<'YWM:A)9)3F5J?TA1>4%@B(R1'5E$EG;7$D^FM
MV4?M_HRR=:-,?J/V_QI=(/HI8I"*W]SUV\D6G^8>[OWN0&IWD[#5WIE.LUWK
M-DZ3T4U"F8U-Z4?<](F!T>[6X/5>XZR9BH&<]9-%[C12P")7:QS<-]\0S(T=
MV!^@?$,& U+O&Z6E/&\TFS4;JL)\X2EJ\CP'=F2-JQ;)C=B\S+Y:W5"6(:R*
M&HTYBO,5=AEK3W7=YL_3HN.!:#39S&6KV6R[])#3_;SWY4RL.K5,M]<'R5Y'
MHF+4 2.A!-AK87(\$Z-84&*BIHQ&GSJU3''8[MNIQ3(2#<>>4.NXE][&P +
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M.L\-3X-QQX,[U^!V8"TK9CMH&YR^W4ALJV6:M7;GR+0:E\.\_!1[:,?8<.D
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MG E8M!%]_3/VEF*_TTY1K ) "S]VD.M"CH+3;L:F%=U96&KN_E:B.J5;='*
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M^DX,DU[<2\^A;>.S]]T0=[HCWQN,)L.XUW\9!X=#>]+I^J>PZ$9_#OJ'?X(
MAJQ=QJ-7_5=]Z%PW3&SOQ6 (H]M_!F@U'G;CZ(^SZM>S?6CO'[V!__0P]4LO
M_N?-V8?WX<11+@^./-Y[#]>\?/ZE??RATW[Y=_?@Z)#L[G_B[>,# >WI[;Z'
MS^G?"3XCNX<?DS> V2P@)CQ'7 J,-+4:"84MPRQPS-1&*X(2/LEH-)S$2_"I
M"XNS/WY"52&L/P.>,M]HP6N[LPF'M5CFMW42AZ.3Z#,P;[8&_=Y9:]R)K7?
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MV_E$VSOMHUWZW^.#HT_BP\M=?$#;QWL[;SK0RLM"_I@@4DNLD"1>Y@+(-!=
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MO5E,G?S%%/ONOC_;/?VHDM=@HSM$E ?5'B5#3CF*7 HT<%#R8$=L;./+8NH
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M* WA<N6[8,HN&SPW3(Y;.\OM%J&T:@VJV1#\K]E(_[PAO"0(]%[:=/F@_.
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M(GU+6+"MT\Z@Y!D49C":N%$W=.VPQ-._ "[<;_W5L3 GFZW0O08^5KT#+"6
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M .X"1I<]G&"V!"^,0DX9@;@4$5DF'0*(]#BQF(A1=^8!:*"T@=(&2N_)B=I
MZ0^&TF5GJI;)!YD$,H$K@%*7D*$ JM[ KRIHIW)QEP9*&RAMH/1A^6L;(_Z.
M('/9;ZNQ\51RG(^,(HA3SP RA476BQ23D<PX\;B,^.+8_:VDUEV5T;\&V>8/
MH_# _::"7E'N\];9H$TNY@/+&&P:V^1B-KF832YFDXO9Y&(VN9A-+F:3B_F#
MQ[K)Q6QR,=<S%W-JE?4'I2C9->/07'GQRF9@?\[ -MG#MXC>?-3[!+?K_*/9
M R D>64)YEAS[@*Q@L6@1:($:Z6CON(8E5\E9OOH\,N'_7R"1?C4WG]UOKO_
MYNA@_YWXL//T]$.I*;A[GMO]X>B0+?O^]W9>]-K[NV=M^IKL'NU^:;]L=]K[
MO4^[.W]\:I_W.@?GN_EDC>.]G9#:SU8"^&@26%IO8848C&!J<@"?8.6@KLB#
MLRREC6TC^8^.V7X422<-=#T^Z.*<AT "YSXJGKPSW#*:")94RB@X^0[H>LP1
M(/<':<O!="R C@G)U*>D!ZR1H3HASWRD!K2.EOK>TND:6&M@;2UA#4OEDL$4
M6Q<YP<&!QM=8,P8?\R0;6/O9L+8<V*8D-\EJBZ+'N<)+I,@&E1#GC%$5I:?Z
M_JH@/ I8^]61[?&"&R4AINA8B"SD0^B-T6#'.# WE0(3)S7FYCV!V'*HF9,T
M62DPPC2"D:FX0]JQA!S,& /@HC+R>S$W[S22K$D1;E*$F^CBA^U9?.31Q?<%
M^6]7/(S*6^.]M @S*Q&/C"%+N4$Q">PBH'[(U;ON /+7)KJX2<9HX')=X?*N
MO)F_:%[;_<'HBE=3>DN!.L,*$F#^<VV1$6#^&T43BX;(H&63U]9 :0.E#\V#
MVD#I#X;2E7J+"I!3<(Q(T@YQ*CC2AC,4#<6"NJ!";*HM-%#:0.F#\]<V1OP=
M0>:RWY9P14V(&EFF->)>8F2Y9(AQS(.DQ%!I'Y<1?TF*\&\7#M!=FV-%?V)B
M<'GBD^X8!M#?H-TWC"#]&4/:JM5]:V\RG+:G=3(8CA.LK$%&JU%W-"XIR)_M
ML#N8C.ISTZL\XGEO9D>M%[]X:$U&^4G_*XDKK9.2LY*SDVU)5:F?,=JZ?BZ;
M7/0;MO+% ":O$^'?883!A>L[HU:$9H7+SA#>;-E^*$GI^9ZS:(?UM9<GF6_F
MRV!B3_./_F!Q]Z/>%#DN.>_5C(_F>1^M0;ZQ-<_[@ 60<SY:_RQI>BWZKQ:T
M8?&&2?_*B]F_OK)8?OXL/(RUDNL6>#L<GN79FM8-&,;4BSZ+ZJ!?5@4(/C1T
M%$.!@*QE;/[6V9[M>Q#\3LR;8GD->3OJE 55?HG_FW1A;>0% <O,^^GC?>R6
M6:W6WNR+$WM6YMJ>G P'7X#?C./B^@KP[WB0&P0?C3H 2PB@X!C8SQB6W5;K
M0E_J#;E42BV$Z,:+3QU=\MANW3)8>-9#NT?=PM=R \N[ *7&&=[.MEH[D[*]
M=W,9*T^II.<47@A*NC\8MSH6L,_VS^"UZ(+L0*M!PZ+4[</P=N>[CI=L-L)U
M2_N-K=$$I.9_D]R1V6AU@77F!\&U@\-^Z=F2 &6UGMEHMS^QA;+<8+%NE]2M
MU25>N*4-QG/M."7,\&2-)9JR8*)WSB?&U$?%-K;O[VCRE:RKLOS_2>B_?HC"
M93=Z?;5*5G_>#P>XO$W_OL#OEHH81268AQG%AG&=K Y:1:V(T!HKJ>C'G5+$
MB&""YM6,+AHG;P"_^Y/X8C@X?@:/S@3Y?7?<>389 >V,PWUXUQ^]@?_TLRV4
MLZF% M;)?J?W8>>0@17R96_G36?O_8?NWOZ'7OOX SSW4,#?1^WCYU_ VNC%
M_[PY^_ ^G#C*Y=[^W[V]EW]_ FNB!VWD[9?/Q8?C5Z)]_(Y^./[[:&_G$_R]
M2P_V7Z3VSE/2?OHQ),UL53+>8L0-#T@[I[*3F^.$+94I558CR&D,3[-7C">2
M739)&HTY]\DXJ:RT-'KEA(]\HQ7![#O)8CR<Q(WM>@9:;^98L$+J;Z*UF+P6
M");PI)K.K[?U8M^P%U@H[>%_FC/B+>.,QESU&KMH.=WXB=AQZ3A^_[BM'T=H
M1[!40(MGRNY[DQ#KOT!-@48-$Y]54U&3W9.3PB/@CP[\Z.4_?,<.#R/H_SX\
M!FX!VV>J@X$OU \ Q03*M5\]IU*)O4(Q9N_-.>N?\TN'\)TK]X.ZRZ;%"2RN
M#I@E@V$V8^':RE\\5=Y9.19="#_#:*LUG;;N8A3/J"CSBO_D1A9+!TSKZC&@
ML^.7$V!$6:%6["434O@0.M<_C!5['L(0IUAIXNFX;+6>]K+6G;VR5L#G\-+3
M3BR/'L%+1NFL$)63."RMSZQJX,#@*0T -@V+8#BE8@4TMUKOX_QILU>XLXL-
MR;= 8XZ[HV)XU;-5\0(8F@IT@94 !,^>L=!&8!SE"8,NC$LN)P7K*O_WM-/U
MG0O/@.:.;1>:6AHXZ.51K%]>WKF9^U:-\B%0IH75DCE<7:LJOWN4!WIN%5:T
M[M@>#3+WFA*ZZ2B,:A+5RM9&+KEUZ?A5JVH8:R)72".\;\H;G\T>5H;A>-(;
M=T^N?-BH/ EZ.K=48):/%ZEMK.RI2;_T$?Z"\<DK)< LE+OS" ]#M?"RSV^8
M%V$]_%NMW6)VY7M;*<;J?;.K2E>.H1O5_(QFLS;X7(]O#]3T=/2/9X_:S&8W
M#"G  S#'RM#;:CU.P'J:EQ$8CO%2B*FEL(S_Y1"2A7W8C7G>+T,0$#R;*[VU
M<D]/8NEN00Q8.+9?B5?ULC('D_ZD"%^>,WC/(FKF]08+\0=1+EC?PRG?2@M\
MZW2!;\%+ %O^@O<.PH6=-AA[_R1,AJ<P4*/8_\7HV.[^ZR] QZ**P47F4!YL
MQ(,-R(4D$8V<<AH"S(S>V.[# @1H"O9LM$RDRFQ/LO"#Y'>+3)X5><[V7P7\
MW:P*,NXLH.56ZQ4(#<S/%.]J#]EFC9%@GDYMQ?E:FZ[S_'@ B(*E8VA$!M.;
M>4L>G*!G*Z+225FCP7\WRVB]VWJ[U1J<U.H;[/(OXS@UXRN7@0<H[8ZS73T
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M< [7F;OB08QS.%EV/,),#JZ6Z?H6#ZSV<# \6SZQY%L\3U?+=WN2$6N0_@)
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M7 MMAN^:T=09(_GBYY/AX"2N[,17&%-;KJ-+O4%7UJ&ZKQ51]7-S/K!_@,"
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M.!OUT)JR?QTF?VY>7FC23+S\3?HRSV UMU'L;RZ"2W*;E6R6EW <\%.E@3A
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ML0[I&5^]">+!T[>Q-^$WCG2FMEG+@6I+E_8^PS4Y5%Z.7 $5J=BHA4^%BIP
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MQ68/:$H8932#>;T>F=DG$E3 4#;$#]CQ\! ;=.:#9CO\\5Q8&<3J$,,BR5D
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M +D.B=2W2:)6JJJ],.%BB?P^])\OQ9:,*BF8)NAAH*,D(2(<3XGPVN< .7"
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M2+%,-K%,'%6:4)],%AFG6'S2Q,XEM"&Y:[5X45<?U?,Z5W/7(YN3L,QSPC,
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M@M:"&QW:.)XK  UJH:]*ILW&OAH1KGF,5'@FDR1&EO,%V23BK#,D)AN$E32
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M;<EQ56!2RO%I#5S>C2=S]<]FDV$\G85XC!_';\84UHQFI&5ZXM'+T0Q)E-E
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MIM]QC@%3T'[0Y05;]A6XMKOI,WK'Z&A.H%^^??_(,@?I66W8\NH\V8$K$[E
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M!D9FJ[S1-7M0@I*AWL3G"NA_AFEO58D-]YIV*NL]FO1ZW&LZ7#JU\M]W(O%
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M9?HV9-OZ)A1FCR?#V;>S,N]O_QCAA S[^1T%!30+AB/\Y1N]G;X=!"$\NJS
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MCLN:7>'EK^N7&*;X'__V_P%02P,$%     @ B8FE5!7UF;J)< $ 7,H! !0
M  !N871R+3(P,C(P,S,Q7V<Q+FIP9^RZ!UA36],HO$,'*2(H-@@"BHW>:T"Z
MB"B]" @A0*0$20("0JR@H""@($4B@B)%>I%NI4B3#M*47J6$%DBY&ZSGO.>\
MW_M_S[W_\_WW/RO/WIDU:]:LF5FSUEYEJ-W4+SN8M"XAG0# P  X"@  $\ (
MV0'0@A $_ &0O0#]%@P #I!]/^$+D,/?:6C E\3F&S@ /EX0R2V8&WRB@I$
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M%=G*,6Q9A&8+P_2]/[8&"8W:M^=[7;X_\=J["='J_=3]FP$L-L^<M^QL"GB
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M\T(8^YTV@?NYPA4<!6"J_,J7%"^Y>[HC,/;\E]S=/-"*EU0$MI@K@O F6DR
M?XL$XZHB\"TFV,+@#+\&R@O!+R,J*P*7D);GEU,0E9"5%I>2/<XO*2ZA("8N
M+R8A)2(NH2@NJR@CQ_\]"8"M>3DZ*1II:G]O"\RI"'Q7RL?'1]1'2A3EY2PF
MH:  \I 4DY04 2E$T+X>&/M+(AYHP1\<-!%HN!=RZS:'?S-O[X#"8E0$!'ZH
MX.[YD^U?VNH'H2/\)YTGULMMJW%'N!@"W)8B/#!HD%;B)ZWGC]NWOV;]L_@/
M#8"2&!C\>UG<W7]2HS%:WIA_3XW>/ ,4,T*@45@O.$++&Q13<+.ZIZ*&%\(>
M@_(R0:'<?G34WP=O_U8%H0D^*@*;_28B(2DB*66R&<TMH2@E*R(NIR@N_HW4
M .6(=/+]02HI#G:NB*2,R8_ [S^0@D[C:(^Q_R^)'>&*3B@O=WM09:2[O3-"
M[((GPEF _Z<E%;<./<&60392O^/U-#3.>*&<D&Y@ =I(YP2_GI:&K(2"K*R(
MI*C$EA &!HIZ'FB,O<?FT;>* (@112(=%>7DI&5DX$[B(I(.<%D1:;B4E(@#
M7$9&Q,G>$2XKJR N[R3I]*.^)@J.W?2"S?K?!H0C"@[R^"4&0D;:7@HN8R_B
M(.7D**+@("TIHB M)R7BB)"#.THXR<HXV<O_X/;M+-W>[7>NFU(Y@ASMX0H2
M,A+R$B+2#N)R(M(23DXB#K*2]B+B\I+V<K+V,K(RDO*;GO^-DRX2#7:S[_>1
M8(RX^!UR0_)O^0_(;G-<J C MWK74> [&OD7]OB/6OY>W\<%X?%OW>0;&1KE
MA/&Q]T*H.X-:_@>.*/:WXJ,\-H_/?RG@:>]E#TY(""^TBH"3%\J=W][3TPT)
MM]\D%_/V</P^6G[V#S\&Q?^;7_UM0VA[[W]OI?_,:_YHI;]U^O^>E;Y7@[O8
M>S@CP!E=;$L=L5\>(/9GYQ#[TSSY P5.OEOD/V9]5?Y_TC_IG_1/^B?]D_Y)
M__]+O_:-" ]P:>$#[@JI0ZP6X"+;[HR1H;;>*:VM32ZK[BFD!XIF.P"X>V"\
M-E?=%I96_(Q-  W #.Y1)0# 'H[V-##6-MD* ]'2X-]<F@._$LACI?-;($6;
MB.X9?G[@_UGBA'MZ84 V9T!8RA%<V8#P#1!V\\%X;N(WHQ2X'5PW89K-^ 1N
M+U! $-Z]"3M_@X]OT7R#U39A1W</1Q#>E-G3T=UQ$WX'PK>\L9N!+K2G0#C(
M&XGP >%V$!9RP[HC07@SLHK;'6&/!H"M" @A# +N L*;VW=6+Q,C#1!6!@ F
M5N??8(??8 SBTE94G ;*TW<K!H/_,/P(/[CQE>?71?BX(3 8D3-@I]A[.8);
M;7=/>P]? /BF\U;:\2_;GM\,]6\+_\.TV;??(,+9K3Z#[&KXA?LK.M03 )!?
M!FUS[Q?.(18 BF\"P.Y/OW!"CP&  ^RWHN;?]-FUZ2^_'00@$7#138/^3/\E
MP7^0?FM/=)/=3_/P:WZ+P>'?M!L<W'1BO?C1X)A \(O\V8G_VQ7_6H[C1@@G
MA!<"W'#PFX%>AO1P!KO;PQ&Y=;*!]/B[3OQO5OM3^N;78.)*H0#<=J+ ]F9N
M@':V :#CV@;0GDL$-F.O?O3;*68S8'/DF4/'O_G]5OJ+@#B:\,T7&KD5!@9H
M&)GPP[%>WM_*MB*_Z $6@ /@!O8 ?( @<!@0 20!.4 )4 .T@). (6 "6 *V
M !QP =P!+\ 'N Q<!8* 4. >\ "( _! "I &9 %Y0#%0#KP&JH%ZX"/0 ?0"
MGX%18!J8!U: #0@$P@AA@W!!]D"@D(.08Q!)B#Q$%:(%.04Q@EA"SD.<(1X0
M+.0RY#HD%!()B8,D0=(@N9 2R&M(':0%T@/Y IF$+$+6:6AI6&FX:7AI#M&(
MT<C3J-/HTYC0V- XTURD\:.Y01-&\Y#F"4TF31'-:YIZF@Z:SS33-,NT .TV
MVEVT!VA%:.5I-6@-::UHG6B]: -I0VBC:9_09M&6TM;0MM%^IIVA)=(QT''1
M\=.)T"G1Z=*9TL'I+M(%TMVABZ-[3E=$]XZNC>X+W3P=A9Z-?C_],7I%>CUZ
M"WIG>A_Z(/IH^F?TA?3OZ3OH1^E7&!@8=C$(,\@QZ#)8,EQ@\&>XP_"((9OA
M%4,+PS##,B,CXQ[&8XPJC(:,]HP8QB#&6,9,QBK&5L91QC6F;4Q0)DDF;28K
M)@^F:TS13.E,E4RM3.-,&\S;F0\R*S(;,CLR^S*',Z<PES(W,X\R;[!PL@BS
MJ+"8L%Q@N<KRD"6+Y3U+'PMAV[9M ML4MIW=AMQV9=O#;3G;:K=]V49DW<%Z
ME%6#]1PKEC6,-97U%6L/*X&-C>T0FQJ;%1N&+8PMC>TMVP#;&CL7NRB['KLC
M.XX]GKV(O97]*P<SQT$.=0Y;#C^.:(Y\CF:.F>W,VP]MU]ANOSUP>_SVDNU=
MVY<YN3@E. TYW3GO<*9SUG%.[&#<<6B'U@[''3=V).]XNV.8BY9+D$N#"\YU
MG2N%ZSW7*#<#MS"W'O<%[E#N%]Q-W/,[=^R4WFFV\]+.^)T5.S_OHMUU:)?>
M+K==X;OR=G7N6N?AY5'G0?#<YLGB:>59W;UOM]INQ.Z0W=F[.W:O[^'?H[7'
M=4_$GN(]_7OI]A[=>W:OS][$O>_WSNSCWJ>T#[XO9%_>OD_[:?8?W6^TWW]_
M\OZ&_<N\?+PZO)Z\L;QO>6?X=O&I\5W@N\]7R3<)Y8*J0I'0^] JZ!3_3GYU
M?C?^A_SO^.</[#^@>P![(.E TX$- 6$!4X%K MD"_8(L@O*"3H+W!=\(S@M!
MA0R$+@ME"'TZR'Q0_J#+P9B#-0=7#PD?,C\4?*CXT(3P;F$]83_A#.&^PVR'
M88<O'GYRN/T(PQ'Y(ZY''AWY>)3FJ,Q1EZ/Q1YN/T1R3/88\]NA8RW'ZXPK'
M/8X_.=XEPBJB+N(MDB'R1727Z"G1:Z+%HE_%A,2LQ"+$:L0HXC+B;N(IXKT2
M.R1.2ER3*)58E#PJ"9>,EVR78I/2EL))O91:D#XFC9!.E.Z6X9(QD F6>2-#
MEI63]9+-DIV4$Y([+Y<@UR7/+7]&_HY\K0*]P@D%G$*Y E%15A&CF*<XIR2B
MY*J4KC2A+*R,4$Y1'E814+%725+YK,JO>E[UL>IGV &8/>P);$A-4,U1[9G:
MN/H1]0OJF>I?3XB?\#I1>&)50U$C0..5)JVFCF:(9I/6#BU3K3BM 6T!;6?M
M#.UY'1D=?YU7NO2Z^KH1NEUZO'IPO32]^9-R)P-.OM-GU3?6C],?.G7TE->I
M4@,:@Y,&409]IP^>]CA=; @8ZAE&&?:?$3YS\4S968:S9\[&GQTSDC"Z;%1C
MS&5L9YQNO&)RPB3<I-?TL"G6](T9A]DYLS2S57--\TCSSQ9B%@$6]99[+9&6
M+ZT8K<RLGEDM6VM9/[ >/2=S+NA<IXVPS26;.MN]MFZV%78<=O9V^>?ISYN?
M3S]/LC>T?V*_[*#GD. P#]> Q\"G'=4<[SM.(E00D8AQ)Q6G2*<)9Q7G*.=)
M%YA+M,L,4@,9AURXH'L!?V'5U= UU97J9NZ6[<[D?MZ]Q&.'AZO'.Q0?ZA*J
MQ?.89Y#GYXN*%Q]<G/?2]WJ&AJ!MT"\QW.!BJ@%[&'L3^\5;U3O>>\W'S"?_
M$N<ECTL-OD=];_N.^VG[/?6G\X?[O[E\X/+5RU\"U .2 B&!#H%O<(*X&[C1
M*SI7GE]EN>IZM?&:^+7(:TO7S:^7WN"]<>7&\$V=FQE![$%>05W!2L'X6W2W
MD+>:;DO=CKU-"7$,^1 J'AH=2KH#O_/AKL3=AW>I84YA3>&RX8GW&.YYW.N,
M@$4\C^2,](L<CC*(*KK/?S_D_M(#NP=UT=+1^!B6&&S,YX>G'KZ,%8J]%TN*
M<XGKB#\1GYVP/^%VPNHCQT>MB6J)67A>?"A^_3'R<7>23E+1DT-/HI,9DKV3
MQU+,4FJ>RC]->[;W6>@S<JI'ZN?G1L_?I<FEI:7O3P_/H,G 9DQFGLO\^$+S
MQ<LLD:RD[%W9H3E #C9G*O=\;F>>?MZ;?/G\K(*#!0F%7(4A19 BWZ+Y8I?B
MSR\M7[:4G"QY4ZI46E@F6I9:?J \OF)G17@E2^6-2FJ57]7R*\]7,Z^=7P^_
ML7O3^];B;?N[L^^:WNN_KZW6KGY;HUY35:M26UZG6%?R0?Y#<;UL?5&#3$-A
MHTQC89-L4U&S7//+CPH?2UN46RI;8:VOVS3;JMOUVNL[3G>T=)IV=G>=Z_K<
M[=@]T>/6L_#)^]-&[Y4^^KZ0_NW]T0/[!YX,'AG,_BS[N>*+YI>&(>.AWF'X
M\/0(>H0T>F.,;2QZ'#J>-B$Y43ZI/?EQRGIJ=-IS>F,F:)9S-N'KX:\%<VIS
M#?,6\Z,+7@O4Q3N$/834)>FE-\MGE@=6W%<V5D/6]JP])\H3:];-U\<W?$B,
MI(?D(^12BCZEC^I.I?X6^ZL&_(C]I?F9:#<?.MK-%SW=9J)GH-]*# R,C$R,
MC S,S"PLS,Q_COVEI:6EIZ-G9F!@9F-A9F'CV(S]Y>#8*OO^Q\KQ7\;^0BSH
M<F@AG+_'_D93WT' 92W ^'MT+T!'3TO#  &^Q_Z"LOY]["\-*!H-'0T#(RWX
MHD%#:&@YZ0#Z SLDU,\R<-D+7+S*+1F1Q+CS6^SM%ZE=#O-"7M<6#FI(&T<^
MR8.CW\AH"D<EY\ORF#ABWK8.,1VZSLRR>\^-^UK:*05F;::']RX.$S:C;Q'8
MFP^^1>#^30BPO*Z%RZ5;#Y^_K.V>6#NBH&>)]+T=FU92US-)/*IXTNJ"7TA<
M>NF'3U/KWV*%:>E!<S+0,='2NO\,5U:G/PM*S'#Q:H1D4NX\]^N6+X(G=AHY
M>"U("4EK7-L5:7SP"3SO#2.Z569(\SJ/2133IJB'9+7V"CMB3.46D_/?'C[2
M-DRX<3^EX(\B:_\6-?RW,O\;D?\87KQ!#"G;Z7UTQK0[(]?<(>N]S>_9[,.$
MN?&84;'1>Q'*T^,58KKE=TP+'MSK&_3'/;&^?2AIX<BIHMW.JNKMTQMHK20*
M%3CNX%]23SZ<OZ*J2,"32*ZUI1?C. 1]H68$Z313_=F3+DN]7OZ2Z:&Q%OZ2
M240G$^D=L+.I89U4X#74@"W'X3ZICA,Z%]Y'#&^@ H1YL6851(H-BPCCA^U[
M;\4UU?:?9B0:^A$.P Z_6FEX.'$QS-L6;DH%Z/A:ZLF##!(CQZE 7NZ*LI0U
M%4B()I$($/3S0#??D /"O?K;BMKN=Q7O.\"46BCY);4:=D/Q.*7-.Q&5H4QA
M#"8W*K>=(10G+#N)I!/+K-IC*]ML[/I.&3:4!Q_??FN$U\/ (UFX*U)G4 "G
MOS_2$J'\-.*I1WE"M!)I\;2$$,$D:&JL[SK]NYR=$W!OJX!W<#TNP0B$HL\8
M%+\4I-UZF3#&)I*\P89,ZU<S'X%'("/DAWROC,)G>4_#DH_7E&H&QCQWP1$>
M0 GW$FT=7:&--A?&@V>F4'S/F%9YTE2\TI"Y^"_>#U729T_!3OM"ITVJ^FE6
M<<>H0/-;G'Q!=!A,TJ72CH#(24T[<$U_WS.B'NW#8%*(PJF"[<J92K-BI.W+
M:U2@XLXAE6KAF5YRZ!3T(%CU'>Z83!0W'V9Q('\D(R95Z>'+J6CDT*D(IM2-
MQPIW5>AJ!%%GGU"!:X?"17N2CCN3I0,_P&;L'(B"!./%<8) WSE?:).?^4,*
MNY>555.5U=W+B*) *1U*(X.#(7?2,HL_+\>%29DG\XYW2%<'AQ3";SD3&<__
MM8_]7Y:E?OR[$77:TN':$>%$K:#=)N5M"BSIZ4<M;W<#BE$AS(#ER%HV 45!
MXQ?QBVM]DX$F3J0ZPGZAI%"#>SK/W@VC!NQV(G#$H2RE'5)2NT+0?3-\QPK)
MI2TN7^6K_&%BJ<-B:_&![H%.N"8[BD\@HK"QH-()=7C"N$/[YNA7,]TSL]7Z
M5ZJ'3MY]*)U@N'BG&]XZ'*ROBHKWQA?Q)F?E.+_F(HDOD9K; [$CQ)NQCV+[
M0\LBFV8NZ*GH*=Q;'.FU^!>-3?VMRS+V/40=ST+DEQ5=/%C1SMY2MR_L3EC*
M=IU;\A%N20IJU[DTL1S9N..X<;DJQ<M7.CO]!E+P#^-83<QSNIA=<ZYGIP8F
M=X[.B3UG7!P3-=@O7.^P3(Z9K7%QF3AM>USI:?,749RJ\*3S*)0T)CQ"!<;R
M>Y'A:<61Y6T7W_.H=>T1L'14NEA4QM@:G7J>V5PE2J8'$Q5$>CL9$#$;%EQP
M5-EV?_-\O>NJ?L0&1]140[5?\?\(W_@_F:6V_+7?$6L(;RE>N,7!1=4!?16S
MF6F*YR5BCZ^<(58.NCU=IB'^12EO,>K6W8Y]DN*33V.BWU:,;: _W15&L,0.
MU;72XFN(R8-5GF(UH&\1ZYH;Q9K2QHJZ9.#)OA:%[N7XI_D:3MS0&TVN35^"
M>FMU&;&FD_'GK"[!1YLK%@9Z5O"6GV[<B?P23! L"(0UK9& RX28<L*6=+;7
M1PT_X!H&E=?=1Z$'7$M).\CQT_I[XKK-B5DLMV(FW6[DO5&N97^KUZ/8:+<J
MGWI@ )*-%_X8QTCZ'$,:42W@S,:(B-4S;01U8.69D[Z:-4^?4M4T/QQ=O'L:
MI9&ZPE4H23Y[!_;B &7U]M0G%&G#G\!B:IQ!L2=ZOV_NM9;W^/J*N&?'0)6W
MB?\)%8AW-Q7XC$J'V;IP> I3#C[0H@*J;>7\?N!WQ+/:_\9'2RI@^[@$.LHQ
M0:[*_0"=EXZQ4:,">E2 SPA/"4A+.YI;1/I<%$L%$(B/ ^*!"%0BWAOV@998
M=0&<:VGUEMHYEO +0V^7[8BK/&,W6*RU"<W1,@(PA[GIZ!NDE^KRV0TCU96\
MZIZ+5.#5L(7JG1Q5RH'U;;67WU(!>; 5A9V/F85"ZSHI]L4A3[.D'YWHM&HC
M.D3K/D,E279/2R063"[SO?/.XK-X%[SDR-&M"X./ATOY<C0-Z,>T$'SN8_''
M:ZU# J/R$MLEJ,"!IUIL,^KUP_+U$<6)[1,R>XTM094ZZ0)FC(6&E+8<:+EX
M))PT)C;F,[K/"KGW;CUQO.[,@L8H^:295*^VDF7_O69>1LWS=:=#%,=$W84D
M4;45/@[^\,R9J1OAM\.)*5]A&:+P_I>+@6\#SP;Z!=I0L).,9Q=M<_C6>V@O
M#)PK&]Z5Y'1ZL"+H68;-]21'%06S9!E+S_H]_2M\M;/]8A<T0EF+]P]YWP\8
M7@KE./_AT=O_,6/L_T26"E!;_W7DIADJRWYL1*,EK7M[D_64%\4U-=7-G.!J
M $U*PMDC3*%* .DEZ)SWP&=2HC)I!%^WK="A_,6R88.X LL2ILTD!,IA637^
M<$/2J=[PR30L:K2RU1]K?OW$Y3##M?"U[)@3I.+R\K)VT2S4W-=GE97E$<_*
MRE]Z1ULZHLU\? [&WI81BDOH@1A&-WDEW$G1$XY5_@#=)?K>,C42)GJ90(Q(
M9X/6#IA7$43FCTV+I&B^9W*_;BAU,>0@K&$F>?" <L25DKUHC,JCM"[#ZW2L
MS3&&OB.J8A]1]8;$5>U43-&GX+&J!"[]N\];?=%J-*XAO&MUOI+K+CHG=LCQ
ML3U4D!E>TVE<$@67@%<;1HTZ1KY0[LC!)L,&^0/FRI1O@T.BF7B B,F%Q5 !
ML:6>9:;GVOGIJ9/[*N$KG?K9QFVPA3N'5QJ.3$D:QOJ_8,Q7>?2$,L>M-Q?S
MG#2*G4\MO<)-?V:GR5D3-V"/?B7JE]G3>62+NHH6/PU8O_=Q5;R?^,G14A"K
MHG&,AHDXQ"9Q7_.FKH58'(D,-G^=N&U\0;J+[U1H_=Z$QVUFB\-L"J]5K#]J
MR3;H]47?2J@-RA!2'*P8*Z34K'CDU=6\%EWS"VQ.'8/2!SKCFBLN4X'1D9)V
MG$AA/4K%0L?<9N^$2%!*1E<(#YRN@-=06CAOS%L%8]A^Y'.9(86Q-$%.1#I(
MO2] D@K<ADE\O;QOC$.$>/V#W]/JVV,!NU;KURO2J(!N&Y:);P#!F/2%GR$H
MGC-W-C;WWKW<LM<7I'LP!/%ZKCWL-\[J>1:4[3Q-*AFSP7W8VQC^\')N1K^+
MU4"\<!HBS;(6_H#CXMEVSOPCSP4=F%X?OLTBLNY^VD96/8K[CJ/"=O)-T-,N
M@$]'2Y6$[=LZN]AF]]%!9?UJ-CEK[E###KLG:5D?3P_6K^PGA^S@DK&ZNR=H
MH4_U[4Q7T<OEPNNF9^IK^<[B2:?*2_@>-5=)T<_U_T\:@O^[5X!M?Q[/1OUP
MBU92U=/!:;^!)(8'*<@S*DW)S_M>AAUVN&/ZJ'L&V*TF]-&U,6[W>6=)P=VA
M0HN0M61PUM< 'VPFQ:/?UE>NCJO/!1_MJ: 7?RD+&QF\41]V\\#S=*W!6;V*
MG;+K[H=K2L97585G=0I[E#03Y)G#. GX6$HX)E#XY:5P*;X#W>G()RY^S;$R
M^B(<]>LVG869%R29,C'UA^.0H^B>LQ!A]^8KKQR!O-[K#*<(VVNXCO"I;3NX
MCB4> #^$)*,B6P?2UPK^1,F:$1%9*^.J?;VUS0/W\,3)=J<RV;(4552J-Y3$
M4>+8!25 J !6K 6ZU-Q*!41\S>L##5K=EZ!'7;QM;5MF<25MF0=T!1F3'+:S
MGT*6[8WJ&ZLTDI0UJ(Q]UCK4I@9_S[D[[(H1+L*+]Z]L^ZJ<"A#M1\0:>84F
M!OP7W\<\% 'LW:7KJH?ZBLV*7YZ6?!?0<M-_Y$OD&3FNTXQ@B_%V[*SS.Z N
MJWSPSZ0T$@%T7U:"750KH<'N 0\/G_?BTKFG\?61S\EB;H]PWMOI2VE)][*[
M!3W0SL%6!PN*8/!1E;*97>XR(ZU<D=!&BL17BL^;\(C   /6HL5ZN@5EKE>S
M^S_6/K7A-=AC:<#$'[(=K4 88I+V31L*=LAN"R>^%R,V3!9TM>%$</)8#=F'
M?2+EA>/QJ1F]O ]$YD90A5#$_;A4G7227E;[I%@'1]3DP =_)WLK=\<*Y62I
MM@^V-JV37>XUG3((K+DVZQV(&</CZQ^OQ]5TJA<M_%L''$$U51$;[.KGZNQD
M\4)3>T5?C*EX#PP<>W16>H%%PTWXS()VLU2::*W&&1% T&]&,F?RX#T[_D65
MXMFPF#S"VHX[J?P0&1.Q&*FF8C_SD>#QN0@JH+*D5&'\(<\ GH;T8EK&BPQZ
M6M=[F"Z-'-AS7>>@*H_QR?:]V[7-X^ER]XK6YVS@##]U-^1:2(QS-02^'5@A
M/1U0^EU4.]B4W>9^-SS.@#P0[T],3GG1?^<%VX<WQ5R/,=+G#P8):R=]S=2V
ME>YA7R(05=)GRKTDHB]UK^(+6-1Q'_MP30K@%-K:5C6B-4X^\Y9XKJ(!UN*#
MP&74C.",/UZ^2:PCVA/Q*LNI]TCC]F-*C;(2(K/WZ8<?"0J)I4V>?#YZ0>TX
M/83?Y\-XB.?Z324V1K>)Y9&[JNJ2"E>;1VQC'Y3)_<FXP11?2@!1:9%+O0T;
M+JWADV8S[</AGNP232-U4>&VAOX!2<6C*?8Q$=EF9R!9-L%T>7'LX<7^.$9'
M^)W%:Z?N @J)E #&26:[$1AI)#@2!WM16#4_^F@E-,/7]XEBV-WGM\C&K'TW
MT)HM2L$GTXP_IDW)&9T.4,XU7;XP T5*DW,.?KF^1^>A3.WRSI:E0V>61'\3
M;GQ6A^*53+E(.%E9UH:"21=$^"".:7CFO'@WP<NV^WC.NXEVE8Y;]=7Q!R;^
M;$@J\%]8LFK" S:^GPHL3B('%P4(E.=PL+R>$EIVC&P+$UQ_1 4T+H)?PW$J
M$*-_F@I$\."7-: ?1K_:+=GTV$TM$*'M<^O[PHDU,%*IE0_I%CAZTW=3S,6\
MJ,"3KQ^H@'EX+27U7WJS9K'$/X;,XVV^7AZHLZQ$"1JF7&RF J+18',"8K"I
M(-B#^KZJB;*\JH[A15C:X)(<E!"&(V(*YHB<OE3 1(*493M*!;3Z'U"RH1%D
M4*ZDS842F@K4/TW%U88VKR>%CWJMBJV+SF0O7R*%3_F0V6I(PWB*C8@21=,6
MU\&*.Q93@OMIA);RF\0*(I+X&-56:^N90Q#Z=-ZLJJA8-$HSRR7+X<'9M:CB
MHT9EYL<2CVA,<<]@>+-3N@9'%YF[%,<7E2J@Q[Q/@YV5@U>FP(G[%ML,KIL1
M!F,SRPOM?<22D")M?,9Z)Q^$2;-^5>M;,%;O$F;UBGT>ZHGM?_KLXRM#Y7>0
M;CL[S['%\#];<0\*U$ Q^Z>9OX#?"138$V.ZT,6"@G[2^7(H0?"//;':*&C>
MNDR6K+%JD=D68*W;_L7Z+LRH, (1Y))@:L.K1[?_\34V'ERPM)3::;J30A:"
M$:<\97^,V:;R#6(A$46T+6(;'Y3K)B(+3^.2/[\\WMH@F"IK\<3<*^/,-J,K
MJ_4'0HS7M4IG<:Z3TCN)=Z[M/Y<=N\8V@/HK/SD.=M.X]4]?BGD/JN ,$DU+
MY[[#Q_E9^%H<C0F9DJ&+NWQZ_N;9KP;B@>;"!".5%S-/7&O">]?Q)ZS[K >L
M7_L@E7W,BL]F=G:)YUP:N?L*@4$(2>;(T+EIGUGBO'>/;A^]]:[-'BC0!2)=
M&$823 FS<Z119])P$]X7#4<34U/B0_7V'JG8^3)1]:3+I7KNTW>^#Q<*3R*^
M,""&>7?"0NX<S(7[YE\X4C#HJP__9WFS63%8G ,^WB4/',()QGKF<#6$_L.8
M2=\#IE"]U\1S^,93 9DS:7OW#*^$EZN@ZFTO+^HD#$OZZC3M%8OMT'(D\P30
M]ZA3C-[-F$_N,4DZ3.">7?I$5GUNNS\"OZP+0Q^O+?'X-?^DWVULK'A4ONJ#
MKG%%NNXSP&*EZ,+D/^[R\7&@2;^B)WQ> GZ$Z9K>8ZA*/=C!2+"#)UDC-:E
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ML'XY_I[=_<P9F^#HF?L[+KBDO=?Y"-!**X;/'9P+#%UQ''0"UU7/^8;OE]6
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M7WTC12CC;G_<4D/2N&7C*<N7/]EYHWSAO1WN9(4QI1O>6S9%<SJDFTT6C",
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M=?5Z@G/ KEV0#;LGOK:CZL%I#;ZU"K\/5QE879?J^<YP6T)_14]I3B!3?)*
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M1:V] /FX\+B'3#@@'^XPT;$9I*Y]L,>BG)PK;QII4,C1>M?$.DA'6CK'N5[
M#8R @2]IP@Y0'+A3P^$J=9JD>WKH$3K/<'5K*;09189T?E>L'YO-R.+<\Z57
M95$WJ7%)P2 B:VQRV ?HP)ZKX+S$"# DCI(WEU4=H$ :M&0 (*#A3F'P;6IP
M0=EG)!$ENOB0 ;!P\I(W#J.P1,\]DF5_5GMG7UT[;@%S>#4:G(/DSPXON<2J
M?LY0[['Z._[+^!#'4JW_8$>^2 *:.CN"-R1>;4#-,  BW^LZ'YVGVP\L..6K
M*JO2]EX)'!^S,=3YA;3$*01&9*^XV%4\S04' 0W);_LI6SN7@%TN/264;Z+8
M$HQJ_3 U^Q*9H^LV*898]NYSCN.%Z9WM9Z6N686MIK4VRJD*<ATXJ]+ K"K:
MNZ%Y9U]X *+#/[0)G U- H9K7(Y691L-278Y>Q"TEA&4=@B%2<UE8(^T;/ E
MXLG4"8I;A^!\.\PPQ8&CWJB#D*8.545P[%\])C#C(%G:63/:B"S/&+5;_B9F
M4_MK=0G$O.2MI-6\%4ALPQH>BH7<&J44=M9AN0BAGT0LZE^N1@'P9S\][^NH
MW(UYR5_3??^@JG3HXXC%\,Q%UXX'@B7SBNT=90T1B?_>-0A]D0$@SC29</D0
MT D-F+,6?&11I*Y0"LIYYIO?Z7'T1KA1:%^J$\MG%A_.[TPYGOMSN.4Z_4Y0
MJ>#FJ;^2]I+MHBMG\5 %B@3VURX\U*L;K"OR4\39*IY^/";-]Z.ZK_LF%P*S
MZ(:G6W^$W>?<_)6VM#G[?]A!1U(?L3]AQXRTLPQ V DM869,1><+$Z;S#X;T
M(Q(0>$0"7"8P/=]/HGL8UOAFGFCO^_)XA'P"BZJ'\QSOK03*:7V'?'[A]NC9
MA-"GX^G(T I7;MDW(1U;8?/J2;0T%&Z:",*SIJ"O!A(#\"")EFY5VSZI3X,1
M0?=Z8\_XAA4K7'34=P@932<(9PF\ (.]<5:$Y4;EEO@ A";[QI[Z/5)1Z=!O
M[O)?OJM6P*HW6.3I)/-X6$HKOFS L]#>1>IXY\DSUR^K",2*K>OK/CHEW&N!
M%':[VZ.6=4I3\:L'7 :5!DX:.:!NR4J.Y,DU26WGK:AD!V) P/67X<,\507W
M"[C23?*:7#:LUF?XJ),3/%FW>H?F<*(S\NSSD1^5H([=XNT'Z?\%?,.KJUWZ
M&5V+IIHCR]W'*YR5'F9S:U3II'UPOA8Q1*UFBJ%#E#'\M??ST!1>R^JH&_[>
M2,XR<]-P.*:Q+U%TUZS 2 R3Q#ZAO<+ZG,DJZG%B<YK\^)O W(8<!@#\![6S
MLBI.D]I&ZHF@A'R<NK^]%\FQZ?6C[T&.@,'SD*_*NMZ;JH$>O"87R&%YN?WP
M9E;#T\WYK]U;E^&O8T:0>;2(7TY/*ZJ'O 3[^&I"U0+R4S7?SN>GBT3$G>EZ
M$FTD<H@_']OL5?^-<%L">61]K)#X5$3TVS". ;C)E."?Z(:P9Q1#G+^=( HS
MTJG85I;BO]UMM/I,D"X2EJQ8:/96XUAKZY8W3\(X1Z]#*1%Q!Y6TJ,37LO>@
M3RI2'FNBE% ROW/3+WO)VW7:OMI^V^;5+Y:8&DKAX30*"Y=HOY&$BO2=N>":
MCC^ ,3^N^5[ZOW SS@B.ZZH8NTE1*2R(8^,:2NL>,Z7]J='>+QLT5K9,W@)Z
MX.'K6M_AS42:&YVXC18NMZ98E1JNH*C[2]A>)B6/Y30!?E*JQHOXDR9_?IXY
M_@6ITZAP<2X:Z"7[:42M#.H;5$UG'<^,*X]2^I(,.KP(\J,H+6 %_^,QW"].
M*E$F^0.9DSHGF"12G,VA@G=2:E';.COH'_/=V4:'GHT\D?>#>_+YK%%[ZB_>
M28>WSH-)H*\L, S8/C X&<*[K$^[ KMG7V8/CH7&#W,(:7XD9<22KRR6B&2[
MBZ-B+"64TZ8T Z:SY0]?;!_;Y?/;==L/]A]^LC+YWWA.7 LG3H,H2B[@]7.#
MX#G:Y]]=N'%4('Q6@P'XAM]IVW=)\9E(#T>?90(@<YU<!S>#DT_1GRU(-Z&0
M:+':[H"O.E>&9@XO71[(^YS]X.90(^3$Q'S9AOIK,C \((!)&!.&(N^S9HF"
MA:+@2K#]0%!RR=%E_?T#LJ5".5A\@J1FA;RBIWM3+ZAU1A7[(?P&6I&2KX3S
MIMWUG[1.+[Z5;[+?2O(5M(H)PHS"QJG;B&_)-,(-WET&X!B-=9*PKW=[:NA_
M%P/^UU,5:2 F7V#*@:X@2@1SFFAHFNJM9]ZA_8IKV?"O$U0[F2W6*5I0M][2
MZO\'@@\<!&S]9' 9?M28P0J7R\I*F0'L.?8!Q?-5];B@/-.PB[_"CJYB1'-$
M3]>[?F#IY4X7F.5&"L9OXU3SA[8],_-8,BYK<.-/![#3YD?BUA\8Y;PROIPA
M_?:Y479OS8VNKN?ZP3].>5\FK*S?8Y/T*VIC_]L1;,*[<%TE=^BN?I]Q7>:/
M!E(6"98EGQS8V2I+JXMY9PAWV9Y V8M@YXZ\NVC^L/2[</VMKN4B6DZ2Q3?A
M+44^^<[5?0KKYD6*)L4"SP!T,@!\SYO42(O)(IN#XM!%]DR;AH;$MP')0D\G
MZ_[,N'%.K4M"'7FE\Q8?C76,!QE1[MG7C(@FP-/\X];VC^(8PXM@<@**' M.
M6:(T$R'7*:8X.52B0@D^(F% >+G";[Q[7.,CI$A38'TC(:G+**@  #B<+Q\D
MG<$-B+%N$EJ!5J1,XZQ;(H0SV7A/\?GZG5R.I$S,1$*Q359DEK=/ [!<B=4W
MN2JJ=SS,2I4$NK >M^^S*\^4.[@39&+=D0UQ.]DU)K_3@-/M>:W)G$@\QW.Y
M[:R/#T_>KPL:'.Z&<K5VN5X(P<I8#.*_N7!C@UH1M2LP$R:.,%5"6@BI%/()
M]MQA9"//R"N$M^""[_E&S:0@%NY<DQ?N\ZN;4T/;N:@%'#_- ;5?&"2$!U)V
M1U";Y+-*WB0U!,'H?/B.B6?L0C6+CRU^*VETGT6'A/6;Y_/C\G\*HI[>NCVA
M=!WK$Q'&  0J?=TC=Z#(:0Q C)+;<R>OI[H['2GO*Z#J9B&1M;#-NFH)-<ZI
M>\D1BN<U2)-+F[R3WLZYK^?<4 LGT0/'07)!CME+<DIH"_;\3(<J_^%D]YLN
MGT8A/-@SP'.QUVS REA=MM%&9^Y1\GT(]^N/_B%6! [AOS7J#T0</+>Y Z?X
M4%J1*5/)9V$/R',?:LA'XE5ZZ^.^[4WZAMV<4LW:33P<96,QI,7;[DI2;%R&
M(2L^N]&FH'_SFD"AXS8*R1!2 &XZ+H7\7,FW+Z,S6]ASTH0+8Q7 A:IV4@0X
M?RQXCM'I5',JM8E2=@MTK P Z8TE!RIL?)ZEBN^ FGE4?O>"669B*BHCPYL:
M2>9;@AG6[?4D>W<T/2.UM<@,B<[H];TL.7:6XYOJ.:B7<&[1J%6\CL_3L(FZ
MJ"Y,^[L?D"&.+I5-WMF!R?(=. E.1G2BT\V?A&#I.@V%@A>VBL]8'IE"N:H^
MU/NP_-SWRZZ1LWQP#B;<J)MS<A]4Y4G+?VWS+6BV".)&8XWQKWKRGQ6B:GBM
M25+LNJK0YF1P4@7NEG$OJGC1QW5<O1H:;J<<^_YA[?'G@PY?%F;;$MU>KL4<
M7@MD$BA*-YC2CA#V+RU)-\7ZN!E4I5S-WM'/(_7HW@%2WV-FLSMOQ9/]2YP"
M1(]."5Y<?2>X,@YV_*K0?&!P0@JJ=<-#,=I6ALNQ#M6)>S[]!N<:]PN1[>7X
MP;J3ZM0SKNK[1>+(K7>(R=;="+H[B.ZN=W";]#5<F!Y/*@Y%\I$*S7D4QKN%
M236-FT&J,=/AT8I'^,(E)(ZF6=;)N !7."MJY>U"$!="CPR=@1344NM1D@25
M;OES\$?FJD.73$GJ<95Y"JF&O9O[PRX<;D[<KQF %CMY,5W^[CT?963;P"R*
MG,5!!I05_6ZG_C]PF_4OBVEYRB1%! _'@:Z94:#8TQ&.N[(0/.ZV6G#>P.J"
M,M_F7.1=@0=]H2%';*K9K<(->&2<O6_Q#@VD&4OS^V**((MK/$&;4-P:008_
MG0*_J3!9P*2SVT<Q!@.@7S$.%K7!89NK(C^">V0!G\"W[SZ[.V75<4T8#-Y&
MVMDN4TDM24]".Z)>^X&^+X.N_3PXM__.G=%U=2IQFM"^JT(:QY'(6K6;6VBL
MYI_3K\'<)MJ%-[5-G!7M[ZB!DX.4D^NXS71G%'E9)^C#U*IH^YD@8S]F6/:@
MI/ NP43^:DSXKPVGQUPH.VL$]"Z*Q #H4<N';ODMTN\A1_H/IU2DZ$\D @P]
MYA\:0UY56$G)+9N)S_! ;1F X!U'WSUC>^L@HUKX8WK6]BG:42QG[_\\V0ID
M#B=+G,L/'*"<\R@:_V;=0)(N="S,X"MR0B5D_PPX)-<QU9GL+[0^]WDG?'OG
MOA=/BJWL;#2R90$<1 6]I=0&2HT6+J$H+?">"6@7$#N=O[1C.=#9Y!<E(O.T
MUD-CQ4[M6O_*_I'(])BP4?YR6(_EXOINS$22_YI5@+-B:E'1V]*Y<7/U79OU
MN< PT:ES_^S%:3BE7/E[3F]2"=3A7OBUAN!BOQ'3&%XM(ZP<;Z()(@C.A[HW
MR?JTH_#T]F,);XR;I>Q5Y2%OG*/5<K=D.2[O"G7!$U128PR7]2=4?J(@3(:H
M+45FEQI-S1HR& #=.N<RB!N_)G^0<+M,'^!/8(\Q&:*D:9U<JQ$;1'1/^.5@
M8ZY&*E[+4,#C703M?S55$YQT1QZ%#1J^K$G0R5;JR"Y5?-G18R8F6-O5NV!3
M.*ARPJ_G;B!N'JXM[9VX?3ZQ2CKFG=.+3 V13)XS=P9O?*(<>DC4K%ZHN7N/
MCS_Z;%C;0;%-T4VR( -P=02%7N<>@B^>,?OM)<*D/>=^FXE@?YN)[(A2]YEZ
M4+";2/^C+I2*JL0J'ES;6N;B6:/:@W;-FG;13N1'^QZEAI$P&%W?A.X.,Z#$
M=3I_JLN."?+!R$ >J.2;_C&\HK>M,OB]G<)3MGPQ4/;50CV\+-1^GABZ6]NZ
MH^%.(2G=1Z<?QV@5*ZTN,D/-BNB+W(  C/&3PG;A%_I]\:M_?KG\?OJP2X]'
M\.OWUM<CPT'G19F** U&':^G)E%[F6L^32?;Z3)Z4&' -D&I*=7UR:,[4<4\
M+)_ R9Q5^BC.L#]X1LIIQ;>PPRHRZZ3HM3 BB:#0LB=4VE@Q6%2TQ:,T(X\Y
MOLM?6U8?%J(N+/[)=_+""Q4A%N[>&$B?ZU]5 RQ&2JKG@N/^;Q+'I^%-7M1I
MYJF94;.I>/O*DSZJ3I>PI,B&L:R$J@;+HU,U-_IPHP;W1;03D*)M^1E*9AD>
M58J)O=OI& %?.^K\,DP1V I-)>-P4/(:$$OCTLPCB29YHN1&7SV4KF990+9Z
M<UN+'LI[L->"3UX?^4J[AU(8@7]=,WX7]\JM0QZ1"W7)H\41)AWI;D@R W#7
M)XIYHJE8B3(NL8'B1]GUOE)A:: /A+N#5N!67A=P.4]>Z&(S^.4, ^#Q0IW^
M9(= !$/H^G:IM$<9J'GY/=I4E%9;J"^E!MZQMVI^%+(92WLX</=OI8DOR0)A
M/*'X1_6./:B&H<M<)H" Q*;G1]5,TJQV0U+SMJ$5Y)2H8X@E=M#.D[UIT@@]
M:(!PO+-X#2W5,.:2-?J*2YM5&6Q4[T8M\;K!]A&\F(U2:.LL 7WCK2\'__1*
MO*]E&'T?+BV/VFRW(,5M8DC[I(E.<$+="7-3DG2P2Z9]N INX=6 F<811=.P
M-&0"+H)#^<N'":DQ\0>V<U#M97KWP+S8KN]E?E %)0Z;Z!'M@6*,S(%3_9.'
MT5)P\4KW']_S".F63-XG;M[5Q?J%Y5 Z^Y7'ASO DMY-4$[3E""* 'R,,V-N
M,N!?PJ(HR8? FHX6K3Q4X"?8+8=,=-$\:EB:/JMY;]/X8\DQP[%!Q(OWORZ&
M\_WH!CUWD'2?:9:]2^&%;710H7"Z/@. :Y6B*8POH%(SS!#0BK.:"KB/!:93
MGU9)XV)&-N#%"_D_/5AOO>3Y:;^V?Y/.EFRA,ZSR#BXGKS7+J_[K&TV(6D\=
MIS90AP<>Y<V!)8V72K]GE@C'O/?Q_E$/<;IL;#7][$'OMJ 4Y:]$O?Y]^<J*
MQDQV88XS:SSJ#1Y U:[)B ,LT>O)4"?E$4#(-842HLB9"?,^T= UIUN<GJYL
MQGQNZI'#Z..9)^2Y#QY_WDF99.=QYH^0O/_1']3@ [I-/:#8L<S7/;+,W"#2
M_#FIMH8,P=?+VJ)GN\@/3WAK#=T]I#U_[?'9]*0K_(G3D(*+TO*<;8W9VRHR
MMAS(<SC@0?MQ4\R>6?W"1H9- U.49\/TZ0X4-"F@>]C<A12TD^EUA']0DG),
M>F2X]=7V#AO;7+$V0E_2YO)+]X::K&@=[Z<)X[7[,G>Z7_=QM_]EEY$$H] ?
MP+S\(.26SG4_%,:=9D)BOTT)Q9!J'".5YL.3IN+G(N]9N5YO:0ZYL2!A<2='
M=6>J=:6(I_"E37OIWSW!"+PM"?*A_W"YW_H-D#D[T$AO4';#&J%1!B-=="QT
MJ;Q 2TKNG<6Y6+WE\$>/+N E[IJ^*5[AD0Y7,":I'<:2=]CM?NY:D8_384)S
M00(X.XH+WG1->E+$0-%*UZ5O6W]Y@8?7C[5<V&Y:0FQ> )8%.3X.7E<=F*U9
M*$W.("\@,(O@92B''Y'N(4_>[R$\1W9G=>X%5N:B\#5-6=^;. 68 CX!VV$O
MUIZS/R7X="7/?K%J0T%L$@B9:&@:P:8DYN<OR<0N<C5E>15,]S@J;LWA%'K@
M7;'WL+"X9,"A3H*X38:QV\-DCL'4Z]S"?R^UI%VAW_LA-3(7BC_1XR=&<GY7
M-'55V.(>_$2O'9UD3J+QCYZ965Z190 <0_>CM]+R)^3_E6+_'U:B:-I)TQ[\
MG1VE,P!$O@,WJ$ TA8P_7YK:/Z PFY75B0>+)4P)L>579[PJ/I$-:"E($5^]
M[C) O),S1V[JVU>,J%QW32]37T#ZQ-##]F71AQ7&\)#;?B"L276"0E\N)GNI
M3GC%Y9-1EXS!I;>ZTC;/5&X>5M-EDY2M?__Z310DV&$SV;/6)D+8UX;C/DRI
M90AAG>;S7V[Q4B@0>R?+S\8K_'I\0ZSLGP4%-S0%GP':6%X*H]-1E(ZU;DWP
M'; T%4>HR;67O&-#NXBWEOJX,/PZ^^&AA<78@=.CM=W;*,Y0 "B],7M%;]QD
M 0^"#( 6HZ#@PIEU;&V?N.AU/Z@^N3HE$(WG.2-JJD_FH7(%A:^U*JQRI.I]
M_*"0M U(>S_'=TR1.YTWT;^HMP588'UH WYWZF#/.E C28287/L04@M&KK4N
M*%MZP,$_ ^GHY^;:=UDMQ2!=H+"6.VQ#-BLQZXJ,S1ZK]O*(W;/75C_O/0'4
MWC\3V!U2:ZT+4Z,_P.984S-)>G\(,0#<)^^<)O']^1X1"2:"4J,#@.4X1271
MS1C:0U%CYB\^/F@/-J(32R:5:U;-">$>22PL*[8/78VX)B7+:GA<IBP(B<Q@
M0WBUTSJ!&50B Z"T3"T;RDITN>J79TR*7#J\8#KI[Y^>I!AZ=-,6)"%$L5D?
MP7J<)X]/[_(\)QT_0-:]K#W@^*X>68_N2B9GD>INIFMN/B$CD"*+_8XIK/(H
M[:/4O*H;Y=\!DZG!RE1*:H3A,0I(YLT*U*I>Y>Z)FD -X PS2(IA PN[2=^M
M&_Y:>P=$)9#:ETH*(5MU3;G9\WB^1BTJV;YQ"-*6GG]=4X"HL!K7YQGCO(%#
MM :S+XVM#BJF%K]U^56'W(* D6!?N.IZ][E6,3/3KKAF.>'H[HLGHM[?*"J2
MOASRV.,N[>(9 6'W&TDYOTOB.<DJ3%:71Q"D'^9"TY2UXMJW@ $AXZB99'2^
MZ,Y5:@_Q'A6[K+]=0OTI2*\X64+[(@4>XK5T1/^5)0;:R 7GB_;2VO_99[!
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MO-Q?WK>[ 6AK47 Q,/$07#!PM'S2[Y[I&J;8X$'\7FHJYH_V^O$?,I<5LQ(
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MH7PT:'E8L)*H2XF7?'VZBFX#ZC&Z(2:GOJDV)B?%^,)0^IR[<9BBIFS&$:4
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MI^X.+0<[L-BCF%/CZV)/BVH?ET$=49&!$G#3DZ)@E._N)!%XU:^D@VL2AU3
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ML/M4\F7'THQULC'Z9]#X8Z6X8P%A(-\3_B!*LRBEH]::C6XV(#)<L64]Y/2
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MJK*HH&&(_<>DJ%)9(LO7/E2N7\G(YCI^WC]8,1XI69T&>N?H)EI#O;G"[VO
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MNO^\0W%O@PI.'*&>M?2WR1\9793S')?9YNB]WA2_4E,8K74^E),_HC^J[4?
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MHW;K*XAP&I5$*C,]"\%K%+&W7NQ4$9;Q%B N'YJ^D!C#1Q0/;TZON82S6O*
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M/<^<5FR*!\W7?$4/S!)!^4OT1Z2U6+28A\L&2XQ"HQU>ZXKF(-'42$PIM>6
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ML<P@J<6.SB_KO(+F]?O1;1D!$\ BH'ZL63X&RA(([V'RN2[9"#3.[F\W8\4
MQ+>/S\-[O:W@!9@YN*X#\SV=F$YT?CD/)+G9\^S-216O;/BY%P#_NTS1NB$<
M?&\P $A$"SVW1UIFT"@G/CWGTT0C/'?Q#,;=TM]YB5]7Y5:P.I\GO_C7*.6C
M[ZP.Z_98MEZ./A=R^.R+R ?7UO\B+!'0RBXE Z) B#L><M<AH=ZT5^1$(>7]
MV+JVLVU>AEY2XJ;>8=2IN!<O;4^Z5OATR&G:"-@=^^4IRL$ 9'YG$C=W!J ]
M)Q?>$M9-R43"F"O.1,B'$_'T$F#T?OWS_W .@JG%HI3;RR5;KVG[Y<^G,;19
M%-U$1)[^P!0^< HNA*SZEP30_^F*+<G/Z]K_J5)I#("*ZWXO(J88-)@WB^9
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MB' =+NII./9ZC@K6\@)]'4MTZ!D4&P ,.7@P ,U*HGG4DRM7#]NZIR%V7C(
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MCQ7>G]A'?8XOL)*=2M<#,)"*"(N@2U$Z3^[V''G,<N^HW7'^$7\2[XV9#^\
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MWJ4#Z6P3D/9YI=U-!D"ZKHD\ *1-EQ 62+5*FBFM?>#SL9];\;A7%+D?VCM
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M"QPB2-0]R $3909RF,2UOYYX='_"%$,<"PBCO%%?:9D^?QKT"TBP=A0EAE;
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MDF[H%3M?34ZQOO%33D=&W$5-/W+7-P"R^'"Z14[OS!N1CS-*J0KP<KP@@JR
MD0 2"VT9[E^_ @U=4ZD[ RK&=C9I#OFI:H:9J'&U5DRB%9?VN:LMUM\6\4YE
MW^U"GXLV=-AB/G,P+N.D"(08 C4>%\;E]>BE,%#/4._[_,E!MO6.D/F)\9A
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MO.*3-JCP&\A/G"^&FNJ61\I@/I.7)WUHL7#T_W[I'EY\#[)?DG&^]-'8L8?
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M; _"5V_S K:_I8-U<0"P N5CE@*YW%)X:=]EZW#4:!PUJ!^7&"^7[$0)*37
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M>9HB*V*V;L]!9.H]42)7R2JS!^-W8%U^P(QGK'Y>D!8/W_]*E>KR7HIJ@<<
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ME%?.L:KV*.J7O)Q>6^-E'"TO\/K-"?YEJ9I_#]XL$"B+ &4V:7CD%F6.4C4
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M\5F1F!H+1UW&Y2.1KY93TY<0MO8_21#UA$+"BT ;[QU Y1.A!DERG\ZS.QB
M&/\D5?[/6,3N/LV[:+44B^>A]!U= EXM22FT(P33MEI3K,[O]V[0)GM"R_.5
M.W7V^0'-]3@%V%/E4X &EA0V_ 1'\\01WYWB!!=\N6,R-;L]:P?,D'2*%.*Q
M&ON"K*P=[U6>D]N2^LA1FU%TBBE)F1<GW85D8M-&6)&<)-]2#S!9?L18'?OD
M^/374U%TM@EV<6X=MPJFC9TG"J%^S$K.V$%0]GL,;_?TJ)JM#F-S5 H SW,/
M59+,[J-$19U.-PQ#(R;I[),$.>/2=@!2X(*ZZRRA1A:SMUMB=6,$<:(EGMHO
M\V+"CA4=UJ.'O;-9T8>3/L/3X:2TZ00@\;O/2Z25#^4SZ=8O654#%XP*U.<0
MT].@#A? B1__=FY$9L,%K]K]84[9>2+H=/A,V&[%VO--="#6E *)@Z9A,)@4
M(,,J=#@07_JV_VMT>S[9KNVLW'?[T;S+%T8/Z2BR0#UN3<@GO]$Y.T:T&5FE
MPN]>)^GW*UZ[Q[9.O8C[[#5R8\4TCJS<GNE,IX/)[BJE\U3NN3LCER_.W7/T
MJ,I!5PF]<'D5,901=E,I_<4BOQC1J])?;+PS]_39%-U-2&1H"FH2Z):CIQ01
MI#?Q:H>DE)L36!KE,*7YF6 Y9R&WY:GSY)/43[>XY?*8/##'8FL+!N\:6H=\
MV"8X!<6WC!EM")MT(C-CB.@EE9[HL:TIN\: ?^PB*Z8.,:V75(QS<)R/2F)J
MCI> ;VJ,OKBI+A#1=1EHA[53D>/6]L3ZCFH2=J(N3K=R*Q*8[3L)M(IQY2NR
M?Y?UO1@J7?OU,VQ+B[*$UJ$/VQ'R$<[,')HQTJ'*3>=MY CM\&-(B#Z)"YI^
MQW-EQ(D12 IM4X7@:+I$>'Q\64)@;@[9U<(H),$6X6Q$^"9@+AJ_(.$TF8C1
M+!@X /E$2=%*KJ&^=LA(F/SU7RAJMXMRF>+*M;2+N=[.\:BCP_\)ZR>>']W&
M^0!M/>T9_CH8,THQL73R4UK[@P?%MU***?U"=UN7%%VZI#NTAA97Q)GLO3^\
MR*2Q 4K72P$\#W"^9)Z]F:RSX.Q9P['4VXU=ERDNFWFZ+ .9%;^YC:BP<W?=
M. "]/$+P3XQ<6&7$)4Z;$+=#"[Z9I0$Y2\-]5JW5L"<7C'8=M:^1) 98,:<9
MFJ,$!&M :O-SC-[_S/P_M'\TO8\/CTB];&G\*&=^FOCJP0-/;3.3WPN>QY2?
MD"3%:7HH(R34,J)3S8)2U_O P./+E7>#J^YS>G9;#&:;J1@&_ICU 3N=&^66
M!>>O)5GFKQBPI@D_CS@N>'Z0P7[RRY98Z?@?JB)FRJ_)FATH%PU(2L/;/'*X
MU)6P+>6?)88S.5,@%[B2B7)S^+ZO/>\LM(%A$)4@3T?7Z?<IS^J]A;#Q*',S
MU>R![&? 5SM32(@E^06F6Z+<IFO;O79IAA8/KKW<#PA@+VPJF@5)$HL[$D>.
M:D3A-PU*8@MYA_4$G2 :[[UOD&+NM8Q:8\*^2-D?V<O=4KU^UJXZ_ K_<_Z0
M"RR<TJ],37E!1NI,MU;503='+]DE_1/+_>M-X@%(EG:=9DP>L "DD,5$TM41
MGUI3]B##M7Z%5(VSLT^T"UK503S%[R9EVA;3M0Y9VQ2_E;,JR;QX1SJ^OFUR
M2?[=NV'YX6TSLPW+L?%KT>-6ZA$\1EIGCX6%91TV!8% 65R6\BNY;"!!-G6O
M8[OE?[<[?Y)J_:<QNXSFC4^BLJP2^# %E=V !(SBFN(/(:B!3_U67&S91:0E
M-5N'8W,@Y)8IZ*8D)H%'"?4D'*N&@+?^]1O2FZJ$'XJ[\"X_O+HC998R:KYO
MWVVU?G>7%IU9VVN[)[@&[@JJHD$Q-"[HCM9BBGU)T%OZ&%8DA\X#.)@:>:)3
M+8!TJBQ);IC8_ 'AX]U967X.YRS=PG.7('BR:K;(@,G.3;K#\Y# 3@#"MEX'
MECTXWYYIQ_:U] !4(L^8LJN60_E,1XWA9,T;'&,H"[(AH7/'KIBOJCC.W@'L
MI'LFGHAVVHRRM^_5I6IGYE8"7R.">5OU7W3NX 8@2;*T%O)W,AW)*7*1&\DU
M3L%=3>X9#RRMBA<BE:E@0R.K1[V?W<25N2S;-CI7_!_:ST-45V$N6Y.Y]O*:
MS92^2I0U2GZ=4MOWPZA[LD19FF<<B8/4L2T:*3'XC<\@RE )G4[(111'78Q*
M;%]/>\YT #J6R4]]9_4B5S[G2NU:0";Z36/RD&_):\%0B&4F'(R'^'T*70V=
MWYD'H@&A2D@OS7  &/ P!0R0X3\J!TH[B>J'.2'EX8?*GND)PY+DRL])OO.%
MVB[5BYYA8JO%"V[I3P'J8RM<)C7_9][\W]K\LZ+9/_-P$LV[O/<+T*V$3+QK
MOLR=F*"X73JN21^BLI+7 '\^Y8D:3]];/0]R4+U0_?4T!<FG]718@B&%)3W9
MIWFV$NL<+S/;>B/@ 0'?PV"S*;E#QSK@6=1H#,3Q%[5K@7F:2\=;_77LRO"2
M-"^9#Y73/>BN"3^;B[#+=_W4 ZP-1T!4@>N+!R!#!$]03[=-W]S757'U Y![
M##F-*GD&9RWZEYY62 K2;,@C)$$+M 81FD@(;"UL/!YC5; V8R8'5NGZ?"46
M6[ERI$D;*<C@);?H$J!L]+I]YNOC](:Z@!Y^%=R6*%&3=I\%1X.[0:5HGE-:
MBQF65W#@>+&QD#06GT.+\&=K1]>R+OD<&>0J[7HM[')O<0]CN\\0<<)AF$\1
MD H2G$+B5OAVOC5F)&1FN-ZS+1C7M+=WYFYV=41PMW :9>7D"("*LMQ!G%U(
M^3VY\V>O:?.#%!G:!#P=_FO<X3_<_)\:$?^H<MY#\YJXKM1*F2M83,@ID&5-
M.[%UQ-;>[W ?5#V\-N;EY7@5?-5H@V%'-S0'O&=\80_2@T) ,B?#L=Y8_*$J
MST*@6]753(,,D?QNE9_93-;OD!39N3,B-]YGJ4JHW3^<ABZ?@RQV:*[.'H "
M]Y6E^?I&B]?M:=[ 524Z#'9.%V;^> (U83"XVAH6H/LU&IW^IK9K.,H\#*G&
MLOH9S%+EQ1?+EC1Z9(IEOJ0#^:."9=-*]B$SD.O)K]:Q<0T)@%\^'9!GUL&+
M7+_Z"2RCCFZNG:P(<+24_<B#JUTA.&]-9MNPRNB0HOK(&4UF\&QL H:T1I!<
MRI\PH4R0!,E1"RZ$A0S.QJIHU>';^2PJCPY T6\AWLE</O.K;+#L;7,*Z\;5
ME\48+IJ[+_KSG9[F9WL<"XB?D;?;N6\HG8F78X%(N)[T2)0_6?*S5;P$1<L:
M[6NGM^;-9"(C;]#T[&7?3/][^V:&HU&/S.>FVH@2^O\U_O&?;P)_NS[U[Y[T
MB;*_T(R'"")Q'1HQYSKW^+)?"L6:AU<M5$87<]]:L:EWR);@8OQRQP"51E)R
M3P8P7#J+1P$U_Q_ERE8\.K&@)O@6I9@D<OIUN_A0)D9U%?O1U4BU",=UY.V)
M&U.M:HI>T:C P0#E\2O,[!]4Z\)2P,EO2/H$"62H_OQE51:C@9H@;,DX[H1:
MX*#C$_4MGQ2Y,4^JD>#4450UT%,S-W*>4D?JG[* (;+ON/7=^59=+F*Q=M'-
MDW<D'S9^5. %N_SKR0KSLM?GIV&O@?=?';CO-*B'I3P!(XL2 H,WS:4@6KZ7
M*'0REOY#G"J(M+-HAIV?5J+!D4A*N[=K05/DZ[&)=G88MU"7:N5C!X?YJE1U
M7>5[UA6VN3UG#PFYDA >09F#W\OG>@I"N1A#U$U);WNFX")(!.V^ LV+Q5HZ
M0_]ZOTHN1V_*96MMX?.!#RTB<N'VL%P9Q]+/*E,F!BMG[CKNY9X%K#2I!(XE
MJ/ /Y>4'82],R#LD@>5==\>!!Z+7WC&.WOF2\OP(3>I%*\8%,@/6SST /:YD
MVGOQB7S-?!Q!Q7W'"@#=XC0ME$VE K=DM#MBZV<7<_-AM\([WKR\J')K0<3#
M(>_3_NEQBS98C95J9Y=OS2=E"$FOJ/7@1^"L4W\JZ\F$9B'^6SST_U83>S#V
MOP!02P,$%     @ B8FE5*G48OT%O    <<' !4   !N871R+3(P,C(P,S,Q
M7VQA8BYX;6S<O>MRY#:6+OI_G@+''=%C1P@V08(DV#TS.U0JE5MGJDK:*MG>
M.QPG,G"CQ' JJ2&9JE(__0%XR8LRDPDP28KN?6F7)!)8ZP/Q80%8E__X7]\>
MY^!99GF2+O[S._2C\QV0"YZ*9''_G]_]<O<!DN_^UW_]V[_]Q_\#X?]Y=_L1
MO$_Y\E$N"G"125I( ;XFQ0/X3<C\#Q!GZ2/X+<W^2)XIA/]5OG21/KUDR?U#
M 5S'=5__-?N;(!Y#@D30CZB .' X9!%!4(J(N,(AR/?0V?W?4.!C[E,$22 1
MQ*$7J,?\"!(JJ7K$\1"-RD;GR>*/O^G_83270"FWR,L?__.[AZ)X^MM//WW]
M^O7';RR;_YAF]S^YCN/]U#S]7?WXMYWGOWKETRB*HI_*OZX>S9-]#ZIFT4__
MY]/'+_Q!/E*8+/*"+KCN($_^EI>__)AR6I28'Y4+''Q"_P2;QZ#^%40N]-"/
MWW+QW7_]&P 5'%DZE[<R!OJ_O]Q>'>PR^DD_\=-"WNN1O9%9DHHO!<V*CY3)
MN9*^;*UX>9+_^5V>/#[-9?.[ATS&^YN=9]E6JUK*2$N) BWE7PYU]M,)XO<D
M;[$K:P_"E>I^[DO&-DP_]R;NG>('.;S &]V<+'+U05TNQ%C?[JJKDT4?7N*^
M/HNTH/,1/HMU-QLBS_4O/JI_U=WHAEK(M.RGINX-4>6W0BZ$K-ARJVF0B/_\
M3OUKMLSA/:5/LR]%RO^XE4_+C#\HNKW)TON,/IXOBX<T2_XIQ?ECNEP4:,8I
M]T(1>Y!BCT,L8K5*>=B!"(=4^$[DJC5M5JP^]9E<P%^^-%*577?J]SL+'(H#
M\SF3>:JZ6:^$C_-]RYM:V?1:2'Y:T$>9/]'Z!26\-AHJ??ZK%!MD*[G!4R7X
M&: KT0$M9?^/G]:Z]S<.\[="=SX&L&N1P4T#[%IJ<-X.;,JWQ)MK8R3-7L.4
M\JXPK>=\KC0L,8IISDHEZR858"[Z2<Z+O/D-U+^!#JH-F+_8]OW3SK=SGC5Z
MTHP?&;KZB9]XJBRUIP)NC:*V;$\"I$A/^NRJ85(B?@?23,A,6>I[U%U-E04M
MLMG[9+XLDF?Y1?)EEA2)S"^_\?E2D9W6YB)]?%H6I0F:QI<T6RB#/Y^)*&).
M3#DDG$NH^$O R ]]Z,:N3S GTG<]$^[J*L#D2.R!9A)JZUIQU5>:B1Q\GRQ
MKG^=_V#&6YT'HYW QH!X8"9KI =K\4$C?[69W-  I#%H=!@8>%'O<<O?O^D
M;$DRW$ H(E+-J7YR\)0J@ZA(Z'S^ D0S/OEZ?.36^)1/J!^>9%9-BGI%SW\$
M5P5(%N6SN?YSG&:/>@]<3Z;T26N4@R(%JW6LFE5ZG'GZ^*A&/"]7NJ\/"7\
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MT=1(P(2(,"(!#"5!B@%8!(D;,QAQ10 H"GTAC(M+O&Y\>C-?R0=* :V+2^P
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M=R=X=H+!N[72I9#3JK3C%WFO.[R53VFFN[M:E.6B](W3NY?ZC^A5_5+?X<J
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MZ4(LI10^"T,?&]TK'&A_:C1SEQ9T#OB&G+KTJ!+4)I/ +HH&]NUIV R^F=\
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MDV*?\EG1YDK*X3?)&TKJ'8G2$GRO"V%:AHSV/9K&-/I68S0\T6X,S%4],+K
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M4Q0[&(<NY!Y#$$L:0B(0AB$G-$)QR#W/J#[N3LM38ZM:.+-YN8M3.T^=I/W
M!%7+U>.4.ZAMVQ9$O;2Q_5 _O=YZ[+8ZRDP\J$PS!0\_T.V<X><LS?.;+(V3
M8N;3&#$A8AA[1)<;03$DQ'-@'!!'1)Y#?6I5-7*C;:OY-T)ZKE(T\%3*9G>(
ML F8V;%!1Q@&GH@5 C?M"%B?"^S1M=>3@,WV1]W[[U'L]6Y_WR-='286\CJ^
MR*10'QF1,2.!YT-?ALJ0=V4$"7;5PL@\PHD7<"G0[%EF+#5WBU@W;_-%;G8R
MX!5]NKB':@U^!*J#TK6)EY+:NCIL0&@V3[O",O!$7>/QL<;CHAV/#IX*NXKW
M[(VPT<'('@>[JNUZ%>QYIN.M7AQ+7ES'EW5M*IUI\WJABXOI_Z^=%)[I7#O>
MWLJ\R!)>2*'_<+X0V[_8>'*&8A1Y/!00<S>"F D/1DZ 8!C'$8YC%LG0RBEJ
M !FG9EU7*NJILBH2IC/WYKKT,]<5_K3K3_D/N5;"\JIQ@)$VHZDW'K^A#S!6
M0]?H5^8/UB.GA3ZK*C1NR'X&UFI5?]2#^_IWEP;C;']#.MQ(]'NW.H"<X][*
M#@?TSGWN@%UU#">4<_77^Y_E0F9TKCHZ%X]J Z@ODO01<GVU-"/49X0Z5*T0
M.J8?$009CQ'$/@D=RGWF,J.R1W;=3HWY:ZG/P'TE=TD&=$MRRP@^,_01"0A&
MOH0DEFJE1G$ 28@"*'TWD"Y&,O(".R.]?_S',=\-1F!U?S_(4)BMHOW#._#"
MN,+UYPU<MX5NKOQ[##.T0JG?\$"SKL<-Z[."8R<<S^[M@8+/CX3\?4BS6";%
M,BM=K)5,25:V8!: [/M$[4D<# F)'8B].(+4BP*(0^01YG)),+&DP;?49WKL
M6JNCS-HT4SL8]=7.QPI5'_3#,23M/\O',/1:8!#(;AK'OH%)%1&S1F6:D>UC
MC/&X@>Z#:C2MN/<Q!L\Z#'X4H>ROQK\L69Z(A&:)S.M[7T]BB7TW@E*Z:IOA
MJ[T&0X) SW=<-W0<'T>QZ?WX;O.3V\QM2&A^4[X'MN/7Y:>!,33=;PC7\\7Y
M8;U/OCW?T_1H5^B'U=J\1V]YJIOQ_<LBDSR]7R3_E&(=5YW/_,A' ?9C*$FD
MPP51 *D0+N2NR[F#F1]Z5D?X!_J9VOQ=Y;\$65T=KDC!<D-V4*PS4%@>!AR"
MVLR0[ ' @>?\IH2;.1UZ/+X^ D*O-M"AOD:U3HXH_-IN./9X5]]]984\IHLR
M>KFT._+K99$7M*R8,Z.!3T(2^=#QD NQ#-1>6L8(!I)+*9P(J^VUG0=_6W=3
M8XS:,;T2&90RGU6[F!QLB&WKS]^*>#MC](_CT!=H)T+8P<??!)D3/?U;NQC9
MW]]$W5VO?Z.WNE+*N1"JQ?Q+H6^KLILL?4Z4,C-E<N"0RP!R%'&(0X9@A)T(
M^IXK!?89#T.C(K['.IHHC=3"JL^_**^0,] (;$L@!_ UI8[341N'-#H UH$N
MVM$XD2@.-#XR1;2KN$L.1Y[O6MX[+[(E+Y:9HACU@\R>%240YL<2<^AY^IJ8
M*'*@/ @@<HF4*!)"4,NZWKN=3(T.MF0$M9"V9;SW8&FVUS@5H8&GOATX'<IU
M']:^YSK=>SH:N4#W855W*W.W/-LA O!#FB\7-\JN>*3UF9>#(LDQQ5!(BB 6
MO@^)YQ#(0B^288PD8YYQ_-].\U.;XJ6 H)(05"):Q+SMHM<^M4_'9.!)O05'
MAR# 74 L0@!/ F:D ,!-@'J*^CNH=FO,W^Y;XT7\'91X*][O\%,=>*H.7?J\
MU U=QQ=SFCSF^EJ&+A*=9CA?9OI2^R*MKE(^T9?/:5'^-(N%^K\2^S (B=K,
MB)# 2 1";6LB[(>2,R3,:_9VEV-JS-<$U"U*5<IPB5(94#S0HLSH6ZGU\N_Z
M/K?6"_!:,?!(7\ B+73QC'P9QPE/]"5QD59/6%#&"2-K0+;CC-? K-P,U>?5
M4%5Z@)4B8*4):%0!2A>@E*E^,<Z 6)#]. /S-F5G'@]/K9-F55_%9T['OG5I
M.J'Y\=:PTS'86NQZ:*[;9KTIF5@EP+NCW\[S7!;Y9UG,9.@'"*GE+B1"6?)!
MA" -HQARSZ'(\T@82ZM\]H>[FMK:MJHC65=?T]>%M!36;O?> J[9'KX?R 9>
M7E9HU4D4]:UA)><94)+VMZ<_CD:O._N6[D;=WQ]7^_4NW^"-DS.JU^F#5JGL
MF%0,$:$8.C&*(*9"'_!Y E+/=27%0KC(*GWHX:ZFQA:U>&"^EM@R06 +K&8\
MT0]8 _/$AI"K>K)#9T _@,90.<]?=_=66<X/J-V2U_S0&Z<G$FA<" ,<"(][
MBA7T-IHXD3X7I!#[$2>$22Z0T;G@X2ZFQ@L?S<+F30$T98)38!F< 381Z=&E
M\+CV@^45&//T[+B:;3D&>G$U_$"3[%<Z7\JKQ=.RR#_*9SGWZB^4,!%'42B@
MXV!]Q^=3R*@", RI)V48R<BQ,@%:^IK<7->R 0] \"6Y7R1JYTW5XO;+(F7Z
MBD7G;0>5$G8TT(:V&1_TA.'0]P9*2E"*>5;C= 8:2/MG"0-,>J6+MOY&Y0T#
MQ5\3B,DK7:N=/"N#(\U>WB<YGZ?Y<C-O/E)$(BB.8>#KA'PN<B$-? D=$?J!
M"'Q7"&)7Z.1P9U/CDD96X^@#(T3-Z*(OG ;FBY688"WG0.4(3!#IN9))2X<C
M%S$YKOIN_1*#=[H11G,X>BN?TJS0:VJ=##2?84F8AZ2$2/\/CCB&3*/+**81
MY<@)I%5M@L-=38TLUG<Z;)DK8R_/05Z+:D<>+>B:44<_F U,'&NXUF(VZ7A[
M#'$XCD6OE-'2W:B$<5SMUW1A\$;'? 3\08KE7&U^*D_'WQ*A3)@XS1[+N[Q;
M9<<LEK(J/:GFZ8+.+Y9YD3ZJ*?ONY29+Q9(79;&WJH9EOE$G202>+N<+'1Y[
M$ ?2A9'TB/I1! 'S4:AV058);X:2=&I4U2BJ9U]6:54G:]$A6NP%2,H?]!^W
MKSF?*A7+K(RVF5L&^PC,*'$20SLPH]9*5(6<&S7 2@\]KHTF54W16A=EKI7D
M.XC1-CCP_0;J#R;MN$'X0X.^$V _>(?V<3'O:X^1NXPN\J020R]M,\_G+J*!
M"YW2C0Q+!Y+05R:J$_HN=SR7(Z,=;5LG4V/\1DZP%K2VN\P#80X"VD[!?<$T
M]-VY/4)6D2_'(.@<]7*PX=$B7HZIMAGM<O39;D;F1FQ=>48V<]5>TPM= 6/*
M(QUPSR'!S-'U>5FH],,,NW9YJ%YW8?/MCI,:JH[XS*N(ST4*GF@&GJNS7-\Y
M<QRGR@NEEO]E\9!F.JSY#*#H3,%36@3JGZ&+FX>2/%]*\=>_H,#YN_YKN@Y7
M/%-F8_XDRPI&<\L2Y#M#96;!G0+_P-2Q'6G;')Z7Z/5G2!W2OU?[9Z>34<V6
M0RJ^MC8./M?1\2[)Z?U])N]+6T7O@$MK15_8717R,9_QR)'$B2@D/M81^32
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M U//11Z-NAZYX*,-'+O%'ZW>/K%XRV]I]L?5XB9+N:P]Y&^E+GDD\QF1$I.
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M]NM0<L5B7,R6A@'1'ICL#P&](7X#-/A=JP!J'7HMB-@)O?[+HEC(,'X-%'N
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MC:)W[35?W]4U7^OG]FJ^-B5?H^UWT>@?U0!$)0*1A6!G;SC.[\3#*7R<W\M
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MBT-> ^?E0I)7M1YF+-T*,5_/5CO9MK^JU?NZM%9,)5=8YT C10T?8P*8B#.
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M$%<ZCP'**0.(\Q1PQ"E@>9YJIICY%Z^H$9=.QT;0&YG+P\=&ZJ@1.SADW&D
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MY1\_L)7:Y'J8$*1AC&(-8DVHV6HG.>":YF9)1A!I062L_#*H#RO_V-;@1F#
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M9FZ%=LYW,3;6W0H9E5)ZT,-I"!V(]6I@>K^7W<<DA#M/@^-!EU>#-!!#.G]
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MS@9=IB^I?+A.7WP^M$K\<WU(<*>K38&Q6!^,P6KM@HF&9O]N;74E4ANTC6-
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MY.7P=@F$8+>WLPT/YOQV2;5=%[B+SW91;^RK&>EZ0R^R%.HTU8#DQL)!G&:
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M,K*X_N006O]?)V%!3SS^_AZ_SA>KB2-"F48)QK  BIL GBL#.C'M@H].IN$
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M)O-#<V &+-^[3E@W*;+VV!M"-1T@;5UU=I6%RS6#LDZ^41*RM('< Z/!:63
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M[(CK:+$(LT]X>J@:I/ ^2P8.0SVL0 XAIPPL&AU-*%F(-G#=G_9Q'<*#8OC
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M:%?O,ZNO+P86<64B1=Z,]EA.+I9!#BX)!B;*4+!8@[K-J>;^M(_;BZJ/W>W
M".@ \U>:JC^O>2N<Y8O[Z,_"\O.[,,T3%UU0262(A8?:83V C\Y 1",-!A-5
M;'.%=A/J.J^!&Q@Q\\;JZP"2%XQ<8:[R,@G>H \R@%&%HM9Z=A@SA;/!%&ZS
MS"'8-B7#]U'4>;5(6^@-HJ8.X+8F_#U^/5FDSR2I=XOYIT7X<G2R^CQ?3/\+
M\VG7%SYQ61EO:\9-8VV!*10$1DO)QB*M%EP6W::+Z88$CIS='A>,+938'S;S
M\Y/%=/;I="SJ:3.7";G8*G.E(;$Z&<HJ!,<M.3XF.V>**1$;W3K[(6TCYTNZ
M0N2^JNL<C'\-QR<XD4[4 ;P(*=0I*-7E\&@8: H"F=66)]OFOMD/21LYN.D7
MBMLKKC\DGEG[]UC3&+6KU879O_S,^0;@-9,.O0?AB$DEM*SE:!I\Y@71.5;T
M0<SE%C2/V[^W+^RV4G4/H-Y5T-<[Q5]*9.+J5-O:@\1;SBGN0T<"< C2"\M,
MLERUZLDQ-"OCMF0=>PF,"HRGL#*.<I[6/PG'MT0AB7':^BP8IQ/Y8-I"4(;^
MF0M+D:(!GQJY+.V8VFBUN'^NEJ9@><SK9OWE['K:J9O()\)YZ7D18+,3H'@0
M$&@[A7I50RGF93%M&K8-R<5&*\/_<V4,"X>QSW=W9OSB-N;9/<RW,YQD4[Q+
MQD#PSM69W!J<UO6@20O.,FHO;CA5]YP)#TG59F<@[(D!>USE/AE4?_Q]/O'D
M_JE:C.Y530!D92'2#T"*+#E2_)\S.RRJB:K-4/W4CO;&5>[3037!%">IH&21
M)1 H)2ATY+&A%N3 U>:%7B&/Y<"XKG1MANRG=G(XMH([<,F/CM>?P7RW&%[\
M4;_%B12T0',=LJ>C!L7H2U3%03981T1JY4V;S,UF]&T&WZ=ZUMA AQT@\Z+Y
M"2Z^31/>S=N;^>P;Q0%X&A(L/\Y/AYY>_/[9?+EZ,U_]'UR]QS3_-*M1\]66
M)Q.7D8E2NT_H3$()BAPLQC1PX5 [H;71;4;:'H2]S=;%4SWQ[ ]!'2RK/;:[
M-;]7AK6<)J@F,4COLB60&V= :3(IP9D"+&AKO/9:2MMD"0W.RF;+Y<F>RHZ*
MC*>U-%[-5@MR":?I]#C;R^!-B@)\UHH"'EG &_(,A=+9YZQXT&U&W31C:;.E
M\F0/@;M 2@]+INZ$KY;+D[OJB:YNDR_^P$6:DC0FOD[KH4T1?!$>E(T1 A-U
MD'?RU@J!+C7:+K:F=3.0/]ECWK:Z[0&].]_LN,'Y\M7L5#@WAMV=__[=@OS/
M"?/:BE3TV8UYY^HI=RH@,3A1%,LR-RKU.2B?FZV:?]CCWO$P]1A6W+;"6<=K
M-_=0$1GZ+ "=X;2'DF"B]P%DG92=5:&P;*1U-@!WFZVN?QX9'P@_':RIC=(<
M'\,?O^ ,RW15I[^>B^%MN9;*4!R9SBQ $IRV;X7UM)%\45<P*J:$9R6-EPS;
MA(7-+D ]M7/G<9'0P1)8<QI_+/=XCUFX2 )>KU"<R"2L0F6!B]I93Y7:XRAZ
M<%YP)/F0<-HLB$8,;;8\GMH!=D\H&?LX^[Q5+?%SN@&^G"]JC%=[V5XPY")7
M25+PQNO"5]P)B/7@R J7F& .3=RL5_ F;]L,DT_RZ'EP98R-KIV%>3IJ[=6,
MY'&R#I+>KC[CXN/G,+NY]CZ<Q/^+:?5Q?DMX9TEGEIWP/&B(*!6HX@)$41PX
M[ECD6#L^;]8CI0-F-EL;3^U<NQ?I;P6E7KR@)B+["SUB=1$S363VCNN"X&PB
MDY2DKFV9,MB2C(]%QW*SE_S8 ?:6'&ZV[I[JN7F7.'K,Z^M.[F^D]=:_?!Y6
M^#),%Z=Y"!N$T((D4VPH=6Y JA,$#/D 62.BKL-(^UIFNS&ZV6K[Y['[X5'5
MA3_Y4,06[XG8+M@](G?ZRZF@GD^7J5[$+?/%ZY#^/B^_AL7?<17B])BLUL2Q
M0!ZUM9!D5K6+OJ/-WA5P43(G8LG6;>$W'H;HS5;.4SN%[QH:/>Q3#QW<WIA5
MLQ;)7Q;S)06:I394C+3])N7(,#@/+H0,D<5"02;+[.8".,3!_+WT;H;]?\C#
M^6%TW &2FU5P7J1;SGY4/\<G.HG@$S> M$.>EB_$: 4DCXQCM,;R-G'-8?G<
M;.4\U0/ZCC'UE%?<Y9-._^AF:#A),F0IR1MU*9.@1'00F$Q@LPY29T^J;M/]
M>C26-UN'3_4H_W$@K8L(J$DNYFP41QT*]7E^7$M1WR/]S>*T2&F"+F?&<H1L
M2QWO(AE$XY T70J2S%2^V6+WX&GTASG8K/WD4RL%>#R@>;0K:_WER@C0LV2F
M]\Q'%248P3*HJ!EXRP)XE;U@6 R[V8]DZ 5S-V&;K8.G=N8_NHH'@_>__GQ+
M<22:OZ]_M?Y-_:OW6'ZJ__WM_:N+YY,(3NB/EB=UV-\,_YSF7T[?\"Q\G=(^
M^I'$L SK4Z^KY=Q'])-O=2H@KL+T>'F=G^64=FW\$8RW>\'/EZS<9/+L/=<
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M$*"3MR)('HI_;/'A=0X[*,']1U^/>T#NB2_&F\X\E\9G5PQP8VJ?%4>B,4E
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M2RVY,AM.$-B'C)$SN4/B]< Z&0Q]ATA)[-%U^/Z'M4M*M.PN?"_F5$K,R%*
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MXV(>!HD7)ICN&J4!&L9@XM1 .*-A%O75 S'PR3*D9$E+[\!DTF[*<T9&%8O
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M_%%7LU[P>7&2F"4M2.5I5WLMP#GD8*)56B6>$-OTQ'E&2B?'_^EAL1A31AV
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MVF*)#8^P,3G<_GIA^X/Z5PPK_/=_^7]02P,$%     @ B8FE5&:6 69$"
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MT/D'T6+F6^KS4$B1>1'?\ZA("'U"FK"4G=^8QC%#=]K8&V;N+Z#*+)/. 3S
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M2>V,[*\1W?WIZCS701P[8F0V/IL.56GOMV =_L%GTD"E@OCA0AD+IT4(Y[7
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M^\JJ>V_+ZV=U=U_^BG#T-U!+ P04    " ")B:54H1C3X 8%  "_&   %0
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M81)Q%L(A3TD:<!+#/ S10I: ?$R5.89-Z@CJ4>MHM $M% _Q)2MD7A"<>B7
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M     &YA='(M,C R,C S,S$N:'1M4$L! A0#%     @ B8FE5%,\U9_%#0
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M,#(R,#,S,5]G,2YJ<&=02P$"% ,4    " ")B:54J=1B_06\   !QP< %0
M            @ $+3@, ;F%T<BTR,#(R,#,S,5]L86(N>&UL4$L! A0#%
M  @ B8FE5(NIR,:T90  D9D$ !4              ( !0PH$ &YA='(M,C R
M,C S,S%?<')E+GAM;%!+ 0(4 Q0    ( (F)I51FE@%F1 @  #\W   5
M          "  2IP! !N871R,C R,C,S,2UE>#,Q,2YH=&U02P$"% ,4
M" ")B:54Z^D<]4H(  !"-P  %0              @ &A> 0 ;F%T<C(P,C(S
M,S$M97@S,3(N:'1M4$L! A0#%     @ B8FE5#_V9LWX!   H!@  !4
M         ( !'H$$ &YA='(R,#(R,S,Q+65X,S(Q+FAT;5!+ 0(4 Q0    (
M (F)I52A&-/@!@4  +\8   5              "  4F&! !N871R,C R,C,S
A,2UE>#,R,BYH=&U02P4&      L "P#8 @  @HL$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
